<?xml version="1.0" encoding="UTF-8"?>
<projectSnippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC6518571\results\search\tropicalVirus\results.xml">
   <result pre="Kraemer et al. [1] Preprint publication date Peer-reviewed publication date" exact="Zika" post="virus outbreak in the Americas (2014â€&quot;2017) Geographic origin NA"/>
   <result pre="multiple data types 2 September 2016 doi:10.1101/071779 12 April 2017" exact="Yellow fever" post="outbreak in Central Africa (2015â€&quot;2016) Geographic origin NA 20"/>
   <result pre="Epidemiology and Infection147, e34. 2.collab: Wellcome Trust. Sharing data during" exact="Zika" post="and other global health emergencies; 10 February 2016. Available"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC6688121\results\search\tropicalVirus\results.xml">
   <result pre="well-established epidemics of e.g., Human Immunodeficiency Virus Type 1 (HIV-1)," exact="Dengue" post="virus (DENV) or Hepatitis C virus (HCV), and as"/>
   <result pre="virus (HCV), and as emerging or re-emerging epidemics of e.g.," exact="Zika" post="virus (ZIKV), Middle East Respiratory Syndrome Coronavirus (MERS-CoV), Measles"/>
   <result pre="to SpreaD3 (40). Shown here is the current situation for" exact="Zika" post="virus evolution, based on analyses of 506 genomes sampled"/>
   <result pre="(48) visualization of a phylogenetic tree constructed from publicly available" exact="Zika" post="virus (ZIKV) genomes. ggtree allows similar advanced customized visualization"/>
   <result pre="visualization of the ancestral reconstruction of state locations of the" exact="ZIKV" post="dataset used in Figure 6. The top-down visualization corresponds"/>
   <result pre="data alongside visualization for a number of pathogens such as" exact="West Nile" post="virus, Ebola virus, and Zika virus. For the latter"/>
   <result pre="of pathogens such as West Nile virus, Ebola virus, and" exact="Zika" post="virus. For the latter virus, we provide the currently"/>
   <result pre="showing a color-coded time-scaled maximum-likelihood tree alongside an animation of" exact="Zika" post="geographic transmissions over time as well as the genetic"/>
   <result pre="can span from hundreds of years [e.g., HCV (103) and" exact="DENV" post="(104)] to decades [e.g., HIV-1 (3)]. RNA viruses are"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC6711314\results\search\tropicalVirus\results.xml">
   <result pre="humans [15,16] Canine parvovirus (CPV) carnivore to dog pandemic [17]" exact="Zika" post="virus primate to human, adaptation to mosquito vector and"/>
   <result pre="RodriguezM, BissetJA, LourenÃ§o-de-OliveiraR, WeaverSC, VasilakisN, Vega-RÃºaA2019Vector-borne transmission and evolution of" exact="Zika" post="virus. Nat. Ecol. Evol.3, 561â€&quot;569. (10.1038/s41559-019-0836-z)30886369 19HumphreysM2018The influenza of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC6721507\results\search\tropicalVirus\results.xml">
   <result pre="doi: 10.1155/2019/9782892 : Case Report A Rare Presentation of Coinfection:" exact="Dengue" post="Virus and Hepatitis A Virus https://orcid.org/0000-0002-2188-5309RanathungaI.ish_75@yahoo.com1KannangaraL. S.2BandaraK. A. S1GunatilakeS."/>
   <result pre="any medium, provided the original work is properly cited. Abstract" exact="Dengue" post="fever caused by dengue virus is a common tropical"/>
   <result pre="with dengue virus and hepatitis A virus coinfection. 1. Introduction" exact="Dengue" post="fever (DF) is a common arthropod-borne tropical infection. It"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC6722215\results\search\tropicalVirus\results.xml">
   <result pre="al.. (2018). NS1 codon usage adaptation to humans in pandemic" exact="Zika" post="virus. Mem. Inst. Oswaldo Cruz113:e170385. 10.1590/0074-0276017038529768530 FuruseY.SuzukiA.OshitaniH. (2010). Origin"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC6728053\results\search\tropicalVirus\results.xml">
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Medicine and Health Sciences : Infectious Diseases"/>
   <result pre="dengue epidemics in coastal Mombasa compared to Kisumu. Author summary" exact="Dengue" post="is a viral disease of global public health significance"/>
   <result pre="deposited in GenBank under accession numbers MH410177 â€&quot; MH410212 Introduction" exact="Dengue" post="virus (DENV) is a global public health threat with"/>
   <result pre="with epidemics mostly reported in urban and semi-urban areas [1,2]." exact="Dengue" post="virus consists of four related serotypes (DENV-1-4), belonging to"/>
   <result pre="with DENV-2 responsible for the highest number of epidemics [4,5]." exact="Dengue" post="epidemics have been linked to urbanization, globalization, climate change,"/>
   <result pre="extrinsic incubation period (EIP), and vector competence that can affect" exact="DENV" post="transmission [10â€&quot;17]. Whilst determination of individual factors is valuable,"/>
   <result pre="may be critical to fully understanding the complex interrelationships influencing" exact="DENV" post="transmission risk. Studies investigating the various dengue risk factors"/>
   <result pre="cities. Previous entomological studies in Kenya have examined risk of" exact="DENV" post="transmission by studying vector density/abundance and vector competence data"/>
   <result pre="unexplained. In this study, different risk parameters related to the" exact="DENV" post="vector in the three major cities of Kenya; Mombasa,"/>
   <result pre="used in the vector competence study for all three cities." exact="Dengue" post="virus strain and assay The DENV-2 strain used in"/>
   <result pre="in Aedes aegypti populations To determine possible genetic differences between" exact="DENV" post="susceptible and non-susceptible Ae. aegypti mosquito populations from the"/>
   <result pre="However, there are currently no suitable animal models to estimate" exact="DENV" post="transmission [33]. Because the methods of virus exposure and"/>
   <result pre="the most prevalent serotype, and further studies on the other" exact="DENV" post="serotypes (DENV-1 and -3) circulating in Kenya [18,34,35] are"/>
   <result pre="significantly reduce vector density/human-vector contact, consequently lowering the risk of" exact="DENV" post="transmission by Ae. aegypti mosquitoes in an area [37]."/>
   <result pre="interpreted individually, may not sufficiently inform risk of transmission of" exact="DENV" post="and must therefore be evaluated collectively. Although the risk"/>
   <result pre="and must therefore be evaluated collectively. Although the risk of" exact="DENV" post="transmission is high in Mombasa, and low in Kisumu"/>
   <result pre="Mombasa, and low in Kisumu and Nairobi, continued monitoring of" exact="DENV" post="transmission risk and vector surveillance, as well as monitoring"/>
   <result pre="consensus. PLoS Negl Trop Dis. 2012;6(8):e176010.1371/journal.pntd.000176022880140 2collab: World Health Organisation." exact="Dengue" post="and severe dengue. 2018 Available from http://www.who.int/mediacentre/factsheets/fs117/en/ Cited 23"/>
   <result pre="2015 Nov 24];33(4):330â€&quot;42. Available from: http://www.sciencedirect.com/science/article/pii/S018844090200378812234522 4AmarasingheA, KuritskJN, LetsonGW, MargolisHS." exact="Dengue" post="virus infection in Africa. Emerg Infect Dis. 2011;17(8):1349â€&quot;54. 10.3201/eid1708.10151521801609"/>
   <result pre="infection in Africa. Emerg Infect Dis. 2011;17(8):1349â€&quot;54. 10.3201/eid1708.10151521801609 5Sang RC." exact="Dengue" post="in Africa. In:Report of the scientific working group meeting"/>
   <result pre="indices. PLoS Negl Trop Dis. 2017;11(8):e000585810.1371/journal.pntd.000585828817563 11AghaSB, TchouassiDP, BastosADS, SangR." exact="Dengue" post="and yellow fever virus vectors: seasonal abundance, diversity and"/>
   <result pre="and the influence of temperature. Parasit Vectors. 2014;7(1):1â€&quot;8.24411014 13EbiKL, NealonJ." exact="Dengue" post="in a changing climate. Environ Res. 2016;151:115â€&quot;23. 10.1016/j.envres.2016.07.02627475051 14KramerLD,"/>
   <result pre="computing; 2012 2015. Available from: https://www.r-project.org/. 30AkhterR, HayesCG, BaqarS, ReisenWK." exact="West Nile" post="virus in Pakistan. III. Comparative vector capability of Culex"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC6735916\results\search\tropicalVirus\results.xml">
   <result pre="Abstract The rapid spread and severity of pathogens, such as" exact="Zika" post="(ZIKV) and Chikungunya (CHIKV) viruses in the Americas, demonstrate"/>
   <result pre="spread and severity of pathogens, such as Zika (ZIKV) and" exact="Chikungunya" post="(CHIKV) viruses in the Americas, demonstrate the need for"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC6742212\results\search\tropicalVirus\results.xml">
   <result pre="and Health Sciences : Tropical Diseases : Neglected Tropical Diseases:" exact="Chikungunya" post="Infection : Medicine and Health Sciences : Infectious Diseases"/>
   <result pre="Medicine and Health Sciences : Infectious Diseases : Viral Diseases:" exact="Chikungunya" post="Infection : Biology and life sciences : Organisms :"/>
   <result pre="Organisms : Viruses : RNA viruses : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Microbial Pathogens : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Organisms : Viruses : Viral Pathogens : Togaviruses : Alphaviruses:" exact="Chikungunya" post="Virus : People and places : Geographical locations :"/>
   <result pre="to publish, or preparation of the manuscript. fig-count: table-count: page-count:" exact="Chikungunya" post="is caused by an arbovirus RNA of the genus"/>
   <result pre="the genus alphavirus (CHIKV) of Togaviridae family [1]. Symptomatic acute" exact="CHIKV" post="infection is mainly characterized by high fever and severe"/>
   <result pre="American and Caribbean preparedness and response to the introduction of" exact="CHIKV" post="was precarious; as of 2017, only Canada, Cuba, and"/>
   <result pre="and Brazil (after 2016), the countries that recorded the largest" exact="CHIKV" post="epidemics, along with the Dominican Republic. Nonetheless, if a"/>
   <result pre="considered, more than 35,000 deaths caused primarily or secondarily by" exact="CHIKV" post="infection may have occurred in the Americas and the"/>
   <result pre="On the one hand, chikungunya deaths caused primarily by acute" exact="CHIKV" post="infection with direct impairment of organs (hepatitis, meningoencephalitis, myocarditis/pericarditis,"/>
   <result pre="death in order to try to establish an association between" exact="CHIKV" post="infection and the recorded cause of death of each"/>
   <result pre="diagnosis substantially reduced the underreporting of deaths due to dengue," exact="Zika" post="virus, and chikungunya in Fortaleza [17]. Unfortunately, very few"/>
   <result pre="for further studies to establish a definite causal link between" exact="CHIKV" post="and mortality, current evidence suggest that chikungunya may be"/>
   <result pre="disease, chikungunya does not always have a self-limited clinical course." exact="CHIKV" post="infection and its complications can be the underlying cause"/>
   <result pre="mitigate mortality, particularly among elderly patients with specific comorbidities. Currently," exact="CHIKV" post="transmission in the Americas is very low. Yet it"/>
   <result pre="will be foretold. Time will tell. References References 1WeaverSC, LecuitM." exact="Chikungunya" post="Virus and the Global Spread of a Mosquito-Borne Disease."/>
   <result pre="New England Journal of Medicine. 2015;372(13):1231â€&quot;9. 10.1056/NEJMra1406035 .25806915 2CunhaRVD, TrintaKS." exact="Chikungunya" post="virus: clinical aspects and treatmentâ€&quot;A Review. Memorias do Instituto"/>
   <result pre="10.1016/S1473-3099(07)70294-3 .18156079 5EconomopoulouA, DominguezM, HelynckB, SissokoD, WichmannO, QuenelP, et al.Atypical" exact="Chikungunya" post="virus infections: clinical manifestations, mortality and risk factors for"/>
   <result pre="2007/11/06. .17978079 7SissokoD, MalvyD, EzzedineK, RenaultP, MoscettiF, LedransM, et al.Post-epidemic" exact="Chikungunya" post="disease on Reunion Island: course of rheumatic manifestations and"/>
   <result pre="diseases. 2008;14(3):412â€&quot;5. Epub 2008/03/08. 10.3201/eid1403.07072018325255 9BeesoonS, FunkhouserE, KoteaN, SpielmanA, RobichRM." exact="Chikungunya" post="fever, Mauritius, 2006. Emerging infectious diseases. 2008;14(2):337â€&quot;8. Epub 2008/02/09."/>
   <result pre=".30085307 13FreitasARR, CavalcantiL, Von ZubenAP, DonalisioMR. Excess Mortality Related to" exact="Chikungunya" post="Epidemics in the Context of Co-circulation of Other Arboviruses"/>
   <result pre="CheahWK. A Two-Year Review on Epidemiology and Clinical Characteristics of" exact="Dengue" post="Deaths in Malaysia, 2013â€&quot;2014. PLoS Negl Trop Dis. 2016;10(5):e0004575"/>
   <result pre="BragaDN, da SilvaLM, AguiarMG, CastiglioniM, Silva-JuniorJU, et al.Postmortem Diagnosis of" exact="Dengue" post="as an Epidemiological Surveillance Tool. The American journal of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC6745427\results\search\tropicalVirus\results.xml">
   <result pre="Gulf countries are still free from the threat of a" exact="Zika" post="virus epidemic. This article provides a vision of integrated"/>
   <result pre="sites, dengue, and other arboviral infections. Keywords: Mosquito Vectors Aedes" exact="Zika" post="Virus Arboviruses Dengue Information Dissemination Saudi Arabia Introduction With"/>
   <result pre="other arboviral infections. Keywords: Mosquito Vectors Aedes Zika Virus Arboviruses" exact="Dengue" post="Information Dissemination Saudi Arabia Introduction With people in Saudi"/>
   <result pre="threat of sudden outspread of mosquito vectors of dengue and" exact="Zika" post="virus.1 A total of 2926 confirmed cases of dengue"/>
   <result pre="feed indoors and outdoors, which increases transmission in Saudi Arabia.1-3" exact="Dengue" post="is closely related to other mosquito-borne flaviviruses within the"/>
   <result pre="flaviviruses within the Flaviviridae family such as Zika, yellow fever," exact="West Nile," post="and Japanese encephalitis.1,3-5 In 2006, a total of 10"/>
   <result pre="million at risk in 2016 in more than 130 countries." exact="Zika" post="virus causal factor infection is associated with congenital malformations"/>
   <result pre="other emerging arboviral asymptomatic carriers, antigenic diversity and phylogenetic of" exact="DENV" post="1-4 and other arboviral diseases in Saudi Arabia, Yemen,"/>
   <result pre="the GCC announced that all Gulf countries are free from" exact="Zika" post="virus, innovative preventive and control methods are encouraged.11 A"/>
   <result pre="tailored cost-effective community-based programs. Importantly, safe and effective dengue and" exact="Zika" post="drugs and vaccines discovery for pilgrims/traveler immunization programs should"/>
   <result pre="of mosquito vectors: past, present, and future.Insects2016 Oct;7(4):E52. 10.3390/insects704005227706105 2WHO." exact="Dengue" post="control. Biological control. 2016 [cited 2016 October 24]. Available"/>
   <result pre="2016 October 24]. Available from: http://www.who.int/denguecontrol/control_strategies/biological_control/en/. 3PetersenLRHayesEBWestward ho?Æ’??The spread of" exact="West Nile" post="virus.N Engl J Med2004 Nov;351(22):2257-2259. 10.1056/NEJMp04826115564540 4TamboEChuisseuPDNgogangJYKhaterEIDeciphering emerging Zika"/>
   <result pre="West Nile virus.N Engl J Med2004 Nov;351(22):2257-2259. 10.1056/NEJMp04826115564540 4TamboEChuisseuPDNgogangJYKhaterEIDeciphering emerging" exact="Zika" post="and dengue viral epidemics: Implications for global maternal-child health"/>
   <result pre="of colloidal silver nanoparticles using Hugonia mystax: larvicidal potential against" exact="Zika" post="virus, dengue, and malaria vector mosquitoes.Artif Cells Nanomed Biotechnol2017"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC6779206\results\search\tropicalVirus\results.xml">
   <result pre="virus from patients and sequenced its genome. The sequences of" exact="DENV" post="isolated from Guangdong and other countries screened since 2005"/>
   <result pre="number of indigenous cases significantly exceeded that of imported cases." exact="Dengue" post="virus 1 is the most important serotype and caused"/>
   <result pre="evolution since 2005 among the four lineages was present. The" exact="DENV" post="isolated from Guangdong was closely related to those causing"/>
   <result pre="of sufficient epidemiological data and evidence on the local mosquito-borne" exact="DENV" post="emphasizes the importance of studying the molecular evolutionary features"/>
   <result pre="tree for dengue prevention and control in Guangdong. page-count: INTRODUCTION" exact="Dengue" post="virus (DENV), a mosquito-borne flavivirus, is transmitted primarily by"/>
   <result pre="with the highest morbidity and great harm.5 The genome of" exact="DENV" post="is a single-stranded, positive-sense RNA, and its single open"/>
   <result pre="and NS5, are also present in its structure.9 Four distinct" exact="DENV" post="serotypes (DENV1, DENV2, DENV3, and DENV4) have been identified,"/>
   <result pre="III (Malaysia), genotype IV (South Pacific), and genotype V (America/Africa).10" exact="Dengue" post="genotypes are phylogenetically distinct clusters of viruses, often associated"/>
   <result pre="biological sequences.13 Alignment of the nucleic acid sequences of the" exact="DENV" post="followed by its phylogenetic analysis and subsequent generation of"/>
   <result pre="epidemiology of the disease worldwide.14â€&quot;16 The E protein of the" exact="DENV" post="is responsible for its tropism and virulence.17 The gene"/>
   <result pre="analysis of the coding region can help assign the correct" exact="DENV" post="genotype and infer the relationships within genotypes and lineages"/>
   <result pre="of dengue have occurred in the past 30 years.22 The" exact="DENV" post="found in these areas may have different origins. There"/>
   <result pre="over the previous 10 years. Although three serotypes of the" exact="DENV" post="(DENV1, DENV2, and DENV3) were identified, DENV1 was found"/>
   <result pre="laboratory diagnosis and clinical signs. Sample collection and epidemiological data." exact="Dengue" post="virus RNA samples (n = 29) were obtained from"/>
   <result pre="by the Health Care Center of Guangdong International Travel. Twenty-five" exact="DENV" post="strains were isolated by the Guangdong CDC on C6/36"/>
   <result pre="each city), the distribution of imported cases and indigenous cases," exact="DENV" post="serotype data confirmed by laboratory, and other information. We"/>
   <result pre="(TaKaRa Bio, Shiga, Japan) was used for the transcription of" exact="DENV" post="RNA. Type-specific primers (Table 1) were used to confirm"/>
   <result pre="with up to four serotypes emerging in recent years. Each" exact="DENV" post="serotype was identified. Dengue virus 1 was the major"/>
   <result pre="serotypes emerging in recent years. Each DENV serotype was identified." exact="Dengue" post="virus 1 was the major cause of the outbreak"/>
   <result pre="and Shanwei were included in the collection areas (Figure 1E)." exact="Dengue" post="virus 1 was the major causative agent of this"/>
   <result pre="between Lineages II and III. Interestingly, concerning the recent severe" exact="DENV" post="epidemic, since 2006 or 2007 (the previous circulation), Lineages"/>
   <result pre="to clarify the relationship between Guangdong and other countries concerning" exact="DENV" post="outbreaks. For this, we illustrated the origin of molecular"/>
   <result pre="DENV1 in Guangdong was determined from its long-term epidemic history." exact="Dengue" post="virus 1 was first detected in Zhongshan, Guangdong Province."/>
   <result pre="the leading serotype, which triggered massive outbreaks in Guangzhou.33 Thereafter," exact="DENV" post="was circulated continuously across multiple geographies in Guangdong, and"/>
   <result pre="present, imported and local cases are equally responsible for the" exact="DENV" post="outbreaks, which have occurred with a complex pattern wherein"/>
   <result pre="only city in Guangdong Province in which no cases of" exact="DENV" post="were detected since 2005, indicating the criticality of the"/>
   <result pre="since 2005, indicating the criticality of the occurrence of the" exact="DENV" post="epidemic in this region.36,37 Analyses of the epidemiological trends"/>
   <result pre="Analyses of the epidemiological trends suggest that the severity of" exact="DENV" post="outbreaks has increased since 2012. The rising number of"/>
   <result pre="outbreak in 2014, which marked the top of the periodical" exact="DENV" post="infections and transmission. With an increase in the number"/>
   <result pre="dominant in recent years.38â€&quot;40 Previous studies indicated that although three" exact="DENV" post="serotypes (DENV1, DENV2, and DENV3) were identified, DENV1 was"/>
   <result pre="However, several lineages from different origins were responsible for the" exact="DENV" post="outbreak in 2014. Moreover, strains belonging to genotype V"/>
   <result pre="et al. used the term â€œin situ evolutionâ€� to characterize" exact="DENV" post="in Singapore through phylogenetic analysis. Results of the analysis"/>
   <result pre="the correlation between its genetic and evolutionary aspects, suggesting that" exact="DENV" post="had lurked locally and reappeared after some time.46 Rajarethinam"/>
   <result pre="Guangdong since 2005. Another possible transmission and evolution pattern of" exact="DENV" post="broke out in parts (switch of the lineage), followed"/>
   <result pre="2007 to 2012, it was observed that the prevalence of" exact="DENV" post="was low and it frequently interchanged between the three"/>
   <result pre="Guangdong. Castonguay-Vanier et al.57 also described the active circulation of" exact="DENV" post="in Laos and the concurrent multiple introductions of new"/>
   <result pre="evidence on the local mosquito vector regarding its harboring of" exact="DENV" post="during epidemic and nonepidemic periods which can support the"/>
   <result pre="et al.64 regarding the epidemiological characteristics and genetic diversity of" exact="DENV" post="in Guangdong in 2014. Nevertheless, since 2012, with an"/>
   <result pre="Nevertheless, since 2012, with an extremely high incidence of cases," exact="DENV" post="spread more rapidly and affected a wider range of"/>
   <result pre="pH, the specific interaction between DI and DIII of the" exact="DENV" post="E protein is destroyed, resulting in its conformational change"/>
   <result pre="III has an immunoglobulin-like structure and a functional region where" exact="DENV" post="binds to a cellular receptor. Drumond et al.70 predicted"/>
   <result pre="certainty. However, it is highly recommended that we detect the" exact="DENV" post="in local mosquito vectors urgently. At the same time,"/>
   <result pre="Center for Disease Control and Prevention for providing with 25" exact="DENV" post="strains and their epidemiological data. This study was partly"/>
   <result pre="2007Epidemic situation of dengue fever in Guangdong province, China, 1990â€&quot;2005." exact="Dengue" post="Bull31: 1â€&quot;9. 23.WuWet al.2011Molecular epidemiology of dengue viruses in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC6805005\results\search\tropicalVirus\results.xml">
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Zika" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Research and Analysis Methods : Research Assessment:"/>
   <result pre=": Research Assessment: Reproducibility A systematic review and evaluation of" exact="Zika" post="virus forecasting and prediction research during a public health"/>
   <result pre="emergency of international concern A systematic review and evaluation of" exact="Zika" post="virus forecasting and prediction research http://orcid.org/0000-0002-0821-2046KobresPei-YingConceptualizationFormal analysisResourcesValidationWriting â€&quot; original"/>
   <result pre="epidemics. While numerous predictive studies were published during the 2016â€&quot;2017" exact="Zika" post="Virus (ZIKV) pandemic, it remains unknown how timely, reproducible,"/>
   <result pre="infectious disease outbreaks, we conducted a systematic review of all" exact="ZIKV" post="prediction studies published during the recent ZIKV pandemic using"/>
   <result pre="review of all ZIKV prediction studies published during the recent" exact="ZIKV" post="pandemic using the PRISMA guidelines. Using MEDLINE, EMBASE, and"/>
   <result pre="predicted, or simulated ecological or epidemiological phenomena related to the" exact="Zika" post="pandemic that were published as of March 01, 2017."/>
   <result pre="Americas. While the use of preprints improved the accessibility of" exact="ZIKV" post="predictions by a median of 119 days sooner than"/>
   <result pre="they were used in only 30% of studies. Conclusions Many" exact="ZIKV" post="predictions were published during the 2016â€&quot;2017 pandemic. The accessibility,"/>
   <result pre="studies which sought to predict and forecast important features of" exact="Zika" post="virus (ZIKV) infections and their spread during the 2016â€&quot;2017"/>
   <result pre="Zika virus (ZIKV) infections and their spread during the 2016â€&quot;2017" exact="ZIKV" post="pandemic. We conducted a comprehensive review of such ZIKV"/>
   <result pre="2016â€&quot;2017 ZIKV pandemic. We conducted a comprehensive review of such" exact="ZIKV" post="prediction studies and evaluated their aims, the data sources"/>
   <result pre="findings before formal journal publication (â€˜pre-printsâ€™) increased the timeliness of" exact="Zika" post="prediction studies, but note they were infrequently used during"/>
   <result pre="health emergency. Addressing these areas can improve our understanding of" exact="Zika" post="and other outbreaks and ensure forecasts can inform preparedness"/>
   <result pre="is available within the manuscript and supporting information files. Introduction" exact="Zika" post="virus (ZIKV) is a positive-sense RNA flavivirus primarily transmitted"/>
   <result pre="through the Aedes aegypti mosquito [1â€&quot;3]. While the majority of" exact="ZIKV" post="infections are asymptomatic or present as a self-limiting febrile"/>
   <result pre="or present as a self-limiting febrile illness, strong evidence links" exact="ZIKV" post="infection with microcephaly and a range of other birth"/>
   <result pre="other birth defects, including limb deformity and retinopathy [4, 5]." exact="ZIKV" post="is also associated with Guillian-BarrÃ© syndrome, and a spectrum"/>
   <result pre="of other neurological disorders including meningoencephalitis and acute myelitis [6â€&quot;9]." exact="ZIKV" post="was discovered in Uganda in a febrile non-human primate"/>
   <result pre="first human case was detected in Nigeria in 1953 [11]." exact="ZIKV" post="outbreaks were detected in Southeast Asia and the Pacific"/>
   <result pre="with a cumulative count of 583,144 suspected and 223,336 laboratory-confirmed" exact="Zika" post="cases reported across 49 countries and territories by the"/>
   <result pre="18]. The Director-General of the World Health Organization declared the" exact="ZIKV" post="pandemic a public health emergency of international concern (PHEIC)"/>
   <result pre="2016 [20]. As public health and medical research efforts for" exact="Zika" post="increased across the Americas, scientists developed mathematical models to"/>
   <result pre="PHEIC status was lifted in November 2016 and the neotropical" exact="Zika" post="pandemic has waned, the forecasting activities during the pandemic"/>
   <result pre="in a manner and time-frame that was actionable during the" exact="Zika" post="pandemic [27]. Such an exercise is critical, not only"/>
   <result pre="is critical, not only due to the ongoing risk of" exact="Zika" post="globally [28], but also to inform modeling efforts for"/>
   <result pre="We therefore undertook a systematic review to identify all published" exact="ZIKV" post="prediction and forecasting studies during a time period which"/>
   <result pre="forecasted, or simulated any ecological or epidemiological phenomenon about the" exact="Zika" post="pandemic and describe the predicted phenomena, the range of"/>
   <result pre="potentially eligible studies, which predicted or forecasted phenomena of the" exact="ZIKV" post="pandemic. In MEDLINE we performed a highly sensitive search"/>
   <result pre="search results with â€˜grey literature,â€™ including hand-searched bibliographies of major" exact="Zika" post="epidemiological review articles [17, 30, 31] and contacting experts"/>
   <result pre="[17, 30, 31] and contacting experts in the field of" exact="Zika" post="modeling to identify any studies which may have been"/>
   <result pre="predicted, or simulated any epidemiological or ecological phenomena about the" exact="Zika" post="pandemic (including studies regarding previous outbreaks and epidemics, and"/>
   <result pre="by geographic information systems) Models which only examined causality of" exact="ZIKV" post="in Guillain-BarrÃ© Syndrome (GBS) or microcephaly (rather than estimating"/>
   <result pre="aim of the study was to explicitly forecast or predict" exact="ZIKV" post="phenomena based on the known dynamics of other arboviruses"/>
   <result pre="late in the epidemic, well after the peaks in reported" exact="Zika" post="cases (Fig 2, Fig 3). Submitting manuscripts to preprint"/>
   <result pre="by Mann-Whitney U test). Fig 2 Comparative trends of reported" exact="Zika" post="cases in Latin American and publication times of Zika"/>
   <result pre="reported Zika cases in Latin American and publication times of" exact="Zika" post="prediction studies. Zika case counts were obtained from https://andersen-lab.com/"/>
   <result pre="in Latin American and publication times of Zika prediction studies." exact="Zika" post="case counts were obtained from https://andersen-lab.com/ with permission. Fig"/>
   <result pre="with permission. Fig 3 Comparative trends in publication times of" exact="ZIKV" post="prediction studies with and without the use of preprints."/>
   <result pre="[100â€&quot;105]. To date, public health â€˜lessons-learnedâ€™ activities related to the" exact="Zika" post="PHEIC have focused on improved ethics preparedness for rapid"/>
   <result pre="In contrast to existing reviews on models developed during the" exact="ZIKV" post="pandemic, which described specific contributions of modeling [113] or"/>
   <result pre="of uncertainty. Our systematic review identified a large number of" exact="Zika" post="models that predicted a wide range of epidemiological and"/>
   <result pre="the pandemic. Notably one of the global gaps for understanding" exact="ZIKV" post="dynamics is Africa, where ZIKV was discovered, is endemic,"/>
   <result pre="the global gaps for understanding ZIKV dynamics is Africa, where" exact="ZIKV" post="was discovered, is endemic, and poses a risk of"/>
   <result pre="internet search engine data, were used in a minority of" exact="ZIKV" post="prediction studies identified in this systematic review. The limited"/>
   <result pre="not incorporated into prediction frameworks during the first year of" exact="ZIKV" post="pandemic. This may reflect that early molecular epidemiology studies"/>
   <result pre="epidemiology studies aimed to reconstruct the invasion and evolution of" exact="ZIKV" post="rather than forecasting future changes [121, 122]. Some phylodynamic"/>
   <result pre="were published on a time-scale that was relevant to the" exact="Zika" post="response. However, a large number of predictions were published"/>
   <result pre="prior to peer-reviewed publication. An analysis of preprints for all" exact="Zika" post="publications over a similar time period found similar publication"/>
   <result pre="of the funding sources and author affiliations of the published" exact="ZIKV" post="prediction and forecast efforts across the ZIKV pandemic. These"/>
   <result pre="of the published ZIKV prediction and forecast efforts across the" exact="ZIKV" post="pandemic. These results indicated a range of stakeholders, and"/>
   <result pre="that the Government sector was the leading funder of all" exact="Zika" post="prediction and forecasting studies during this period. Despite being"/>
   <result pre="studies during this period. Despite being a major stakeholder in" exact="ZIKV" post="forecasts (e.g. prediction of whether it may have been"/>
   <result pre="communicating uncertainty. Addressing these areas can improve our understanding of" exact="Zika" post="and other outbreaks and ensure that forecasts can inform"/>
   <result pre="their helpful feedback. The authors also acknowledge the valuable curated" exact="Zika" post="case count data used with permission by the Andersen"/>
   <result pre="protection is not available for this work References References 1DickGW." exact="Zika" post="virus. II. Pathogenicity and physical properties. Trans R Soc"/>
   <result pre="World Health Organ. 1972;46(5):669â€&quot;73. 4403105 3MarchetteNJ, GarciaR, RudnickA. Isolation of" exact="Zika" post="virus from Aedes aegypti mosquitoes in Malaysia. Am J"/>
   <result pre="5Oliveira MeloAS, MalingerG, XimenesR, SzejnfeldPO, Alves SampaioS, Bispo de FilippisAM." exact="Zika" post="virus intrauterine infection causes fetal brain abnormality and microcephaly:"/>
   <result pre="HerrmannC, PoullainP, TranTH, DeschampsN, MathonG, et al.Acute myelitis due to" exact="Zika" post="virus infection. Lancet. 2016;387(10026):148110.1016/S0140-6736(16)00644-926946926 8CorrÃªa-OliveiraGE, do AmaralJL, da FonsecaBAL,"/>
   <result pre="virus infection. Lancet. 2016;387(10026):148110.1016/S0140-6736(16)00644-926946926 8CorrÃªa-OliveiraGE, do AmaralJL, da FonsecaBAL, Del-BenCM." exact="Zika" post="virus infection followed by a first episode of psychosis:"/>
   <result pre="psychiatric symptomatology. Rev Bras Psiquiatr. 2017;39(4):381â€&quot;2. 9collab: World Health Organization." exact="Zika" post="Situation Report: Microcephaly and Guillian-Barre Syndrome March 17, 2016."/>
   <result pre="and Guillian-Barre Syndrome March 17, 2016. 2016. 10DICKGW, KITCHENSF, HADDOWAJ." exact="Zika" post="virus. I. Isolations and serological specificity. Trans R Soc"/>
   <result pre="specificity. Trans R Soc Trop Med Hyg. 1952;46(5):509â€&quot;20. 10.1016/0035-9203(52)90042-412995440 11MACNAMARAFN." exact="Zika" post="virus: a report on three cases of human infection"/>
   <result pre="MonsS, LastereS, RocheC, VanhomwegenJ, et al.Guillain-Barre Syndrome outbreak associated with" exact="Zika" post="virus infection in French Polynesia: a case-control study. Lancet"/>
   <result pre="Micronesia. N Engl J Med. 2009;360(24):2536â€&quot;43. 10.1056/NEJMoa080571519516034 14KwongJC, DruceJD, LederK." exact="Zika" post="virus infection acquired during brief travel to Indonesia. Am"/>
   <result pre="10.4269/ajtmh.13-002923878182 15PerkasaA, YudhaputriF, HaryantoS, HayatiRF, Ma'roefCN, AntonjayaU, et al.Isolation of" exact="Zika" post="Virus from Febrile Patient, Indonesia. Emerg Infect Dis. 2016;22(5):924â€&quot;5."/>
   <result pre="KucirkaLM, BiQ, GrantzK, SaljeH, et al.Assessing the global threat from" exact="Zika" post="virus. Science (New York, NY).2016;353(6300):aaf8160. 18Pan American Health Organization,"/>
   <result pre="(New York, NY).2016;353(6300):aaf8160. 18Pan American Health Organization, World Health Organization." exact="Zika" post="Cumulative Cases. 2018. 19WHO Director-General summarizes the outcome of"/>
   <result pre="[press release]. 2016. 20LewnardJA, GonsalvesG, KoAI. Low Risk of International" exact="Zika" post="Virus Spread due to the 2016 Olympics in Brazil."/>
   <result pre="of internal medicine. 2016;165(4):286â€&quot;7. 10.7326/M16-162827454521 21McGoughSF, BrownsteinJS, HawkinsJB, SantillanaM. Forecasting" exact="Zika" post="Incidence in the 2016 Latin America Outbreak Combining Traditional"/>
   <result pre="2017;11(1):e000529510.1371/journal.pntd.000529528085877 22BogochII, BradyOJ, KraemerMU, GermanM, CreatoreMI, BrentS, et al.Potential for" exact="Zika" post="virus introduction and transmission in resource-limited countries in Africa"/>
   <result pre="and determination of the zones susceptible to the development of" exact="Zika" post="virus. Acta Trop. 2017;168:80â€&quot;90. 10.1016/j.actatropica.2017.01.01528111132 24OgdenNH, FazilA, SafronetzD, DrebotMA,"/>
   <result pre="SafronetzD, DrebotMA, WallaceJ, ReesEE, et al.Risk of travel-related cases of" exact="Zika" post="virus infection is predicted by transmission intensity in outbreak-affected"/>
   <result pre="25CraigAT, ButlerMT, PastoreR, PatersonBJ, DurrheimDN. Acute flaccid paralysis incidence and" exact="Zika" post="virus surveillance, Pacific Islands. Bull World Health Organ. 2017;95(1):69â€&quot;75."/>
   <result pre="Health Organ. 2017;95(1):69â€&quot;75. 10.2471/BLT.16.17189228053366 26GardnerLM, ChenN, SarkarS. Global risk of" exact="Zika" post="virus depends critically on vector status of Aedes albopictus."/>
   <result pre="10.1016/S1473-3099(16)00176-626997578 27collab: Pan American Health Organization, collab: World Health Organization." exact="Zika" post="Cumulative Cases. 2018. 28AlthouseBM, VasilakisN, SallAA, DialloM, WeaverSC, HanleyKA."/>
   <result pre="Cases. 2018. 28AlthouseBM, VasilakisN, SallAA, DialloM, WeaverSC, HanleyKA. Potential for" exact="Zika" post="Virus to Establish a Sylvatic Transmission Cycle in the"/>
   <result pre="2009;62(10):1006â€&quot;12. 10.1016/j.jclinepi.2009.06.00519631508 30AlthausCL, LowN. How Relevant Is Sexual Transmission of" exact="Zika" post="Virus?PLoS medicine.2016;13(10):e100215710.1371/journal.pmed.100215727780196 31Diaz-MenendezM, TrigoE, de la Calle-PrietoF, ArsuagaM. Zika"/>
   <result pre="of Zika Virus?PLoS medicine.2016;13(10):e100215710.1371/journal.pmed.100215727780196 31Diaz-MenendezM, TrigoE, de la Calle-PrietoF, ArsuagaM." exact="Zika" post="virus infection during the Olympic Games in Rio: A"/>
   <result pre="journal. 2017. 34PerkinsTA, SirajAS, RuktanonchaiCW, KraemerMU, TatemAJ. Model-based projections of" exact="Zika" post="virus infections in childbearing women in the Americas. Nature"/>
   <result pre="MedlockJ, Ndeffo-MbahML, et al.A Cost-Effectiveness Tool for Informing Policies on" exact="Zika" post="Virus Control. PLoS Negl Trop Dis. 2016;10(5):e000474310.1371/journal.pntd.000474327205899 36AlthouseBM, HanleyKA,"/>
   <result pre="GhawcheF, SignateA, et al.Real-Time Assessment of Health-Care Requirements During the" exact="Zika" post="Virus Epidemic in Martinique. American journal of epidemiology. 2017:1â€&quot;10."/>
   <result pre="Martinique. American journal of epidemiology. 2017:1â€&quot;10. 38AttawayDF, WatersNM, GeraghtyEM, JacobsenKH." exact="Zika" post="virus: Endemic and epidemic ranges of Aedes mosquito transmission."/>
   <result pre="10.1016/j.jiph.2016.09.00827707632 39Baca-CarrascoD, Velasco-HernandezJX. Sex, Mosquitoes and Epidemics: An Evaluation of" exact="Zika" post="Disease Dynamics.Bulletin of mathematical biology. 2016;78(11):2228â€&quot;42. 10.1007/s11538-016-0219-427743310 40BonyahE, OkosunKO."/>
   <result pre="of mathematical biology. 2016;78(11):2228â€&quot;42. 10.1007/s11538-016-0219-427743310 40BonyahE, OkosunKO. Mathematical Modeling of" exact="Zika" post="Virus.Asian Pacific Journal of Tropical Disease. 2016;6(9):673â€&quot;9. 41BurattiniMN, CoutinhoFA,"/>
   <result pre="41BurattiniMN, CoutinhoFA, LopezLF, XimenesR, QuamM, Wilder-SmithA, et al.Potential exposure to" exact="Zika" post="virus for foreign tourists during the 2016 Carnival and"/>
   <result pre="Epidemiol Infect. 2016;144(9):1904â€&quot;6. 10.1017/S095026881600064927040593 42ButtAM, SiddiqueS, GardnerLM, SarkarS, LancelotR, QamarR." exact="Zika" post="virus in Pakistan: the tip of the iceberg? The"/>
   <result pre="BlagroveMS, SolomonT, et al.Global risk model for vector-borne transmission of" exact="Zika" post="virus reveals the role of El Nino 2015. Proc"/>
   <result pre="DoughertyER, GetzW. An Ecological Assessment of the Pandemic Threat of" exact="Zika" post="Virus. PLoS Negl Trop Dis. 2016;10(8):e000496810.1371/journal.pntd.000496827564232 45CauchemezS, BesnardM, BompardP,"/>
   <result pre="2016;10(8):e000496810.1371/journal.pntd.000496827564232 45CauchemezS, BesnardM, BompardP, DubT, Guillemette-ArturP, Eyrolle-GuignotD, et al.Association between" exact="Zika" post="virus and microcephaly in French Polynesia, 2013â€&quot;15: a retrospective"/>
   <result pre="a retrospective study. Lancet (London, England).2016;387(10033):2125â€&quot;32. 46CetronM. Revision to CDC's" exact="Zika" post="Travel Notices: Minimal Likelihood for Mosquito-Borne Zika Virus Transmission"/>
   <result pre="Revision to CDC's Zika Travel Notices: Minimal Likelihood for Mosquito-Borne" exact="Zika" post="Virus Transmission at Elevations Above 2,000 Meters. MMWR Morbidity"/>
   <result pre="in the variability of the basic reproductive number (R0) for" exact="Zika" post="epidemics in the Pacific islands. Elife. 2016;5. 48ChowellG, Hincapie-PalacioD,"/>
   <result pre="to Characterize Transmissibility and Forecast Patterns and Final Burden of" exact="Zika" post="Epidemics. PLoS currents. 2016;8. 49DinhL, ChowellG, MizumotoK, NishiuraH. Estimating"/>
   <result pre="49DinhL, ChowellG, MizumotoK, NishiuraH. Estimating the subcritical transmissibility of the" exact="Zika" post="outbreak in the State of Florida, USA, 2016. Theoretical"/>
   <result pre="ThomasD, VirgenCA, MayshackM, et al.Guillain-Barre Syndrome and Healthcare Needs during" exact="Zika" post="Virus Transmission, Puerto Rico, 2016. Emerg Infect Dis. 2017;23(1):134â€&quot;6."/>
   <result pre="Perez-PadillaJ, et al.Estimating the Number of Pregnant Women Infected With" exact="Zika" post="Virus and Expected Infants With Microcephaly Following the Zika"/>
   <result pre="With Zika Virus and Expected Infants With Microcephaly Following the" exact="Zika" post="Virus Outbreak in Puerto Rico, 2016. JAMA pediatrics. 2016;170(10):940â€&quot;5."/>
   <result pre="10.1001/jamapediatrics.2016.297427544075 52EvansMV, DallasTA, HanBA, MurdockCC, DrakeJM. Data-driven identification of potential" exact="Zika" post="virus vectors. Elife. 2017;6. 53FergusonNM, CucunubaZM, DorigattiI, Nedjati-GilaniGL, DonnellyCA,"/>
   <result pre="53FergusonNM, CucunubaZM, DorigattiI, Nedjati-GilaniGL, DonnellyCA, BasanezMG, et al.EPIDEMIOLOGY. Countering the" exact="Zika" post="epidemic in Latin America. Science (New York, NY).2016;353(6297):353â€&quot;4. 54FunkS,"/>
   <result pre="54FunkS, KucharskiAJ, CamachoA, EggoRM, YakobL, MurrayLM, et al.Comparative Analysis of" exact="Dengue" post="and Zika Outbreaks Reveals Differences by Setting and Virus.PLoS"/>
   <result pre="CamachoA, EggoRM, YakobL, MurrayLM, et al.Comparative Analysis of Dengue and" exact="Zika" post="Outbreaks Reveals Differences by Setting and Virus.PLoS Negl Trop"/>
   <result pre="LouY, HeD, PorcoTC, KuangY, ChowellG, et al.Prevention and Control of" exact="Zika" post="as a Mosquito-Borne and Sexually Transmitted Disease: A Mathematical"/>
   <result pre="StephensCR, Sanchez-CorderoV. Predicting the Potential Role of Non-human Hosts in" exact="Zika" post="Virus Maintenance. EcoHealth. 2017. 57GrillsA, MorrisonS, NelsonB, MiniotaJ, WattsA,"/>
   <result pre="Maintenance. EcoHealth. 2017. 57GrillsA, MorrisonS, NelsonB, MiniotaJ, WattsA, CetronMS. Projected" exact="Zika" post="Virus Importation and Subsequent Ongoing Transmission after Travel to"/>
   <result pre="MontarsiF, BaldacchinoF, CapelliG, RizzoliA, et al.Assessing the potential risk of" exact="Zika" post="virus epidemics in temperate areas with established Aedes albopictus"/>
   <result pre="Predict the Movement of Infected Travelers Validated Against the Current" exact="Zika" post="Virus Epidemic. PLoS currents. 2016;8. 60JaenischT, RosenbergerKD, BritoC, BradyO,"/>
   <result pre="60JaenischT, RosenbergerKD, BritoC, BradyO, BrasilP, MarquesET. Risk of microcephaly after" exact="Zika" post="virus infection in Brazil, 2015 to 2016. Bull World"/>
   <result pre="World Health Organ. 2017;95(3):191â€&quot;8. 10.2471/BLT.16.17860828250532 61JohanssonMA, Mier-y-Teran-RomeroL, ReefhuisJ, GilboaSM, HillsSL." exact="Zika" post="and the Risk of Microcephaly. N Engl J Med."/>
   <result pre="10.1056/NEJMp160536727222919 62KucharskiAJ, FunkS, EggoRM, MalletHP, EdmundsWJ, NillesEJ. Transmission Dynamics of" exact="Zika" post="Virus in Island Populations: A Modelling Analysis of the"/>
   <result pre="CarcelenAC, KonikoffJM, WilliamsonJ, BiQ, et al.Times to key events in" exact="Zika" post="virus infection and implications for blood donation: a systematic"/>
   <result pre="RomeroL, et al.Cost-effectiveness of Increasing Access to Contraception during the" exact="Zika" post="Virus Outbreak, Puerto Rico, 2016. Emerg Infect Dis. 2017;23(1):74â€&quot;82."/>
   <result pre="of the analytic hierarchy approach to the risk assessment of" exact="Zika" post="virus disease transmission in Guangdong Province, China.BMC Infect Dis."/>
   <result pre="Near Real-Time Estimation of Transmission Dynamics During the 2015â€&quot;2016 Colombian" exact="Zika" post="Virus Disease Outbreak. JMIR public health and surveillance.2016;2(1):e3010.2196/publichealth.581427251981 67ManoreCA,"/>
   <result pre="surveillance.2016;2(1):e3010.2196/publichealth.581427251981 67ManoreCA, OstfeldRS, AgustoFB, GaffH, LaDeauSL. Defining the Risk of" exact="Zika" post="and Chikungunya Virus Transmission in Human Population Centers of"/>
   <result pre="OstfeldRS, AgustoFB, GaffH, LaDeauSL. Defining the Risk of Zika and" exact="Chikungunya" post="Virus Transmission in Human Population Centers of the Eastern"/>
   <result pre="Eastern United States. PLoS Negl Trop Dis. 2017;11(1):e000525510.1371/journal.pntd.000525528095405 68MartinezME. Preventing" exact="Zika" post="Virus Infection during Pregnancy Using a Seasonal Window of"/>
   <result pre="for Conception. PLoS biology. 2016;14(7):e100252010.1371/journal.pbio.100252027467271 69MassadE, TanSH, KhanK, Wilder-SmithA. Estimated" exact="Zika" post="virus importations to Europe by travellers from Brazil. Global"/>
   <result pre="BradyOJ, PigottDM, ShearerFM, WeissDJ, et al.Mapping global environmental suitability for" exact="Zika" post="virus. Elife. 2016;5. 71MonaghanAJ, MorinCW, SteinhoffDF, WilhelmiO, HaydenM, QuattrochiDA,"/>
   <result pre="QuattrochiDA, et al.On the Seasonal Occurrence and Abundance of the" exact="Zika" post="Virus Vector Mosquito Aedes Aegypti in the Contiguous United"/>
   <result pre="HolechekSA, Castillo-ChavezC. Role of short-term dispersal on the dynamics of" exact="Zika" post="virus in an extreme idealized environment. Infect Dis Model."/>
   <result pre="KinoshitaR, NishiuraH. Estimating risks of importation and local transmission of" exact="Zika" post="virus infection. PeerJ. 2016;4:e190410.7717/peerj.190427069825 74Ndeffo-MbahML, ParpiaAS, GalvaniAP. Mitigating Prenatal"/>
   <result pre="Zika virus infection. PeerJ. 2016;4:e190410.7717/peerj.190427069825 74Ndeffo-MbahML, ParpiaAS, GalvaniAP. Mitigating Prenatal" exact="Zika" post="Virus Infection in the Americas. Annals of internal medicine."/>
   <result pre="theoretical estimate of the risk of microcephaly during pregnancy with" exact="Zika" post="virus infection. Epidemics. 2016;15:66â€&quot;70. 10.1016/j.epidem.2016.03.00127288540 76NishiuraH, MizumotoK, Villamil-GomezWE, Rodriguez-MoralesAJ."/>
   <result pre="Villamil-GomezWE, Rodriguez-MoralesAJ. Preliminary estimation of the basic reproduction number of" exact="Zika" post="virus infection during Colombia epidemic, 2015â€&quot;2016.Travel medicine and infectious"/>
   <result pre="2016;14(3):274â€&quot;6. 10.1016/j.tmaid.2016.03.01627060613 77NishiuraH, KinoshitaR, MizumotoK, YasudaY, NahK. Transmission potential of" exact="Zika" post="virus infection in the South Pacific. Int J Infect"/>
   <result pre="Infect Dis. 2016;45:95â€&quot;7. 10.1016/j.ijid.2016.02.01726923081 78QuamMB, Wilder-SmithA. Estimated global exportations of" exact="Zika" post="virus infections via travellers from Brazil from 2014 to"/>
   <result pre="HillsSL, et al.Projecting Month of Birth for At-Risk Infants after" exact="Zika" post="Virus Disease Outbreaks. Emerg Infect Dis. 2016;22(5):828â€&quot;32. 10.3201/eid2205.16029027088494 80RiouJ,"/>
   <result pre="Dis. 2016;22(5):828â€&quot;32. 10.3201/eid2205.16029027088494 80RiouJ, PolettoC, BoellePY. A comparative analysis of" exact="Chikungunya" post="and Zika transmission. Epidemics. 2017. 81RocklovJ, QuamMB, SudreB, GermanM,"/>
   <result pre="10.3201/eid2205.16029027088494 80RiouJ, PolettoC, BoellePY. A comparative analysis of Chikungunya and" exact="Zika" post="transmission. Epidemics. 2017. 81RocklovJ, QuamMB, SudreB, GermanM, KraemerMU, BradyO,"/>
   <result pre="al.Assessing Seasonal Risks for the Introduction and Mosquito-borne Spread of" exact="Zika" post="Virus in Europe. EBioMedicine. 2016;9:250â€&quot;6. 10.1016/j.ebiom.2016.06.00927344225 82RojasDP, DeanNE, YangY,"/>
   <result pre="YangY, KenahE, QuinteroJ, TomasiS, et al.The epidemiology and transmissibility of" exact="Zika" post="virus in Girardot and San Andres island, Colombia, September"/>
   <result pre="disease bulletin. 2016;21(28). 83Saad-RoyCM, van den DriesscheP, MaJ. Estimation of" exact="Zika" post="virus prevalence by appearance of microcephaly. BMC Infect Dis."/>
   <result pre="ThomasSM, WahedAA, CohoonKP, PetersonAT. Mapping the global geographic potential of" exact="Zika" post="virus spread. Memorias do Instituto Oswaldo Cruz. 2016;111(9):559â€&quot;60. 10.1590/0074-0276016014927653360"/>
   <result pre="2016;6:3710510.1038/srep3710527848978 86TangB, XiaoY, WuJ. Implication of vaccination against dengue for" exact="Zika" post="outbreak. Sci Rep. 2016;6:3562310.1038/srep3562327774987 87TengY, BiD, XieG, JinY, HuangY,"/>
   <result pre="87TengY, BiD, XieG, JinY, HuangY, LinB, et al.Dynamic Forecasting of" exact="Zika" post="Epidemics Using Google Trends. PLoS One. 2017;12(1):e016508510.1371/journal.pone.016508528060809 88TengY, BiD,"/>
   <result pre="BiD, XieG, JinY, HuangY, LinB, et al.Model-informed risk assessment for" exact="Zika" post="virus outbreaks in the Asia-Pacific regions. The Journal of"/>
   <result pre="MubayiA, Romero-VivasCM. Estimate of the reproduction number of the 2015" exact="Zika" post="virus outbreak in Barranquilla, Colombia, and estimation of the"/>
   <result pre="JansenCC, MontgomeryBL, HarleyD, et al.Epidemic Potential for Local Transmission of" exact="Zika" post="Virus in 2015 and 2016 in Queensland, Australia. PLoS"/>
   <result pre="dengue outbreaks. Epidemiol Infect. 2017:1â€&quot;9. 92WiwanitkitS, WiwanitkitV. Predicted pattern of" exact="Zika" post="virus infection distribution with reference to rainfall in Thailand."/>
   <result pre="10.1016/j.apjtm.2016.05.01427393105 93YakobL, KucharskiA, HueS, EdmundsWJ. Low risk of a sexually-transmitted" exact="Zika" post="virus outbreak. Lancet Infect Dis. 2016;16(10):1100â€&quot;2. 10.1016/S1473-3099(16)30324-327676337 94ZinszerK, MorrisonK,"/>
   <result pre="2016;16(10):1100â€&quot;2. 10.1016/S1473-3099(16)30324-327676337 94ZinszerK, MorrisonK, BrownsteinJS, MarinhoF, SantosAF, NsoesieEO. Reconstruction of" exact="Zika" post="Virus Introduction in Brazil. Emerg Infect Dis. 2017;23(1):91â€&quot;4. 10.3201/eid2301.16127427618573"/>
   <result pre="KraemerMUG, GermanM, CreatoreMI, KulkarniMA, et al.Anticipating the international spread of" exact="Zika" post="virus from Brazil. Lancet. 2016;387(10016):335â€&quot;6. 10.1016/S0140-6736(16)00080-526777915 96CastroLA, FoxSJ, ChenX,"/>
   <result pre="10.1016/S0140-6736(16)00080-526777915 96CastroLA, FoxSJ, ChenX, LiuK, BellanSE, DimitrovNB, et al.Assessing real-time" exact="Zika" post="risk in the United States. BMC Infect Dis. 2017;17(1):28410.1186/s12879-017-2394-928468671"/>
   <result pre="Infect Dis. 2017;17(1):28410.1186/s12879-017-2394-928468671 97Rodriguez-BarraquerI, SaljeH, LesslerJ, CummingsDA. Predicting intensities of" exact="Zika" post="infection and microcephaly using transmission intensities of other arboviruses."/>
   <result pre="2016. 98BogochII, BradyOJ, KraemerMUG, GermanM, CreatoreMI, BrentS, et al.Potential for" exact="Zika" post="virus introduction and transmission in resource-limited countries in Africa"/>
   <result pre="2009 August 28, 2009. Contract No.: Briefing Note 9. 106SaenzC." exact="Zika" post="virus: ethics preparedness for old and new challenges. The"/>
   <result pre="and collab: Cultural Organization,. Inform, engage, investigate: Lessons learned from" exact="Zika" post="outbreak2016 November 30, 2017. Available from: http://www.unesco.org/new/en/media-services/single-view/news/inform_engage_investigate_lessons_learned_from_zika_outbr/. 113KeeganLT, LesslerJ,"/>
   <result pre="http://www.unesco.org/new/en/media-services/single-view/news/inform_engage_investigate_lessons_learned_from_zika_outbr/. 113KeeganLT, LesslerJ, JohanssonMA. Quantifying Zika: Advancing the Epidemiology of" exact="Zika" post="With Quantitative Models. J Infect Dis. 2017;216(suppl_10):S884â€&quot;S90. 10.1093/infdis/jix43729267915 114CarlsonCJ,"/>
   <result pre="BootsM, GetzW, RyanSJ. Consensus and conflict among ecological forecasts of" exact="Zika" post="virus outbreaks in the United States. Sci Rep.2018;8(1):492110.1038/s41598-018-22989-029563545 115PollettS,"/>
   <result pre="MonteiroM, ValdezT, Monteiro RodriguesJ, PybusO, Rodrigues FariaN. Epidemiology of the" exact="Zika" post="Virus Outbreak in the Cabo Verde Islands, West Africa."/>
   <result pre="al.Host outdoor exposure variability affects the transmission and spread of" exact="Zika" post="virus: Insights for epidemic control.PLoS Negl Trop Dis. 2017;11(9):e000585110.1371/journal.pntd.000585128910292"/>
   <result pre="120FariaNR, SabinoEC, NunesMR, AlcantaraLC, LomanNJ, PybusOG. Mobile real-time surveillance of" exact="Zika" post="virus in Brazil. Genome medicine. 2016;8(1):9710.1186/s13073-016-0356-227683027 121FariaNR, Azevedo RdoS,"/>
   <result pre="ThÃ©zÃ©J, de JesusJG, GiovanettiM, et al.Establishment and cryptic transmission of" exact="Zika" post="virus in Brazil and the Americas. Nature. 2017;546(7658):406â€&quot;10. 10.1038/nature2240128538727"/>
   <result pre="DudasG, TanAL, GangavarapuK, et al.Genomic epidemiology reveals multiple introductions of" exact="Zika" post="virus into the United States. Nature. 2017;546(7658):401â€&quot;5. 10.1038/nature2240028538723 124ThÃ©zÃ©J,"/>
   <result pre="SomasekarS, et al.Genomic Epidemiology Reconstructs the Introduction and Spread of" exact="Zika" post="Virus in Central America and Mexico. Cell Host Microbe."/>
   <result pre="HatchettR, LegaJC, BrownHE, et al.Summary results of the 2014â€&quot;2015 DARPA" exact="Chikungunya" post="challenge. BMC Infectious Diseases. 2018;18(1):24510.1186/s12879-018-3124-729843621 126KingAA, Domenech de CellÃ¨sM,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC6832525\results\search\tropicalVirus\results.xml">
   <result pre="of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract" exact="Yellow fever" post="virus (YFV) represents a re-emerging zoonotic pathogen, transmitted by"/>
   <result pre="mosquito vectors to humans from primate reservoirs. Sporadic outbreaks of" exact="YFV" post="occur in endemic tropical regions, causing a viral hemorrhagic"/>
   <result pre="a highly effective vaccine, no antiviral treatments currently exist. Therefore," exact="YFV" post="represents a neglected tropical disease and is chronically understudied,"/>
   <result pre="tropical disease and is chronically understudied, with many aspects of" exact="YFV" post="biology incompletely defined including host range, hostâ€&quot;virus interactions and"/>
   <result pre="pathogenicity. In this article, we review the current state of" exact="YFV" post="research, focusing on the viral lifecycle, host responses to"/>
   <result pre="available sequence and structural data to assess global patterns of" exact="YFV" post="sequence diversity and identify potential drug targets. Finally, we"/>
   <result pre="immune response E protein structure re-emerging virus 1. General Introduction" exact="Yellow fever" post="was historically the first described viral hemorrhagic fever (VHF)"/>
   <result pre="subsequent eradication from Europe and North America [1,2,3,4]. However, today," exact="YFV" post="remains prevalent in tropical regions of Africa and South"/>
   <result pre="endemic areas, 500 million of whom reside in Africa [6]." exact="YFV" post="represents a zoonotic pathogen and complete eradication in tropical"/>
   <result pre="vaccination represents one of the core strategies employed to stop" exact="YFV" post="outbreaks or minimize their impact when they do occur"/>
   <result pre="tissue-tropism, pathogenicity and modes of transmission can differ greatly [10]." exact="YFV" post="is a member of the Flavivirus genus, which is"/>
   <result pre="pathogens which can cause acute infections, including dengue virus (DENV)," exact="West Nile" post="virus (WNV), Japanese encephalitis virus (JEV) and Zika virus"/>
   <result pre="(DENV), West Nile virus (WNV), Japanese encephalitis virus (JEV) and" exact="Zika" post="virus (ZIKV) (Figure 1). Transmission is mediated via mosquito"/>
   <result pre="JEV and ZIKV) or fatal hemorrhagic fever (YFV and DENV)." exact="YFV" post="continues to pose a very real threat to public"/>
   <result pre="vaccine production, which can easily be overwhelmed by a large" exact="YFV" post="outbreak, and the collapse of vector control programs [1,14,15],"/>
   <result pre="tissue culture and the availability of reverse genetic systems [19,20,21,22,23,24]," exact="YFV" post="remains a neglected tropical disease attracting relatively little research"/>
   <result pre="and recent commentaries have highlighted the need for intensification of" exact="YFV" post="research, as many facets of the virus life cycle"/>
   <result pre="host-ranges, identification of co-opted host factors which are essential for" exact="YFV" post="propagation in humans and insects, and identification of genetic"/>
   <result pre="humans. 2. Clinical Outcomes and Potential Therapeutic Options Infection with" exact="YFV" post="has a broad spectrum of clinical manifestations ranging from"/>
   <result pre="remain clinically silent [5]. In the majority of symptomatic cases," exact="YFV" post="infection is a self-limiting disease with abrupt onset of"/>
   <result pre="after an incubation period of 3â€&quot;6 days. In this phase," exact="YFV" post="infection is difficult to diagnose, as symptoms are unspecific."/>
   <result pre="such as DENV, is believed to reduce the severity of" exact="YFV" post="infections [5,32]. Patients who survive the disease may suffer"/>
   <result pre="only current approach to control and prevent the spread of" exact="YFV" post="in endemic regions (see Section 6). Indeed, despite the"/>
   <result pre="Indeed, despite the long history of humankind being afflicted by" exact="YFV" post="and the large populations in tropical Africa and Central"/>
   <result pre="It also has described antiviral activity against the related flaviviruses," exact="ZIKV" post="[34] and DENV [35]. Computer modelling and in vitro"/>
   <result pre="described antiviral activity against the related flaviviruses, ZIKV [34] and" exact="DENV" post="[35]. Computer modelling and in vitro experiments in hepatoma"/>
   <result pre="experiments in hepatoma cell lines demonstrated sofosbuvirâ€™s inhibitory effects on" exact="YFV" post="replication: in a mouse model, sofosbuvir was able to"/>
   <result pre="the case of pre-exposure treatment [36]. A varying efficacy against" exact="YFV" post="has also been demonstrated for other compounds targeting the"/>
   <result pre="apply a benzodiazepine compound (BDAA) in a hamster model of" exact="YFV" post="infection, where it protected 90% of animals from death"/>
   <result pre="interference (RNAi) technology, shRNAs (short hairpin RNAs) targeted at the" exact="YFV" post="E and NS1 regions were effective in inhibiting YFV"/>
   <result pre="the YFV E and NS1 regions were effective in inhibiting" exact="YFV" post="replication in cell lines as well as improving survival"/>
   <result pre="phaseâ€�, but approaches targeting the hostâ€™s immune response in severe" exact="YFV" post="disease are lacking. When patients present with severe symptoms,"/>
   <result pre="animal studies and clinical trials. 3. The Replication Cycle of" exact="YFV" post="The replication cycle of YFV is defined by multiple"/>
   <result pre="3. The Replication Cycle of YFV The replication cycle of" exact="YFV" post="is defined by multiple distinct stages, which are shared"/>
   <result pre="processes differ between mosquitos and humans requires further investigation. 3.1." exact="YFV" post="Virion Composition and E Protein Functions The YFV virion"/>
   <result pre="investigation. 3.1. YFV Virion Composition and E Protein Functions The" exact="YFV" post="virion is spherical in shape, with a 40â€&quot;60 nm"/>
   <result pre="highly basic core protein (C) which binds and encapsidates the" exact="YFV" post="RNA genome [47] and two envelope glycoproteins: prM/M (membrane)"/>
   <result pre="also represent ER retention signals [48]. The E protein of" exact="YFV" post="represents a class II fusion protein, which possesses structural"/>
   <result pre="no obvious amino acid conservation [49]. The E protein facilitates" exact="YFV" post="entry into permissive cells, mediating the interaction between the"/>
   <result pre="cell surface receptors, and also elicits host neutralizing antibody responses." exact="YFV" post="E consists of three domains: DI, DII and DIII"/>
   <result pre="2A, lower panel). DIII harbors epitopes essential for neutralization of" exact="YFV" post="[51,52]. However, antibody repertoire cloning from YFV patients also"/>
   <result pre="for neutralization of YFV [51,52]. However, antibody repertoire cloning from" exact="YFV" post="patients also identified key neutralizing epitope residues in domains"/>
   <result pre="antibody 5A identified in [53] was able to neutralize divergent" exact="YFV" post="strains (YFV-17D and Angola lineage) [54,56]. The mAb 5A"/>
   <result pre="is suggested that mAb 5A interferes at three stages during" exact="YFV" post="infection: (A) by inhibition of virus attachment due to"/>
   <result pre="lower panels). To date, only the structure of the immature" exact="YFV" post="particle has been resolved, with the architecture of mature"/>
   <result pre="cells and determining the global structure of the virion, the" exact="YFV" post="E is essential for infection. Thus, it represents an"/>
   <result pre="limits their widespread application in the resource constrained settings where" exact="YFV" post="epidemics often occur. 3.2. YFV Entry: Implicated Host Factors"/>
   <result pre="the resource constrained settings where YFV epidemics often occur. 3.2." exact="YFV" post="Entry: Implicated Host Factors Out of the three domains"/>
   <result pre="Implicated Host Factors Out of the three domains of the" exact="YFV" post="E protein, DIII is suspected to mediate interaction with"/>
   <result pre="the process. These include CD209 and the mannose receptor for" exact="DENV" post="entry [63,64] and G protein-coupled receptor kinase 6 (GRK6)"/>
   <result pre="entry [63,64] and G protein-coupled receptor kinase 6 (GRK6) for" exact="WNV" post="entry [65]. The related GRK2 was reported to both"/>
   <result pre="entry [65]. The related GRK2 was reported to both promote" exact="YFV" post="entry and enhance viral RNA synthesis, properties which were"/>
   <result pre="which were conserved across key members of the Flaviviridae, including" exact="DENV" post="and HCV [66]. The transmembrane immunoglobulin and mucin domain"/>
   <result pre="Mer) families of phosphatidylserine receptors have been shown to mediate" exact="DENV" post="infection, with TIM-1 and TIM-4 also enhancing infection rates"/>
   <result pre="infection, with TIM-1 and TIM-4 also enhancing infection rates for" exact="WNV" post="and YFV-17D to differing degrees, while herpes simplex virus-1"/>
   <result pre="represent general enhancers of flavivirus infection. Additionally, candidates implicated in" exact="YFV" post="host-cell attachment include heparin sulfate, a member of the"/>
   <result pre="(GAG) family, which also facilitates attachment for the related flaviviruses" exact="DENV" post="[68] and tick-borne encephalitis virus (TBEV) [69], as well"/>
   <result pre="effect of PI-88, a heparin sulfate mimetic, was demonstrated against" exact="DENV" post="and neurotropic flaviviruses [72]. Despite reports of multiple factors"/>
   <result pre="Despite reports of multiple factors which are potentially involved in" exact="YFV" post="entry, it is still unknown whether a ubiquitous cellular"/>
   <result pre="facilitating flavivirus infection of permissive cells [73]. Similarly to DENV," exact="YFV" post="is able to infect a range of cell-types from"/>
   <result pre="[74]. RNAi screening has revealed many potential host factors influencing" exact="WNV" post="or DENV infection of human or drosophila cell-lines [65,75]."/>
   <result pre="screening has revealed many potential host factors influencing WNV or" exact="DENV" post="infection of human or drosophila cell-lines [65,75]. Analogous to"/>
   <result pre="Divergent entry mechanisms have been observed for even closely related" exact="YFV" post="strains. The parental Asibi strain and the derived YFV-17D"/>
   <result pre="spread and attenuation [68,78]. In summary, mechanistic insights into the" exact="YFV" post="infection process, in addition to many host factors implicated"/>
   <result pre="infection process, in addition to many host factors implicated in" exact="YFV" post="entry, have been described. Nevertheless, identification of bona fide"/>
   <result pre="been described. Nevertheless, identification of bona fide receptor(s) integral for" exact="YFV" post="entry remains outstanding. The entry cascade of YFV is"/>
   <result pre="integral for YFV entry remains outstanding. The entry cascade of" exact="YFV" post="is comprised of multiple steps which could be targeted"/>
   <result pre="to ribosomes, are essential for efficient ribosomal translation of the" exact="YFV" post="polyprotein and have panflaviviral activity [82]. The YFV polyprotein"/>
   <result pre="of the YFV polyprotein and have panflaviviral activity [82]. The" exact="YFV" post="polyprotein is post-translationally modified by cellular glycosyltransferases, and the"/>
   <result pre="replication complex [85] which occurs on ER membranes [92]. Indeed," exact="DENV" post="NS3 and NS5 were identified on the virus-induced membrane"/>
   <result pre="a double-stranded complex with the genomic template [97]. Experiments with" exact="DENV" post="demonstrated that the phosphorylation of NS5 controls the interaction"/>
   <result pre="with NS3 [98]. Furthermore, mutation of the phosphorylation site on" exact="YFV" post="NS5 (S56) disrupted the capping process via inhibition of"/>
   <result pre="critical steps of the flavivirus replication cycle are described for" exact="DENV" post="or WNV, but confirmation with YFV is lacking. 4."/>
   <result pre="cycle are described for DENV or WNV, but confirmation with" exact="YFV" post="is lacking. 4. Host Responses to YFV Infection 4.1."/>
   <result pre="but confirmation with YFV is lacking. 4. Host Responses to" exact="YFV" post="Infection 4.1. Cytokine Induction by YFV Using paraffin-embedded liver"/>
   <result pre="4. Host Responses to YFV Infection 4.1. Cytokine Induction by" exact="YFV" post="Using paraffin-embedded liver tissue from patients who succumbed to"/>
   <result pre="Using paraffin-embedded liver tissue from patients who succumbed to fatal" exact="YFV" post="disease, it was demonstrated that CD4+ T cells represent"/>
   <result pre="pro- and anti-inflammatory cytokines is associated with the immunopathology of" exact="YFV" post="infection and responses to YFV-17D vaccination. 4.2. Cellular Responses"/>
   <result pre="infection and responses to YFV-17D vaccination. 4.2. Cellular Responses to" exact="YFV" post="Dendritic cells (DCs) are essential antigen-presenting cells, recognizing pathogens"/>
   <result pre="and cell populations of the innate and adaptive immune system." exact="YFV" post="also was shown to induce the production of IFN-Î³"/>
   <result pre="more efficient at stimulating pDCs than mature virions [117]. However," exact="YFV" post="also possesses the ability to antagonize the IFN system."/>
   <result pre="YFV also possesses the ability to antagonize the IFN system." exact="YFV" post="NS5 interacts with STAT2 when STAT1 is phosphorylated during"/>
   <result pre="(MDM) were also shown to be susceptible to infection with" exact="YFV" post="wild-type Asibi and 17D vaccine strains, with differences in"/>
   <result pre="confirming differential patterns of immune induction between attenuated and wild-type" exact="YFV" post="[119]. Natural killer (NK) cells represent an essential component"/>
   <result pre="in YFV-17D infection but not for wild-type virus, indicating that" exact="YFV" post="vaccine attenuation results in increased sensitivity to IFN-Î³ [121]."/>
   <result pre="cells do not appear to be a major reservoir for" exact="YFV" post="replication [122]. After YFV-17D vaccination, NK expression of TLR3,"/>
   <result pre="I and III IFNs [124]. 4.3. Pattern Recognition Receptors and" exact="YFV" post="In addition to TLRs, the pattern recognition receptors (PRRs)"/>
   <result pre="important roles in restricting flavivirus infections ([127] as reported for" exact="DENV" post="[128], WNV [129] and JEV [130]), interacting with both"/>
   <result pre="in restricting flavivirus infections ([127] as reported for DENV [128]," exact="WNV" post="[129] and JEV [130]), interacting with both MAVS and"/>
   <result pre="genome modifications can prevent RIG-I recognition, with cap1 2â€²O-methylation of" exact="YFV" post="RNA constituting an RIG-I evasion mechanism [132]. Cyclic GMP-AMP"/>
   <result pre="including flaviviruses: cGAS knockout mice were more susceptible to lethal" exact="WNV" post="infection outcomes when compared to wild-type mice [134], and"/>
   <result pre="WNV infection outcomes when compared to wild-type mice [134], and" exact="DENV" post="is able to target cGAS for degradation via NS2B,"/>
   <result pre="target cGAS for degradation via NS2B, inhibiting IFN production [135,136]." exact="YFV" post="NS4B exhibits strong homology with the C-terminus of STING"/>
   <result pre="human STING can be targeted for cleavage by ZIKV, DENV," exact="WNV" post="and JEV proteases, it is not susceptible to cleavage"/>
   <result pre="alarmin HMGB1 [139]. While inflammasome activation has been reported for" exact="WNV" post="and DENV infection [126], the exact danger signals detected"/>
   <result pre="[139]. While inflammasome activation has been reported for WNV and" exact="DENV" post="infection [126], the exact danger signals detected and its"/>
   <result pre="[126], the exact danger signals detected and its significance in" exact="YFV" post="infection remains unclear. Together these studies implicate RLRs and"/>
   <result pre="implicate RLRs and the cGAS-STING axis as important modulators of" exact="YFV" post="infection, although further investigation is required. Additionally, whether inflammasome"/>
   <result pre="investigation is required. Additionally, whether inflammasome activation is mediated by" exact="YFV" post="replication warrants further study. 4.4. Anti-YFV Effectors The mammalian"/>
   <result pre="demonstrated to confer protection from YFV-mediated cell-death via inhibition of" exact="YFV" post="replication and possesses broad activity against diverse Flaviviridae members"/>
   <result pre="backgrounds [141]. This comprehensive study identified antiviral effectors which inhibited" exact="YFV" post="replication, including IRF1, TREX1, IFITM3, RTP4, IFI6 and HPSE:"/>
   <result pre="genes APOBEC3A, FAM46C, IDO1, LY6E, MCOLN2 and ADAR genes enhanced" exact="YFV" post="replication [141]. More recently, CRISPR/Cas9 knockout genetic screening confirmed"/>
   <result pre="and differential disease outcomes is currently unclear. 5. Tropism of" exact="YFV" post="In humans, after transcutaneous inoculation, YFV exhibits broad patterns"/>
   <result pre="unclear. 5. Tropism of YFV In humans, after transcutaneous inoculation," exact="YFV" post="exhibits broad patterns of tissue tropism and is disseminated"/>
   <result pre="liver, spleen, and less frequently, the brain tissue, can support" exact="YFV" post="replication [18]. The natural host range of YFV includes"/>
   <result pre="can support YFV replication [18]. The natural host range of" exact="YFV" post="includes humans, non-human primates and mosquitos. Additionally, wild animals"/>
   <result pre="for anti-YFV antibodies, and the elicitation of antibody responses against" exact="YFV" post="indicates a potentially productive infection within these species, indicating"/>
   <result pre="within these species, indicating that diverse mammalian species could represent" exact="YFV" post="potential reservoirs [143] (see Section 8.3). Mouse Models for"/>
   <result pre="YFV potential reservoirs [143] (see Section 8.3). Mouse Models for" exact="YFV" post="YFV research is currently limited as it remains challenging"/>
   <result pre="potential reservoirs [143] (see Section 8.3). Mouse Models for YFV" exact="YFV" post="research is currently limited as it remains challenging and"/>
   <result pre="challenging and expensive to establish workflows with non-human primates. While" exact="YFV" post="has a limited host species-tropism, artificial infection of laboratory"/>
   <result pre="in genetically modified or humanized mice have yielded insights into" exact="YFV" post="infection and dissemination in vivo. Single cell-tracking of YFV-17D"/>
   <result pre="cell-tracking of YFV-17D dissemination in different mouse models identified novel" exact="YFV" post="replication reservoirs in secondary lymphoid compartments, with hematopoietic STAT1"/>
   <result pre="[145,146], and these animals represent ideal tools for monitoring systemic" exact="YFV" post="infection in vivo as both compartments are permissive for"/>
   <result pre="both compartments are permissive for YFV. In addition to hepatotropism," exact="YFV" post="can also be neurotropic in rodents, primates and humans"/>
   <result pre="to antagonize IFN signaling and therefore enhance viral replication, the" exact="YFV" post="NS5 is unable to bind murine STAT2 and in"/>
   <result pre="is unable to bind murine STAT2 and in contrast to" exact="ZIKV" post="and DENV, is unable to engage human STAT2 in"/>
   <result pre="STAT2 in murine cells. Murine STAT2 was demonstrated to repress" exact="YFV" post="replication in murine cells, which was correlated with an"/>
   <result pre="ubiquitination [155]. Together, these mouse studies enhance our understanding of" exact="YFV" post="dissemination and host control in vivo. These findings are"/>
   <result pre="specific anti-YFV effectors that directly inhibit differential aspects of the" exact="YFV" post="lifecycle, rather than upstream master-regulators of the antiviral response."/>
   <result pre="the antiviral response. Screening approaches could identify such factors. 6." exact="YFV" post="Vaccine: Development and Limitations Immunization is one of the"/>
   <result pre="are eleven live attenuated vaccines (LAV) and among them, the" exact="YFV" post="vaccine is the oldest and the most potent. As"/>
   <result pre="the most potent. As there are no specific treatments for" exact="YFV" post="infection, vaccination represents the only current protection against the"/>
   <result pre="protection against the disease. 6.1. History and Development of the" exact="YFV" post="Vaccine In the 1920s, two parallel approaches were taken"/>
   <result pre="to develop a live attenuated vaccine against YFV. In 1927," exact="YFV" post="was isolated from a Ghanaian patient suffering from mild"/>
   <result pre="competence, while retaining its immunogenicity [8]. Concurrently, French researchers isolated" exact="YFV" post="from a patient in Dakar, followed by serial passage"/>
   <result pre="The 17D subculture is the seed strain for all modern-day" exact="YFV" post="vaccines. There are three sub-strains obtained from the original"/>
   <result pre="stick injury or inhalation of aerosolized viral droplets [161]. The" exact="YFV" post="vaccine is a freeze-dried live-attenuated virus delivered subcutaneously. It"/>
   <result pre="for other experimental vaccines including HIV-1, Lassa fever, malaria and" exact="DENV" post="[175,176,177,178,179,180]. After early successes in outbreak prevention and control"/>
   <result pre="routine child immunization programs in endemic countries, a reduction of" exact="YFV" post="cases was observed globally [181]. However, when Angola was"/>
   <result pre="urgent need for more than 28 million doses of the" exact="YFV" post="vaccine, exhausting the existing global vaccine supply [182,183,184]. Furthermore,"/>
   <result pre="in a context of depleted global stockpiles, fractional doses of" exact="YFV" post="vaccine were administered. Because promising data were available on"/>
   <result pre="risk of a large-scale epidemic in Asia remains daunting and" exact="YFV" post="is the only infectious disease where an international vaccination"/>
   <result pre="has been evidence of fake/forged certificates [198]. 6.5. Future Directions" exact="Yellow fever" post="is a re-emerging infectious disease, as vector control and"/>
   <result pre="there is a need to manage the potential risk of" exact="YFV" post="introduction to Asia. In the coming decade, vaccine manufacturers"/>
   <result pre="refining of this effective vaccine [183]. 7. Global Diversity of" exact="YFV" post="At the time of writing this review, n ="/>
   <result pre="At the time of writing this review, n = 1112" exact="YFV" post="sequences were deposited on the NCBI GenBank sequence database."/>
   <result pre="NCBI GenBank sequence database. To assess patterns of globally sampled" exact="YFV" post="diversity, we performed phylogenetic analyses of all available YFV"/>
   <result pre="sampled YFV diversity, we performed phylogenetic analyses of all available" exact="YFV" post="full-length ORF sequences (n = 178) (Figure 4a). Collapsed"/>
   <result pre="addition to 17D vaccine strains. Based on this analysis, global" exact="YFV" post="sequences can be divided into six well-supported lineages: West"/>
   <result pre="with South American lineages representing historical import of West African" exact="YFV" post="strains linked to European colonial expansions and the slave"/>
   <result pre="European colonial expansions and the slave trade [2,6,18,219]. While clinical" exact="YFV" post="isolates can be readily propagated in tissue culture, the"/>
   <result pre="Asibi strain, representing only a small fraction of the global" exact="YFV" post="diversity (Figure 4a). Consequently, the phenotypic correlates of YFV"/>
   <result pre="global YFV diversity (Figure 4a). Consequently, the phenotypic correlates of" exact="YFV" post="global sequence diversity are incompletely defined and future studies"/>
   <result pre="it is currently unknown whether infection with isolates from different" exact="YFV" post="lineages contributes to differential pathogenicity or mortality rates in"/>
   <result pre="humans. However, in spite of these deep-divergences apparent in the" exact="YFV" post="phylogeny, the 17D vaccine provides robust protection against strains"/>
   <result pre="17D vaccine provides robust protection against strains from all known" exact="YFV" post="lineages. YFV Genome and Polyprotein Conservation To visualize variability"/>
   <result pre="provides robust protection against strains from all known YFV lineages." exact="YFV" post="Genome and Polyprotein Conservation To visualize variability across YFV"/>
   <result pre="lineages. YFV Genome and Polyprotein Conservation To visualize variability across" exact="YFV" post="genomes and encoded polyproteins, similarity plots were generated from"/>
   <result pre="YFV genomes and encoded polyproteins, similarity plots were generated from" exact="YFV" post="nucleotide and amino acid alignments. Inspection of genetic and"/>
   <result pre="Inspection of genetic and amino acid variability in globally sampled" exact="YFV" post="isolates highlights conserved and variable regions in the genome"/>
   <result pre="in the genome and encoded polyprotein (Figure 4b). Of note," exact="YFV" post="nucleotide variability is much greater than amino acid variability,"/>
   <result pre="acid variability, indicating strong purifying selection shapes global patterns of" exact="YFV" post="evolution. This is likely a reflection of the selective"/>
   <result pre="of the selective constraints imposed by the viral transmission cycle:" exact="YFV" post="experiences sequential bottlenecks upon continued cycling through an insect"/>
   <result pre="host factor compatibility in both vertebrates and arthropods. Furthermore, the" exact="YFV" post="RdRp has a relatively high fidelity for an RNA"/>
   <result pre="analyses indicate that both the structural and non-structural proteins of" exact="YFV" post="exhibit extensive conserved regions which are therefore viable targets"/>
   <result pre="Consequently, the development or repurposing of direct-acting antiviral compounds targeting" exact="YFV" post="proteins should represent an achievable goal. Indeed, it was"/>
   <result pre="amino acid diversity on to the resolved helicase structures for" exact="YFV" post="[221] is presented in Figure 4c, highlighting the conserved"/>
   <result pre="inform rational development of antivirals targeting different components of the" exact="YFV" post="virion or replication machinery. Currently, structural data is only"/>
   <result pre="or replication machinery. Currently, structural data is only available for" exact="YFV" post="E, NS3 and NS5 proteins. The elucidation of structural"/>
   <result pre="NS5 proteins. The elucidation of structural information for the outstanding" exact="YFV" post="proteins will expand the number of potential viral targets"/>
   <result pre="targets for future structure-based antiviral drug design studies. 8. Monitoring" exact="YFV" post="Outbreaks, Disease-Course and Reservoir Species with NGS 8.1. Diagnostic"/>
   <result pre="surveillance in recent years [225]. In Africa and South America," exact="YFV" post="co-circulates with multiple endemic VHFs which can emerge in"/>
   <result pre="Flaviviridae, has been reported [226]. Indeed, using 454 sequencing (Roche)," exact="YFV" post="was identified as the causative agent of an outbreak"/>
   <result pre="[227], validating the diagnostic utility of NGS technologies for discriminating" exact="YFV" post="outbreaks from unrelated hemorrhagic fever viruses. 8.2. Outbreak Monitoring"/>
   <result pre="data in just a few hours [230]. The re-emergence of" exact="YFV" post="as a global health burden has been demonstrated by"/>
   <result pre="to provide insights into the molecular epidemiology of the 2016â€&quot;2017" exact="YFV" post="outbreak in Brazil, generating data spatially correlating infections of"/>
   <result pre="African outbreaks. While future outbreaks are inevitable, rapid identification of" exact="YFV" post="as the causative agent and subsequent real-time tracking of"/>
   <result pre="patient DNA bio-banking to enable stratification of host-genetic correlates of" exact="YFV" post="infection outcomes, and correlation with host single nucleotide polymorphisms"/>
   <result pre="host genetics underlie the range of clinical symptoms observed in" exact="YFV" post="infection, which include subclinical, symptomatic, severe and fatal outcomes."/>
   <result pre="environmental conditions, including the presence of replication-competent Aedes vector species," exact="YFV" post="outbreaks in Asia remain conspicuously absent. However, import of"/>
   <result pre="YFV outbreaks in Asia remain conspicuously absent. However, import of" exact="YFV" post="from the Angolan outbreak to China was recorded for"/>
   <result pre="Using Illumina sequencing to follow virus evolution in 12 imported" exact="YFV" post="cases revealed the infecting strains were closely related to"/>
   <result pre="[233]. In agreement with these observations, the evolutionary rate of" exact="YFV" post="has been shown to be lower than that of"/>
   <result pre="YFV has been shown to be lower than that of" exact="DENV" post="[234] and the YFV RdRp possesses high fidelity [223]."/>
   <result pre="to be lower than that of DENV [234] and the" exact="YFV" post="RdRp possesses high fidelity [223]. In addition, sequential bottlenecks"/>
   <result pre="with an enhanced capacity for transmission, reducing variation. Constraints on" exact="YFV" post="evolution could also be mediated by the requirement for"/>
   <result pre="infection in human hosts. 8.3. Identification of Novel Animal Reservoirs" exact="YFV" post="represents a zoonotic pathogen: while many zoonotic viruses cause"/>
   <result pre="[235]. After long periods of absence, sporadic and often explosive" exact="YFV" post="outbreaks occur in endemic regions, initiated by vector-mediated spillover"/>
   <result pre="species can act as reservoirs for YFV. Vertical transmission of" exact="YFV" post="between mosquitos has been reported [236,237]. While transmission rates"/>
   <result pre="While transmission rates are low (~1%), this capacity could maintain" exact="YFV" post="reservoirs during dry periods which are not favorable for"/>
   <result pre="is often not sufficient to maintain stable sylvatic transmission, and" exact="YFV" post="reservoirs in non-primate species could maintain inter-epidemic YFV [4]."/>
   <result pre="transmission, and YFV reservoirs in non-primate species could maintain inter-epidemic" exact="YFV" post="[4]. Indeed, serum neutralizing antibodies for YFV were detected"/>
   <result pre="could maintain inter-epidemic YFV [4]. Indeed, serum neutralizing antibodies for" exact="YFV" post="were detected in ten forest mammal species from French"/>
   <result pre="well as multiple primate species [143]. Thus, the breadth of" exact="YFV" post="species-specificity remains to be determined. To further investigate this,"/>
   <result pre="this, extensive sampling and NGS screening of jungle species in" exact="YFV" post="endemic regions could be undertaken, potentially identifying novel animal"/>
   <result pre="be undertaken, potentially identifying novel animal reservoirs which silently maintain" exact="YFV" post="transmission between intermittent outbreaks. In summary, future YFV outbreaks"/>
   <result pre="silently maintain YFV transmission between intermittent outbreaks. In summary, future" exact="YFV" post="outbreaks can be rapidly identified and epidemics monitored at"/>
   <result pre="and the identification of novel animal reservoirs. 9. Modes of" exact="YFV" post="Transmission and Future Vector Control Strategies YFV is transmitted"/>
   <result pre="9. Modes of YFV Transmission and Future Vector Control Strategies" exact="YFV" post="is transmitted by mosquito vectors between primate hosts and"/>
   <result pre="3. The urban cycleâ€&quot;where invasive domesticated mosquitoes (Aedes aegypti) facilitate" exact="YFV" post="transmission from human-to-human in areas of high human and"/>
   <result pre="the epidemic [13]. Contrastingly, detailed analyses of the 2016â€&quot;2017 Brazilian" exact="YFV" post="outbreak suggests the sylvatic cycle represents the dominant mode"/>
   <result pre="sylvatic cycle represents the dominant mode of transmission [16]. Urban" exact="YFV" post="outbreaks are associated with Ae. aegypti transmission, although the"/>
   <result pre="the Asian tiger mosquito, Aedes albopictus, is also competent for" exact="YFV" post="transmission [238]. Both species are invasive, are able to"/>
   <result pre="climate change [239], expanding the risk of human exposure to" exact="YFV" post="infection. The expansion of the 2016â€&quot;2017 outbreak in Brazil"/>
   <result pre="in Brazil to an area not previously considered endemic for" exact="YFV" post="serves to underline this point [15,16]. However, during YFV"/>
   <result pre="for YFV serves to underline this point [15,16]. However, during" exact="YFV" post="outbreaks, while isolated cases can be imported from endemic"/>
   <result pre="from endemic to non-endemic regions [17], continued host-to-host transmission of" exact="YFV" post="observed in outbreaks is only possible in geographic regions"/>
   <result pre="been exploited in the past to control and even eradicate" exact="YFV" post="from specific regions. While YFV has never been controlled"/>
   <result pre="to control and even eradicate YFV from specific regions. While" exact="YFV" post="has never been controlled in Africa, vector control programs"/>
   <result pre="manage and reduce the likelihood of future arbovirus outbreaks, including" exact="YFV" post="[243]. Mosquito population suppression strategies which harness the power"/>
   <result pre="sexes were less susceptible to infection with the pathogenic flaviviruses" exact="DENV" post="and ZIKV [246]. Pupal irradiation boosted viable mosquito numbers"/>
   <result pre="less susceptible to infection with the pathogenic flaviviruses DENV and" exact="ZIKV" post="[246]. Pupal irradiation boosted viable mosquito numbers for use"/>
   <result pre="pave the way for analogous trials with Ae. aegypti in" exact="YFV" post="endemic regions. Arboviruses often replicate in mosquito mid-gut and"/>
   <result pre="another possible strategy for ablating vector-mediated transmission of YFV. Indeed," exact="DENV" post="dissemination and replication were restricted in transgenic Ae. aegypti"/>
   <result pre="factor during 17D attenuation. In the future, genetic modification of" exact="YFV" post="Aedes vector species using CRISPR/Cas9 [222] could preferentially target"/>
   <result pre="in the mosquito midgut or other tissues which are essential" exact="YFV" post="propagation and dissemination. The ability of researchers to identify"/>
   <result pre="[248]. Indeed, these data identified gene loci potentially associated with" exact="DENV" post="competence and insecticide resistance. In addition, quantification and comparison"/>
   <result pre="gene products, which could be further investigated to identify essential" exact="YFV" post="replication cofactors in the mosquito mid-gut via iterative screening"/>
   <result pre="resistant to traditional insecticides, will be key in reducing future" exact="YFV" post="outbreaks. The future of eliminating YFV from endemic regions"/>
   <result pre="key in reducing future YFV outbreaks. The future of eliminating" exact="YFV" post="from endemic regions may involve the suppression or replacement"/>
   <result pre="wild-type mosquitos with modified insects which are not competent for" exact="YFV" post="replication. Furthermore, sequencing efforts to expand the number of"/>
   <result pre="genomes from jungle-resident mosquito species should commence. 10. Concluding Remarks" exact="YFV" post="is the prototypic flavivirusâ€&quot;a zoonotic pathogen which is responsible"/>
   <result pre="increasing the potential for future outbreaks. Therefore, intensification of basic" exact="YFV" post="research is imperative to expand current knowledge of the"/>
   <result pre="of outbreaks and genetic modification of vector species to reduce" exact="YFV" post="permissiveness can all contribute to future efforts aimed at"/>
   <result pre="to future efforts aimed at reducing mortality rates associated with" exact="YFV" post="epidemics. Supplementary Materials The following are available online at"/>
   <result pre="https://www.mdpi.com/1999-4915/11/10/960/s1, Table S1: Summary of structural and functional properties of" exact="YFV" post="proteins. LINK Click here for additional data file. Author"/>
   <result pre="1998-2002Trans. R. Soc. Trop. Med. Hyg.200710116917510.1016/j.trstmh.2006.04.00116814821 32.OliveiraR.A.de Oliveira-FilhoE.F.FernandesI.V.A.BritoC.A.MarquesE.T.TenÃ³rioM.C.GilL.H.Previous dengue or" exact="Zika" post="virus exposure can drive to infection enhancement or neutralisation"/>
   <result pre="34.SacramentoC.Q.de MeloG.R.de FreitasC.S.RochaN.HoelzL.V.B.MirandaM.Fintelman-RodriguesN.MarttorelliA.FerreiraA.C.Barbosa-LimaG.et al.The clinically approved antiviral drug sofosbuvir inhibits" exact="Zika" post="virus replicationSci. Rep.201774092010.1038/srep4092028098253 35.XuH.-T.Colby-GerminarioS.P.HassounahS.A.FogartyC.OsmanN.PalanisamyN.HanY.OliveiraM.QuanY.WainbergM.A.Evaluation of Sofosbuvir (Î²-D-2â€™-deoxy-2â€™-Î±-fluoro-2â€™-Î²-C-methyluridine) as an"/>
   <result pre="replicationSci. Rep.201774092010.1038/srep4092028098253 35.XuH.-T.Colby-GerminarioS.P.HassounahS.A.FogartyC.OsmanN.PalanisamyN.HanY.OliveiraM.QuanY.WainbergM.A.Evaluation of Sofosbuvir (Î²-D-2â€™-deoxy-2â€™-Î±-fluoro-2â€™-Î²-C-methyluridine) as an inhibitor of" exact="Dengue" post="virus replicationSci. Rep.20177634510.1038/s41598-017-06612-228740124 36.De FreitasC.S.HigaL.M.SacramentoC.Q.FerreiraA.C.ReisP.A.DelvecchioR.MonteiroF.L.Barbosa-LimaG.James WestgarthH.VieiraY.R.et al.Yellow fever virus"/>
   <result pre="Med.200319782382910.1084/jem.2002184012682107 65.KrishnanM.N.NgA.SukumaranB.GilfoyF.D.UchilP.D.SultanaH.BrassA.L.AdametzR.TsuiM.QianF.et al.RNA interference screen for human genes associated with" exact="West Nile" post="virus infectionNature200845524224510.1038/nature0720718690214 66.Le SommerC.BarrowsN.J.BradrickS.S.PearsonJ.L.Garcia-BlancoM.A.G protein-coupled receptor kinase 2 promotes"/>
   <result pre="C-type lectin collaborates with a CD45 phosphatase homolog to facilitate" exact="West Nile" post="virus infection of mosquitoesCell201014271472510.1016/j.cell.2010.07.03820797779 78.Fernandez-GarciaM.D.MeertensL.ChazalM.HafirassouM.L.DejarnacO.ZamborliniA.DespresP.SauvonnetN.Arenzana-SeisdedosF.JouvenetN.et al.Vaccine and Wild-Type Strains"/>
   <result pre="protease-helicase as a target for antiviral drug developmentAntivir. Res.201511814815810.1016/j.antiviral.2015.03.01425842996 97.TanB.-H.FuJ.SugrueR.J.YapE.-H.ChanY.-C.TanY.H.Recombinant" exact="Dengue" post="Type 1 Virus NS5 Protein Expressed inEscherichia coliExhibits RNA-Dependent"/>
   <result pre="and NS4AVirology199824520321510.1006/viro.1998.91569636360 105.KaufusiP.H.KelleyJ.F.YanagiharaR.NerurkarV.R.Induction of endoplasmic reticulum-derived replication-competent membrane structures by" exact="West Nile" post="virus non-structural protein 4BPLoS ONE20149e8404010.1371/journal.pone.008404024465392 106.DesprÃ¨sP.GirardM.BouloyM.Characterization of yellow fever"/>
   <result pre="Med.200620341342410.1084/jem.2005172016461338 117.SinigagliaL.GraciasS.DÃ©cembreE.FritzM.BruniD.SmithN.HerbeuvalJ.-P.MartinA.DreuxM.TangyF.et al.Immature particles and capsid-free viral RNA produced by" exact="Yellow fever" post="virus-infected cells stimulate plasmacytoid dendritic cells to secrete interferonsSci."/>
   <result pre="Virol.2014884180419410.1128/JVI.03114-1324478443 129.FredericksenB.L.KellerB.C.FornekJ.KatzeM.G.GaleM.Establishment and maintenance of the innate antiviral response to" exact="West Nile" post="Virus involves both RIG-I and MDA5 signaling through IPS-1J."/>
   <result pre="new roles for cGAS in innate immunityNature201450569169510.1038/nature1286224284630 135.van GentM.GackM.U.Viral pathogenesis:" exact="Dengue" post="virus takes on cGASNat. Microbiol.201721705010.1038/nmicrobiol.2017.5028346454 136.AguirreS.LuthraP.Sanchez-AparicioM.T.MaestreA.M.PatelJ.LamotheF.FredericksA.C.TripathiS.ZhuT.Pintado-SilvaJ.et al.Dengue virus NS2B"/>
   <result pre="immunityNature200946178879210.1038/nature0847619776740 138.DingQ.GaskaJ.M.DouamF.WeiL.KimD.BalevM.HellerB.PlossA.Species-specific disruption of STING-dependent antiviral cellular defenses by the" exact="Zika" post="virus NS2B3 proteaseProc. Natl. Acad. Sci. USA2018115E6310E631810.1073/pnas.180340611529915078 139.LamkanfiM.DixitV.M.Modulation of"/>
   <result pre="vector for HIV-1 vaccine developmentVaccine2010285676568510.1016/j.vaccine.2010.06.05220600494 178.GuyB.GuirakhooF.BarbanV.HiggsS.MonathT.P.LangJ.Preclinical and clinical development of" exact="YFV" post="17D-based chimeric vaccines against dengue, West Nile and Japanese"/>
   <result pre="and clinical development of YFV 17D-based chimeric vaccines against dengue," exact="West Nile" post="and Japanese encephalitis virusesVaccine20102863264910.1016/j.vaccine.2009.09.09819808029 179.StoyanovC.T.BoscardinS.B.DeroubaixS.Barba-SpaethG.FrancoD.NussenzweigR.S.NussenzweigM.RiceC.M.Immunogenicity and protective efficacy of"/>
   <result pre="ModelsAm. J. Trop. Med. Hyg.20189842043110.4269/ajtmh.16-029329231157 206.TripathiN.K.ShrivastavaA.Recent Developments in Recombinant Protein-Based" exact="Dengue" post="VaccinesFront. Immunol.20189191910.3389/fimmu.2018.0191930190720 207.KheraT.BehrendtP.BankwitzD.BrownR.J.P.TodtD.DoepkeM.KhanA.G.SchulzeK.LawJ.LoganM.et al.Functional and immunogenic characterization of diverse"/>
   <result pre="LamballerieX.Random codon re-encoding induces stable reduction of replicative fitness of" exact="Chikungunya" post="virus in primate and mosquito cellsPLoS Pathog.20139e100317210.1371/journal.ppat.100317223436995 218.de FabritusL.NougairedeA.AubryF.GouldE.A.de"/>
   <result pre="to the scale bar (units: substitutions per site). Figure 2" exact="YFV" post="E protein structures with 17D attenuating mutations and fusion"/>
   <result pre="with both top (left) and side (right) views presented. The" exact="YFV" post="E structures presented were previously described in [54] (PDB"/>
   <result pre="in UCSF Chimera [55]. Figure 3 Schematic representation of the" exact="YFV" post="genome and encoded polyprotein. The genome of YFV is"/>
   <result pre="of the YFV genome and encoded polyprotein. The genome of" exact="YFV" post="is a single-stranded positive-stranded RNA of approximately 11kb encoding"/>
   <result pre="proteins which are incorporated into the ER membrane. Figure 4" exact="YFV" post="genomic and amino acid diversity. (A) Phylogenetic analysis of"/>
   <result pre="YFV genomic and amino acid diversity. (A) Phylogenetic analysis of" exact="YFV" post="genomes. The presented tree was generated using PhyML [220]"/>
   <result pre="ensure maintenance of the polyprotein ORF. Collapsed clades in the" exact="YFV" post="phylogeny contain closely related isolates from the 2016â€&quot;2017 Brazilian"/>
   <result pre="green filled circles in SAL I (n = 3) represent" exact="YFV" post="sequences isolated from non-human primates during the 2016â€&quot;2017 Brazilian"/>
   <result pre="the main outbreak grouping (green triangle). The statistical robustness of" exact="YFV" post="lineages were calculated using the bootstrap approach in MEGA7"/>
   <result pre="bar (units: substitutions per site). (B) Conservation and variability in" exact="YFV" post="genomes. Amino acid and underlying nucleotide similarity plots for"/>
   <result pre="Amino acid and underlying nucleotide similarity plots for globally sampled" exact="YFV" post="genomes are presented. For the purpose of positional referencing,"/>
   <result pre="For the purpose of positional referencing, a cartoon of the" exact="YFV" post="reference strain polyprotein is provided directly above, with coordinates"/>
   <result pre="nucleotides in the alignment. (C) Conservation and variability in the" exact="YFV" post="RNA helicase. Amino acid conservation and variability estimated in"/>
   <result pre="conservation and variability estimated in (B) were mapped onto the" exact="YFV" post="NS3 RNA helicase structure. Relative conservation of amino acids"/>
   <result pre="while variable residues highlighted dark green through to orange. The" exact="YFV" post="helicase structure presented was described in [221] (PDB ID:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC6853075\results\search\tropicalVirus\results.xml">
   <result pre="CientÃ­fica pmcid: 685307500605 doi: 10.1590/1414-431X20198339 : Research Article Identification of" exact="Zika" post="virus in immature phases of Aedes aegypti and Aedes"/>
   <result pre="objective of this article was to identify the presence of" exact="Zika" post="(ZIKV), dengue (DENV), and Chikungunya (CHIKV) viruses in immature"/>
   <result pre="to identify the presence of Zika (ZIKV), dengue (DENV), and" exact="Chikungunya" post="(CHIKV) viruses in immature stages of Aedes aegypti and"/>
   <result pre="This reduction was accompanied by a decrease in suspected human" exact="ZIKV" post="cases from March to June 2015. The RT-qPCR performed"/>
   <result pre="albopictus) were positive for ZIKV, and none were positive for" exact="DENV" post="or CHIKV. Our findings demonstrated that ZIKV was present"/>
   <result pre="were positive for DENV or CHIKV. Our findings demonstrated that" exact="ZIKV" post="was present in immature stages of insect vectors in"/>
   <result pre="region at least five months prior to the peak of" exact="ZIKV" post="associated cases. Xenomonitoring of immature phases of the vectors"/>
   <result pre="phases of the vectors may prove useful for predicting outbreaks." exact="Zika" post="virus Aedes aegypti Aedes albopictus Arbovirus Georeferencing Xenomonitoring fig-count:"/>
   <result pre="has been considered endemic for this arbovirus (2). In 2014," exact="Chikungunya" post="(CHIKV) and Zika (ZIKV) viruses, two exotic arboviruses, were"/>
   <result pre="endemic for this arbovirus (2). In 2014, Chikungunya (CHIKV) and" exact="Zika" post="(ZIKV) viruses, two exotic arboviruses, were introduced in Brazil"/>
   <result pre="rapid dispersion in different states (3). The increasing outbreaks of" exact="ZIKV" post="due to vector dispersion and lack of effective control"/>
   <result pre="public health concern (4). The most alarming clinical manifestations of" exact="ZIKV" post="were cases associated with Guillain-BarrÃ© syndrome in adults (5)"/>
   <result pre="associated with Guillain-BarrÃ© syndrome in adults (5) and the congenital" exact="ZIKV" post="syndrome (6). Furthermore, reports of outbreaks of CHIKV emphasize"/>
   <result pre="the congenital ZIKV syndrome (6). Furthermore, reports of outbreaks of" exact="CHIKV" post="emphasize the magnitude of its epidemics that accounted for"/>
   <result pre="2018 in the Southeast of Brazil (7). Adverse outcomes of" exact="CHIKV" post="include neurological disease in the acute phase, and longstanding"/>
   <result pre="attempt to eradicate dengue, the Brazilian government created the National" exact="Dengue" post="Control Program (PNCD). This program promoted initiatives aimed at"/>
   <result pre="study was to identify the presence of ZIKV, DENV, and" exact="CHIKV" post="in the immature stages of Ae. aegypti and Ae."/>
   <result pre="and/or non-purulent conjunctivitis were included in the study as suspected" exact="ZIKV" post="cases. All illegible or incomplete medical records were excluded"/>
   <result pre="those suggested by the Ministry of Health to classify suspected" exact="ZIKV" post="cases (14). Any other related description in the medical"/>
   <result pre="of the National Guidelines for the Prevention and Control of" exact="Dengue" post="Epidemics (10)) was carried out during the months of"/>
   <result pre="detect the presence of nucleic acid of ZIKV, DENV, and" exact="CHIKV" post="in each pool containing viral RNA extracted. For this,"/>
   <result pre="with primers and probes specifically designed for DENV, ZIKV, and" exact="CHIKV" post="(19-20) (Supplementary Table S1). Cycle threshold values below 38.5"/>
   <result pre="of the QGIS software (version 3.2.0; ). The number of" exact="ZIKV" post="cases per 100,000 inhabitants was calculated from the total"/>
   <result pre="per 100,000 inhabitants was calculated from the total number of" exact="ZIKV" post="cases in the census tract, divided by the total"/>
   <result pre="777 (38.6%) were classified as ZIKV. Although the symptoms of" exact="ZIKV" post="among other arboviruses are very similar, the analyses showed"/>
   <result pre="that in the years 2015 and 2016, among 146 suspected" exact="ZIKV" post="cases, two symptoms were the most frequent: rash occurred"/>
   <result pre="or 38.6% of Ae. albopictus). Our data demonstrated that suspected" exact="ZIKV" post="cases were concentrated in the urbanized area of Xerem."/>
   <result pre="noteworthy that in 2015 there were already suspected cases of" exact="ZIKV" post="in this region, and the number of cases reached"/>
   <result pre="outbreak was characterized (Figure 1.). Figure 1 Spatial distribution of" exact="Zika" post="virus (ZIKV) suspected cases in March and June 2015"/>
   <result pre="169 mm (Figure 2). Figure 2. Relationship of number of" exact="Zika" post="virus (ZIKV) suspected cases with rainfall and temperature data"/>
   <result pre="rainfall index was high (Figure 2), and there were 777" exact="ZIKV" post="suspected cases, a considerable number. A strong positive correlation"/>
   <result pre="(28%) as Ae. aegypti. The RT-qPCR for DENV, ZIKV, and" exact="CHIKV" post="was performed in all pools and, of the 18"/>
   <result pre="positive for ZIKV, suggesting the occurrence of transovarian transmission of" exact="ZIKV" post="of 11.6% (2/173) for Ae. aegypti and 2.3% (1/442)"/>
   <result pre="and December/2015: 36.00 (larvae Ae. albopictus); 37.84 (larvae Ae. aegypti)." exact="CHIKV" post="and DENV were not identified in any of the"/>
   <result pre="36.00 (larvae Ae. albopictus); 37.84 (larvae Ae. aegypti). CHIKV and" exact="DENV" post="were not identified in any of the pools evaluated."/>
   <result pre="the pools evaluated. Table 1. Identification of dengue virus (DENV)," exact="Zika" post="virus (ZIKV), and Chikungunya virus (CHIKV) in the immature"/>
   <result pre="1. Identification of dengue virus (DENV), Zika virus (ZIKV), and" exact="Chikungunya" post="virus (CHIKV) in the immature stages of Aedes aegypti"/>
   <result pre="by RT-qPCR. Month/year Ae. aegypti Ae. albopictus RT-qPCR Pools Pools" exact="DENV" post="ZIKV CHIKV Larvae Pupae Larvae Pupae Jun/15 0 0"/>
   <result pre="RT-qPCR. Month/year Ae. aegypti Ae. albopictus RT-qPCR Pools Pools DENV" exact="ZIKV" post="CHIKV Larvae Pupae Larvae Pupae Jun/15 0 0 80"/>
   <result pre="Month/year Ae. aegypti Ae. albopictus RT-qPCR Pools Pools DENV ZIKV" exact="CHIKV" post="Larvae Pupae Larvae Pupae Jun/15 0 0 80 0"/>
   <result pre="neg neg neg Discussion Our results showed the identification of" exact="ZIKV" post="in immature phases of the vectors Ae. aegypti and"/>
   <result pre="and Ae. albopictus mosquitoes from Thailand were capable of transmitting" exact="CHIKV" post="vertically in the laboratory; Ae. albopictus was more susceptible"/>
   <result pre="Ae. aegypti and Ae. albopictus mosquitoes were able to transmit" exact="CHIKV" post="vertically to F5 and F6 progenies, respectively (24). However,"/>
   <result pre="However, in the present study, none of our pools yielded" exact="CHIKV" post="or DENV, which may be related to the small"/>
   <result pre="tested associated to the fact that in 2015 and 2016" exact="CHIKV" post="and DENV were not epidemic in this area in"/>
   <result pre="to the fact that in 2015 and 2016 CHIKV and" exact="DENV" post="were not epidemic in this area in Brazil (25)."/>
   <result pre="adult Ae. aegypti females, the MIR was 11.6 (24/2065) for" exact="DENV" post="but no vertical transmission of DENV could be detected"/>
   <result pre="was 11.6 (24/2065) for DENV but no vertical transmission of" exact="DENV" post="could be detected in 1552 male Ae. aegypti collected"/>
   <result pre="Ae. albopictus, may be related to the persistent survival of" exact="ZIKV" post="during interepidemic periods, which has already been demonstrated by"/>
   <result pre="albopictus may play an important role in the maintenance of" exact="ZIKV" post="throughout the year, as it was found persistently in"/>
   <result pre="an area not distant from ours showed the presence of" exact="ZIKV" post="in nature, in the adult insect (mosquitoes). A total"/>
   <result pre="transmission, as only female mosquitoes are blood-sucking. These results reinforced" exact="ZIKV" post="circulation in this region during this period, indicating the"/>
   <result pre="difference between their study and ours is that we identified" exact="ZIKV" post="in the immature forms of both Aedes species, showing"/>
   <result pre="showing that Ae. albopictus may also be a vector for" exact="ZIKV" post="in Brazil (32). Aedes albopictus has been found naturally"/>
   <result pre="low efficiency (34). In another study, designed to test whether" exact="ZIKV" post="could be vertically transmitted, female Ae. aegypti and Ae."/>
   <result pre="with ZIKV, and their F1 adult progeny were tested for" exact="ZIKV" post="infection. Six of 69 Ae. aegypti pools, comprised of"/>
   <result pre="pools, comprised of a total of 1738 F1 adults, yielded" exact="ZIKV" post="upon culture, giving a minimum filial infection rate of"/>
   <result pre="none of 803 F1 Ae. albopictus adults (32 pools) yielded" exact="ZIKV" post="(35). It is important to note that injecting mosquitoes"/>
   <result pre="by Ciota et al. (36), adult insects fed orally with" exact="ZIKV" post="in the laboratory had their progeny tested; of 104"/>
   <result pre="their progeny tested; of 104 Ae. aegypti pools, 6 were" exact="ZIKV" post="positive, indicating a filial infection rate (FIR) of 11.9,"/>
   <result pre="aegypti, as obtained in other studies (27,39). Due to the" exact="ZIKV" post="outbreak in Brazil, several cases of the congenital syndrome,"/>
   <result pre="fluid of the affected patients (6). The threat posed by" exact="ZIKV" post="has great implications not only on immediate public health"/>
   <result pre="resources, due to the persistent long-term sequelae of the congenital" exact="ZIKV" post="syndrome (40). Reliable and sensitive surveillance of these arboviruses,"/>
   <result pre="order to effectively manage future outbreaks. Our findings demonstrated that" exact="ZIKV" post="was present in immature stages of vector insects in"/>
   <result pre="region at least five months prior to the peak of" exact="ZIKV" post="associated cases in March 2016. Data from molecular xenomonitoring"/>
   <result pre="3CardosoCWPaploskiIAKikutiMRodriguesMSSilvaMMCamposGSet al.Outbreak of exanthematous illness associated with Zika, Chikungunya, and" exact="Dengue" post="Viruses, Salvador, BrazilEmerging Infect Dis2015212274227610.3201/eid2112.15116726584464 4collab: PAHO/WHO (Pan American"/>
   <result pre="challengesPLoS Negl Trop Dis201610e000453010.1371/journal.pntd.000453026934531 6CalvetGAguiarRSMeloASOSampaioSAde FilippisIFabriAet al.Detection and sequencing of" exact="Zika" post="virus from amniotic fluid of fetuses with microcephaly in"/>
   <result pre="da SaÃºde,201384p: Il 11CostaCFDos PassosRALimaJBPRoqueRAde Souza SampaioVCampolinaTBet al.Transovarial transmission of" exact="DENV" post="in Aedes aegypti in the Amazon basin: a local"/>
   <result pre="a serem adotados para a vigilÃ¢ncia da Febre do vÃ­rus" exact="Zika" post="no Brasilhttp://portalsaude.saude.gov.br/images/pdf/2016/marco/07/Nota-informativa-zika.pdfaccessed Nov 202017 15collab: Consoli, RAGB; Lourenco de"/>
   <result pre="India, 2006Emerg Infect Dis20071376476710.3201/eid1305.07001517553261 20LanciottiRSKosoyOLLavenJJVelezJOLambertAJJohnsonAJet al.Genetic and serologic properties of" exact="Zika" post="virus associated with an epidemic, Yap State, Micronesia, 2007Emerg"/>
   <result pre="in ColombiaMed Vet Entomol19981228428810.1046/j.1365-2915.1998.00117.x9737600 29GrunnillMBootsMJHow Important is Vertical Transmission of" exact="Dengue" post="Viruses by Mosquitoes (Diptera: Culicidae)?J Med Entomol20165311910.1093/jme/tjv16826545718 30LiCXGuoXXDengYQXingDSunAJLiuQMet al.Vector"/>
   <result pre="competence and transovarial transmission of two Aedes aegypti strains to" exact="Zika" post="virusEmerg Microbes Infect20176e2310.1038/emi.2017.828442754 31Pereira Dos SantosTRoizDSantos AbreuFVLuzSLBSantaluciaMJiolleDet al.Potential of"/>
   <result pre="32Ferreira-de-BritoARibeiroIPMirandaRMFernandesRSCamposSSSilvaKABet al.First detection of natural infection of Aedes aegypti with" exact="Zika" post="virus in Brazil and throughout South AmericaMem Inst Oswaldo"/>
   <result pre="of Aedes aegypti and Aedes albopictus from the Americas to" exact="Zika" post="virusPLoS Negl Trop Dis201610e000454310.1371/journal.pntd.000454326938868 35ThangamaniSHuangJHartCEGuzmanHTeshRBVertical transmission of Zika virus"/>
   <result pre="Americas to Zika virusPLoS Negl Trop Dis201610e000454310.1371/journal.pntd.000454326938868 35ThangamaniSHuangJHartCEGuzmanHTeshRBVertical transmission of" exact="Zika" post="virus in Aedes aegypti mosquitoesAm J Trop Med Hyg2016951169117310.4269/ajtmh.16-044827573623"/>
   <result pre="Aedes aegypti mosquitoesAm J Trop Med Hyg2016951169117310.4269/ajtmh.16-044827573623 36CiotaATBialosukniaSMEhrbarDJKramerLDVertical transmission of" exact="Zika" post="virus by Aedes aegypti and Ae. albopictusmosquitoes.Emerg Infect Dis20172388088210.3201/eid2305.16204128277199"/>
   <result pre="al.Development of real time PCR for detection and quantitation of" exact="Dengue" post="VirusesVirol J200961010.1186/1743-422X-6-1019166574 38MiagostovichMPSantosFBAraÃºjoESMDiasJSchatzmayrHGNogueiraRMDiagnosis of dengue by using reverse transcriptase-polimerase"/>
   <result pre="chain reactionInfect Genet Evol2005517718410.1016/j.meegid.2004.09.00415639750 40BogochIIBradyOJKraemerMUGGermanMCreatoreMIKulkarniMAet al.Anticipating the international spread of" exact="Zika" post="virus from BrazilLancet201638733533610.1016/S0140-6736(16)00080-526777915"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC6856290\results\search\tropicalVirus\results.xml">
   <result pre="10.1128/MRA.01719-18 : Genome Sequences Complete Genome Sequence of a Colombian" exact="Zika" post="Virus Strain Obtained from BALB/c Mouse Brain after Intraperitoneal"/>
   <result pre="L, PelÃ¡ez-Carvajal D. 2019. Complete genome sequence of a Colombian" exact="Zika" post="virus strain obtained from BALB/c mouse brain after intraperitoneal"/>
   <result pre="terms of the Creative Commons Attribution 4.0 International license.MRA.01719-18.pdfMRA.01719-18-thumb0001.jpg A" exact="Zika" post="virus (ZIKV) strain was isolated from an acute febrile"/>
   <result pre="strain was isolated from an acute febrile patient during the" exact="Zika" post="epidemics in Colombia. The strain was intraperitoneally inoculated into"/>
   <result pre="into BALB/c mice, and 7 days postinoculation, neurological manifestations and" exact="ZIKV" post="infection in the brain were demonstrated. The reported genome"/>
   <result pre="related to strains circulating in the Americas. Abstract ABSTRACT A" exact="Zika" post="virus (ZIKV) strain was isolated from an acute febrile"/>
   <result pre="strain was isolated from an acute febrile patient during the" exact="Zika" post="epidemics in Colombia. The strain was intraperitoneally inoculated into"/>
   <result pre="into BALB/c mice, and 7 days postinoculation, neurological manifestations and" exact="ZIKV" post="infection in the brain were demonstrated. The reported genome"/>
   <result pre="AlonsoSantamarÃ­aGerardoNaizaqueJuliÃ¡nMonroy-GÃ³mezJeison AlexanderSarmientoLadysGunturizMarÃ­a LuzMuÃ±ozAlejandraVanegasRicardoRicoAngÃ©licaPardoLissethePelÃ¡ez-CarvajalDioselina fig-count: table-count: equation-count: ref-count: page-count: word-count: ANNOUNCEMENT" exact="Zika" post="virus (ZIKV) is the etiological agent of an emerging"/>
   <result pre="August 2015 to November 2016, Colombia reported 105,000 cases of" exact="ZIKV" post="infection, and 147 cases of microcephaly were confirmed by"/>
   <result pre="(3). Different factors have been associated with the development of" exact="ZIKV" post="neuropathogenesis, including the selective infection and damage of neural"/>
   <result pre="neuroinvasiveness and neurovirulence (7). Thus, BALB/c mice were infected with" exact="ZIKV" post="as a means to understand the neuropathogenesis of Zika."/>
   <result pre="diagnosis as part of the national public health surveillance system." exact="ZIKV" post="infection was confirmed by real-time reverse transcription-PCR (RT-PCR) Trioplex"/>
   <result pre="Vero cells. Cytopathic effect was observed 6â€‰days after inoculation, and" exact="ZIKV" post="was confirmed in cell supernatants by Trioplex assay. Five"/>
   <result pre="supernatants by Trioplex assay. Five newborn mice were inoculated with" exact="ZIKV" post="and mock infected with their respective controls by the"/>
   <result pre="controls by the intracerebral pathway. In this assay, coinfection of" exact="ZIKV" post="and CHIKV was detected in the brains using the"/>
   <result pre="the intracerebral pathway. In this assay, coinfection of ZIKV and" exact="CHIKV" post="was detected in the brains using the Trioplex assay,"/>
   <result pre="detected in the brains using the Trioplex assay, although no" exact="CHIKV" post="was detected in the cell culture inoculated with the"/>
   <result pre="cell culture inoculated with the isolate. The initial inoculum contained" exact="CHIKV" post="at a level below the detection limit of the"/>
   <result pre="assay (coinfections are frequently encountered in our region), and the" exact="CHIKV" post="titers increased in the mouse brain due to the"/>
   <result pre="in the mouse brain due to the strong capacity of" exact="CHIKV" post="to infect neurons (9, 10). To obtain a pure"/>
   <result pre="CHIKV to infect neurons (9, 10). To obtain a pure" exact="ZIKV" post="strain without coinfections, a plaque-to-plaque transfer assay was performed."/>
   <result pre="for ZIKV, while clone 1 showed coinfection with CHIKV. The" exact="ZIKV" post="clone 7 isolate was named Zika_virus_459148_Meta_Colombia_2016. The third passage"/>
   <result pre="(PFA) solution for immunohistochemistry assays. The presence and purity of" exact="ZIKV" post="was confirmed by immunoassays against ZIKV (anti-ZIKV pAb, lot"/>
   <result pre="presence and purity of ZIKV was confirmed by immunoassays against" exact="ZIKV" post="(anti-ZIKV pAb, lot 6 1576; donated by the CDC)"/>
   <result pre="Switzerland). One RNA sample from the brain was taken for" exact="ZIKV" post="sequencing. The library was prepared with the Nextera XT"/>
   <result pre="sequence. In summary, we report here the sequence of a" exact="ZIKV" post="strain that is closely related to circulating strains in"/>
   <result pre="in a model of developing murine brain. Data availability. The" exact="ZIKV" post="genome sequence obtained from brains of infected BALB/c mice"/>
   <result pre="Meaney-DelmanD, JamiesonDJ, HoneinMA, MartÃ­nezMLO2016Preliminary report of microcephaly potentially associated with" exact="Zika" post="virus infection during pregnancyâ€&quot;Colombia, Januaryâ€&quot;November 2016. MMWR Morb Mortal"/>
   <result pre="5.TsunodaI, OmuraS, SatoF, KusunokiS, FujitaM, ParkAM, HasanovicF, YanagiharaR, NagataS2016Neuropathogenesis of" exact="Zika" post="virus infection: potential roles of antibody-mediated pathology. Acta Medica"/>
   <result pre="HuangXY, LiG, YeQ, YangH, ShiL, DengYQ, QinCF, XuZ2017American strain of" exact="Zika" post="virus causes more severe microcephaly than an old Asian"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC6857389\results\search\tropicalVirus\results.xml">
   <result pre="6857389JFMPC-8-3125 doi: 10.4103/jfmpc.jfmpc_716_19 : Review Article A notorious vector-borne disease:" exact="Dengue" post="fever, its evolution as public health threat PathakVineet K.1MohanM1[1],"/>
   <result pre="the new creations are licensed under the identical terms. Abstract" exact="Dengue" post="fever, the most notorious of vector borne diseases is"/>
   <result pre="is available in India. Aedes dengue epidemiology surveillance urbanization Background" exact="Dengue" post="virus (DENV) is a positive-stranded encapsulated RNA virus of"/>
   <result pre="Aedes albopictus.[2] Aedes Aegypti also transmits Chikungunya, yellow fever, and" exact="Zika" post="infections.[1] Dengue also referred to as â€œwater poison,â€� â€œcramp-like"/>
   <result pre="Aedes Aegypti also transmits Chikungunya, yellow fever, and Zika infections.[1]" exact="Dengue" post="also referred to as â€œwater poison,â€� â€œcramp-like seizure,â€� or"/>
   <result pre="importance Government of India has named 16th May 2019 â€œNational" exact="Dengue" post="day.â€� The theme was â€œFight the bite: Prevent Dengueâ€�"/>
   <result pre="of prevention and role of primary healthcare providers.[6] Epidemiology of" exact="Dengue" post="Virus The epidemiology of dengue significantly changed in south-east"/>
   <result pre="some patients with multiple serotypes of DEN.[18] Concurrent infection by" exact="Chikungunya" post="and DEN-2 was reported from Vellore and Delhi.[1920] Transmission"/>
   <result pre="known as dengue shock syndrome. Infection with one serotype of" exact="DENV" post="confers short-lived immunity against heterologous serotypes and with waning"/>
   <result pre="5KutsunaSKatoYMoiMLKotakiAOtaMShinoharaKet al.Autochthonous dengue fever, Tokyo, Japan, 2014Emerg Infect Dis2015215172025695200 6National" exact="Dengue" post="Day 2019 | National Health Portal of India [Internet]cited"/>
   <result pre="from: https://linkinghub.elsevier.com/retrieve/pii/S1201971219300153 35RajapakseSRodrigoCRajapakseTreatment of dengue feverInfect Drug Resist201251031222870039 36WHO |" exact="Dengue" post="guidelines for diagnosis, treatment, prevention and control: New edition"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC6883514\results\search\tropicalVirus\results.xml">
   <result pre="meningitis in adults was rather associated with herpes simplex and" exact="West Nile" post="virus, whereas children were more likely to be tested"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC6893508\results\search\tropicalVirus\results.xml">
   <result pre="culicoides midges [1]. 2. Epidemiology Various virulent arboviruses, such as" exact="West Nile" post="virus, Rift Valley fever virus, Chikungunya virus, Zika virus,"/>
   <result pre="arboviruses, such as West Nile virus, Rift Valley fever virus," exact="Chikungunya" post="virus, Zika virus, and Bluetongue virus (BTV), have emerged"/>
   <result pre="as West Nile virus, Rift Valley fever virus, Chikungunya virus," exact="Zika" post="virus, and Bluetongue virus (BTV), have emerged and caused"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC6904818\results\search\tropicalVirus\results.xml">
   <result pre="6904818S1525-0016(19)30458-7 doi: 10.1016/j.ymthe.2019.10.004 : Commentary Repurposing an HIV Drug for" exact="Zika" post="Virus Therapy XieXuping1ShiPei-Yongpeshi@utmb.edu1âˆ—[1], âˆ—Corresponding author: Pei-Yong Shi, Department of"/>
   <result pre="American Society of Gene and Cell Therapy, 2019 Main Text" exact="Zika" post="virus (ZIKV) is a mosquito-borne flavivirus that can cause"/>
   <result pre="a US Food and Drug Administration (FDA)-approved HIV drug, inhibits" exact="ZIKV" post="RNA-dependent RNA polymerase (RdRp), leading to potent anti-ZIKV activity"/>
   <result pre="repurposing clinically approved drugs for possible prevention and treatment of" exact="ZIKV" post="infection and its associated disease. Although emerging infectious diseases"/>
   <result pre="syndrome (SARS), middle east respiratory syndrome (MERS), Ebola, Nipah, chikungunya," exact="West Nile," post="yellow fever, and ZIKV. Given the unpredictable nature of"/>
   <result pre="blocking the viral RdRp (FigureÂ 1). FigureÂ 1 Rilpivirine Inhibits" exact="ZIKV" post="by Blocking Viral RdRp (A) Proposed rilpivirine binding site"/>
   <result pre="by Blocking Viral RdRp (A) Proposed rilpivirine binding site on" exact="ZIKV" post="RdRp. ZIKV NS5 (PDB: 5TMH)15 contains an N-terminal methyltransferase"/>
   <result pre="Viral RdRp (A) Proposed rilpivirine binding site on ZIKV RdRp." exact="ZIKV" post="NS5 (PDB: 5TMH)15 contains an N-terminal methyltransferase domain (blue)"/>
   <result pre="al.2 found that human primary astrocytes are more susceptible to" exact="ZIKV" post="infection than several other human cell types, including fetal"/>
   <result pre="including fetal microglia, fetal neuron, and neural progenitor cells. Using" exact="ZIKV" post="infection of astrocytes as a screening assay, they identified"/>
   <result pre="astrocytes as a screening assay, they identified rilpivirine as a" exact="ZIKV" post="inhibitor from eight FDA-approved HIV nucleoside and non-nucleoside reverse"/>
   <result pre="reverse transcriptase drugs. Rilpivirine is a non-nucleoside inhibitor and suppressed" exact="ZIKV" post="RNA replication by âˆ¼70% at 5Â Î¼M concentration. The"/>
   <result pre="The higher susceptibility of astrocytes than other cell types to" exact="ZIKV" post="infection is intriguing because previous studies suggested that ZIKV"/>
   <result pre="to ZIKV infection is intriguing because previous studies suggested that" exact="ZIKV" post="preferentially infected human neural progenitor cells.6, 7, 8 Since"/>
   <result pre="ZIKV preferentially infected human neural progenitor cells.6, 7, 8 Since" exact="ZIKV" post="was proposed as a potential oncolytic virotherapy for glioblastoma,7,"/>
   <result pre="also inhibits closely related flaviviruses, such as dengue, yellow fever," exact="West Nile," post="and Japanese encephalitis viruses. Nevertheless, the authors have established"/>
   <result pre="the authors have established the antiviral activity of rilpivirine against" exact="ZIKV" post="in cell culture. Second, Sariyer etÂ al.2 provided five"/>
   <result pre="provided five lines of evidence to support that rilpivirine targets" exact="ZIKV" post="RdRp (FigureÂ 1A). (1) Computational docking suggests that rilpivirine"/>
   <result pre="design of analogs with improved potency. (2) The selection of" exact="ZIKV" post="variants resistant to rilpivirine will identify mutations that are"/>
   <result pre="al.2 demonstrated the inÂ vivo efficacy of rilpivirine in a" exact="ZIKV" post="interferon Î±/Î² receptor (IFNAR)âˆ’/âˆ’ mouse (type I interferon receptor"/>
   <result pre="cells, and neurons, but not neural progenitor cells.Â In addition," exact="ZIKV" post="infection caused significant inflammation and abundant apoptotic/necrotic cell damage."/>
   <result pre="good example of repurposing clinical drugs for potential treatment of" exact="ZIKV" post="infection. For any repurposed drug to work, the compound"/>
   <result pre="trials for the new indication.11 As rilpivirine inhibits HIV-1 and" exact="ZIKV" post="with EC50 in the single-digit nanomolar and micromolar range,"/>
   <result pre="single-digit nanomolar and micromolar range, respectively,2, 12 its potency against" exact="ZIKV" post="needs to be improved to ensure clinical efficacy in"/>
   <result pre="lead optimization could be tested against ZIKV. Because HIV-1 and" exact="ZIKV" post="may have different structure-and-activity (SAR) relationships, compounds with better"/>
   <result pre="have different structure-and-activity (SAR) relationships, compounds with better potency for" exact="ZIKV" post="may be identified from the rilpivirine analogs. Meanwhile, efforts"/>
   <result pre="A report from the Global Virus NetworkAntiviral Res.144201722324628595824 2SariyerI.K.GordonJ.BurdoT.H.WolleboH.GiantiE.DonadoniM.BellizziA.CicaleseS.LoomisR.RobinsonJ.A.Suppression of" exact="Zika" post="virus infection in the brain by the antiretroviral drug"/>
   <result pre="Infect. Dis.2201617017227623030 4BarrowsN.J.CamposR.K.PowellS.T.PrasanthK.R.Schott-LernerG.Soto-AcostaR.Galarza-MuÃ±ozG.McGrathE.L.Urrabaz-GarzaR.GaoJ.A Screen of FDA-Approved Drugs for Inhibitors of" exact="Zika" post="Virus InfectionCell Host Microbe20201625927027476412 5XuM.LeeE.M.WenZ.ChengY.HuangW.K.QianX.TcwJ.KouznetsovaJ.OgdenS.C.HammackC.Identification of small-molecule inhibitors of"/>
   <result pre="Zika Virus InfectionCell Host Microbe20201625927027476412 5XuM.LeeE.M.WenZ.ChengY.HuangW.K.QianX.TcwJ.KouznetsovaJ.OgdenS.C.HammackC.Identification of small-molecule inhibitors of" exact="Zika" post="virus infection and induced neural cell death via a"/>
   <result pre="Exp. Med.21420172843285728874392 8ChenQ.WuJ.YeQ.MaF.ZhuQ.WuY.ShanC.XieX.LiD.ZhanX.Treatment of Human Glioblastoma with a Live Attenuated" exact="Zika" post="Virus Vaccine CandidateMBio92018e01683-1830228241 9FerreiraA.C.Zaverucha-do-ValleC.ReisP.A.Barbosa-LimaG.VieiraY.R.MattosM.SilvaP.P.SacramentoC.de Castro Faria NetoH.C.CampanatiL.Sofosbuvir protectsÂ Zika"/>
   <result pre="Attenuated Zika Virus Vaccine CandidateMBio92018e01683-1830228241 9FerreiraA.C.Zaverucha-do-ValleC.ReisP.A.Barbosa-LimaG.VieiraY.R.MattosM.SilvaP.P.SacramentoC.de Castro Faria NetoH.C.CampanatiL.Sofosbuvir protectsÂ" exact="Zika" post="virus-infected mice from mortality, preventing short- and long-term sequelaeSci."/>
   <result pre="sequelaeSci. Rep.72017940928842610 10DengY.Q.ZhangN.N.LiC.F.TianM.HaoJ.N.XieX.P.ShiP.Y.QinC.F.Adenosine Analog NITD008 Is a Potent Inhibitor of" exact="Zika" post="VirusOpen Forum Infect. Dis.32016ofw17527747251 11ZouJ.ShiP.Y.Strategies for Zika drug discoveryCurr."/>
   <result pre="Potent Inhibitor of Zika VirusOpen Forum Infect. Dis.32016ofw17527747251 11ZouJ.ShiP.Y.Strategies for" exact="Zika" post="drug discoveryCurr. Opin. Virol.352019192630852345 12AzijnH.TirryI.VingerhoetsJ.de BÃ©thuneM.P.KrausG.BovenK.JochmansD.Van CraenenbroeckE.PicchioG.RimskyL.T.TMC278, a next-generation"/>
   <result pre="and NNRTI-resistant HIV-1Antimicrob. Agents Chemother.54201071872719933797 13NobleC.G.LimS.P.AroraR.YokokawaF.NilarS.SehC.C.WrightS.K.BensonT.E.SmithP.W.ShiP.Y.A Conserved Pocket in the" exact="Dengue" post="Virus Polymerase Identified through Fragment-based ScreeningJ.Â Biol. Chem.29120168541854826872970 14RichnerJ.M.JaggerB.W.ShanC.FontesC.R.DowdK.A.CaoB.HimansuS.CaineE.A.NunesB.T.D.MedeirosD.B.A.Vaccine"/>
   <result pre="Identified through Fragment-based ScreeningJ.Â Biol. Chem.29120168541854826872970 14RichnerJ.M.JaggerB.W.ShanC.FontesC.R.DowdK.A.CaoB.HimansuS.CaineE.A.NunesB.T.D.MedeirosD.B.A.Vaccine mediated protection against" exact="Zika" post="virus induced congenital diseaseCell1702017273283.e1228708997 15DuanW.SongH.WangH.ChaiY.SuC.QiJ.ShiY.GaoG.F.The crystal structure of Zika"/>
   <result pre="against Zika virus induced congenital diseaseCell1702017273283.e1228708997 15DuanW.SongH.WangH.ChaiY.SuC.QiJ.ShiY.GaoG.F.The crystal structure of" exact="Zika" post="virus NS5 reveals conserved drug targetsEMBO J.36201791993328254839"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC6905541\results\search\tropicalVirus\results.xml">
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus Re-introduction of dengue virus serotype 2 in the"/>
   <result pre="has been facing large arbovirus epidemics year by year [5]." exact="Dengue" post="virus (DENV) is an arbovirus that belongs to the"/>
   <result pre="mosquitoes from genera Aedes. Four genetically related but antigenically distinct" exact="DENV" post="serotypes have been described: DENV-1, DENV-2, DENV-3, and DENV-4."/>
   <result pre="have been described: DENV-1, DENV-2, DENV-3, and DENV-4. Besides Brazil," exact="DENV" post="is widely distributed across tropical and subtropical areas of"/>
   <result pre="since late 2014, different arboviruses such as chikungunya virus (CHIKV)," exact="Zika" post="virus (ZIKV), and yellow fever virus (YFV), joined alternating"/>
   <result pre="the statal health department claimed to intensify surveillance, even though" exact="DENV" post="detection during 2017 was low, and the focus was"/>
   <result pre="lineage IV could be consistent with the fact that other" exact="DENV" post="serotypes and arboviruses like ZIKV and CHIKV have been"/>
   <result pre="with the fact that other DENV serotypes and arboviruses like" exact="ZIKV" post="and CHIKV have been responsible for the main epidemics"/>
   <result pre="fact that other DENV serotypes and arboviruses like ZIKV and" exact="CHIKV" post="have been responsible for the main epidemics of these"/>
   <result pre="last years in the American continent [37â€&quot;39]. Furthermore, the four" exact="DENV" post="serotypes are circulating in the Americas, and have been"/>
   <result pre="may be difficult to trace the exact history of each" exact="DENV" post="serotype in the whole Latin America, it is visible"/>
   <result pre="[41]. This means that in a certain way, Latin American" exact="DENV" post="history is capturing the Brazilian one. In this regard,"/>
   <result pre="Cruz. 1990, 85: 25310.1590/s0074-027619900002000222087163 9NogueiraRM, MiagostovichMP, LampeE, SouzaRW, ZagneSM, SchatzmayrHG." exact="Dengue" post="epidemic in the stage of Rio de Janeiro, Brazil,"/>
   <result pre="em SaÃºde.â€&quot;BrasÃ­lia: MinistÃ©rio da SaÃºde; 2011 p. 157â€&quot;72. 14CONASS. 2011." exact="Dengue" post="situaÃ§Ã£o atual, desafios e estratÃ©gias para enfrentamento [Dengue: presente"/>
   <result pre="de Morais BronzoniRV, BoschI, NogueiraML. Circulation of different lineages of" exact="Dengue" post="virus 2, genotype American/Asian in Brazil: dynamics and molecular"/>
   <result pre="Janeiro, Brazil. J Med Virol. 2016;88(7):1130â€&quot;6. 10.1002/jmv.2446427061403 17NogueiraRMR &amp;amp; EppinghausALF." exact="Dengue" post="virus type 4 arrives in the state of Rio"/>
   <result pre="anÃ¡lise da situaÃ§Ã£o de saÃºde e da epidemia pelo vÃ­rus" exact="Zika" post="e por outras doenÃ§as transmitidas pelo Aedes aegypti. Pages"/>
   <result pre="de Janeiro. Boletim epidemiolÃ³gico arboviroses NÂ° 001/2017. CenÃ¡rio epidemiolÃ³gico: Dengue," exact="Chikungunya" post="e Zika no Estado RJ. http://www.riocomsaude.rj.gov.br/Publico/MostrarArquivo.aspx?C=7eeHrPVyjGk%3d 22Secretaria de estado"/>
   <result pre="Boletim epidemiolÃ³gico arboviroses NÂ° 001/2017. CenÃ¡rio epidemiolÃ³gico: Dengue, Chikungunya e" exact="Zika" post="no Estado RJ. http://www.riocomsaude.rj.gov.br/Publico/MostrarArquivo.aspx?C=7eeHrPVyjGk%3d 22Secretaria de estado de saÃºde"/>
   <result pre="casos de dengue, febre de chikungunya e febre pelo vÃ­rus" exact="Zika" post="atÃ© a Semana EpidemiolÃ³gica 5 de 2018. http://portalarquivos2.saude.gov.br/images/pdf/2018/fevereiro/20/2018-007.pdf 25Secretaria"/>
   <result pre="de dengue, febre de chikungunya e doenÃ§a aguda pelo vÃ­rus" exact="Zika" post="atÃ© a Semana EpidemiolÃ³gica 52 de 2018. http://portalarquivos2.saude.gov.br/images/pdf/2019/janeiro/28/2019-002.pdf 26Secretaria"/>
   <result pre="de Janeiro. Boletim epidemiolÃ³gico arboviroses. NÂ° 002/2019. CenÃ¡rio epidemiolÃ³gico: Dengue," exact="Chikungunya" post="e Zika no Estado RJ. 1Â° semestre de 2019."/>
   <result pre="Boletim epidemiolÃ³gico arboviroses. NÂ° 002/2019. CenÃ¡rio epidemiolÃ³gico: Dengue, Chikungunya e" exact="Zika" post="no Estado RJ. 1Â° semestre de 2019. http://www.riocomsaude.rj.gov.br/Publico/MostrarArquivo.aspx?C=F%2bJ77ZiVqng%3d 35Secretaria"/>
   <result pre="a junho 2008. http://bvsms.saude.gov.br/bvs/publicacoes/informe_epidemiologico_dengue_janeiro_junho_2008.pdf 36PAHO, Pan-American Health Organization. ActualizaciÃ³n EpidemiolÃ³gica" exact="Dengue" post="2019. https://www.paho.org/hq/index.php?option=com_docman&amp;amp;view=download&amp;amp;category_slug=2019-3&amp;amp;alias=47784-22-de-febrero-de-2019-dengue-actualizacion-epidemiologica&amp;amp;Itemid=270&amp;amp;lang=en 37Brathwaite DickO, San MartÃ­nJL, MontoyaRH, del DiegoJ,"/>
   <result pre="http://www.paho.org/data/index.php/es/temas/indicadores-dengue/dengue-regional/506-dengue-reg-ano-es.html?start=1 42TeixeiraMG, SiqueiraJBJr, FerreiraGLC, BricksL, JointG (2013) Epidemiological Trends of" exact="Dengue" post="Disease in Brazil (2000â€&quot;2010): A Systematic Literature Search and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC6910063\results\search\tropicalVirus\results.xml">
   <result pre="arboviruses simultaneously, an advantage during concomitant epidemics. Keywords: Arbovirus infections" exact="Dengue" post="Enzyme-linked immunosorbent assay Serologic tests Fluorescent antibody technique indirect"/>
   <result pre="tests Fluorescent antibody technique indirect fig-count: table-count: equation-count: ref-count: INTRODUCTION" exact="Dengue" post="fever, an arbovirus infection predominantly transmitted by vectors of"/>
   <result pre="cases, 6 to 10 days after the onset of fever.(8)" exact="Dengue" post="virus-specific immunoglobulin G (IgG) can be detected in current"/>
   <result pre="have not experienced concomitant outbreaks of other arboviruses, such as" exact="Zika" post="and Chikungunya, and this could lead to false-positive results"/>
   <result pre="developed in Germany and promising to serologically detect the dengue," exact="Zika" post="and Chikungunya viruses, was released in Brazil to compete"/>
   <result pre="Germany and promising to serologically detect the dengue, Zika and" exact="Chikungunya" post="viruses, was released in Brazil to compete with ELISA"/>
   <result pre="Polymerase chain reaction is a molecular assay which quantitatively detects" exact="DENV" post="RNA, and is considered the gold standard, since it"/>
   <result pre="of these 9 discordant samples, 3 (33%) were positive for" exact="DENV" post="in the PCR (Table 1). Table 1 Detection of"/>
   <result pre="of these 4 discordant samples, only 1 (25%) had undetectable" exact="DENV" post="in the PCR. However, of the 169 negative samples,"/>
   <result pre="casos de dengue, febre de chikungunya e febre pelo vÃ­rus" exact="Zika" post="atÃ© a Semana EpidemiolÃ³gica 7 de 2018Boletim EpidemiolÃ³gico20184991132. Brasil."/>
   <result pre="casos de dengue, febre de chikungunya e febre pelo vÃ­rus" exact="Zika" post="atÃ© a Semana EpidemiolÃ³gica 7 de 2018. Boletim EpidemiolÃ³gico."/>
   <result pre="casos de dengue, febre de chikungunya e febre pelo vÃ­rus" exact="Zika" post="atÃ© a Semana EpidemiolÃ³gica 51, 2015Boletim EpidemiolÃ³gico2016472193. Brasil. MinistÃ©rio"/>
   <result pre="casos de dengue, febre de chikungunya e febre pelo vÃ­rus" exact="Zika" post="atÃ© a Semana EpidemiolÃ³gica 51, 2015. Boletim EpidemiolÃ³gico. 2016;47(2):1-9."/>
   <result pre="casos de dengue, febre de chikungunya e febre pelo vÃ­rus" exact="Zika" post="atÃ© a Semana EpidemiolÃ³gica 52 de 2018Boletim EpidemiolÃ³gico20195041144. Brasil."/>
   <result pre="casos de dengue, febre de chikungunya e febre pelo vÃ­rus" exact="Zika" post="atÃ© a Semana EpidemiolÃ³gica 52 de 2018. Boletim EpidemiolÃ³gico."/>
   <result pre="Paniai-Papua. AIP Conference Proceedings. 2016;1718(1):id.040001. 14MullerDADepelsenaireACYoungPRClinical and Laboratory Diagnosis of" exact="Dengue" post="Virus InfectionJ Infect Dis2017215Suppl_2S89S95Review2840344114. Muller DA, Depelsenaire AC, Young"/>
   <result pre="DA, Depelsenaire AC, Young PR. Clinical and Laboratory Diagnosis of" exact="Dengue" post="Virus Infection. J Infect Dis. 2017;215(Suppl_2):S89-95. Review. 15GartJJBuckAAComparison of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC6925075\results\search\tropicalVirus\results.xml">
   <result pre="fever virus, and Rift Valley fever virus, as well as" exact="Chikungunya" post="virus, which is on the WHO watch list. The"/>
   <result pre="fÃ¼r zukÃ¼nftige klinische Studien in entsprechenden Risikogebieten. Keywords Nipah MERS-CoV" exact="Chikungunya" post="Rift Valley fever CEPI SchlÃ¼sselwÃ¶rter Nipah MERS-CoV Chikungunya Rifttalfieber"/>
   <result pre="Nipah MERS-CoV Chikungunya Rift Valley fever CEPI SchlÃ¼sselwÃ¶rter Nipah MERS-CoV" exact="Chikungunya" post="Rifttalfieber Coalition for Epidemic Preparedness Innovation Background Global trends,"/>
   <result pre="2012, Ebola virus in 2013â€&quot;2016 and from 2018 onward, and" exact="Zika" post="virus in 2015â€&quot;16 are some examples [5â€&quot;9]. In each"/>
   <result pre="high-priority pathogens, which currently include Lassa, MERS-CoV, Nipah, RVF, and" exact="Chikungunya" post="viruses. The second is the development of vaccine platform"/>
   <result pre="pathogens, supporting candidate vaccines against MERS-CoV, Nipah, Lassa, RVF, and" exact="Chikungunya" post="viruses. The second CfP aims to advance rapid-response platforms"/>
   <result pre="Bioscience Lassa US$58.5 million Recombinant virus PhaseÂ I MERS-CoV Preclinical" exact="Chikungunya" post="PhaseÂ III University of Tokyo Nipah US$31.0 million Recombinant"/>
   <result pre="Rift Valley fever US$12.5 million Attenuated virus PhaseÂ I Valneva" exact="Chikungunya" post="US$23.4 million Attenuated virus PhaseÂ I Public health vaccines"/>
   <result pre="Rabies CureVac Lassa US$34.0 million RNA Preclinical PhaseÂ I Rabies" exact="Yellow fever" post="University of Queensland MERS-CoV US$10.6 million Recombinant protein Preclinical"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC6950258\results\search\tropicalVirus\results.xml">
   <result pre="Aedes mosquito is a well-established vector of several viruses, primarily" exact="Zika" post="(ZIKV), dengue (DENV) and chikungunya virus (CHIKV). Development and"/>
   <result pre="Diseases in the Pacific Regionâ€&quot;A Review on DENV, ZIKV, and" exact="CHIKV" post="In the Pacific region, Aedes mosquitoes have been identified"/>
   <result pre="vector species. Mainly causing dengue epidemics linked to a single" exact="DENV" post="serotype throughout the past, recent research identified the co-circulation"/>
   <result pre="virus serotypes (types one to four), but newly emerging Aedes-borne" exact="Zika" post="and chikungunya transmission [28]. Regular DENV outbreaks had been"/>
   <result pre="but newly emerging Aedes-borne Zika and chikungunya transmission [28]. Regular" exact="DENV" post="outbreaks had been reported since 1960s from the Pacific"/>
   <result pre="been reported since 1960s from the Pacific region. Since then," exact="DENV" post="has established endemic and epidemic circulation. In the early"/>
   <result pre="established endemic and epidemic circulation. In the early 21st century," exact="ZIKV" post="(since 2007) and CHIKV (since 2011) epidemics occurred for"/>
   <result pre="circulation. In the early 21st century, ZIKV (since 2007) and" exact="CHIKV" post="(since 2011) epidemics occurred for the first time [21]."/>
   <result pre="(family Togaviridae), e.g., chikungunya virus, and Flaviviruses (family Flaviviridae), e.g.," exact="Zika" post="and dengue virus. Those viruses could primarily be linked"/>
   <result pre="found in peri-urban or rural areas [29]. DEN, ZIKV, and" exact="CHIKV" post="are tropical mosquito-borne viruses that share biological similarities with"/>
   <result pre="agents such as Ross River virus (closely related to CHIKV)," exact="West Nile" post="virus, and yellow fever virus (closely related to DENV"/>
   <result pre="West Nile virus, and yellow fever virus (closely related to" exact="DENV" post="and ZIKV). They primarily spread through the bite of"/>
   <result pre="africanus, Ae. hensilli, and Ae. albopictus [30]. Unlike other flaviviruses," exact="ZIKV" post="is known to further be passed from human to"/>
   <result pre="Blood-borne transmission and intrapartum transmission have also been reported for" exact="CHIKV" post="[32]. The main reservoir hosts include human and non-human"/>
   <result pre="2 describes the nature of some recent DENV, ZIKV, and" exact="CHIKV" post="outbreaks in different Pacific Island States, with an emphasis"/>
   <result pre="their epidemic potential, the clinical picture of DENV, ZIKV, and" exact="CHIKV" post="is often mild, and symptoms often go unrecognized [37]."/>
   <result pre="highly susceptible areas such as Pacific island nations. The 2016" exact="ZIKV" post="epidemic in the Americas fueled the debate how climate"/>
   <result pre="and Research (BMBF), aimed at investigating the outbreak of emerging" exact="ZIKV" post="disease in the Fiji Islands from an ecological perspective"/>
   <result pre="recent reports, 2019 has been an exceptionally active year of" exact="DENV" post="outbreaks worldwide [45]. As outlined, with increasing climate change"/>
   <result pre="approaches to cut off transmission routes for DENV, ZIKV, and" exact="CHIKV" post="disease gain increasing attention in public health. Control of"/>
   <result pre="September 2019) 17.AsadH.CarpenterD.O.Effects of climate change on the spread of" exact="Zika" post="Virus: A public health threatRev. Environ. Health201833314210.1515/reveh-2017-004229500926 18.ChangA.Y.FullerD.O.CarrasquilloO.BeierJ.C.Social justice,"/>
   <result pre="24.PazS.SemenzaJ.C.El NiÃ±o and climate changeâ€&quot;Contributing factors in the dispersal of" exact="Zika" post="virus in the Americas?Lancet201638774510.1016/S0140-6736(16)00256-7 25.LeeS.H.NamK.W.JeongJ.Y.YooS.J.KohY.-S.LeeS.HeoS.T.SeongS.-Y.LeeK.H.The Effects of Climate Change"/>
   <result pre="Rep.2016444444610.1016/j.pmedr.2016.07.01127617189 27.MatysiakA.RoessA.Interrelationship between Climatic, Ecologic, Social, and Cultural Determinants Affecting" exact="Dengue" post="Emergence and Transmission in Puerto Rico and Their Implications"/>
   <result pre="Emergence and Transmission in Puerto Rico and Their Implications for" exact="Zika" post="ResponseJ. Trop. Med.2017201711410.1155/2017/894706728717366 28.Cao-LormeauV.-M.MussoD.Emerging arboviruses in the PacificLancet20143841571157210.1016/S0140-6736(14)61977-225443481 29.MavianC.DulceyM.MunozO.SalemiM.VittorA.Y.CapuaI.Islands"/>
   <result pre="of regional vectorsPLoS Negl. Trop. Dis.201812e000663710.1371/journal.pntd.000663730016372 31.AbushoukA.NegidaA.AhmedH.An updated review of" exact="Zika" post="virusJ. Clin. Virol.201684535810.1016/j.jcv.2016.09.01227721110 32.Contopoulos-IoannidisD.Newman-LindsayS.ChowC.LaBeaudA.D.Mother-to-child transmission of Chikungunya virus: A"/>
   <result pre="updated review of Zika virusJ. Clin. Virol.201684535810.1016/j.jcv.2016.09.01227721110 32.Contopoulos-IoannidisD.Newman-LindsayS.ChowC.LaBeaudA.D.Mother-to-child transmission of" exact="Chikungunya" post="virus: A systematic review and meta-analysisPLoS Negl. Trop. Dis.201812e000651010.1371/journal.pntd.000651029897898"/>
   <result pre="in French PolynesiaNew Microbes New Infect.20192910051310.1016/j.nmni.2019.01.00930899520 36.RiouJ.PolettoC.BoÃ«lleP.-Y.A comparative analysis of" exact="Chikungunya" post="and Zika transmissionEpidemics201719435210.1016/j.epidem.2017.01.00128139388 37.PattersonJ.SammonM.GargM.Dengue, Zika and Chikungunya: Emerging Arboviruses"/>
   <result pre="PolynesiaNew Microbes New Infect.20192910051310.1016/j.nmni.2019.01.00930899520 36.RiouJ.PolettoC.BoÃ«lleP.-Y.A comparative analysis of Chikungunya and" exact="Zika" post="transmissionEpidemics201719435210.1016/j.epidem.2017.01.00128139388 37.PattersonJ.SammonM.GargM.Dengue, Zika and Chikungunya: Emerging Arboviruses in the"/>
   <result pre="Infect.20192910051310.1016/j.nmni.2019.01.00930899520 36.RiouJ.PolettoC.BoÃ«lleP.-Y.A comparative analysis of Chikungunya and Zika transmissionEpidemics201719435210.1016/j.epidem.2017.01.00128139388 37.PattersonJ.SammonM.GargM.Dengue," exact="Zika" post="and Chikungunya: Emerging Arboviruses in the New WorldWest. J."/>
   <result pre="Cross-Disciplinary ReviewClin. Microbiol. Rev.20011490993210.1128/CMR.14.4.909-932.200111585790 39.RothA.MercierA.LepersC.HoyD.DuituturagaS.BenyonE.GuillaumotL.SouarÃ¨sY.Concurrent outbreaks of dengue, chikungunya and" exact="Zika" post="virus infectionsâ€&quot;An unprecedented epidemic wave of mosquito-borne viruses in"/>
   <result pre="a large outbreak in FijiElife2018710.7554/eLife.34848 43.KamaM.AubryM.NaivaluT.VanhomwegenJ.Mariteragi-HelleT.TeissierA.PaoaafaiteT.HuÃ©S.HibberdM.L.ManuguerraJ.-C.et al.Sustained Low-Level Transmission of" exact="Zika" post="and Chikungunya Viruses after Emergence in the Fiji IslandsEmerg."/>
   <result pre="outbreak in FijiElife2018710.7554/eLife.34848 43.KamaM.AubryM.NaivaluT.VanhomwegenJ.Mariteragi-HelleT.TeissierA.PaoaafaiteT.HuÃ©S.HibberdM.L.ManuguerraJ.-C.et al.Sustained Low-Level Transmission of Zika and" exact="Chikungunya" post="Viruses after Emergence in the Fiji IslandsEmerg. Infect. Dis.2019251535153810.3201/eid2508.18052431310218"/>
   <result pre="of Climate Change ResilienceSpringerCham, Switzerland2019Volume 2 48.Chouin-CarneiroT.AntT.H.HerdC.LouisF.FaillouxA.B.SinkinsS.P.Wolbachia strain wAlbA blocks" exact="Zika" post="virus transmission in Aedes aegyptiMed. Vet. Entomol.201910.1111/mve.12384 49.RyanP.A.TurleyA.P.WilsonG.HurstT.P.RetzkiK.Brown-KenyonJ.HodgsonL.KennyN.CookH.MontgomeryB.L.et al.Establishment"/>
   <result pre="studies of recent Aedes-borne outbreaks in Pacific Island States. Pathogen." exact="ZIKV" post="[21,29,33] DENV (DENV-2) [21,29,34] CHIKV [35,36] Pacific Case Study"/>
   <result pre="recent Aedes-borne outbreaks in Pacific Island States. Pathogen. ZIKV [21,29,33]" exact="DENV" post="(DENV-2) [21,29,34] CHIKV [35,36] Pacific Case Study Yap Island,"/>
   <result pre="in Pacific Island States. Pathogen. ZIKV [21,29,33] DENV (DENV-2) [21,29,34]" exact="CHIKV" post="[35,36] Pacific Case Study Yap Island, Federate States of"/>
   <result pre="suspected cases PublicHealthChallenges Widespread mosquito vector; immunologically naÃ¯ve population; co-circulating" exact="DENV" post="Widespread mosquito vector; endemic dengue virus (DENV) circulation; outbreak"/>
   <result pre="and clinical resources Widespread mosquito vector; immunologically naive population; co-circulating" exact="DENV" post="Mosquito-borne virus co-circulation DENV, zika virus (ZIKV) ZIKV DENV,"/>
   <result pre="population; co-circulating DENV Mosquito-borne virus co-circulation DENV, zika virus (ZIKV)" exact="ZIKV" post="DENV, ZIKV,Ross River virus (silent) PublicHealthImplications Development of robust"/>
   <result pre="the Pacific region. As a consequence, emerging diseases, such as" exact="ZIKV" post="disease, have successfully expanded to geographical areas where only"/>
   <result pre="ZIKV disease, have successfully expanded to geographical areas where only" exact="DENV" post="epidemics used to occur, including the Fiji Islands. The"/>
   <result pre="occur, including the Fiji Islands. The project aimed at exploring" exact="ZIKV" post="environmental suitability and potential of (re-)emergence in the Fiji"/>
   <result pre="temperature Â°C, total precipitation mm/km2, 1960â€&quot;2018) and reports on confirmed" exact="DENV" post="and ZIKV infection (2007â€&quot;2018) were acquired on a monthly"/>
   <result pre="total precipitation mm/km2, 1960â€&quot;2018) and reports on confirmed DENV and" exact="ZIKV" post="infection (2007â€&quot;2018) were acquired on a monthly basis in"/>
   <result pre="epidemiological trends in Viti Levu, Fiji. Additionally, evidence from recent" exact="ZIKV" post="serological studies was acquired to explore overall ZIKV susceptibility"/>
   <result pre="from recent ZIKV serological studies was acquired to explore overall" exact="ZIKV" post="susceptibility levels in the Fiji population. Environmental DENV and"/>
   <result pre="explore overall ZIKV susceptibility levels in the Fiji population. Environmental" exact="DENV" post="and ZIKV epidemic exposure was then assessed using pathogen-specific"/>
   <result pre="ZIKV susceptibility levels in the Fiji population. Environmental DENV and" exact="ZIKV" post="epidemic exposure was then assessed using pathogen-specific thermal thresholds"/>
   <result pre="thermal thresholds derived from laboratory studies (ZIKV = 22.6â€&quot;34.8 Â°C," exact="DENV" post="= 17.8â€&quot;34.6 Â°C) [41] looking at meteorological trends 1960â€&quot;2018."/>
   <result pre="Key findings: Recent findings could only confirm low-level transmission of" exact="ZIKV" post="in Fiji during 2013â€&quot;2017, indicating low-level herd immunity in"/>
   <result pre="to June (warm and wet season), with highest counts of" exact="DENV" post="and ZIKV infection recorded in Fijiâ€™s densely populated areas,"/>
   <result pre="(warm and wet season), with highest counts of DENV and" exact="ZIKV" post="infection recorded in Fijiâ€™s densely populated areas, mainly after"/>
   <result pre="Tmax = 29.1 [+0.3] Â°C) indicate suitable temperature conditions for" exact="DENV" post="year-round transmission since 1960, especially in Fijiâ€™s main urban"/>
   <result pre="the South-East and North-West of Viti Levu, whereas only seasonal" exact="ZIKV" post="transmission risk could be identified, especially due to minimum"/>
   <result pre="identified, especially due to minimum temperature levels dropping beyond the" exact="ZIKV" post="transmission threshold levels. Pathogen Time Tmin suitability(1960â€&quot;2018) Tmean suitability(1960â€&quot;2018)"/>
   <result pre="threshold levels. Pathogen Time Tmin suitability(1960â€&quot;2018) Tmean suitability(1960â€&quot;2018) Tmax suitability(1960â€&quot;2018)" exact="DENV" post="(17.8â€&quot;34.6 Â°C) No months/year 11.2 (â€&quot;0.4) 12.0 (+/â€&quot;0) 11.8"/>
   <result pre="(17.8â€&quot;34.6 Â°C) No months/year 11.2 (â€&quot;0.4) 12.0 (+/â€&quot;0) 11.8 (+0.2)" exact="ZIKV" post="(22.6â€&quot;34.8 Â°C) No months/year 1.9 (+2.1) 10.6 (+0.4) 11.5"/>
   <result pre="No months/year 1.9 (+2.1) 10.6 (+0.4) 11.5 (+0.3) With endemic" exact="ZIKV" post="circulation in Southeast Asia [44], and as temperature rises,"/>
   <result pre="[44], and as temperature rises, there is a risk of" exact="ZIKV" post="re-emergence in Fiji, with potentially extended transmission season in"/>
   <result pre="transmission season in the near future. The findings demonstrate that" exact="ZIKV" post="must still be considered a potential health threat in"/>
   <result pre="Pacific region, aims to eradicate viruses like DENV, CHIKV, and" exact="ZIKV" post="by cutting of the transmission routes for mosquito-borne diseases."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC6956279\results\search\tropicalVirus\results.xml">
   <result pre="two of the aforementioned single-target assays as recently described for" exact="Chikungunya" post="virus [6], and (iii) to attempt transferring this dual-target"/>
   <result pre="and (iii) frequently improves the sensitivity as previously shown with" exact="Chikungunya" post="virus [6]. Here, we selected four assays that were"/>
   <result pre="the Duo assay demonstrated higher RFU, as previously described with" exact="CHIKV" post="Duo [6], that warrants an easier interpretation of the"/>
   <result pre="ProceduresJ. Clin. Virol.20167791410.1016/j.jcv.2016.01.01726874083 6.ThirionL.PezziL.CorcosteguiI.Dubot-PÃ©rÃ¨sA.FalchiA.de LamballerieX.CharrelR.N.Development and Evaluation of a Duo" exact="Chikungunya" post="Virus Real-Time RT-PCR Assay Targeting Two Regions within the"/>
   <result pre="Lassa Virus, Crimean-Congo Hemorrhagic Fever Virus, Rift Valley Fever Virus," exact="Dengue" post="Virus, and Yellow Fever Virus by Real-Time Reverse Transcription-PCRJ."/>
   <result pre="encephalitis virus TBEV UVE/TBEV/2013/FR/32.11 WT-PCR (10 8,82) 001v-02352 West-Nile virus" exact="WNV" post="UVE/WNV/2008/US/R94224 (10 7,32) 001v-02224 Yellow Fever virus YFV UVE/YFV/UNK/XX/French"/>
   <result pre="West-Nile virus WNV UVE/WNV/2008/US/R94224 (10 7,32) 001v-02224 Yellow Fever virus" exact="YFV" post="UVE/YFV/UNK/XX/French neurotropic R94224 (10 7,32) 001v-02226 Usutu virus USUV"/>
   <result pre="5,32) 001v-EVA138 Murray Valley virus MVEV UVE/MVEV/UNK/AU/3329 (10 4,32) 001v-EVA145" exact="Zika" post="virus ZIKV UVE/ZIKV/1947/UG/MR766 (10 4,32) 001v-EVA143 Dengue virus DENV-1"/>
   <result pre="Murray Valley virus MVEV UVE/MVEV/UNK/AU/3329 (10 4,32) 001v-EVA145 Zika virus" exact="ZIKV" post="UVE/ZIKV/1947/UG/MR766 (10 4,32) 001v-EVA143 Dengue virus DENV-1 UVE/DENV-1/2013/NC/CNR_17132 (10"/>
   <result pre="(10 4,32) 001v-EVA145 Zika virus ZIKV UVE/ZIKV/1947/UG/MR766 (10 4,32) 001v-EVA143" exact="Dengue" post="virus DENV-1 UVE/DENV-1/2013/NC/CNR_17132 (10 7,57) 001v-03151 Alphavirus Venezuelan equine"/>
   <result pre="7,82) 001v-EVA1480 Oâ€™nyong-nyong virus ONNV UVE/ONNV/UNK/SN/Dakar 234 (10 4,22) 001v-EVA1044" exact="Chikungunya" post="virus CHIKV UVE/CHIKV/2017/FR/45625-26 (10 6,16) 001v-03433 Semliki Forest virus"/>
   <result pre="Oâ€™nyong-nyong virus ONNV UVE/ONNV/UNK/SN/Dakar 234 (10 4,22) 001v-EVA1044 Chikungunya virus" exact="CHIKV" post="UVE/CHIKV/2017/FR/45625-26 (10 6,16) 001v-03433 Semliki Forest virus SFV UVE/SFV/UNK/XX/1745"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC6958466\results\search\tropicalVirus\results.xml">
   <result pre="Approaches for Surveillance, Drug Discovery, and Vaccine Design for the" exact="Zika" post="Virus BasakSubhash C.1*https://orcid.org/0000-0003-3529-7820MajumdarSubhabrata2â€ https://orcid.org/0000-0002-1649-7731NandyAshesh3RoyProyasha3DuttaTathagata3VrackoMarjan4BhattacharjeeApurba K.5[1], [2], subho@research.att.com[3], anandy43@yahoo.comproyasha.roy@gmail.comtathagata.dk@gmail.com[4], marjan.vracko@ki.si[5],"/>
   <result pre="emerge and reemerge at random. The recent outbreak of the" exact="Zika" post="virus (ZIKV) is one such menace that shook the"/>
   <result pre="and discuss how they can work together to proactively combat" exact="ZIKV" post="or future emerging pathogens. viral epidemics Zika virus (ZIKV)"/>
   <result pre="to proactively combat ZIKV or future emerging pathogens. viral epidemics" exact="Zika" post="virus (ZIKV) SIR models 2D graphical method peptide vaccine"/>
   <result pre="Of the Black Death 1. Discovery and Brief History The" exact="Zika" post="Virus (ZIKV) was first isolated in 1947 from a"/>
   <result pre="first isolated in 1947 from a rhesus monkey in the" exact="Zika" post="forest of Uganda [1]. In 1952, the virus was"/>
   <result pre="Africa and Asia at first. The first major outbreak of" exact="ZIKV" post="infection was reported from the Yap Island in the"/>
   <result pre="the origin and spread of ZIKV. Serosurvey of humans found" exact="ZIKV" post="throughout Africa, Asia, and Oceania. In 1954, there was"/>
   <result pre="there was a report of the first three cases of" exact="ZIKV" post="infection in humans in Oyo state, Nigeria [2]. In"/>
   <result pre="antibodies of ZIKV. The first direct evidence of the presence" exact="ZIKV" post="in the Asian continent and the first proof of"/>
   <result pre="stomach ache, anorexia, and dizziness [6]. Regarding the spread of" exact="ZIKV" post="from Africa to Asia, Liang et al. [7] put"/>
   <result pre="on mathematical modeling. These authors carried out quantitative analysis of" exact="ZIKV" post="evolution, nucleotide substitution rate, and the time to the"/>
   <result pre="their results these authors concluded that a â€œglobal dissemination of" exact="ZIKV" post="spread was likely to have originated from Africa, followed"/>
   <result pre="as a possible portal of entry for the transmission of" exact="ZIKV" post="from Africa to south-eastern Asia during that wartime period.â€�"/>
   <result pre="from Africa to south-eastern Asia during that wartime period.â€� The" exact="Zika" post="virus attracted a heightened international attention following huge incidence"/>
   <result pre="the Latin Americas in 2015 [8]. Historically, the spread of" exact="ZIKV" post="happened in two phases [9]: (a) Cases of ZIKV"/>
   <result pre="of ZIKV happened in two phases [9]: (a) Cases of" exact="ZIKV" post="detected during the pre-epidemic period (1947 to 1999), and"/>
   <result pre="pre-epidemic period (1947 to 1999), and (b) case history of" exact="ZIKV" post="during 2007 to 2017, respectively. On 2 March 2015"/>
   <result pre="these states. All cases were mild, with no reported deaths." exact="Zika" post="was not suspected at that stage, and no tests"/>
   <result pre="was not suspected at that stage, and no tests for" exact="Zika" post="were carried out. On 1 February 2016, WHO [1]"/>
   <result pre="February 2016, WHO [1] declared that the recent association of" exact="Zika" post="infection with clusters of microcephaly and other neurological disorders"/>
   <result pre="subsequently in the November of 2016. 2. Virology 2.1. Structure" exact="ZIKV" post="is a member of the Flavivirus genus that is"/>
   <result pre="Flaviviridae family. Some important disease-causing viruses of this genus are" exact="Dengue" post="fever virus, Tick-borne encephalitis virus, West Nile virus, Japanese"/>
   <result pre="of this genus are Dengue fever virus, Tick-borne encephalitis virus," exact="West Nile" post="virus, Japanese encephalitis virus, and Zika virus [10]. These"/>
   <result pre="Tick-borne encephalitis virus, West Nile virus, Japanese encephalitis virus, and" exact="Zika" post="virus [10]. These viruses possess a single stranded positive"/>
   <result pre="5â€²-UTR and 3â€²-UTR regions [1,9,10,11]. The 3â€² terminal end of" exact="ZIKV" post="has a sub-genomic Flavivirus RNA (sfRNA) region that is"/>
   <result pre="viral-host cell binding and membrane fusion during replication. Replication of" exact="ZIKV" post="occurs in the cytoplasm of infected cells [15,16]. After"/>
   <result pre="Evolution and Spread From its initial stage in Uganda, the" exact="ZIKV" post="has numerous alterations. Figure 2 gives a phylogenetic tree"/>
   <result pre="numerous alterations. Figure 2 gives a phylogenetic tree of 22" exact="ZIKV" post="sequences [17]. There are two major groups: one with"/>
   <result pre="was first detected in 1947, the pre-epidemics period of the" exact="Zika" post="virus spanned till 1999. Table 2 provides a brief"/>
   <result pre="country-wise details of infection. Following this, a summary of the" exact="ZIKV" post="epidemics, from 2007 to the present time, is given"/>
   <result pre="detailed list of information about the clinical aspects of the" exact="Zika" post="virus infection. A majority of people infected with Zika"/>
   <result pre="the Zika virus infection. A majority of people infected with" exact="Zika" post="virus do not develop too many overt symptoms. Typical"/>
   <result pre="do not develop too many overt symptoms. Typical symptoms of" exact="Zika" post="virus infection include mild fever, rash, joint/muscle pain, headache,"/>
   <result pre="Most people recover from these symptoms in around a week." exact="ZIKV" post="infection during pregnancy has been linked to several complications,"/>
   <result pre="to several complications, which are collectively referred to as congenital" exact="Zika" post="syndrome. These include miscarriage, severe microcephaly, and other fetal"/>
   <result pre="tissue damage in brain, eye damage [20,21]. Another complication of" exact="ZIKV" post="infection is its association with the Guillainâ€&quot;BarrÃ© syndrome (GBS),"/>
   <result pre="website gives the following information regarding the transmission of the" exact="ZIKV" post="transmission [24]. (a)Through mosquito bites: ZIKV is transmitted to"/>
   <result pre="the transmission of the ZIKV transmission [24]. (a)Through mosquito bites:" exact="ZIKV" post="is transmitted to people primarily through the bite of"/>
   <result pre="bites. (b)From mother to child: A pregnant woman can pass" exact="ZIKV" post="to her fetus during pregnancy. (c)Through sex: ZIKV can"/>
   <result pre="can pass ZIKV to her fetus during pregnancy. (c)Through sex:" exact="ZIKV" post="can be transmitted through sex from a person who"/>
   <result pre="can be transmitted through sex from a person who has" exact="Zika" post="to his or her partners. The virus can be"/>
   <result pre="the time. It can be passed from a person with" exact="Zika" post="before their symptoms start, while they have symptoms, and"/>
   <result pre="have symptoms, and after their symptoms end. This scenario of" exact="ZIKV" post="disease transmission is not without precedents in the human"/>
   <result pre="is a new disease! 4. Mathematical/Computational Analysis and Results in" exact="ZIKV" post="Virology, Peptide Vaccine Design, and Anti-Zika Drug Design Currently,"/>
   <result pre="of the above-mentioned multidisciplinary approach for the management of the" exact="ZIKV" post="issues. 4.1. Quantitative Epidemiological Modelling Strategies to Prevent Zika"/>
   <result pre="the ZIKV issues. 4.1. Quantitative Epidemiological Modelling Strategies to Prevent" exact="Zika" post="The major approaches of quantitative modelling for prevention and"/>
   <result pre="major approaches of quantitative modelling for prevention and mitigation of" exact="ZIKV" post="can be broadly categorized into two parts: mathematical models"/>
   <result pre="accurately predict future disease incidences. Data-driven modelling strategies for countering" exact="Zika" post="have been explored keeping a diverse types of end"/>
   <result pre="epidemiological modelling, [37] attempted to predict new primate reservoirs of" exact="ZIKV" post="in the wild based on their phenotypical characteristics. This"/>
   <result pre="spreads of the virus through proactive surveillance and prevention of" exact="ZIKV" post="spread from the at-risk primate species. A number of"/>
   <result pre="novel compounds that are inhibitors of different enzymes present in" exact="ZIKV" post="[38,39,40], as well as repurposing existing drugs used in"/>
   <result pre="as repurposing existing drugs used in treating diseases similar to" exact="Zika" post="[41]. A more detailed list of such in-silico methods"/>
   <result pre="later in this review. 4.2. Computer-Assisted Peptide Vaccine Design for" exact="Zika" post="Virus Vaccination is the most effective way to induce"/>
   <result pre="look at the current methods of vaccine development and particularly," exact="Zika" post="virus vaccines that hopefully might reach the market within"/>
   <result pre="in which two surface proteins are recombined with a weakened" exact="YFV" post="strain [47]. None exist for the Zika or Dengue"/>
   <result pre="with a weakened YFV strain [47]. None exist for the" exact="Zika" post="or Dengue viruses. An important point to note is"/>
   <result pre="weakened YFV strain [47]. None exist for the Zika or" exact="Dengue" post="viruses. An important point to note is that vaccines,"/>
   <result pre="II [48]. They are either DNA-based vaccines or inactivated whole" exact="Zika" post="virus (ZIKV) vaccines. Additionally, there are two recombinant viral"/>
   <result pre="with ZIKV. However, one of the challenges faced in administering" exact="Zika" post="vaccines is a naturally occurring phenomenon called antibody dependent"/>
   <result pre="dependent enhancement or ADE. Reportedly, in cases of a secondary" exact="Dengue" post="infection, it has been seen that the disease severity"/>
   <result pre="probable cause is an abnormal behavior of the antibodies against" exact="Dengue" post="virusâ€&quot;they aid in the virulence of this arbovirus resulting"/>
   <result pre="virusâ€&quot;they aid in the virulence of this arbovirus resulting in" exact="Dengue" post="Shock Syndrome or Dengue Hemorrhagic Fever [49]. Since Zika"/>
   <result pre="virulence of this arbovirus resulting in Dengue Shock Syndrome or" exact="Dengue" post="Hemorrhagic Fever [49]. Since Zika is closely related to"/>
   <result pre="in Dengue Shock Syndrome or Dengue Hemorrhagic Fever [49]. Since" exact="Zika" post="is closely related to Dengue, an individual with a"/>
   <result pre="Zika is closely related to Dengue, an individual with a" exact="Zika" post="vaccination might be severely affected by ADE if she"/>
   <result pre="she or he is subsequently or naturally infected with the" exact="Zika" post="virus. Despite the advancement of vaccine over the last"/>
   <result pre="every year incurring massive production and distribution costs. Hypothetically, a" exact="Zika" post="virus would mutate at the rate of 0.12â€&quot;0.25% [50]"/>
   <result pre="the capsid, envelope, NS2A, NS3, NS4B, and NS5 proteins of" exact="Zika" post="virus [51,52,53,54,55,56]. Addressing the issue of ADE, Dos Santos"/>
   <result pre="response by constructing a NS5-based peptide vaccines that targets both" exact="Zika" post="as well as Dengue viruses. Furthermore, Richner et al."/>
   <result pre="NS5-based peptide vaccines that targets both Zika as well as" exact="Dengue" post="viruses. Furthermore, Richner et al. (2017) [58] assembled modified"/>
   <result pre="Richner et al. (2017) [58] assembled modified prME mRNA of" exact="Zika" post="virus in lipid nanoparticles. The genetic modification allowed for"/>
   <result pre="VP7 surface glycoprotein and for more than 200 sequences of" exact="HPV" post="L1 capsid protein [61]. Subsequently, the conserved peptide regions"/>
   <result pre="al. (2017) [62] were able to identify and characterize four" exact="Zika" post="virus epitopes in the envelope protein for an effective"/>
   <result pre="AI may not be too far a goal [66]. The" exact="Zika" post="virus pandemic has eased considerably after the sudden eruption"/>
   <result pre="Principle and Alignment Free Sequence Descriptors in the Characterization of" exact="ZIKV" post="Sequences â€œAll cases are unique and very similar to"/>
   <result pre="The Cocktail Party As indicated in Section 1 above [1,9,17,27]," exact="Zika" post="virus is an evolving pathogen undergoing numerous changes during"/>
   <result pre="and gain new insights. For the comparison of sequences of" exact="ZIKV" post="we have used two classes of descriptors based on"/>
   <result pre="distribution in the sequence. Thus, a graphical representation of the" exact="Zika" post="virus whole genome sequence would look like the one"/>
   <result pre="gives an overview of the base distributions along the whole" exact="Zika" post="virus genome. It shows that while the structural genes"/>
   <result pre="the sequence. Table 4 shows the gR values of the" exact="Zika" post="virus genomic sequences in Africa, Asia, and South America"/>
   <result pre="more set and compact with time. A phylogenetic tree of" exact="Zika" post="virus sequences (Figure 2) also shows clear separation between"/>
   <result pre="the application are given in [78]. Clustering and Analysis of" exact="ZIKV" post="Sequences Clustering (grouping) and classification (categorization) of objects are"/>
   <result pre="areas of the globe (Africa, Asia, South America). Comparison of" exact="ZIKV" post="sequesters using calculated sequence descriptors follows the sequence (structure)-property"/>
   <result pre="PCA- and SOM-based clustering analysis using the orthogonal descriptors for" exact="ZIKV" post="sequences [81]. For PCA and SOM calculations, the standard"/>
   <result pre="[82]. The data set consists of 310 genome sequences of" exact="ZIKV" post="hosted in different species (83% in Homo sapiens, 17%"/>
   <result pre="inaccurate, and brilliant. Together they are powerful beyond imagination.â€�Albert Einstein" exact="ZIKV" post="is a flavivirus family of infection transmitted by mosquitos."/>
   <result pre="concern for the infection heightened because of babies born from" exact="ZIKV" post="infected mothers showed microcephaly and neurological complications [84]. Since"/>
   <result pre="pharmacophoresâ€�. Although no anti-Zika drug is currently available, several promising" exact="ZIKV" post="drug targets have been reported in recent years [90]."/>
   <result pre="[90]. These targets with compounds have shown potent activity against" exact="ZIKV" post="and its proteins. Non-structural (NS) flavivirus proteins are believed"/>
   <result pre="both replication and virion maturation [91]. Crystallographic structures of several" exact="ZIKV" post="related NS proteins are now available from protein structural"/>
   <result pre="and therapeutic antibodies have been identified and developed having anti-" exact="ZIKV" post="activity. However, most of these studies were in vitro"/>
   <result pre="nine vaccines reached phase I or II clinical trials against" exact="ZIKV" post="[97]. However, none of these compounds has yet been"/>
   <result pre="in recent years with the potential to be drugs for" exact="ZIKV" post="is presented in Table 6. In addition, the following"/>
   <result pre="targets that have been frequently implicated for potential discovery of" exact="ZIKV" post="drugs and are thus further discussed below. Viral proteins"/>
   <result pre="drugs and are thus further discussed below. Viral proteins as" exact="ZIKV" post="drug targets: Viral glycoproteins play important roles for virus"/>
   <result pre="In general, small molecules interfering with the function of any" exact="ZIKV" post="viral proteins should have the potential to restrict virus"/>
   <result pre="potential to restrict virus replication and prevent from progress of" exact="ZIKV" post="related pathogenesis and diseases. Envelope glycoprotein inhibitors too are"/>
   <result pre="in green tea has exhibited inhibition to the entry of" exact="ZIKV" post="into the host cell [114]. Protease inhibitors: ZIKV being"/>
   <result pre="entry of ZIKV into the host cell [114]. Protease inhibitors:" exact="ZIKV" post="being a flavivirus also possesses the NS2B-NS3 protease. Many"/>
   <result pre="protease and surprisingly, some of them were found to inhibit" exact="ZIKV" post="protease activity [108,115]. NS3 helicase inhibitors: These inhibitors bind"/>
   <result pre="are experimentally validated [116]. NS4B inhibitors: Very few studies on" exact="ZIKV" post="NS4B protein inhibition are performed so far, mainly because"/>
   <result pre="developing resistant viruses [117,118,119]. NS5 methyltransferase inhibitors: The structure of" exact="ZIKV" post="MTase with the S-adenosyl-L-methionine (SAM) analog, sinefungin was recently"/>
   <result pre="values &amp;lt;10 mM [110]. Host proteins as drug targets: Since" exact="ZIKV" post="like other flaviviruses contains a small genome, the host"/>
   <result pre="the viral protein functions could be an attractive target for" exact="ZIKV" post="drug discovery. Moreover, broad-spectrum strategy to target host cell"/>
   <result pre="inhibit the virus-induced cytopathic effects (CPE) of several flaviviruses, including" exact="ZIKV" post="(EC50 = 142.9 mg/mL) [126]. However, poor inhibition of"/>
   <result pre="indicates that it is not a suitable candidate as a" exact="ZIKV" post="drug [111]. Other tested nucleoside biosynthesis inhibitors showed better"/>
   <result pre="promising lead candidates for further development particularly as antivirals against" exact="ZIKV" post="[127]. BCX4430 an adenosine nucleoside analog has shown EC50"/>
   <result pre="from mortality induced by a Malaysian strain (P 6â€&quot;740) of" exact="ZIKV" post="[128]. This protective efficacy of BCX4430 encourages its further"/>
   <result pre="an adenosine nucleoside analog, has also exhibited antiviral activity against" exact="ZIKV" post="in vitro with EC50 at the sub-micro molar range"/>
   <result pre="of a compound library of 100,000 small molecules based on" exact="Zika" post="RNA-dependent RNA polymerase (RdRp) structure, ten lead compounds were"/>
   <result pre="these compounds, 3-chloro-N-[(amino)carbonothioyl]-1-benzothiophene-2-carbox-amide (TPB), a non-nucleoside, was found to inhibit" exact="ZIKV" post="replication with an EC50 in submicromolar concentration (0.94 Î¼M)"/>
   <result pre="that the compound binds to the catalytic site of the" exact="ZIKV" post="RdRp, acting as an allosteric agent to block the"/>
   <result pre="vivo studies (25 mg/kg) in animals (immunocompetent mice) infected with" exact="ZIKV" post="and treating with the compound, TPB showed a reduction"/>
   <result pre="h. Thus, TPB appears to be a promising compound against" exact="ZIKV" post="infection [130]. Another non-nucleoside inhibitor, emetine was reported to"/>
   <result pre="[130]. Another non-nucleoside inhibitor, emetine was reported to potently inhibit" exact="ZIKV" post="NS5 RNA polymerase activity by binding to its active"/>
   <result pre="and significantly reduced the levels of both NS1 protein and" exact="ZIKV" post="RNA in serum and liver, respectively [131]. Host cell"/>
   <result pre="Host cell lipid biosynthesis inhibitors: Viral infections including dengue and" exact="ZIKV" post="are known to be associated with alterations in the"/>
   <result pre="pathway of cholesterol could be an attractive therapeutic approach for" exact="ZIKV" post="drug discovery. As a part of cell-based screening of"/>
   <result pre="FDA-approved drugs, Lovastatin, an HMG-CoA reductase inhibitor was tested against" exact="ZIKV" post="and found to be potent through a doseâ€&quot;response assay"/>
   <result pre="discover PHA-690509, a cyclin- dependent kinase inhibitor (CDKi), that inhibited" exact="ZIKV" post="infection with an EC50 value of 1.72 mM [94]."/>
   <result pre="tested by the group to identify nine that could inhibit" exact="ZIKV" post="replication. Among these inhibitors, seliciclib (a purine analog, also"/>
   <result pre="also known as roscovitine) and RGB-286147 were found to inhibit" exact="ZIKV" post="infection at sub micro molar concentrations [95]. From these"/>
   <result pre="that one or more host CDKs might be important for" exact="ZIKV" post="replication process as flaviviruses are not known to encode"/>
   <result pre="uncontrolled) to be a target for discovery of compounds against" exact="ZIKV" post="infection [137]. The inhibitors for the receptor seem to"/>
   <result pre="only one known disruptor, celgosvir (6-O-buta-noyl castanospermine) was tested against" exact="ZIKV" post="that showed poor activity in a CPE- based assay"/>
   <result pre="yet fully understood [141]. It was identified through screening against" exact="ZIKV" post="in SNB-19 cells showing an EC50 value of 0.37"/>
   <result pre="has yet been approved by FDA for the treatment of" exact="ZIKV" post="infection, numerous small molecules have been identified that have"/>
   <result pre="which may provide completely new class of antiviral drugs including" exact="Zika" post="drugs. The approaches should include knowledge-based drug repurposing [143],"/>
   <result pre="against ZIKV. Pursuit of repurposing strategy on known drugs against" exact="ZIKV" post="revealed that a few antimalarial drugs do possess anti-ZIKV"/>
   <result pre="antimalarial aminoquinolines, Quinacrine (QC), Mefloquine (MQ), and GSK369796 active against" exact="ZIKV" post="in in vitro assay [41]. Activities against ZIKV of"/>
   <result pre="active against ZIKV in in vitro assay [41]. Activities against" exact="ZIKV" post="of the three aminoquinolines were found to be: EC50"/>
   <result pre="to reduce filovirus infections in vitro and in vivo, including" exact="DENV" post="infection [160]. Therefore, these novel host-based targets have the"/>
   <result pre="siRNA [144] and interacting peptides [147] could be useful for" exact="ZIKV" post="drug discovery. In silico structural-bioinformatics-based methodologies and frameworks have"/>
   <result pre="and frameworks have also been developed for the design of" exact="ZIKV" post="antibodies. One of these methodologies deals with RosettaAntibodyDesign (RAbD)"/>
   <result pre="weâ€™ve got to think.â€�Ernest Rutherford This review article on the" exact="Zika" post="virus covers the following stages of modern computer-assisted approaches"/>
   <result pre="following stages of modern computer-assisted approaches in the characterization of" exact="Zika" post="virus, risk assessment, and the prevention as well as"/>
   <result pre="characterization: modelling of disease spread mechanisms, vectors, and reservoirs of" exact="ZIKV" post="(and emerging pathogens in general); (b)Internal characterization: bioinformatics-based sequence"/>
   <result pre="stages provide a holistic and proactive step-by-step approach toward combating" exact="ZIKV" post="and potential future pathogens using computational methods. 5.1. Quantitative"/>
   <result pre="potential future pathogens using computational methods. 5.1. Quantitative Characterization of" exact="ZIKV" post="Infection In the realm of mathematical epidemiology discussed in"/>
   <result pre="the SIR model have been explored for the prediction of" exact="ZIKV" post="infection [30,31,32,33,34,35,36]. Besides SIR-type models, public health management in"/>
   <result pre="and associated computational tools. Because viruses are very complex (e.g.," exact="ZIKV" post="has around 11,000 bases in its RNA), the sequences"/>
   <result pre="5) the results on applications of alignment-free methods to the" exact="Zika" post="virus based on the structure (sequence)-property similarity principle [79]"/>
   <result pre="of the orthogonal variables or PCs derived from the calculated" exact="ZIKV" post="RNA sequence descriptors is evident from the PC1 versus"/>
   <result pre="plot in Figure 4 which can clearly separate the African" exact="ZIKV" post="sequences from those from Asia and South America. With"/>
   <result pre="the SOM approach (Figure 5) is even more interesting. Here" exact="ZIKV" post="sequences from various countries and regions are clearly separated"/>
   <result pre="and pathogenicity. 5.3. Computer-Assisted Vaccine Design Development of vaccines against" exact="ZIKV" post="is being attempted. But as of now, no vaccine"/>
   <result pre="as of now, no vaccine is available for use in" exact="Zika" post="Virus infected patients. Traditional vaccine development methods with its"/>
   <result pre="made to assist in this agenda, and designs for a" exact="Zika" post="virus vaccine have already been advanced using these procedures"/>
   <result pre="sphere. 5.4. Anti-Zika Drug Discovery Since a 3D structure of" exact="ZIKV" post="protein is now known, discovery for potential anti ZIKV"/>
   <result pre="of ZIKV protein is now known, discovery for potential anti" exact="ZIKV" post="drugs can be accomplished through a combination of structure-based"/>
   <result pre="important to note that even though the 3D structure of" exact="ZIKV" post="proteins are known, specific features, such as polarization factors,"/>
   <result pre="addition, alternative targets of established 3D protein structures implicated for" exact="ZIKV" post="proteins should also be explored for ZIKV drugs. Although"/>
   <result pre="structures implicated for ZIKV proteins should also be explored for" exact="ZIKV" post="drugs. Although pharmacophore modeling has demonstrated many successes in"/>
   <result pre="summary, it may be commented that for accomplishing a successful" exact="ZIKV" post="drug discovery program, the research team should have good"/>
   <result pre="review for vaccine design; T.D. did the computation of the" exact="Zika" post="genome data for the gR values for all 310"/>
   <result pre="for all 310 sequences available; M.V. performed clustering analysis of" exact="ZIKV" post="sequences; S.C.B., S.M., A.N., A.K.B. wrote the manuscript. Funding"/>
   <result pre="âˆ’0.07488 âˆ’0.03129 References References 1.World Health Organization (WHO) Report on" exact="Zika" post="VirusAvailable online: http://www.who.int/emergencies/zika-virus/mediacentre/press-releases/en/(accessed on 7 July 2019) 2.MacNamaraF.N.Zika virus:"/>
   <result pre="History, Emergence, Biology, and Prospects for ControlAntiviral Res.2016130698010.1016/j.antiviral.2016.03.01026996139 5.MarchetteN.J.GarciaR.RudnickA.Isolation of" exact="Zika" post="virus from Aedes aegypti mosquitoes in MalaysiaAm. J. Trop."/>
   <result pre="R. Soc. Trop. Med. Hyg.19817538939310.1016/0035-9203(81)90100-06275577 7.LiangD.LeungR.K.K.LeeS.S.KamK.M.Insights into intercontinental spread of" exact="Zika" post="virusPLoS ONE201712e017671010.1371/journal.pone.017671028448611 8.WHO Report on Zika VIRUS, Microcephaly and"/>
   <result pre="into intercontinental spread of Zika virusPLoS ONE201712e017671010.1371/journal.pone.017671028448611 8.WHO Report on" exact="Zika" post="VIRUS, Microcephaly and Guillainâ€&quot;BarrÃ© SyndromeAvailable online: http://apps.who.int/iris/bitstream/handle/10665/204609/zikasitrep_10Mar2016_eng.pdf;jsessionid=F9E4895E6176562081D34C0DED1A6550?sequence=1(accessed on 7"/>
   <result pre="on 7 July 2019) 9.NandyA.BasakS.C.The Epidemic that Shook the Worldâ€&quot;The" exact="Zika" post="Virus RampageExplor. Res. Hypothesis Med.20172435610.14218/ERHM.2017.00018 10.ArmstrongN.HouW.TangQ.Biological and historical overview"/>
   <result pre="Virus RampageExplor. Res. Hypothesis Med.20172435610.14218/ERHM.2017.00018 10.ArmstrongN.HouW.TangQ.Biological and historical overview of" exact="Zika" post="virusWorld J. Virol.201761810.5501/wjv.v6.i1.128239566 11.FayeO.FreireC.C.M.IamarinoA.FayeO.de OlivieraJ.V.C.DialloM.ZanottoP.M.A.SallA.A.Molecular Evolution of Zika Virus"/>
   <result pre="overview of Zika virusWorld J. Virol.201761810.5501/wjv.v6.i1.128239566 11.FayeO.FreireC.C.M.IamarinoA.FayeO.de OlivieraJ.V.C.DialloM.ZanottoP.M.A.SallA.A.Molecular Evolution of" exact="Zika" post="Virus during Its Emergence in the 20th CenturyPLoS Negl."/>
   <result pre="16.SutharM.S.DiamondM.S.GaleM.Jr.West Nile virus infection and immunityNat. Rev. Microbiol.20131111512810.1038/nrmicro295023321534 17.NandyA.DeyS.BasakS.C.Bielinska-WazD.WazP.Characterizing the" exact="Zika" post="Virus Genomeâ€&quot;A Bioinformatics StudyCurr. Comp. Aided Drug Des.201612879710.2174/1573409912666160401115812 18.KindhauserM.K.AllenT.FrankV.SanthanaR.S.DyeC.Zika:"/>
   <result pre="a mosquito-borne virusBull. World Health Organ.20169467568610.2471/BLT.16.17108227708473 19.WHO Situation Report on" exact="Zika" post="Virus, 9th March 2017Available online: http://apps.who.int/iris/bitstream/10665/254714/1/zikasitrep10Mar17-eng.pdf(accessed on 7 July"/>
   <result pre="on 3 September 2019) 22.Cao-LormeauV.M.BlakeA.MonsS.LastereS.RocheC.VanhomwegenJ.DubT.BaudouinL.TeissierA.LarreP.et al.Guillain-BarrÃ© Syndrome outbreak associated with" exact="Zika" post="virus infection in French Polynesia: A case-control studyLancet20163871531153910.1016/S0140-6736(16)00562-626948433 23.ParraB.LizarazoJ.JorgeA.Jimenez-ArangoJ.A.Zea-VaraA.F.Gonzalez-ManriqueG.VargasJ.AngaritaJ.A.ZunigaG.Lopez-GonzalezR.et"/>
   <result pre="French Polynesia: A case-control studyLancet20163871531153910.1016/S0140-6736(16)00562-626948433 23.ParraB.LizarazoJ.JorgeA.Jimenez-ArangoJ.A.Zea-VaraA.F.Gonzalez-ManriqueG.VargasJ.AngaritaJ.A.ZunigaG.Lopez-GonzalezR.et al.Guillainâ€&quot;BarrÃ© Syndrome Associated with" exact="Zika" post="Virus Infection in ColombiaN. Engl. J. Med.20163751513152310.1056/NEJMoa160556427705091 24.Zika Virus"/>
   <result pre="29.HethcoteH.The Mathematics of Infectious DiseasesSIAM Rev.20004259965310.1137/S0036144500371907 30.SuparitP.WiratsudakulA.ModchangC.A mathematical model for" exact="Zika" post="virus transmission dynamics with a time-dependent mosquito biting rateTheor."/>
   <result pre="Med. Model.2018151110.1186/s12976-018-0083-z30064447 31.NishiuraH.MizumotoK.Villamil-GomezW.E.Rodriguez-MoralesA.J.Preliminary estimation of the basic reproduction number of" exact="Zika" post="virus infection during Colombia epidemic, 2015â€&quot;2016Trav. Med. Infect. Dis.20161427427610.1016/j.tmaid.2016.03.01627060613"/>
   <result pre="virus associated with microcephalyN. Eng. J. Med.201637495195810.1056/NEJMoa160065126862926 33.AgustoF.B.BewickS.FaganW.F.Mathematical model of" exact="Zika" post="virus with vertical transmissionInfect. Dis. Model.20172324426710.1016/j.idm.2017.05.00329928740 34.PadmanabhanP.SeshaiyerP.Castillo-ChavezC.Mathematical modeling, analysis"/>
   <result pre="Model.20172324426710.1016/j.idm.2017.05.00329928740 34.PadmanabhanP.SeshaiyerP.Castillo-ChavezC.Mathematical modeling, analysis and simulation of the spread of" exact="Zika" post="with influence of sexual transmission and preventive measuresLett. Bioinform.2017414816610.1080/23737867.2017.1319746"/>
   <result pre="Strategies to Combat the MenaceBasakS.C.BhattacharjeeA.K.NandyA.NovaNew York, NY, USA2019129152 36.WiratsudakulA.SuparitP.ModchangC.Dynamics of" exact="Zika" post="virus outbreaks: An overview of mathematical modeling approachesPeerJ20186e452610.7717/peerj.452629593941 37.HanB.MajumdarS.CalmonF.P.GlicksbergB.S.HoreshR.KumarA.PererA.von"/>
   <result pre="37.HanB.MajumdarS.CalmonF.P.GlicksbergB.S.HoreshR.KumarA.PererA.von MarschallE.B.WeiD.MojsilovicA.et al.Confronting data sparsity to identify potential sources of" exact="Zika" post="virus spillover infection among primatesEpidemics201927596510.1016/j.epidem.2019.01.00530902616 38.SahooM.JenaL.DafS.KumarS.Virtual Screening for Potential"/>
   <result pre="primatesEpidemics201927596510.1016/j.epidem.2019.01.00530902616 38.SahooM.JenaL.DafS.KumarS.Virtual Screening for Potential Inhibitors of NS3 Protein of" exact="Zika" post="VirusGenomics Inform.20161410411110.5808/GI.2016.14.3.10427729840 39.SinghA.JanaN.K.Discovery of potential Zika virus RNA polymerase"/>
   <result pre="of NS3 Protein of Zika VirusGenomics Inform.20161410411110.5808/GI.2016.14.3.10427729840 39.SinghA.JanaN.K.Discovery of potential" exact="Zika" post="virus RNA polymerase inhibitors by docking-based virtual screeningComp. Biol."/>
   <result pre="activities of selected antimalarials against dengue virus type 2 and" exact="Zika" post="virusAntivir. Res.201713714115010.1016/j.antiviral.2016.11.01527889529 42.SinigagliaA.RiccettiS.TrevisanM.BarzonL.In silico approaches to Zika virus drug"/>
   <result pre="type 2 and Zika virusAntivir. Res.201713714115010.1016/j.antiviral.2016.11.01527889529 42.SinigagliaA.RiccettiS.TrevisanM.BarzonL.In silico approaches to" exact="Zika" post="virus drug discoveryExpert Opin. Drug Discov.20181382583510.1080/17460441.2018.151590930160181 43.LucaS.MihaescuT.History of BCG"/>
   <result pre="brief reviewInt. J. Gen. Med.2009219520010.2147/IJGM.S628120360904 47.GuyB.GuirakhooF.BarbanV.HiggsS.MonathT.P.LangJ.Preclinical and clinical development of" exact="YFV" post="17D-based chimeric vaccines against dengue, West Nile and Japanese"/>
   <result pre="and clinical development of YFV 17D-based chimeric vaccines against dengue," exact="West Nile" post="and Japanese encephalitis virusesVaccine20102863264910.1016/j.vaccine.2009.09.09819808029 48.WHO Vaccine Pipeline TrackerAvailable online:"/>
   <result pre="al.Computational prediction and analysis of potential antigenic CTL epitopes in" exact="Zika" post="virus: A first step towards vaccine developmentInfect. Genet. Evol.20164518719710.1016/j.meegid.2016.08.03727590716"/>
   <result pre="and Immunoinformatics Probing Disclose the Epitope Based Peptide Vaccine Against" exact="Zika" post="Virus Envelope GlycoproteinInd. J. Pharma. Biol. Res.201424457 54.MirzaM.U.RafiqueS.AliA.MunirM.IkramN.MananA.Salo-AhenO.M.H.IdreesM.Towards peptide"/>
   <result pre="Envelope GlycoproteinInd. J. Pharma. Biol. Res.201424457 54.MirzaM.U.RafiqueS.AliA.MunirM.IkramN.MananA.Salo-AhenO.M.H.IdreesM.Towards peptide vaccines against" exact="Zika" post="virus: Immunoinformatics combined with molecular dynamics simulations to predict"/>
   <result pre="combined with molecular dynamics simulations to predict antigenic epitopes of" exact="Zika" post="viral proteinsSci. Rep.201663731310.1038/srep4463327934901 55.DeyS.DasS.NandyA.Characterization of Zika and Other Human"/>
   <result pre="predict antigenic epitopes of Zika viral proteinsSci. Rep.201663731310.1038/srep4463327934901 55.DeyS.DasS.NandyA.Characterization of" exact="Zika" post="and Other Human Infecting Flavivirus Envelope Proteins and Determination"/>
   <result pre="Epitope RegionsEC Microbiol.201782946 56.DarH.ZaheerT.RehmanM.T.AliA.JavedA.KhanG.A.BabarM.M.WaheedY.Prediction of promiscuous T-cell epitopes in the" exact="Zika" post="virus polyprotein: An in silico approachAsian Pac. J. Trop."/>
   <result pre="Trop. Med.2016984485010.1016/j.apjtm.2016.07.00427633296 57.Dos Santos FrancoL.Oliveira VidalP.AmorimJ.H.In silico design of a" exact="Zika" post="virus non-structural protein 5 aiming vaccine protection against zika"/>
   <result pre="human populationsJ. Biomed. Sci.2017248810.1186/s12929-017-0395-z29169357 58.RichnerJ.M.HimansuS.DowdK.A.ButlerS.L.SalazarV.FoxJ.M.JulanderJ.G.TangW.W.ShrestaS.PiersonT.C.et al.Modified mRNA vaccines protect against" exact="Zika" post="virus infectionCell20171681114112510.1016/j.cell.2017.02.01728222903 59.NandyA.GhoshA.NandyP.Numerical characterization of protein sequences and application"/>
   <result pre="of Human PapillomavirusCancer Inform.20161511610.4137/CIN.S39071 62.DeyS.NandyA.BasakS.C.NandyP.DasS.A Bioinformatics approach to designing a" exact="Zika" post="virus vaccineComput. Biol. Chem.20176814315210.1016/j.compbiolchem.2017.03.00228342423 63.CellisE.Getting peptide vaccines to work:"/>
   <result pre="ChoudhuryA.ZhukovN.VrackoM.Mathematical Characterization of Protein Transmembrane RegionsSci. World. J.2013201360783010.1155/2013/60783023690747 81.VrackoM.BasakS.C.NandyA.SenD.Clustering of" exact="Zika" post="viruses originating from different geographical regions using computational sequence"/>
   <result pre="drug development parametersCurr. Opin. Drug Discov.20011210210910.1124/pr.112.007336 90.MottinM.BorbaJ.V.V.B.BragaR.C.TorresP.H.M.MartiniM.C.Proenca-ModenaJ.L.JudiceC.C.CostaF.T.M.EkinsS.PerrymanA.L.et al.The Aâ€&quot;Z of" exact="Zika" post="drug discoveryDrug Discov. Today20182310.1016/j.drudis.2018.06.01429935345 91.WattersonD.ModhiranN.YoungP.R.The many faces of the"/>
   <result pre="Res.20002823524210.1093/nar/28.1.23510592235 93.BarrowsN.J.CamposR.K.PowellS.T.PrasanthK.R.Schott-LernerG.Soto-AcostaR.Galarza-MuÃ±ozG.McGrathE.L.Urrabaz-GarzaR.GaoJ.et al.A screen of FDA-approved drugs for inhibitors of" exact="Zika" post="virus infectionCell Host Microbe20162025927010.1016/j.chom.2016.07.00427476412 94.XuM.LeeE.M.WenZ.ChengY.HuangW.K.QianX.TcwJ.KouznetsovaJ.OgdenS.C.HammackC.et al.Identification of small-molecule inhibitors"/>
   <result pre="virus infectionCell Host Microbe20162025927010.1016/j.chom.2016.07.00427476412 94.XuM.LeeE.M.WenZ.ChengY.HuangW.K.QianX.TcwJ.KouznetsovaJ.OgdenS.C.HammackC.et al.Identification of small-molecule inhibitors of" exact="Zika" post="virus infection and induced neural cell death via a"/>
   <result pre="libraryF1000Research20165252310.12688/f1000research.9648.127909576 96.ZhuS.ZhangC.HuangL.S.ZhangX.Q.XuY.FangX.ZhouJ.WuM.SchooleyR.T.HuangZ.et al.Discovery and Computational Analyses of Novel Small Molecule" exact="Zika" post="Virus InhibitorsMolecules201924146510.3390/molecules24081465 97.Wilder-SmithA.VanniceK.DurbinA.HombachJ.ThomasS.J.ThevarjanI.SimmonsC.P.Zika vaccines and therapeutics: Landscape analysis and"/>
   <result pre="challenges aheadBMC Med.2018168410.1186/s12916-018-1067-x29871628 98.DelvecchioR.HigaL.M.PezzutoP.ValadaoA.L.GarcezP.P.MonteiroF.L.LoiolaE.C.DiasA.A.SilvaF.J.M.AliotaM.T.et al.Chloroquine, an Endocytosis Blocking Agent, Inhibits" exact="Zika" post="Virus Infection in Different Cell ModelsViruses2016832210.3390/v812032227916837 99.DevillersJ.Repurposing drugs for"/>
   <result pre="Infection in Different Cell ModelsViruses2016832210.3390/v812032227916837 99.DevillersJ.Repurposing drugs for use against" exact="Zika" post="virus infectionSAR QSAR Environ. Res.20182910311510.1080/1062936X.2017.141164229299939 100.OguntadeS.RamharackP.SolimanM.E.S.Characterizing the ligand-binding landscape"/>
   <result pre="virus infectionSAR QSAR Environ. Res.20182910311510.1080/1062936X.2017.141164229299939 100.OguntadeS.RamharackP.SolimanM.E.S.Characterizing the ligand-binding landscape of" exact="Zika" post="NS3 helicase-promising lead compounds as potential inhibitorsFuture Virol.20171226127310.2217/fvl-2017-0014 101.HercÃ­kK.KozakJ.SalaM.DejmekM.XuL.BeiZ.ZhangD.DouY.WangH.Viral"/>
   <result pre="101.HercÃ­kK.KozakJ.SalaM.DejmekM.XuL.BeiZ.ZhangD.DouY.WangH.Viral polymerase inhibitors T-705 and T-1105 are potential inhibitors of" exact="Zika" post="virus replicationAntivir. Res.201713713113310.1016/j.antiviral.2016.11.02027902932 102.MunjalA.KhandiaR.DhamaK.SachanS.KarthikK.TiwariR.MalikY.S.KumarD.SinghR.K.IqbalH.M.N.et al.Advances in Developing Therapies to"/>
   <result pre="virus replicationAntivir. Res.201713713113310.1016/j.antiviral.2016.11.02027902932 102.MunjalA.KhandiaR.DhamaK.SachanS.KarthikK.TiwariR.MalikY.S.KumarD.SinghR.K.IqbalH.M.N.et al.Advances in Developing Therapies to Combat" exact="Zika" post="Virus: Current Knowledge and Future PerspectivesFront. Microbiol.20178146910.3389/fmicb.2017.0146928824594 103.EkinsS.MietchenD.CoffeeM.StrattonT.P.FreundlichJ.S.Freitas-JuniorL.MuratovE.Siqueira-NetoJ.WilliamsA.J.AndradeC.Open drug"/>
   <result pre="Knowledge and Future PerspectivesFront. Microbiol.20178146910.3389/fmicb.2017.0146928824594 103.EkinsS.MietchenD.CoffeeM.StrattonT.P.FreundlichJ.S.Freitas-JuniorL.MuratovE.Siqueira-NetoJ.WilliamsA.J.AndradeC.Open drug discovery fore the" exact="Zika" post="virusF1000Research2016515010.12688/f1000research.8013.127134728 104.MicewiczE.D.KhachatoorianR.FrenchS.W.RuchalaP.Identification of novel small-molecule inhibitors of Zika virus"/>
   <result pre="fore the Zika virusF1000Research2016515010.12688/f1000research.8013.127134728 104.MicewiczE.D.KhachatoorianR.FrenchS.W.RuchalaP.Identification of novel small-molecule inhibitors of" exact="Zika" post="virus infectionBioorg. Med. Chem. Lett.20182845245810.1016/j.bmcl.2017.12.01929258771 105.NcubeN.B.RamharackP.SolimanM.E.S.An â€œAll-In-Oneâ€� Pharmacophoric Architecture"/>
   <result pre="Biotechnol.201818579981410.1007/s12010-017-2690-229349531 106.SarukhanyanE.ShityakovS.DandekarT.In Silico Designed Axl Receptor Blocking Drug Candidates Against" exact="Zika" post="VirusACS Omega201835281529010.1021/acsomega.8b0022330023915 107.PanT.PengZ.TanL.ZouF.ZhouN.LiuB.LiangL.ChenC.LiuJ.WuL.Nonsteroidal Anti-inflammatory Drugs Potently Inhibit the Replication"/>
   <result pre="VirusACS Omega201835281529010.1021/acsomega.8b0022330023915 107.PanT.PengZ.TanL.ZouF.ZhouN.LiuB.LiangL.ChenC.LiuJ.WuL.Nonsteroidal Anti-inflammatory Drugs Potently Inhibit the Replication of" exact="Zika" post="Viruses by Inducing the Degradation of AXLJ. Virol.2018269210.1128/JVI.01018-1830068645 108.LimH.J.NguyenT.T.KimN.M.ParkJ.S.JangT.J.KimD.Inhibitory"/>
   <result pre="structure activity relationshipBiotechnol. Lett.20173941544210.1007/s10529-016-2261-627885509 109.JainR.ColomaJ.Garcia-SastreA.AggarwalA.K.Structure of the NS3 helicase from" exact="Zika" post="virusNat. Struct. Mol. Biol.20162375275410.1038/nsmb.325827399257 110.EyerL.NenckaR.HuvarovaI.PalusM.Joao AlvesM.GouldE.A.De ClercqE.RÅ¯Å¾ekD.Nucleoside Inhibitors of"/>
   <result pre="Zika virusNat. Struct. Mol. Biol.20162375275410.1038/nsmb.325827399257 110.EyerL.NenckaR.HuvarovaI.PalusM.Joao AlvesM.GouldE.A.De ClercqE.RÅ¯Å¾ekD.Nucleoside Inhibitors of" exact="Zika" post="VirusJ. Infect. Dis.201621470771110.1093/infdis/jiw22627234417 111.HercikK.BryndaJ.NenckaR.BouraE.Structural basis of Zika virus methyltransferase"/>
   <result pre="ClercqE.RÅ¯Å¾ekD.Nucleoside Inhibitors of Zika VirusJ. Infect. Dis.201621470771110.1093/infdis/jiw22627234417 111.HercikK.BryndaJ.NenckaR.BouraE.Structural basis of" exact="Zika" post="virus methyltransferase inhibition by sinefunginArch. Virol.20171622091209610.1007/s00705-017-3345-x28357511 112.AdcockR.S.ChuY.K.GoldenJ.E.ChungD.H.Evaluation of anti-Zika"/>
   <result pre="high-throughput screen assayAntivir. Res.2017138475610.1016/j.antiviral.2016.11.01827919709 113.HanY.MesplÃ¨deT.Investigational drugs for the treatment of" exact="Zika" post="virus infection: A preclinical and clinical updateExpert Opin. Investig."/>
   <result pre="updateExpert Opin. Investig. Drugs20182795196210.1080/13543784.2018.1548609 114.CarneiroB.M.BatistaM.N.BragaA.C.S.NogueiraM.L.RahalP.The green tea molecule EGCG inhibits" exact="Zika" post="virus entryVirology201649621521810.1016/j.virol.2016.06.01227344138 115.RoyA.LimL.SrivastavaS.LuY.SongJ.Solution conformations of Zika NS2B-NS3pro and its"/>
   <result pre="tea molecule EGCG inhibits Zika virus entryVirology201649621521810.1016/j.virol.2016.06.01227344138 115.RoyA.LimL.SrivastavaS.LuY.SongJ.Solution conformations of" exact="Zika" post="NS2B-NS3pro and its inhibition by natural products from edible"/>
   <result pre="restricts genomic RNA replicationAntivir. Res.20139916517110.1016/j.antiviral.2013.05.01123735301 120.StephenP.BazM.BolvinG.LinS.X.Structural insight into NS5 of" exact="Zika" post="virus leading to the discovery of MTase inhibitorsJ. Am."/>
   <result pre="Targets2016171560157610.2174/138945011766615120912375126648061 128.JulanderJ.G.SiddharthanV.EvansJ.TaylorR.TolbertK.ApuliC.StewartJ.CollinsP.GebreM.NeilsonS.et al.Efficacy of the broad-spectrum antiviral compound BCX4430 against" exact="Zika" post="virus in cell culture and in a mouse modelAntivir."/>
   <result pre="modelAntivir. Res.2017137142210.1016/j.antiviral.2016.11.00327838352 129.DengY.Q.ZhangN.N.LiC.F.TianM.HaoJ.-N.XieX.-P.ShiP.-Y.QinC.-F.Adenosine analog NITD008 is a potent inhibitor of" exact="Zika" post="virusOpen Forum Infect. Dis.20163ofw17510.1093/ofid/ofw17527747251 130.PattnaikA.PalermoN.SahooB.R.YuanZ.HuD.AnnamalaiA.S.VuH.L.X.CorreasI.PrathipatiP.K.DestacheC.J.et al.Discovery of a non-nucleoside"/>
   <result pre="130.PattnaikA.PalermoN.SahooB.R.YuanZ.HuD.AnnamalaiA.S.VuH.L.X.CorreasI.PrathipatiP.K.DestacheC.J.et al.Discovery of a non-nucleoside RNA polymerase inhibitor for blocking" exact="Zika" post="virus replication through in silico screeningAntivir. Res.2018151788610.1016/j.antiviral.2017.12.01629274845 131.YangS.XuM.LeeE.M.ShiryaevS.A.HeS.SunW.ChengY.-S.HuX.TharappelA.M.LuB.et al.Emetine"/>
   <result pre="virus replication through in silico screeningAntivir. Res.2018151788610.1016/j.antiviral.2017.12.01629274845 131.YangS.XuM.LeeE.M.ShiryaevS.A.HeS.SunW.ChengY.-S.HuX.TharappelA.M.LuB.et al.Emetine inhibits" exact="Zika" post="and Ebola virus infections through two molecular mechanisms: Inhibiting"/>
   <result pre="response and autophagyFront. Microbiol.201451710.3389/fmicb.2014.0026624478763 140.KuivanenS.BespalovM.M.NandaniaJ.IanevskiA.VelagapudiV.De BrabanderJ.K.KainovD.E.VapalahtiO.Obatoclax, saliphenylhalamide and gemcitabine inhibit" exact="Zika" post="virus infection in vitro and differentially affect cellular signaling,"/>
   <result pre="with broad antiviral effectsPLoS Pathog.20128e100297610.1371/journal.ppat.100297623133371 142.ChengF.MurrayJ.L.RubinD.H.Drug repurposing: New treatments for" exact="Zika" post="virus infection?Trends Mol. Med.20162291992110.1016/j.molmed.2016.09.00627692879 143.YangH.T.JuJ.H.WongY.T.ShmulevichI.ChiangJ.H.Literature-based discovery of new candidates"/>
   <result pre="new candidates for drug repurposingBrief Bioinform.20171848849710.1093/bib/bbw03027113728 144.GiuliettiM.RighettiA.CianfrugliaL.Å abanoviÄ‡B.ArmeniT.PrincipatoG.PivaF.To accelerate the" exact="Zika" post="beat: Candidate design for RNA interference-based therapyVirus Res.201825513314010.1016/j.virusres.2018.07.01030031046 145.MengX.Y.LuoY.AnwarM.N.SunY.GaoY.ZhangH.MunirM.QiuH.-J.Long"/>
   <result pre="predicted human-Zika virus protein-protein interactionsComput. Biol. Chem.20177118018710.1016/j.compbiolchem.2017.10.01129112936 148.GoertzG.P.AbboS.R.FrosJ.J.PijlmanG.P.Functional RNA during" exact="Zika" post="virus 980 infectionVirus Res.2017254415310.1016/j.virusres.2017.08.01528864425 149.HermannT.Small molecules targeting viral RNAWiley"/>
   <result pre="by Flaviviridae virusesFront. Microbiol.20167123310.3389/fmicb.2016.0123327610098 155.LiC.ZhuX.JiX.QuanquinN.DengY.-Q.TianM.AliyariR.ZuoX.YuanL.AfridiS.K.et al.Chloroquine, a FDA-approved drug, prevents" exact="Zika" post="Virus infection and its associated congenital microcephaly in miceEBioMedicine20172418919410.1016/j.ebiom.2017.09.03429033372"/>
   <result pre="in miceEBioMedicine20172418919410.1016/j.ebiom.2017.09.03429033372 156.ShiryaevS.A.MesciP.PintoA.FernandesI.SheetsN.ShrestaS.FarhyC.HuangC.-T.StronginA.Y.MuotriA.R.et al.Repurposing of the anti-malaria drug chloroquine for" exact="Zika" post="virus treatment and prophylaxisSci. Rep.201771577110.1038/s41598-017-15467-629150641 157.HanY.MespledeT.XuH.QuanY.WainbergM.A.The antimalarial drug amodiaquine"/>
   <result pre="al.High-content screening in hPSC-neural progenitors identifies drug candidates that inhibit" exact="Zika" post="virus infection in fetal-like organoids and adult brainCell Stem"/>
   <result pre="brainCell Stem Cell20172127428310.1016/j.stem.2017.06.01728736217 159.CaoB.ParnellL.A.DiamondM.S.MysorekarI.U.Inhibition of autophagy limits vertical transmission of" exact="Zika" post="virus in pregnant miceJ. Exp. Med.20172142303231310.1084/jem.2017095728694387 160.WarfieldK.L.WarrenT.K.QiuX.WellsJ.MireC.E.GeisbertJ.B.StuthmanK.S.GarzaN.L.Van TongerenS.A.ShurtleffA.C.et al.Assessment"/>
   <result pre="invertebrate hostsâ€™Phil. Trans. R. Soc. B201437010.1098/rstb.2014.030725750231 168.GaoD.LouY.HeD.PorcoT.C.KuangY.ChowellG.RuanS.Prevention and Control of" exact="Zika" post="as a Mosquito-Borne and Sexually Transmitted Disease: A Mathematical"/>
   <result pre="Attribution License from [12]. Figure 2 Phylogenetic tree of 22" exact="ZIKV" post="genome sequences [17]. Each sequence is identified with its"/>
   <result pre="Publishers, www.benthamscience.com. Figure 3 The 2D graphical representation of the" exact="Zika" post="virus whole genome (GenBank Locus ID KY241706), methodology as"/>
   <result pre="y-axis. Figure 4 Principal component analysis (PCA) score plots of" exact="ZIKV" post="strains from different continents. Figure 5 Distribution of objects"/>
   <result pre="flavivirus genome including UTRs. Typical sequence length data taken from" exact="ZIKV" post="isolate ZIKV/H. sapiens/Brazil/PE243/2015 (GenBank Locus ID KX197192), complete genome."/>
   <result pre="and translation. pharmaceuticals-12-00157-t002_Table 2Table 2 The pre-epidemics period of the" exact="Zika" post="virus after its detection in 1947. A. africanus: Aedes"/>
   <result pre="after its detection in 1947. A. africanus: Aedes africanus; ZIKV:" exact="Zika" post="virus. Year Country Remarks 1947 Uganda First isolation and"/>
   <result pre="identification of ZIKV. Found in rhesus monkey, R766, caged in" exact="Zika" post="forest. 1948 Uganda Detected in A. africanus mosquitoes. Found"/>
   <result pre="forest. 1948 Uganda Detected in A. africanus mosquitoes. Found in" exact="Zika" post="forest. 1951 Nigeria First instance of ZIKV antibodies in"/>
   <result pre="mosquitoes. Found in Zika forest. 1951 Nigeria First instance of" exact="ZIKV" post="antibodies in human blood, found in children. 1952 Uganda,"/>
   <result pre="found in children. 1952 Uganda, Tanganyika First human cases of" exact="ZIKV" post="infection detected. India ZIKV antibodies found in human blood."/>
   <result pre="Uganda, Tanganyika First human cases of ZIKV infection detected. India" exact="ZIKV" post="antibodies found in human blood. 1953 Malaya, North Borneo,"/>
   <result pre="antibodies found in human blood. 1953 Malaya, North Borneo, Philippines" exact="ZIKV" post="antibodies found in residents. Nigeria ZIKV infection detected in"/>
   <result pre="Malaya, North Borneo, Philippines ZIKV antibodies found in residents. Nigeria" exact="ZIKV" post="infection detected in three persons. 1954 Egypt, Vietnam ZIKV"/>
   <result pre="Nigeria ZIKV infection detected in three persons. 1954 Egypt, Vietnam" exact="ZIKV" post="antibodies found in few residents. 1955 Nigeria ZIKV antibodies"/>
   <result pre="Egypt, Vietnam ZIKV antibodies found in few residents. 1955 Nigeria" exact="ZIKV" post="antibodies found in human blood. 1957 Mozambique ZIKV antibodies"/>
   <result pre="1955 Nigeria ZIKV antibodies found in human blood. 1957 Mozambique" exact="ZIKV" post="antibodies found in human blood. 1958 Uganda Two strains"/>
   <result pre="antibodies found in human blood. 1958 Uganda Two strains of" exact="ZIKV" post="found in A. aegypti mosquitoes in Zika forest. 1960"/>
   <result pre="Two strains of ZIKV found in A. aegypti mosquitoes in" exact="Zika" post="forest. 1960 Angola ZIKV antibodies found in indigenous residents."/>
   <result pre="found in A. aegypti mosquitoes in Zika forest. 1960 Angola" exact="ZIKV" post="antibodies found in indigenous residents. 1961â€&quot;1962 Central African Republic"/>
   <result pre="ZIKV antibodies found in indigenous residents. 1961â€&quot;1962 Central African Republic" exact="ZIKV" post="antibodies found in human blood. 1961â€&quot;1964 Ethiopia ZIKV antibodies"/>
   <result pre="African Republic ZIKV antibodies found in human blood. 1961â€&quot;1964 Ethiopia" exact="ZIKV" post="antibodies found in human blood. 1962 Senegal ZIKV antibodies"/>
   <result pre="1961â€&quot;1964 Ethiopia ZIKV antibodies found in human blood. 1962 Senegal" exact="ZIKV" post="antibodies found in human blood. 1963â€&quot;1964 Central African Republic,"/>
   <result pre="antibodies found in human blood. 1963â€&quot;1964 Central African Republic, Burkina-Faso" exact="ZIKV" post="antibodies found in human blood. 1963â€&quot;1965 Ivory Coast ZIKV"/>
   <result pre="Burkina-Faso ZIKV antibodies found in human blood. 1963â€&quot;1965 Ivory Coast" exact="ZIKV" post="antibodies found in human blood. 1964 Uganda First confirmation"/>
   <result pre="antibodies found in human blood. 1964 Uganda First confirmation that" exact="ZIKV" post="causes human disease.Clinical features reported. 1964â€&quot;1965 Guinea-Bissau ZIKV antibodies"/>
   <result pre="confirmation that ZIKV causes human disease.Clinical features reported. 1964â€&quot;1965 Guinea-Bissau" exact="ZIKV" post="antibodies found in human blood. 1964â€&quot;1966 Togo, Cameroon ZIKV"/>
   <result pre="Guinea-Bissau ZIKV antibodies found in human blood. 1964â€&quot;1966 Togo, Cameroon" exact="ZIKV" post="antibodies found in human blood. 1965 Niger ZIKV antibodies"/>
   <result pre="Togo, Cameroon ZIKV antibodies found in human blood. 1965 Niger" exact="ZIKV" post="antibodies found in human blood. 1965â€&quot;1967 Nigeria ZIKV antibodies"/>
   <result pre="1965 Niger ZIKV antibodies found in human blood. 1965â€&quot;1967 Nigeria" exact="ZIKV" post="antibodies found in human blood. 1967 Benin, Gabon, Liberia"/>
   <result pre="ZIKV antibodies found in human blood. 1967 Benin, Gabon, Liberia" exact="ZIKV" post="antibodies found in human blood. 1966â€&quot;1967 Uganda, Kenya, Somalia,"/>
   <result pre="antibodies found in human blood. 1966â€&quot;1967 Uganda, Kenya, Somalia, Morocco" exact="ZIKV" post="antibodies found in human blood. 1967â€&quot;1969 Uganda ZIKV antibodies"/>
   <result pre="Somalia, Morocco ZIKV antibodies found in human blood. 1967â€&quot;1969 Uganda" exact="ZIKV" post="antibodies found in human blood. 1968 Kenya ZIKV antibodies"/>
   <result pre="1967â€&quot;1969 Uganda ZIKV antibodies found in human blood. 1968 Kenya" exact="ZIKV" post="antibodies found in human blood. 1969â€&quot;1972 Nigeria ZIKV antibodies"/>
   <result pre="1968 Kenya ZIKV antibodies found in human blood. 1969â€&quot;1972 Nigeria" exact="ZIKV" post="antibodies found in human blood. 1969 Malaysia ZIKV found"/>
   <result pre="1969â€&quot;1972 Nigeria ZIKV antibodies found in human blood. 1969 Malaysia" exact="ZIKV" post="found in A. aegypti mosquitoes. 1969â€&quot;1983 Indonesia, Malaysia, Pakistan"/>
   <result pre="ZIKV found in A. aegypti mosquitoes. 1969â€&quot;1983 Indonesia, Malaysia, Pakistan" exact="ZIKV" post="found in mosquitoes.Sporadic human infections. 1970 Nigeria ZIKV antibodies"/>
   <result pre="Malaysia, Pakistan ZIKV found in mosquitoes.Sporadic human infections. 1970 Nigeria" exact="ZIKV" post="antibodies found in human blood. 1971â€&quot;1972 Angola ZIKV antibodies"/>
   <result pre="1970 Nigeria ZIKV antibodies found in human blood. 1971â€&quot;1972 Angola" exact="ZIKV" post="antibodies found in human blood. 1972,1975, 1988,1990 Senegal ZIKV"/>
   <result pre="Angola ZIKV antibodies found in human blood. 1972,1975, 1988,1990 Senegal" exact="ZIKV" post="antibodies found in human blood. 1979 Central African Republic"/>
   <result pre="ZIKV antibodies found in human blood. 1979 Central African Republic" exact="ZIKV" post="antibodies found in human blood. 1980 Nigeria ZIKV antibodies"/>
   <result pre="African Republic ZIKV antibodies found in human blood. 1980 Nigeria" exact="ZIKV" post="antibodies found in human blood. 1984 Uganda ZIKV antibodies"/>
   <result pre="1980 Nigeria ZIKV antibodies found in human blood. 1984 Uganda" exact="ZIKV" post="antibodies found in human blood. 1996â€&quot;1997 Malaysia ZIKV antibodies"/>
   <result pre="1984 Uganda ZIKV antibodies found in human blood. 1996â€&quot;1997 Malaysia" exact="ZIKV" post="antibodies found in human blood. 1999 Ivory Coast ZIKV"/>
   <result pre="Malaysia ZIKV antibodies found in human blood. 1999 Ivory Coast" exact="ZIKV" post="antibodies found in human blood. pharmaceuticals-12-00157-t003_Table 3Table 3 A"/>
   <result pre="in human blood. pharmaceuticals-12-00157-t003_Table 3Table 3 A brief summary of" exact="ZIKV" post="epidemics, 2007 to present. Data summarized from [18,19]. Year"/>
   <result pre="home country and passing infection through sexual contact. 2010 Cameroon" exact="ZIKV" post="antibodies found in human blood. 2010â€&quot;2015 Cambodia, Indonesia, Malaysia,"/>
   <result pre="2010â€&quot;2015 Cambodia, Indonesia, Malaysia, Philippines, Thailand, Maldives Mosquito transmission of" exact="ZIKV" post="in these countries to travelers who then carried the"/>
   <result pre="their home countries. 2011â€&quot;2014 French Polynesia Second reported outbreak of" exact="ZIKV" post="infections. Connection with microcephaly and neurological disorders established later."/>
   <result pre="and neurological disorders established later. 2013â€&quot;2014 Chile, Cook Islands,New Caledonia" exact="ZIKV" post="outbreak. 2013 Tahiti ZIKV isolated from patientâ€™s semen showing"/>
   <result pre="later. 2013â€&quot;2014 Chile, Cook Islands,New Caledonia ZIKV outbreak. 2013 Tahiti" exact="ZIKV" post="isolated from patientâ€™s semen showing sexual transmissibility. 2014 Zambia"/>
   <result pre="ZIKV isolated from patientâ€™s semen showing sexual transmissibility. 2014 Zambia" exact="ZIKV" post="antibodies found in human blood. 2015 April/May Brazil, Bahia"/>
   <result pre="Brazil, Bahia state National Reference Laboratory, Brazil confirmed, by PCR," exact="ZIKV" post="infections, for the first time in the Americas. 2015"/>
   <result pre="for the first time in the Americas. 2015 July Brazil" exact="Zika" post="cases confirmed by laboratory tests in 12 states. Neurological"/>
   <result pre="America Colombia, Republic of Cabo Verde report confirmed cases of" exact="ZIKV" post="infections.Brazil reported unusual increase in the number of cases"/>
   <result pre="declared a national public health emergency. Brazil reported detection of" exact="ZIKV" post="in amniotic fluid of fetuses with confirmed microcephaly. Suriname,"/>
   <result pre="Suriname, Panama, El Salvador, Guatemala, and Paraguay confirmed cases of" exact="ZIKV" post="infection. The Pan American Health Organization and WHO issued"/>
   <result pre="issued an epidemiological alert. 2015 November Mexico Three cases of" exact="ZIKV" post="infection confirmed by PCR. 2015 November French Polynesia Retrospective"/>
   <result pre="America Honduras, French Guiana, and Martinique reported confirmed cases of" exact="ZIKV" post="infections. 2015 December Puerto Rico First confirmed case of"/>
   <result pre="ZIKV infections. 2015 December Puerto Rico First confirmed case of" exact="Zika" post="infection reported. 2016 Maldives Finnish national working in Maldivestested"/>
   <result pre="reported. 2016 Maldives Finnish national working in Maldivestested positive for" exact="Zika" post="after return to Finland. 2016 January Americas Guyana reported"/>
   <result pre="Americas Guyana reported the first PCR-confirmed case of locally acquired" exact="Zika" post="infection.Ecuador, Bolivia, Barbados, Haiti, Dominican Republic, Nicaragua, Curacao and"/>
   <result pre="Nicaragua, Curacao and Jamaica reported the first confirmed cases of" exact="Zika" post="infections.First case of Zika in St. Martin reported. 2016"/>
   <result pre="reported the first confirmed cases of Zika infections.First case of" exact="Zika" post="in St. Martin reported. 2016 January US Virgin Islands"/>
   <result pre="reported. 2016 January US Virgin Islands First confirmed case of" exact="Zika" post="in St. Croix reported. 2016 February Americas First confirmed"/>
   <result pre="St. Croix reported. 2016 February Americas First confirmed case of" exact="ZIKV" post="infection in Chile reported.First case of sexually transmitted Zika"/>
   <result pre="of ZIKV infection in Chile reported.First case of sexually transmitted" exact="Zika" post="infection in Texas, USA reported. 2016 Various countries Angola,"/>
   <result pre="Papua New Guinea, and other countries report first cases of" exact="ZIKV" post="infections. 2016 Singapore ZIKV infection reported. 2016/2017 India Three"/>
   <result pre="other countries report first cases of ZIKV infections. 2016 Singapore" exact="ZIKV" post="infection reported. 2016/2017 India Three cases of ZIKV infection"/>
   <result pre="2016 Singapore ZIKV infection reported. 2016/2017 India Three cases of" exact="ZIKV" post="infection reported in Ahmedabad. 2017 Singapore Several cases of"/>
   <result pre="reported in Ahmedabad. 2017 Singapore Several cases of locally transmitted" exact="ZIKV" post="confirmed. pharmaceuticals-12-00157-t004_Table 4Table 4 gR values of all sequences"/>
   <result pre="pharmaceuticals-12-00157-t004_Table 4Table 4 gR values of all sequences of the" exact="Zika" post="virus genome with 10,272 identified bases and selected hosts"/>
   <result pre="compounds led to twenty compounds that were found to reduce" exact="ZIKV" post="infection [93] NIH clinical library of compounds By screening"/>
   <result pre="ibuprofen, naproxen, acetaminophen, and lornoxicam, potently inhibited the entry of" exact="Zika" post="virus Env/HIV-1-pseudotyped viruses Inhibited replication of wild-type ZIKV both"/>
   <result pre="entry of Zika virus Env/HIV-1-pseudotyped viruses Inhibited replication of wild-type" exact="ZIKV" post="both in cell lines and in primary human fetal"/>
   <result pre="favorable selective index (SI) values. In a mouse model of" exact="ZIKV" post="infection (300 mg/kg/d), treatment with BCX4430 showed promising results."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC6964091\results\search\tropicalVirus\results.xml">
   <result pre="to Cholera, Measles, Meningitis and Viral Haemorrhagic Diseases (Crimean Congo," exact="Dengue" post="Fever, Ebola Virus Disease, Lassa Fever, Marburg Virus Disease,"/>
   <result pre="Viral Haemorrhagic Diseases, such as Ebola Virus Disease, Yellow Fever," exact="Dengue" post="Fever, Lassa Fever, and Rift Valley Fever. Other causes"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC6979359\results\search\tropicalVirus\results.xml">
   <result pre="data made available in this article, unless otherwise stated. Abstract" exact="Yellow fever" post="(YF) is an acute viral disease, affecting humans and"/>
   <result pre="epidemiological aspects, new clinical findings in humans, and issues regarding" exact="YFV" post="infection in vectors and NHP in Brazil. The 2016â€&quot;2019"/>
   <result pre="higher than total cases in the previous 36â€‰years. A new" exact="YFV" post="lineage was associated with the recent outbreaks, with persistent"/>
   <result pre="human case suggested the occurrence of the urban transmission cycle." exact="YFV" post="was detected in a variety of NHP specimens presenting"/>
   <result pre="YF surveillance, control, and future strategies for NHP conservation. Keywords" exact="Yellow fever" post="virus Yellow fever Arbovirus Flavivirus Non-human primate Epizootic Outbreak"/>
   <result pre="and future strategies for NHP conservation. Keywords Yellow fever virus" exact="Yellow fever" post="Arbovirus Flavivirus Non-human primate Epizootic Outbreak Epidemiology Vector Pathogenesis"/>
   <result pre="Funding National Council for Scientific and Technological Development (CNPq)440593/2016-6 Background" exact="Yellow fever" post="virus (YFV) causes yellow fever (YF), an acute disease"/>
   <result pre="and NHP [2, 7â€&quot;9]. Most of the experimental studies with" exact="YFV" post="were performed with Old World NHP, but little is"/>
   <result pre="in Neotropical NHP. Neotropical NHP are considered highly susceptible to" exact="YFV" post="infection [10], which may be related to the recent"/>
   <result pre="in the country. Main text The virus and transmission cycle" exact="YFV" post="is the prototype member of the genus Flavivirus (family"/>
   <result pre="NS2B, NS3, NS4A, NS4B, and NS5) [11]. Until now, one" exact="YFV" post="serotype and seven genotypes have been described in Africa"/>
   <result pre="and Aedes bromeliae as vectors [12, 13]. In South America," exact="YFV" post="is endemic in the Amazon Basin (Brazil, Peru, Bolivia,"/>
   <result pre="mosquitoes primarily belonging to the genera Haemagogus and Sabethes [15]." exact="YFV" post="South American I and II genotypes are derived from"/>
   <result pre="African genotype [16, 17]. South American I is the predominant" exact="YFV" post="genotype in Brazil, possessing five distinct lineages 1A-1E [17,"/>
   <result pre="endemic areas in North Brazil [20, 21]. Genomic analyses of" exact="YFV" post="causing the recent outbreaks revealed unique mutations leading to"/>
   <result pre="of hospitalization, the child died, and postmortem analysis showed wild-type" exact="YFV" post="RNA in the cerebrospinal fluid [29]. The persistence of"/>
   <result pre="in the cerebrospinal fluid [29]. The persistence of the wild-type" exact="YFV" post="genome has been demonstrated in serum [28] and in"/>
   <result pre="after the onset of symptoms, respectively. These findings indicate that" exact="YFV" post="might persist in the host for more extended periods"/>
   <result pre="factors related to the host and the phase of infection." exact="Yellow fever" post="surveillance and control Since all South American NHP are"/>
   <result pre="control Since all South American NHP are highly susceptible to" exact="YFV" post="infection, and epizootics often precede human cases, NHP can"/>
   <result pre="tests [33]. Immunohistochemistry and histopathology analyses allow the detection of" exact="YFV" post="antigens and the identification of histological alterations observed in"/>
   <result pre="infection of monkeys by other flaviviruses, some studies have detected" exact="Zika" post="virus RNA in NHP, during the latest YFV outbreaks"/>
   <result pre="have detected Zika virus RNA in NHP, during the latest" exact="YFV" post="outbreaks in Brazil [34, 35]. Faced with this, molecular"/>
   <result pre="the most reliable and specific tool to diagnose and confirm" exact="YFV" post="infection. YF laboratory diagnosis is performed through virologic or"/>
   <result pre="Reference Laboratories linked to the MOH. For molecular detection of" exact="YFV" post="RNA by RT-qPCR, sera collected from the first up"/>
   <result pre="onset of symptoms is recommended, and the positive result confirms" exact="YFV" post="infection. Serological tests, especially MAC-ELISA to detect IgM antibodies,"/>
   <result pre="other flaviviruses, which are widespread throughout the same regions of" exact="YFV" post="occurrence, the detection of IgM anti-YFV is only presumptive"/>
   <result pre="Finally, epizootics surveillance programs could fail in early detection of" exact="YFV" post="circulation, due to the loss of naÃ¯ve sentinel NHP."/>
   <result pre="yellow fever in Brazil During the 18th and 19th centuries," exact="YFV" post="caused devastating urban outbreaks in the Americas, and it"/>
   <result pre="de Janeiro, and Bahia states in 2017 [4, 5]. The" exact="YFV" post="lineage causing this outbreak was estimated to exist for"/>
   <result pre="in the Southeast region, which was later confirmed [54, 57]." exact="YFV" post="cases occurred until 2018 [53, 54] in Minas Gerais,"/>
   <result pre="males aged 14 to 35, who are more exposed to" exact="YFV" post="by occupational or ecotourism activities in rural and sylvatic"/>
   <result pre="Brazilian Ministry of Health Brazil and State Health Departments [60â€&quot;73]" exact="Yellow fever" post="virus vectors in Brazil Unlike NHP and humans, which"/>
   <result pre="heal by developing long-term immunity, mosquitoes are considered reservoirs of" exact="YFV" post="since they remain infected and can transmit the virus"/>
   <result pre="cyaneus, S. glaucodaemon, and S. albiprivus) are the primary sylvatic" exact="YFV" post="vectors [2, 33, 75]. YFV-naturally infected specimens of Aedes"/>
   <result pre="reported in Brazil, however, these mosquitoes are not considered primary" exact="YFV" post="vectors [75â€&quot;79]. H. janthinomys and H. leucocelaenus have a"/>
   <result pre="in the South American continent and are considered the main" exact="YFV" post="vectors in the Americas and South/Southeast Brazil, respectively [80,"/>
   <result pre="chloropterus is limited to forest areas and considered the primary" exact="YFV" post="sylvatic vector. Their eggs can persist through the dry"/>
   <result pre="the dry season, which is probably a key factor in" exact="YFV" post="maintenance through unfavorable dry periods [86]. Sylvatic YFV vectors"/>
   <result pre="factor in YFV maintenance through unfavorable dry periods [86]. Sylvatic" exact="YFV" post="vectors are abundant in the treetops, with daytime activity"/>
   <result pre="93]. Experimental studies have demonstrated that A. albopictus can transmit" exact="YFV" post="[77, 94â€&quot;96], and it was found naturally infected with"/>
   <result pre="anthropophilic and endophilic habits and is the urban vector of" exact="YFV" post="[81]. Despite the sensitivity to YFV infection and the"/>
   <result pre="the urban vector of YFV [81]. Despite the sensitivity to" exact="YFV" post="infection and the high infestation indices of A. aegypti"/>
   <result pre="Brazil [75, 77, 98, 99], there is no evidence of" exact="YFV" post="transmission by A. aegypti, since the eradication of urban"/>
   <result pre="degraded habitats [104, 105]. Neotropical NHP are potential hosts for" exact="YFV" post="due to their ecological and behavioral patterns and their"/>
   <result pre="favor of hematophagous mosquitoes and, consequently, the transmission of viruses." exact="Yellow fever" post="in non-human primates Old World NHP are sensitive to"/>
   <result pre="fever in non-human primates Old World NHP are sensitive to" exact="YFV" post="and develop enough viremia to reinfect mosquitoes but rarely"/>
   <result pre="they show clinical signs or die. In Africa, the primary" exact="YFV" post="amplifier hosts are Cercopithecus spp. (with viremia lasting for"/>
   <result pre="and possibly Galago senegalensis could be infected and contribute to" exact="YFV" post="transmission [7]. Serological and clinical findings related to YFV"/>
   <result pre="to YFV transmission [7]. Serological and clinical findings related to" exact="YFV" post="infection are described in many Neotropical NHP [112â€&quot;114]. All"/>
   <result pre="NHP [112â€&quot;114]. All Neotropical NHP genera are considered susceptible to" exact="YFV" post="infection with differing degrees of sensitivity [115, 116]. Early"/>
   <result pre="sensitivity [115, 116]. Early reports in Brazil showed antibodies against" exact="YFV" post="in specimens of Cebus, Callithrix, and Leontopithecus, in Mato"/>
   <result pre="states [117â€&quot;119]. An extensive immunological survey detected humoral immunity against" exact="YFV" post="in Alouatta, Ateles, Aotus, Callicebus, Callithrix, Cebus, Brachyteles, Leontopithecus,"/>
   <result pre="[121]. Alouatta is described as the most susceptible genus to" exact="YFV" post="infection, developing clinical illness and fatal disease [114, 122,"/>
   <result pre="123], even when infected with low virus inoculum [2]. However," exact="YFV" post="antibodies have been detected in some specimens of Alouatta,"/>
   <result pre="sudden silence is considered a signal for the circulation of" exact="YFV" post="[33, 89]. High numbers of NHP deaths, especially of"/>
   <result pre="of Callithrix are also involved in the sylvatic cycle of" exact="YFV" post="in Brazil. Experimental studies demonstrated the susceptibility of Callithrix"/>
   <result pre="susceptibility of Callithrix albicolis, Callithrix penicillata, and hybrids marmosets to" exact="YFV" post="[113]. Wild specimens of C. penicillata presenting histopathological findings"/>
   <result pre="Wild specimens of C. penicillata presenting histopathological findings suggestive of" exact="YFV" post="infection, and marmosets showing anti-YFV antibodies have been reported"/>
   <result pre="states [53]. From 2017 on, genomic and epidemiological studies described" exact="YFV" post="infection in NHP in the Southeast region of Brazil."/>
   <result pre="that some species of Callithrix may have different sensitivity to" exact="YFV" post="when compared to Alouatta spp. and Sapajus spp. [20]."/>
   <result pre="Basin, a YF endemic region, could be more resistant to" exact="YFV" post="compared to NHP from YFV-free areas. Besides other ecological"/>
   <result pre="139]. The first successful infection of a rhesus monkey with" exact="YFV" post="was demonstrated in 1928, by Stokes and colleagues (1928)."/>
   <result pre="cells [141]. In general, NHP exhibit the viscerotropic disease, and" exact="YFV" post="can be found in the liver, kidneys, bone marrow,"/>
   <result pre="edema in lungs and eyelid, and hyperemia of the eyelid." exact="YFV" post="RNA was detected in the lungs, liver, kidneys, bladder,"/>
   <result pre="intestine, suggesting that the pathological picture was probably caused by" exact="YFV" post="[137]. Fernandes and colleagues (2017) performed histologic analyses of"/>
   <result pre="latest YF outbreak in Brazil are an alert. A new" exact="YFV" post="lineage was associated with the 2016â€&quot;2019 outbreaks. However, whether"/>
   <result pre="Genomic surveillance and evolutionary studies demonstrated the sustained circulation of" exact="YFV" post="before December 2016 until 2019, reaching extensive YF-free areas"/>
   <result pre="was described in Leontopithecus rosalia. NHP are amplifier hosts for" exact="YFV" post="but are not viral reservoirs since they die or"/>
   <result pre="studies to better understand the duration of protective immunity against" exact="YFV" post="in NHP are required. Further investigation of viremia in"/>
   <result pre="Neotropical NHP could contribute to the assessment of sensitivity to" exact="YFV" post="and the potential for vector infection. This information is"/>
   <result pre="cycle. Further studies to understand the role of NHP in" exact="YFV" post="circulation in different environments are needed, as well as"/>
   <result pre="Ministry of Health TCID50 Median tissue culture infectious dose YF" exact="Yellow fever" post="YFV Yellow fever virus Publisherâ€™s Note Springer Nature remains"/>
   <result pre="Health TCID50 Median tissue culture infectious dose YF Yellow fever" exact="YFV" post="Yellow fever virus Publisherâ€™s Note Springer Nature remains neutral"/>
   <result pre="TCID50 Median tissue culture infectious dose YF Yellow fever YFV" exact="Yellow fever" post="virus Publisherâ€™s Note Springer Nature remains neutral with regard"/>
   <result pre="2.VasconcelosPFCYellow feverRev Soc Bras Med Trop20033627529310.1590/S0037-8682200300020001212806465 3.Maguire HCF, Heymann DL." exact="Yellow fever" post="in Africa. BMJ. 2016:i3764. 4.MS-BR. Centro de OperaÃ§Ãµes deÂ"/>
   <result pre="N, Mesquita F, Zanotto P, et al. First detection of" exact="Zika" post="virus in neotropical primates in Brazil: a possible new"/>
   <result pre="Parra MCP, Del Sarto JL, et al. Evidence of natural" exact="Zika" post="virus infection in neotropical non-human primates in Brazil. Sci"/>
   <result pre="from: http://portalarquivos.saude.gov.br/images/pdf/2017/outubro/06/Volume-Unico-2017.pdf [cited 2019 Jul 18] 53.DelatorreEde AbreuFVSRibeiroIPGÃ³mezMMdos SantosAACFerreira-de-BritoAet al.Distinct" exact="YFV" post="lineages co-circulated in the Central-Western and southeastern Brazilian regions"/>
   <result pre="SoaresDutraMaria Rita TeixeiraRamalhoDario Brockde ThoisyBenoitKroonErna GeessienTrindadeGiliane de SouzaDrumondBetÃ¢nia PaivaPersistence of" exact="Yellow fever" post="virus outside the Amazon Basin, causing epidemics in Southeast"/>
   <result pre="E, da Fonseca DF, Sallum MAM, Noll CA, et al." exact="Yellow fever" post="virus in Haemagogus leucocelaenus and Aedes serratus mosquitoes, southern"/>
   <result pre="PL, Pinheiro FP, Pissinatti A, da Cunha RV, et al." exact="Yellow fever" post="outbreak in Brazil: the puzzle of rapid viral spread"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC6985921\results\search\tropicalVirus\results.xml">
   <result pre="A significant number of GBS cases were also inflicted by" exact="Zika" post="virus infection. After a large-scale vaccination campaign in 1976"/>
   <result pre="as herpes simplex virus (HSV), cytomegalovirus (CMV), Epsteinâ€&quot;Barr virus (EBV)," exact="Zika" post="virus (ZIKV), Mycoplasma pneumoniae, Haemophilus influenza, and influenza have"/>
   <result pre="what has changed?Trop Med Int Health2019241324230444562 22JavanianMMasrour-RoudsariJEbrahimpourSClinical diagnosis challenges in" exact="Zika" post="virus infectionCaspian J Intern Med20189416730510661 23VellozziCIqbalSBroderKGuillain-BarrÃ© Syndrome, Influenza, and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC6986850\results\search\tropicalVirus\results.xml">
   <result pre="2014;69:351â€&quot;82. 10.1093/jhmas/jrs06123090980 16. CovelloVT, PetersRG, WojteckiJG, HydeRC. Risk communication, the" exact="West Nile" post="virus epidemic, and bioterrorism: responding to the communication challenges"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC6988270\results\search\tropicalVirus\results.xml">
   <result pre="assays.Viruses. 2015;7(6):3130-54. 10.3390/v706276326090727 11CormanVMRascheABarontiCAldabbaghSCadarDReuskenCBet al.Assay optimization for molecular detection of" exact="Zika" post="virus.Bull World Health Organ. 2016;94(12):880-92. 10.2471/BLT.16.17595027994281 12FischerCde LamballerieXDrexlerJFEnhanced molecular"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC6993835\results\search\tropicalVirus\results.xml">
   <result pre="Louis encephalitis virus Â Â Â Â â€¢Â Â Â" exact="West Nile" post="virus Â Â Â Â â€¢Â Â Â Murray"/>
   <result pre="Â Shigella encephalopathy Â Â Â Â â€¢Â Â Â" exact="Dengue" post="encephalopathy Â Â Â Â â€¢Â Â Â Sepsis"/>
   <result pre="of encephalitis in the southern state of Kerela 19, 20." exact="Dengue" post="infection was known to produce neurologic manifestations, including encephalopathy,"/>
   <result pre="worldwide with little seasonal or age and sex predilection 4." exact="West Nile" post="encephalitis virus was introduced in the US in the"/>
   <result pre="in India.PLoS Negl Trop Dis.2019;13(6):e0007393. 10.1371/journal.pntd.000739331246966 F1000 Recommendation 21LumLCLamSKChoyYSet al.:" exact="Dengue" post="encephalitis: a true entity?Am J Trop Med Hyg.1996;54(3):256â€&quot;9. 10.4269/ajtmh.1996.54.2568600761"/>
   <result pre="a true entity?Am J Trop Med Hyg.1996;54(3):256â€&quot;9. 10.4269/ajtmh.1996.54.2568600761 22KumarRTripathiSTambeJJet al.:" exact="Dengue" post="encephalopathy in children in Northern India: clinical features and"/>
   <result pre="10.1186/s13071-019-3515-731133059 F1000 Recommendation 26YeungMWShingENelderMet al.: Epidemiologic and clinical parameters of" exact="West Nile" post="virus infections in humans: a scoping review.BMC Infect Dis.2017;17(1):"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC6995199\results\search\tropicalVirus\results.xml">
   <result pre="500â€‰U/mL penicillin (Cristalia), and 50â€‰Î¼g/mL streptomycin (Schering-Plough, SÃ£o Paulo, Brazil)." exact="YFV" post="(vaccine strain 17DD), MAYV (Strain BeAr20290), CHIKV (Genotype ECSA"/>
   <result pre="SÃ£o Paulo, Brazil). YFV (vaccine strain 17DD), MAYV (Strain BeAr20290)," exact="CHIKV" post="(Genotype ECSA â€&quot; Strain BHI3762/H804917, kindly provided by Dr."/>
   <result pre="plaques generated by arbovirus infection in the Vero cell monolayers." exact="YFV" post="generated largely undefined edge lysis plaques that included numerous"/>
   <result pre="edge lysis plaques that included numerous stretched cells (Fig.Â 3)." exact="CHIKV" post="presented large circular plaques, while MAYV showed small undefined"/>
   <result pre="Virus Goes Viral educational kit. Abbreviations APMV Acanthamoeba polyphaga mimivirus" exact="CHIKV" post="Chikungunya virus CPEs Cytopathic effects CPXV Cowpoxvirus CVG Cedratvirus"/>
   <result pre="Goes Viral educational kit. Abbreviations APMV Acanthamoeba polyphaga mimivirus CHIKV" exact="Chikungunya" post="virus CPEs Cytopathic effects CPXV Cowpoxvirus CVG Cedratvirus DNA"/>
   <result pre="PYG Peptone-yeast extract with glucose TPV Tupanvirus VACV Vaccinia virus" exact="YFV" post="Yellow fever virus Publisherâ€™s Note Springer Nature remains neutral"/>
   <result pre="Peptone-yeast extract with glucose TPV Tupanvirus VACV Vaccinia virus YFV" exact="Yellow fever" post="virus Publisherâ€™s Note Springer Nature remains neutral with regard"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7000767\results\search\tropicalVirus\results.xml">
   <result pre="Association of past dengue fever epidemics with the risk of" exact="Zika" post="microcephaly at the population level in Brazil http://orcid.org/0000-0002-9566-0284CarvalhoMarilia SÃ¡marilia.carvalho@fiocruz.br1http://orcid.org/0000-0001-9012-9382FreitasLaÃ­s"/>
   <result pre="http://creativecommons.org/licenses/by/4.0/. Abstract Despite all the research done on the first" exact="Zika" post="virus (ZIKV) epidemics, it was only after the Brazilian"/>
   <result pre="it was only after the Brazilian epidemic that the Congenital" exact="Zika" post="Syndrome was described. This was made possible due to"/>
   <result pre="is partially an effect of the population prior immunity against" exact="Dengue" post="viruses (DENV), that cross-react with ZIKV. In this ecological"/>
   <result pre="an effect of herd immunity and of multiple exposures to" exact="DENV" post="that could boost immunity. Subject terms Viral infection Epidemiology"/>
   <result pre="epidemic in the Northeast (NE) region of Brazil with the" exact="Zika" post="virus (ZIKV) was the high rate of dispersion of"/>
   <result pre="Despite all the research done on the first epidemics of" exact="ZIKV" post="in Yap Islands and later in French Polynesia2â€&quot;4, it"/>
   <result pre="Polynesia2â€&quot;4, it was only after the Brazilian epidemic that Congenital" exact="Zika" post="Syndrome (CZS) was described5. This could be due to"/>
   <result pre="any other region in the world that had undergone a" exact="Zika" post="epidemic7â€&quot;9. Several reasons for this discrepancy were suggested â€&quot;"/>
   <result pre="women postponing pregnancy or having abortions18â€&quot;20. The antigenic similarity between" exact="ZIKV" post="and dengue virus (DENV), sharing approximately 54% of their"/>
   <result pre="have shown that anti-DENV antibodies can both enhance and neutralize" exact="ZIKV" post="infection22â€&quot;26. In animal models, mice that received plasma with"/>
   <result pre="level of anti-DENV antibodies had a higher mortality rate after" exact="ZIKV" post="infection than mice that received plasma without antibodies. However,"/>
   <result pre="plasma with a high level of anti-DENV antibodies survived after" exact="ZIKV" post="challenge and presented milder symptoms22. Human plasma collected â‰¤100"/>
   <result pre="presented milder symptoms22. Human plasma collected â‰¤100 days after PCR-confirmed" exact="DENV" post="infection binds and cross-neutralizes ZIKV in vitro. On the"/>
   <result pre="collected â‰¤100 days after PCR-confirmed DENV infection binds and cross-neutralizes" exact="ZIKV" post="in vitro. On the other hand, late-convalescent-phase plasma does"/>
   <result pre="the understanding of cross-neutralizing antibody responses among individuals with prior" exact="DENV" post="exposure, particularly how these responses evolve over time and"/>
   <result pre="countries is quite unknown28. In summary, it is known that" exact="ZIKV" post="shares structural similarities with other flaviviruses, especially DENV, and"/>
   <result pre="with other flaviviruses, especially DENV, and co-circulates in dengue-endemic regions." exact="ZIKV" post="and DENV cross-immunity can be either protective or enhancing"/>
   <result pre="flaviviruses, especially DENV, and co-circulates in dengue-endemic regions. ZIKV and" exact="DENV" post="cross-immunity can be either protective or enhancing in experimental"/>
   <result pre="2014 data, both in the exploratory analysis and the maps." exact="Dengue" post="data are collected by the Brazilian Information System for"/>
   <result pre="cases decreased first in the NE, the dispersion centre of" exact="Zika" post="epidemic, followed by the SE and CW regions. Table"/>
   <result pre="of microcephaly rate among live-born neonates in 2014, before the" exact="Zika" post="epidemic. Among the 400 microregions included in the analysis,"/>
   <result pre="described. It should be noted that the notification system for" exact="Zika" post="was only implemented in February 2016, when the Zika"/>
   <result pre="for Zika was only implemented in February 2016, when the" exact="Zika" post="epidemic was decreasing in the NE region. Therefore, we"/>
   <result pre="in the NE region. Therefore, we could not control for" exact="Zika" post="incidence in the models. It is possible that the"/>
   <result pre="the differences in microcephaly rates were a consequence of different" exact="ZIKV" post="attack rates across the regions, as suggested in a"/>
   <result pre="paper37. In this study, after testing for other concurrent factors," exact="ZIKV" post="was assumed to be the only cause of the"/>
   <result pre="epidemic, with no unmeasured confounders or effect modifiers. However, if" exact="Zika" post="incidence alone explains the excess microcephaly rates, then microcephaly"/>
   <result pre="to why the NE region would have presented with a" exact="Zika" post="incidence more than ten times larger than anywhere else"/>
   <result pre="interval between infections changes the role of anti-DENV antibodies on" exact="ZIKV" post="infection, either to protect or to increase the risk"/>
   <result pre="hypothesis is based on what is described for sequential heterotypic" exact="DENV" post="infections (there are four DENV serotypes). It has been"/>
   <result pre="is described for sequential heterotypic DENV infections (there are four" exact="DENV" post="serotypes). It has been established that a narrow range"/>
   <result pre="over time, there is a window of cross-protection between the" exact="DENV" post="serotypes. A previous study found that a shorter interval"/>
   <result pre="seems to play a role against ZIKV. Mice primed with" exact="DENV" post="and 30 days later challenged with ZIKV during pregnancy"/>
   <result pre="Mice primed with DENV and 30 days later challenged with" exact="ZIKV" post="during pregnancy presented reduced burden in maternal and fetal"/>
   <result pre="required for this cross-protection. However, mice challenged 80 days after" exact="DENV" post="priming were not protected, indicating the transient nature of"/>
   <result pre="of cross-protection again40. Figure 7 Hypothesized interaction between dengue and" exact="Zika" post="infections on the development of microcephaly. Most research on"/>
   <result pre="of previous DENV-immunity on the severity of clinical symptoms of" exact="ZIKV" post="infection is based on experimental models41,42. Cohort studies are"/>
   <result pre="give the most reliable understanding of the role of previous" exact="DENV" post="exposure on ZIKV infection. However, the reduction in the"/>
   <result pre="reliable understanding of the role of previous DENV exposure on" exact="ZIKV" post="infection. However, the reduction in the incidence of Zika"/>
   <result pre="on ZIKV infection. However, the reduction in the incidence of" exact="Zika" post="after the last epidemic in Brazil in 2016 limits"/>
   <result pre="study dengue and that have been adapted to also study" exact="Zika" post="are of great value. For example, a recent study"/>
   <result pre="Brazil, found that the titres of DENV-antibodies measured before the" exact="Zika" post="epidemic were inversely associated with the risk of ZIKV"/>
   <result pre="the Zika epidemic were inversely associated with the risk of" exact="ZIKV" post="infection46. In a paediatric cohort in Nicaragua, prior DENV"/>
   <result pre="of ZIKV infection46. In a paediatric cohort in Nicaragua, prior" exact="DENV" post="infection was inversely associated with the risk of symptomatic"/>
   <result pre="DENV infection was inversely associated with the risk of symptomatic" exact="ZIKV" post="infection47. In a cohort of ZIKV-infected pregnant women, previous"/>
   <result pre="ZIKV infection47. In a cohort of ZIKV-infected pregnant women, previous" exact="DENV" post="infection was not associated with disease severity and abnormal"/>
   <result pre="human immune sera, which showed a cross-neutralizing antibody response to" exact="ZIKV" post="on DENV-immune subjects 1â€&quot;3 years after DENV infection28. The"/>
   <result pre="antibody response to ZIKV on DENV-immune subjects 1â€&quot;3 years after" exact="DENV" post="infection28. The larger window at the ecological level is"/>
   <result pre="an effect of herd immunity and of multiple exposures to" exact="DENV" post="that would boost immunity. This is consistent with a"/>
   <result pre="This is consistent with a case-control study in which the" exact="DENV" post="seroprevalence and the mean number of neutralized serotypes (indicative"/>
   <result pre="led to the early discovery of the causal link between" exact="Zika" post="and microcephaly may have generated a hyper-awareness of the"/>
   <result pre="surveillance system for neonatal malformation clustered in space and time." exact="Dengue" post="epidemics in the previous 15 years were used as"/>
   <result pre="published since 2002. Other possible factors in the pathway between" exact="Zika" post="infection and microcephaly have been suggested, the most important"/>
   <result pre="limitations of this study, in addition to not controlling for" exact="Zika" post="incidence, are well known: accuracy of microcephaly classification and"/>
   <result pre="our results. The detection of either ADE or cross-protection between" exact="DENV" post="and ZIKV is not a trivial task, either in"/>
   <result pre="The detection of either ADE or cross-protection between DENV and" exact="ZIKV" post="is not a trivial task, either in animal models"/>
   <result pre="contribute to building the knowledge regarding the relationship between DENV," exact="ZIKV" post="and congenital Zika syndrome. Supplementary information LINK Supplementary information"/>
   <result pre="the knowledge regarding the relationship between DENV, ZIKV and congenital" exact="Zika" post="syndrome. Supplementary information LINK Supplementary information Publisherâ€™s note Springer"/>
   <result pre="The authors declare no competing interests. References References 1.LoweRet al.The" exact="Zika" post="Virus Epidemic in Brazil: From Discovery to Future ImplicationsInt."/>
   <result pre="in French PolynesiaLancet20163871051105210.1016/S0140-6736(16)00625-5 5.Miranda-FilhoDEBet al.Initial Description of the Presumed Congenital" exact="Zika" post="SyndromeAm. J. Public. Health201610659860010.2105/AJPH.2016.30311526959258 6.de OliveiraWKet al.Infection-related microcephaly after"/>
   <result pre="Health201610659860010.2105/AJPH.2016.30311526959258 6.de OliveiraWKet al.Infection-related microcephaly after the 2015 and 2016" exact="Zika" post="virus outbreaks in Brazil: a surveillance-based analysisLancet201739086187010.1016/S0140-6736(17)31368-528647172 7.CoelhoACrovellaSMicrocephaly Prevalence"/>
   <result pre="Brazil: a surveillance-based analysisLancet201739086187010.1016/S0140-6736(17)31368-528647172 7.CoelhoACrovellaSMicrocephaly Prevalence in Infants Born to" exact="Zika" post="Virus-Infected Women: A Systematic Review and Meta-AnalysisInt. J. Mol."/>
   <result pre="in Rio de JaneiroN. Engl. J. Med.20163752321233410.1056/NEJMoa160241226943629 9.VogelGOne year later," exact="Zika" post="scientists prepare for a long warSci.20163541088108910.1126/science.354.6316.1088 10.Albuquerque, M. de"/>
   <result pre="Microcephaly at Birth in Brazil in 2010Pediatrics2018141e2017058910.1542/peds.2017-058929305391 12.RodriguesLaura CMicrocephaly and" exact="Zika" post="virus infectionThe Lancet2016387100332070207210.1016/S0140-6736(16)00742-X 13.ButlerDMicrocephaly surge in doubtNat.2016530131410.1038/nature.2016.19259 14.Lopez-Camelo, J."/>
   <result pre="I. M. &amp;amp; Castilla, E. ECLAMC FINAL DOCUMENT (2015). 15.RossiSLEbelGDShanCShiP-YVasilakisNDid" exact="Zika" post="Virus Mutate to Cause Severe Outbreaks?Trends Microbiology20182687788510.1016/j.tim.2018.05.007 16.Souza, W."/>
   <result pre="W. V. de et al. Microcephaly epidemic related to the" exact="Zika" post="virus and living conditions in Recife, Northeast Brazil. BMC"/>
   <result pre="Northeast Brazil. BMC Public Health18 (2018). 17.HalsteadSBBiologic Evidence Required for" exact="Zika" post="Disease Enhancement by Dengue AntibodiesEmerg. Infect. Dis.20172356957310.3201/eid2304.16187928322690 18.AikenARAet al.Requests"/>
   <result pre="Health18 (2018). 17.HalsteadSBBiologic Evidence Required for Zika Disease Enhancement by" exact="Dengue" post="AntibodiesEmerg. Infect. Dis.20172356957310.3201/eid2304.16187928322690 18.AikenARAet al.Requests for Abortion in Latin"/>
   <result pre="al.Requests for Abortion in Latin America in the Wake of" exact="Zika" post="VirusN. Engl. J. Med.201637539639810.1056/NEJMc160538927331661 19.Diaz-QuijanoFAPelissariDMChiavegatto FilhoADPZika-Associated Microcephaly Epidemic and"/>
   <result pre="Rate Reduction in Brazilian CitiesAm. J. Public. Health201810851451610.2105/AJPH.2017.30426029470110 20.CastroMCHanQCCarvalhoLRVictoraCGFranÃ§aGVAImplications of" exact="Zika" post="virus and congenital Zika syndrome for the number of"/>
   <result pre="CitiesAm. J. Public. Health201810851451610.2105/AJPH.2017.30426029470110 20.CastroMCHanQCCarvalhoLRVictoraCGFranÃ§aGVAImplications of Zika virus and congenital" exact="Zika" post="syndrome for the number of live births in BrazilProc."/>
   <result pre="antibody responses after dengue virus infection are highly cross-reactive to" exact="Zika" post="virusProc. Natl Acad. Sci. USA20161137852785710.1073/pnas.160793111327354515 22.BardinaSVet al.Enhancement of Zika"/>
   <result pre="to Zika virusProc. Natl Acad. Sci. USA20161137852785710.1073/pnas.160793111327354515 22.BardinaSVet al.Enhancement of" exact="Zika" post="virus pathogenesis by preexisting antiflavivirus immunitySci.201735617518010.1126/science.aal4365 23.DurbinAPDengue Antibody and"/>
   <result pre="Sequence in MiceImmun.20174677177310.1016/j.immuni.2017.04.023 25.RobbianiDFet al.Recurrent Potent Human Neutralizing Antibodies to" exact="Zika" post="Virus in Brazil and MexicoCell2017169597609.e1110.1016/j.cell.2017.04.02428475892 26.WenJShrestaSADE-ing and Abetting ZikaCell"/>
   <result pre="ZikaCell Host Microbe20172155755810.1016/j.chom.2017.04.00628494235 27.CollinsMHet al.Lack of Durable Cross-Neutralizing Antibodies Against" exact="Zika" post="Virus from Dengue Virus InfectionEmerg. Infect. Dis.20172377378110.3201/eid2305.16163028418292 28.MontoyaMageldaCollinsMatthewDejnirattisaiWanwisaKatzelnickLeah CPuerta-GuardoHenryJadiRameshSchildhauerSamuelSupasaPiyadaVasanawathanaSirijittMalasitPridaMongkolsapayaJuthathipde"/>
   <result pre="27.CollinsMHet al.Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from" exact="Dengue" post="Virus InfectionEmerg. Infect. Dis.20172377378110.3201/eid2305.16163028418292 28.MontoyaMageldaCollinsMatthewDejnirattisaiWanwisaKatzelnickLeah CPuerta-GuardoHenryJadiRameshSchildhauerSamuelSupasaPiyadaVasanawathanaSirijittMalasitPridaMongkolsapayaJuthathipde SilvaAruna DTisseraHasithaBalmasedaAngelScreatonGavinde SilvaAravinda"/>
   <result pre="CPuerta-GuardoHenryJadiRameshSchildhauerSamuelSupasaPiyadaVasanawathanaSirijittMalasitPridaMongkolsapayaJuthathipde SilvaAruna DTisseraHasithaBalmasedaAngelScreatonGavinde SilvaAravinda MHarrisEvaLongitudinal Analysis of Antibody Cross-neutralization Following" exact="Zika" post="Virus and Dengue Virus Infection in Asia and the"/>
   <result pre="SilvaAravinda MHarrisEvaLongitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and" exact="Dengue" post="Virus Infection in Asia and the AmericasThe Journal of"/>
   <result pre="30.AndradeDaniela V.HarrisEvaRecent advances in understanding the adaptive immune response to" exact="Zika" post="virus and the effect of previous flavivirus exposureVirus Research2018254273310.1016/j.virusres.2017.06.01928655548"/>
   <result pre="â€˜Tidyverseâ€™ (2017). 36.The R-INLA project http://www.r-inla.org/home. 37.BradyOJet al.The association between" exact="Zika" post="virus infection and microcephaly in Brazil 2015â€&quot;2017: An observational"/>
   <result pre="Med.197042311328 39.AndersonKBet al.A Shorter Time Interval Between First and Second" exact="Dengue" post="Infections Is Associated With Protection From Clinical Illness in"/>
   <result pre="in ThailandJ. Infect. Dis.201420936036810.1093/infdis/jit43623964110 40.Regla-Nava, J. A. et al. Cross-reactive" exact="Dengue" post="virus-specific CD8+ T cells protect against Zika virus during"/>
   <result pre="et al. Cross-reactive Dengue virus-specific CD8+ T cells protect against" exact="Zika" post="virus during pregnancy. Nature Communications9 (2018). 41.MartÃ­n-Acebes, M. A.,"/>
   <result pre="by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in" exact="Zika" post="Virus Infection. Front Immunol9 (2018). 43.CohenJWhere has all the"/>
   <result pre="Zika Virus Infection. Front Immunol9 (2018). 43.CohenJWhere has all the" exact="Zika" post="gone?Sci.201735763163210.1126/science.357.6352.631 44.SiednerMJRyanETBogochIIGone or forgotten? The rise and fall of"/>
   <result pre="Zika gone?Sci.201735763163210.1126/science.357.6352.631 44.SiednerMJRyanETBogochIIGone or forgotten? The rise and fall of" exact="Zika" post="virusLancet Public. Health20183e109e11010.1016/S2468-2667(18)30029-X29519697 45.Netto, E. M. et al. High"/>
   <result pre="Zika virusLancet Public. Health20183e109e11010.1016/S2468-2667(18)30029-X29519697 45.Netto, E. M. et al. High" exact="Zika" post="Virus Seroprevalence in Salvador, Northeastern Brazil Limits the Potential"/>
   <result pre="46.Rodriguez-Barraquer, I. et al. Impact of preexisting dengue immunity on" exact="Zika" post="virus emergence in a dengue endemic region. 5 (2019)."/>
   <result pre="of Zika: A pediatric cohort in NicaraguaPLOS Med.201916e100272610.1371/journal.pmed.100272630668565 48.HalaiU-Aet al.Maternal" exact="Zika" post="Virus Disease Severity, Virus Load, Prior Dengue Antibodies, and"/>
   <result pre="Med.201916e100272610.1371/journal.pmed.100272630668565 48.HalaiU-Aet al.Maternal Zika Virus Disease Severity, Virus Load, Prior" exact="Dengue" post="Antibodies, and Their Relationship to Birth OutcomesClin. Infect. Dis.20176587788310.1093/cid/cix47228535184"/>
   <result pre="to Birth OutcomesClin. Infect. Dis.20176587788310.1093/cid/cix47228535184 49.PedrosoCeliaFischerCarloFeldmannMarieSarnoManoelLuzEstelaMoreira-SotoAndrÃ©sCabralRenataNettoEduardo MartinsBritesCarlosKÃ¼mmererBeate M.DrexlerJan FelixCross-Protection of" exact="Dengue" post="Virus Infection against Congenital Zika Syndrome, Northeastern BrazilEmerging Infectious"/>
   <result pre="49.PedrosoCeliaFischerCarloFeldmannMarieSarnoManoelLuzEstelaMoreira-SotoAndrÃ©sCabralRenataNettoEduardo MartinsBritesCarlosKÃ¼mmererBeate M.DrexlerJan FelixCross-Protection of Dengue Virus Infection against Congenital" exact="Zika" post="Syndrome, Northeastern BrazilEmerging Infectious Diseases20192581485149310.3201/eid2508.19011331075077 50.VictoraCGet al.Microcephaly in Brazil:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7018131\results\search\tropicalVirus\results.xml">
   <result pre="and Health Sciences : Tropical Diseases : Neglected Tropical Diseases:" exact="Dengue" post="Fever : Medicine and Health Sciences : Infectious Diseases"/>
   <result pre="Medicine and Health Sciences : Infectious Diseases : Viral Diseases:" exact="Dengue" post="Fever : Medicine and Health Sciences: Epidemiology : Medicine"/>
   <result pre="and temporal distribution of dengue in Brazil, 1990 - 2017" exact="Dengue" post="in Brazil AndrioliDenise CatarinaConceptualizationData curationFormal analysisInvestigationMethodologySupervisionValidationVisualizationWriting â€&quot; original draftWriting"/>
   <result pre="medium, provided the original author and source are credited.pone.0228346.pdf Abstract" exact="Dengue" post="is a viral disease caused by an arbovirus of"/>
   <result pre="the Epidemiological Bulletins and publications of the Ministry of Health." exact="Dengue" post="incidence increased in all Brazilian regions and the interepidemic"/>
   <result pre="2003-2018. The authors did not have special access privileges. Introduction" exact="Dengue" post="is the most common viral disease in the world"/>
   <result pre="two decades, the introduction and simultaneous circulation of chikungunya and" exact="Zika" post="virus, whose symptoms are similar to those of dengue"/>
   <result pre="pose additional challenges to the current epidemiological scenario of Brazil." exact="Dengue" post="control actions and knowledge on its propagation contribute to"/>
   <result pre="Grande do Sul; SCâ€&quot;Santa Catarina; SPâ€&quot;SÃ£o Paulo; SEâ€&quot;Sergipe; TOâ€&quot;Tocantins. Discussion" exact="Dengue" post="has become one of the greatest public health challenges"/>
   <result pre="serve to identify potentialities and potential weaknesses of the National" exact="Dengue" post="Control Program (Programa Nacional de Controle da Dengue, PNCD)."/>
   <result pre="introduced in Brazil in 1990, when the first cases of" exact="Dengue" post="Hemorrhagic Fever were confirmed [34]. The 2002 epidemic reflected"/>
   <result pre="tropical diseases. PLoS Negl Trop Dis2014; 8(7):e286510.1371/journal.pntd.000286525058013 3World Health Organization." exact="Dengue" post="and Severe Dengue [Internet]. World Health Organization; 2018a. [cited"/>
   <result pre="Negl Trop Dis2014; 8(7):e286510.1371/journal.pntd.000286525058013 3World Health Organization. Dengue and Severe" exact="Dengue" post="[Internet]. World Health Organization; 2018a. [cited 20 Nov 2018]."/>
   <result pre="PLoS Negl Trop Dis2012; 6(8):e176010.1371/journal.pntd.000176022880140 5collab: Brazilian Ministry of Health." exact="Dengue" post="[Internet]. BrasÃ­lia: Brazilian Ministry of Health; 2018 [cited 17"/>
   <result pre="anÃ¡lise da situaÃ§Ã£o de saÃºde e da epidemia pelo vÃ­rus" exact="Zika" post="e por outras doenÃ§as transmitidas pelo Aedes aegypti [Internet]."/>
   <result pre="international travel. Med Clin North Am2008; 92(6):1377â€&quot;139010.1016/j.mcna.2008.07.00219061757 15World Health Organization." exact="Dengue" post="Control [Internet]. World Health Organization; 2018b. [cited 13 Oct"/>
   <result pre="from: https://palaeo-electronica.org/2001_1/past/past.pdf 24TeixeiraMG, SiqueiraJBJr, FerreiraGLC, BricksL, JointG. Epidemiological Trends of" exact="Dengue" post="Disease in Brazil (2000â€&quot;2010): A Systematic Literature Search and"/>
   <result pre="of Aedes aegypti: Effects of Temperature and Implications for Global" exact="Dengue" post="Epidemic Potential. PLoS ONE2014; 9(3):e8978310.1371/journal.pone.008978324603439 33LoweR, Stewart-IbarraAM, PetrovaD, GarcÃ­a-DÃ­ezM,"/>
   <result pre="Lancet Planetary Health2017; 1:e142â€&quot;e151. 10.1016/S2542-5196(17)30064-529851600 34SiqueiraJB, MartelliCM, CoelhoGE, SimplÃ­cioAC, HatchDL." exact="Dengue" post="and Dengue Hemorrhagic Fever, Brazil, 1981â€&quot;2002. Emerg Infect Dis."/>
   <result pre="Health2017; 1:e142â€&quot;e151. 10.1016/S2542-5196(17)30064-529851600 34SiqueiraJB, MartelliCM, CoelhoGE, SimplÃ­cioAC, HatchDL. Dengue and" exact="Dengue" post="Hemorrhagic Fever, Brazil, 1981â€&quot;2002. Emerg Infect Dis. 2005; 11(1):48â€&quot;53."/>
   <result pre="Said RFC, Hoffmann JL, Martins J, Barbiratto SB et al." exact="Dengue" post="no Brasil: tendÃªncias e mudanÃ§as na epidemiologia, com Ãªnfase"/>
   <result pre="PantojaJA, RodriguesSGet al.Air Travel Is Associated with Intracontinental Spread of" exact="Dengue" post="Virus Serotypes 1â€&quot;3 in Brazil. PLoS Negl Trop Dis2014;"/>
   <result pre="MorrisonAC, RitchieSA, et al.A Critical Assessment of Vector Control for" exact="Dengue" post="Prevention. PLoS Negl Trop Dis2015; 9(5):e000365510.1371/journal.pntd.000365525951103 43RoizD, WilsonAL, ScottTW,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7019302\results\search\tropicalVirus\results.xml">
   <result pre="7019302 doi: 10.3390/v12010123viruses-12-00123 : Brief Report Multi-Approach Investigation Regarding the" exact="West Nile" post="Virus Situation in Hungary, 2018 https://orcid.org/0000-0002-3503-8901ZanaBrigitta12ErdÃ©lyiKÃ¡roly3NagyAnna4MezeiEszter5NagyOrsolya4https://orcid.org/0000-0002-2492-6890TakÃ¡csMÃ¡ria4BakonyiTamÃ¡s67ForgÃ¡chPetra6Korbacska-KutasiOrsolya8FehÃ©rOrsolya8MalikPÃ©ter3UrsuKrisztina3KertÃ©szPÃ©ter9KepnerAnett10MartinaMÃ¡tÃ©10SÃ¼liTamÃ¡s10LanszkiZsÃ³fia12TÃ³thGÃ¡bor Endre12KuczmogAnett12https://orcid.org/0000-0002-6006-9873SomogyiBalÃ¡zs1JakabFerenc12https://orcid.org/0000-0001-9775-3065KemenesiGÃ¡bor12*[1], brigitta.zana@gmail.comlanszkizsofi@gmail.comtoth.gabor.endre@gmail.comkuczmog@hotmail.comsobalbundi@gmail.comjakab.ferenc@pte.hu[2], [3],"/>
   <result pre="the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract The" exact="West Nile" post="virus is endemic in multiple European countries and responsible"/>
   <result pre="we summarized and analyzed the genetic and serologic data of" exact="WNV" post="infections from multiple Hungarian public health institutions, universities, and"/>
   <result pre="data through 2018. Wild birds were excellent indicator species for" exact="WNV" post="circulation in each year. Our efforts resulted in documenting"/>
   <result pre="multiple phylogenetic subclades with Balkans and Western-European progenitor sequences of" exact="WNV" post="circulating among human and animal populations in Hungary prior"/>
   <result pre="the epidemic of 2018 was not caused by recently introduced" exact="WNV" post="strains. Unfortunately, Hungary has no country-wide integrated surveillance system"/>
   <result pre="ecological background factors driving the evolution of future epidemics. co-circulation" exact="West Nile" post="encephalitis horse goshawk epizootic epidemiology virus isolation 1. Introduction"/>
   <result pre="Introduction Along with other widely distributed flaviviruses, such as the" exact="Dengue" post="virus or Yellow Fever virus, the West Nile virus"/>
   <result pre="such as the Dengue virus or Yellow Fever virus, the" exact="West Nile" post="virus is a major public health concern throughout multiple"/>
   <result pre="different [2,3]. Among genetic variants, lineage 1 and lineage 2" exact="West Nile" post="virus (ffWNV) strains pose the largest human health risk"/>
   <result pre="degree of infectivity and neuroinvasiveness was attributed to lineage 1" exact="WNV" post="until the appearance of a large number of lineage"/>
   <result pre="until the appearance of a large number of lineage 2" exact="WNV" post="strains in South Africa with elevated infectivity and neuroinvasive"/>
   <result pre="South Africa with elevated infectivity and neuroinvasive properties [4]. The" exact="West Nile" post="virus is transmitted by mosquitoes belonging to the Culex"/>
   <result pre="Until 2004, only the presence of lineage 1 and 3" exact="WNV" post="strains appeared in Europe [3]. Following the first emergence"/>
   <result pre="in Europe [3]. Following the first emergence of lineage 2" exact="WNV" post="in Hungary in 2004 [10], this genetic variant was"/>
   <result pre="200â€&quot;300 human cases annually since the emergence of lineage 2" exact="WNV" post="[12,13,14,15]. According to the seasonal reports of the European"/>
   <result pre="work, we presented epidemic and epizootic data regarding the 2018" exact="WNV" post="situation in Hungary, along with genomic data in reference"/>
   <result pre="obtained from the University of Veterinary Medicine Budapest, and animal-derived" exact="WNV" post="sequences were provided by the University of Veterinary Medicine,"/>
   <result pre="further performed in Hungary, examining the adjacent area of horse" exact="WNV" post="cases in DunafÃ¶ldvÃ¡r in 2018. We conducted a follow-up"/>
   <result pre="of these horse cases in order to assess the overwintering" exact="WNV" post="infection capacity regarding local mosquitoes (Table S2). Larvae collection"/>
   <result pre="histology, and polymerase chain reaction (PCR) were performed, and partial" exact="WNV" post="sequences were obtained from positive cases. 2.2. Nucleic Acid"/>
   <result pre="Samples Mosquito, horse, and northern goshawk samples were subjected to" exact="WNV" post="specific TaqMan real time reverse transcription PCR as described"/>
   <result pre="analyzer platform (Applied Biosystems). 2.4. Molecular Diagnostics of the Human" exact="WNV" post="Infections Diagnostic WNV TaqMan real-time RT-PCR screening of human"/>
   <result pre="Biosystems). 2.4. Molecular Diagnostics of the Human WNV Infections Diagnostic" exact="WNV" post="TaqMan real-time RT-PCR screening of human clinical specimens was"/>
   <result pre="the 5â€²-UTR and part of the capsid gene of the" exact="WNV" post="genome. Primer and probe sequences were described previously [21]."/>
   <result pre="kit (Applied Biosystems, CA, USA). 2.5. Serological Diagnosis of Human" exact="WNV" post="Cases The laboratory diagnosis regarding human WNV infections across"/>
   <result pre="Diagnosis of Human WNV Cases The laboratory diagnosis regarding human" exact="WNV" post="infections across the entire territory of Hungary was performed"/>
   <result pre="viral encephalitis. Due to the milder form of the human" exact="WNV" post="infections, commonly referred to as West Nile fever, patients"/>
   <result pre="form of the human WNV infections, commonly referred to as" exact="West Nile" post="fever, patients afflicted with exanthema, fever, myalgia, and/or arthralgia"/>
   <result pre="fever, myalgia, and/or arthralgia were also investigated and involved in" exact="WNV" post="screening during the transmission season. First-line serological methods included"/>
   <result pre="IgA antibodies and commercial enzyme-linked immunosorbent assays (ELISAs) for determining" exact="WNV" post="IgM response (West Nile Virus IgM Capture DxSelectâ&quot;¢; Focus"/>
   <result pre="DxSelectâ&quot;¢; Focus Diagnostics, DiaSorin Molecular LLC, Cypress, CA, USA) and" exact="WNV" post="IgG avidity (West Nile virus (WNV) avidity determination, (Euroimmun"/>
   <result pre="(WNV) avidity determination, (Euroimmun Medizinische Labordiagnostika, LÃ¼beck, Germany). Confirmation by" exact="WNV" post="microneutralization assay was performed in all cases. Serological cross-reactivity"/>
   <result pre="Acute infections were defined and reported as confirmed or probable" exact="WNV" post="infections in accordance with the EU case definition criteria."/>
   <result pre="24-well plate. An amount of 200 ÂµL of supernatant from" exact="WNV" post="PCR-positive mosquito pool homogenates, goshawk, and horse brain tissue"/>
   <result pre="tree was visualized in FigTree v1.4.4 program. Human-derived partial NS3" exact="WNV" post="sequences were compared via their identity scores. The preliminary"/>
   <result pre="transmission season of 2018, n = 225 autochthonous and imported" exact="WNV" post="cases were reported to the ECDC. In total, n"/>
   <result pre="n = 53 patients were found to be positive for" exact="WNV" post="RNA by diagnostic PCR screening, while only those samples"/>
   <result pre="from n = 46 patients (27.7%) were eventually confirmed by" exact="WNV" post="nested RT-PCR and sequencing. Comprehensively, the results suggest a"/>
   <result pre="showed a nine-fold increase in the cumulative number of human" exact="WNV" post="cases [28]. The geographic distribution of infected birds coincided"/>
   <result pre="from January to November 2018, we identified 14 cases of" exact="WNV" post="related mortality. The first WNV case was detected on"/>
   <result pre="we identified 14 cases of WNV related mortality. The first" exact="WNV" post="case was detected on 2 July in a hooded"/>
   <result pre="future may prove beneficial in the early detection of seasonal" exact="WNV" post="circulation. During the entomological surveillance regarding infected horse cases"/>
   <result pre="in the swimming pool were found to be PCR-positive for" exact="WNV" post="RNA. However, we measured an extremely low viral load,"/>
   <result pre="Anopheles maculipennis, Culiseta annulata) were found to be negative for" exact="WNV" post="RNA, which supports the previous observation regarding low-level infection"/>
   <result pre="regarding low-level infection rates being sufficient for the persistence of" exact="WNV" post="in overwintering mosquito populations [33]. In addition to the"/>
   <result pre="(Table S1). 3.1.2. Equine Serologic Survey Equine cases related to" exact="WNV" post="are reported through the Animal Disease Notification System (ADNS)"/>
   <result pre="the number of cases implies an approximately 30-fold increase in" exact="WNV" post="cases among equines. 3.1.3. In Vitro Virus Propagation Attempts"/>
   <result pre="lines. Following the third blind passage, we could not detect" exact="WNV" post="RNA in the supernatants of lysed cells by the"/>
   <result pre="samples. 3.2. Phylogenetic Analysis The maximum likelihood phylogenetic analysis regarding" exact="WNV" post="strains resulted in two bush-like groups, representing the two"/>
   <result pre="in two bush-like groups, representing the two major subclades of" exact="WNV" post="strains circulating simultaneously in Central Europe as previously described"/>
   <result pre="by others [35]. Our phylogenetic analysis revealed that the circulating" exact="WNV" post="strains of 2018 were segregated into two different subgroups,"/>
   <result pre="to members of the Balkans subclade, while the other contained" exact="WNV" post="strains mainly from Southern and Western European countries. One"/>
   <result pre="segregated outside the two groups, advisably indicating the order of" exact="WNV" post="strains emergence in time and route of introduction to"/>
   <result pre="Italy, where mostly endemic clades persist [37], we reported two" exact="WNV" post="strains simultaneously co-circulating in Hungary. In our study, human-derived"/>
   <result pre="the more detailed work about the evolutionary dynamics of lineage-2" exact="WNV" post="[35]. 4. Conclusions During the transmission season of 2018,"/>
   <result pre="of 2018, several Central-Eastern European countries reported elevated numbers of" exact="WNV" post="infection cases among humans. In total, more than a"/>
   <result pre="2018 compared to 2017, thus exceeding the total number of" exact="WNV" post="cases from the past seven years [8]. Hungary was"/>
   <result pre="likely caused by endemic strains rather than recently introduced novel" exact="WNV" post="strains. We identified the presence of multiple phylogenetic subclades"/>
   <result pre="urgent need for a country-wide, organized surveillance system regarding the" exact="West Nile" post="virus. Acknowledgments Technical and administrative assistance provided by Nikolett"/>
   <result pre="References 1.GrayT.J.WebbC.E.A review of the epidemiological and clinical aspects of" exact="West Nile" post="virusInt. J. Gen. Med.2014719320310.2147/IJGM.S5990224748813 2.KemenesiG.DallosB.OldalM.KutasA.FÃ¶ldesF.NÃ©methV.ReiterP.BakonyiT.BÃ¡nyaiK.JakabF.Putative novel lineage of West"/>
   <result pre="West Nile virusInt. J. Gen. Med.2014719320310.2147/IJGM.S5990224748813 2.KemenesiG.DallosB.OldalM.KutasA.FÃ¶ldesF.NÃ©methV.ReiterP.BakonyiT.BÃ¡nyaiK.JakabF.Putative novel lineage of" exact="West Nile" post="virus in Uranotaenia unguiculata mosquito, HungaryVirusdisease20142550050310.1007/s13337-014-0234-825674630 3.PapaA.BakonyiT.XanthopoulouK.VÃ¡zquezA.TenorioA.NowotnyN.Genetic characterization of"/>
   <result pre="Nile virus in Uranotaenia unguiculata mosquito, HungaryVirusdisease20142550050310.1007/s13337-014-0234-825674630 3.PapaA.BakonyiT.XanthopoulouK.VÃ¡zquezA.TenorioA.NowotnyN.Genetic characterization of" exact="West Nile" post="virus lineage 2, Greece, 2010Emerg. Infect. Dis.20111792092210.3201/eid1705.10175921529413 4.VenterM.SteylJ.HumanS.WeyerJ.ZaaymanD.BlumbergL.LemanP.A.PaweskaJ.SwanepoelR.Transmission of"/>
   <result pre="Nile virus lineage 2, Greece, 2010Emerg. Infect. Dis.20111792092210.3201/eid1705.10175921529413 4.VenterM.SteylJ.HumanS.WeyerJ.ZaaymanD.BlumbergL.LemanP.A.PaweskaJ.SwanepoelR.Transmission of" exact="West Nile" post="virus during horse autopsyEmerg. Infect. Dis.20101657357510.3201/eid1603.09104220202454 5.NappS.PetriÄ‡D.BusquetsN.West Nile virus"/>
   <result pre="Eastern EuropePathog. Glob. Health201811223324810.1080/20477724.2018.148356729979950 6.CiotaA.T.KramerL.D.Vector-virus interactions and transmission dynamics of" exact="West Nile" post="virusViruses201353021304710.3390/v512302124351794 7.PaphitouN.I.TourvasA.FloridouD.RichterJ.TryfonosC.ChristodoulouC.The first human case of neuroinvasive West Nile"/>
   <result pre="of West Nile virusViruses201353021304710.3390/v512302124351794 7.PaphitouN.I.TourvasA.FloridouD.RichterJ.TryfonosC.ChristodoulouC.The first human case of neuroinvasive" exact="West Nile" post="virus infection identified in CyprusJ. Infect. Public Health20171089189310.1016/j.jiph.2017.02.00328233724 8.ZannoliS.SambriV.West"/>
   <result pre="an emerging pathogenIntervirology20115417118410.1159/00032832021576931 10.BakonyiT.IvanicsE.ErdÃ©lyiK.UrsuK.FerencziE.WeissenbÃ¶ckH.NowotnyN.Lineage 1 and 2 strains of encephalitic" exact="West Nile" post="virus, central EuropeEmerg. Infect. Dis.20061261862310.3201/eid1204.05137916704810 11.BakonyiT.FerencziE.ErdÃ©lyiK.KutasiO.CsÃ¶rgÅ‘T.SeidelB.WeissenbÃ¶ckH.BruggerK.BÃ¡nE.NowotnyN.Explosive spread of a"/>
   <result pre="EuropeEmerg. Infect. Dis.20061261862310.3201/eid1204.05137916704810 11.BakonyiT.FerencziE.ErdÃ©lyiK.KutasiO.CsÃ¶rgÅ‘T.SeidelB.WeissenbÃ¶ckH.BruggerK.BÃ¡nE.NowotnyN.Explosive spread of a neuroinvasive lineage 2" exact="West Nile" post="virus in Central Europe, 2008/2009Vet. Microbiol.2013165617010.1016/j.vetmic.2013.03.00523570864 12.HernÃ¡ndez-TrianaL.M.JeffriesC.L.MansfieldK.L.CarnellG.FooksA.R.JohnsonN.Emergence of west"/>
   <result pre="of a mosquito-borne diseaseFront. Public Health2014227110.3389/fpubh.2014.0027125538937 13.KuroltI.C.KrajinoviÄ‡V.TopiÄ‡A.KuzmanI.BarÅ¡iÄ‡B.MarkotiÄ‡A.First molecular analysis of" exact="West Nile" post="virus during the 2013 outbreak in CroatiaVirus Res.2014189636610.1016/j.virusres.2014.04.01724809948 14.ECDC:"/>
   <result pre="RT-PCR assay for detection and quantification of both lineages of" exact="West Nile" post="virus RNAJ. Clin. Virol.20063617718210.1016/j.jcv.2006.02.00816675298 20.VÃ¡zquezA.SÃ¡nchez-SecoM.P.PalaciosG.MoleroF.ReyesN.RuizS.ArandaC.MarquÃ©sE.EscosaR.MorenoJ.et al.Novel flaviviruses detected in"/>
   <result pre="different species of mosquitoes in SpainVector-Borne Zoonotic Dis.20121222322910.1089/vbz.2011.068722022811 21.LinkeS.EllerbrokH.NiedrigM.NitscheA.PauliG.Detection of" exact="West Nile" post="virus lineages 1 and 2 by real-time PCRJ. Virol."/>
   <result pre="by real-time PCRJ. Virol. Methods200714635535810.1016/j.jviromet.2007.05.02117604132 22.ChaskopoulouA.DovasC.ChaintoutisS.BouzalasI.AraG.PapanastassopoulouM.Evidence of enzootic circulation of" exact="West Nile" post="virus (Nea Santa-Greece-2010, lineage 2), Greece, May to July"/>
   <result pre="online: https://www.R-project.org/(accessed on 13 November 2019) 28.NagyA.MezeiE.NagyO.BakonyiT.CsonkaN.KaposiM.KoroknaiA.SzomorK.RigÃ³Z.MolnÃ¡rZ.et al.Extraordinary increase in" exact="West Nile" post="virus cases and first confirmed human Usutu virus infection"/>
   <result pre="in Hungary, 2018Eurosurveillance201924190003810.2807/1560-7917.ES.2019.24.28.190003831311619 29.ErdÃ©lyiK.UrsuK.FerencziE.SzerediL.RÃ¡tzF.SkÃ¡reJ.BakonyiT.Clinical and pathologic features of lineage 2" exact="West Nile" post="virus infections in birds of prey in HungaryVector-Borne Zoonotic"/>
   <result pre="HungaryVector-Borne Zoonotic Dis.2007718118810.1089/vbz.2006.058617627436 30.HubÃ¡lekZ.KosinaM.RudolfI.MendelJ.StrakovÃ¡P.TomeÅ¡ekM.Mortality of Goshawks (Accipiter gentilis) Due to" exact="West Nile" post="Virus Lineage 2Vector-Borne Zoonotic Dis.20181862462710.1089/vbz.2018.228930063186 31.RizzoliA.BolzoniL.ChadwickE.A.CapelliG.MontarsiF.GrisentiM.de la PuenteJ.M.MuÃ±ozJ.FiguerolaJ.SoriguerR.et al.Understanding"/>
   <result pre="Nile Virus Lineage 2Vector-Borne Zoonotic Dis.20181862462710.1089/vbz.2018.228930063186 31.RizzoliA.BolzoniL.ChadwickE.A.CapelliG.MontarsiF.GrisentiM.de la PuenteJ.M.MuÃ±ozJ.FiguerolaJ.SoriguerR.et al.Understanding" exact="West Nile" post="virus ecology in Europe: Culex pipiens host feeding preference"/>
   <result pre="virus emergenceParasit. Vectors2015821310.1186/s13071-015-0831-425888754 32.NappS.MontalvoT.PiÃ±ol-BaenaC.GÃ³mez-MartÃ­nM.B.NicolÃ¡s-FranciscoO.SolerM.BusquetsN.Usefulness of Eurasian Magpies (Pica pica) for" exact="West Nile" post="virus Surveillance in Non-Endemic and Endemic SituationsViruses20191171610.3390/v11080716 33.RudolfI.BetÃ¡Å¡ovÃ¡L.BlaÅ¾ejovÃ¡H.VenclÃ­kovÃ¡K.StrakovÃ¡P.Å ebestaO.MendelJ.BakonyiT.SchaffnerF.NowotnyN.et"/>
   <result pre="al.West Nile virus in overwintering mosquitoes, central EuropeParasit. Vectors20171045210.1186/s13071-017-2399-728969685 34.BakonyiT.GajdonG.K.SchwingR.VoglW.HÃ¤bichA.C.ThallerD.WeissenbÃ¶ckH.RudolfI.HubÃ¡lekZ.NowotnyN.Chronic" exact="West Nile" post="virus infection in kea (Nestor notabilis)Vet. Microbiol.201618313513910.1016/j.vetmic.2015.12.01226790946 35.ChaintoutisS.C.PapaA.PervanidouD.DovasC.I.Evolutionary dynamics"/>
   <result pre="in kea (Nestor notabilis)Vet. Microbiol.201618313513910.1016/j.vetmic.2015.12.01226790946 35.ChaintoutisS.C.PapaA.PervanidouD.DovasC.I.Evolutionary dynamics of lineage 2" exact="West Nile" post="virus in Europe, 2004â€&quot;2018: Phylogeny, selection pressure and phylogeographyMol."/>
   <result pre="Phylogenet. Evol.201914110661710.1016/j.ympev.2019.10661731521822 36.WollantsE.SmoldersD.NaesensR.BruynseelsP.LagrouK.MatthijnssensJ.Van RanstM.Use of Next-Generation Sequencing for Diagnosis of" exact="West Nile" post="Virus Infection in Patient Returning to Belgium from HungaryEmerg."/>
   <result pre="Infect. Dis.2018242380238210.3201/eid2412.18049430457549 37.VeoC.Della VenturaC.MorenoA.RovidaF.PercivalleE.CanzianiS.TorriD.CalzolariM.BaldantiF.GalliM.et al.Evolutionary Dynamics of the Lineage 2" exact="West Nile" post="Virus That Caused the Largest European Epidemic: Italy 2011â€&quot;2018Viruses20191181410.3390/v1109081431484295"/>
   <result pre="Largest European Epidemic: Italy 2011â€&quot;2018Viruses20191181410.3390/v1109081431484295 Figure 1 Geographical distribution of" exact="West Nile" post="virus (WNV) polymerase chain reaction (PCR)-positive cases at the"/>
   <result pre="level and cumulative incidence rates of autochthonous and imported human" exact="WNV" post="infections at NUTS 3 level of Hungary, from 2014"/>
   <result pre="Hungary, from 2014 through 2017. The total number of human" exact="WNV" post="cases between 2014 and 2017: n = 103. Black"/>
   <result pre="units for statistics level 3. IR: Incidence rates (number of" exact="WNV" post="human infections/100,000 inhabitants). Figure 2 Geographical distribution of West"/>
   <result pre="of WNV human infections/100,000 inhabitants). Figure 2 Geographical distribution of" exact="West Nile" post="virus (WNV) PCR-positive cases at LAU 2 level and"/>
   <result pre="LAU 2 level and cumulative incidence rates of autochthonous human" exact="WNV" post="infections at NUTS 3 level of Hungary, 2018. The"/>
   <result pre="level of Hungary, 2018. The total number of autochthonous human" exact="WNV" post="cases in 2018: n = 215. Black dots indicate"/>
   <result pre="units for statistics level 3. IR: Incidence rates (number of" exact="WNV" post="human infections/100,000 inhabitants). Figure 3 Geographical distribution of enzootic"/>
   <result pre="WNV human infections/100,000 inhabitants). Figure 3 Geographical distribution of enzootic" exact="WNV" post="cases. Color background of each county represents the number"/>
   <result pre="between 2010 and 2018. Progenitor African, Hungarian, and a Serbian" exact="WNV" post="lineage 2 strains are highlighted with blue outline, while"/>
   <result pre="case from Hungary to Belgium [36]. Figure 5 Human-derived, partial" exact="WNV" post="NS3 sequences from the 2018 season. The figure represents"/>
   <result pre="season. The figure represents similarity scores of all available human-derived" exact="WNV" post="partial NS3 sequences from 2018. The two dominant genetic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7019415\results\search\tropicalVirus\results.xml">
   <result pre="(arboviruses) have received much global attention recently due to the" exact="Zika" post="virus epidemic in the Americas. The major human arboviruses"/>
   <result pre="in Sudan 2.1. Mosquito-Borne Viral Diseases 2.1.1. Yellow Fever Virus" exact="Yellow fever" post="virus (YFV; Flaviviridae) is endemic in Sudan and infections"/>
   <result pre="cases and 1500 deaths, was reported from 1940 to 1941." exact="YFV" post="was detected in humans, non-human primates, wild and domestic"/>
   <result pre="[27]. A survey in 1973 confirmed the active circulation of" exact="YFV" post="in the area and indicated a high prevalence of"/>
   <result pre="exposure (95%) among the nonvaccinated population of central Sudan [28]." exact="YFV" post="was detected in the Northern Province of Sudan in"/>
   <result pre="spill over into the neighboring country of Chad [32]. 2.1.2." exact="Dengue" post="Virus Dengue virus (DENV; Flaviviridae) is endemic in Sudan"/>
   <result pre="into the neighboring country of Chad [32]. 2.1.2. Dengue Virus" exact="Dengue" post="virus (DENV; Flaviviridae) is endemic in Sudan and its"/>
   <result pre="on the Red Sea coast, Port Sudan city [36,37,38,39]. Recently," exact="DENV" post="has been emerging throughout the country (Figure 2). Indeed,"/>
   <result pre="for the first time during an outbreak in 2016/17 [42,43]." exact="DENV" post="infections were reported from the population of east, north,"/>
   <result pre="febrile illness, following heavy rain and flooding [5,6,35]. Studies of" exact="DENV" post="infection among pregnant women in East Sudan showed that"/>
   <result pre="DENV-2 [42]. Additionally, studies reported a high prevalence (67%) of" exact="DENV" post="infections in Sudan and up to 89% in the"/>
   <result pre="in these areas were infected repeatedly, and reported that all" exact="DENV" post="(1â€&quot;4) serotypes are circulating in the area [52,53]. Recently,"/>
   <result pre="of dengue fever in the Darfur area, western Sudan [54]." exact="DENV" post="transmission in Sudan is heterogeneous in space and time,"/>
   <result pre="water supply, storing drinking water, and geographical location [41,53]. 2.1.3." exact="West Nile" post="Virus West Nile virus (WNV, Flaviviridae) is endemic in"/>
   <result pre="drinking water, and geographical location [41,53]. 2.1.3. West Nile Virus" exact="West Nile" post="virus (WNV, Flaviviridae) is endemic in Sudan with infections"/>
   <result pre="and 1953â€&quot;1954 (Figure 3) [6,35,55,56]. Salim and Porterfield suggested that" exact="WNV" post="circulates enzootically in central Sudan, and this was confirmed"/>
   <result pre="in 1981 by Omer et al. [28,57]. Country-wide epidemics of" exact="WNV" post="infection were reported in 1994, 1996, and 1999, with"/>
   <result pre="associated with heavy rainfall and flooding [5,6,58]. An outbreak of" exact="WNV" post="infection in 2002, southern Sudan, was accompanied by severe"/>
   <result pre="encephalitis among 31 children under 12 years of age [59]." exact="WNV" post="infections have been recently identified in Darfur region, West"/>
   <result pre="in knowledge about the epidemiology and risk factors associated with" exact="WNV" post="infection, and local vectors have never been investigated. 2.1.4."/>
   <result pre="WNV infection, and local vectors have never been investigated. 2.1.4." exact="Zika" post="Virus The first evidence of Zika virus (ZIKV; Flaviviridae)"/>
   <result pre="never been investigated. 2.1.4. Zika Virus The first evidence of" exact="Zika" post="virus (ZIKV; Flaviviridae) circulation in Sudan was reported in"/>
   <result pre="A recent study reported a high rate of exposure to" exact="ZIKV" post="with 62.7% of 845 blood samples collected from all"/>
   <result pre="more specific neutralization test) [60]. Considering the recent association of" exact="ZIKV" post="infection in pregnant women with congenital defects in their"/>
   <result pre="congenital defects in their infants, and the wide distribution of" exact="ZIKV" post="in Sudan (present in seven of 18 states of"/>
   <result pre="seven of 18 states of the country (Figure 4)), studying" exact="ZIKV" post="and it is epidemiology in Sudan is remarkably limited."/>
   <result pre="and it is epidemiology in Sudan is remarkably limited. 2.1.5." exact="Chikungunya" post="Virus Chikungunya virus (CHIKV; Togaviridae) is endemic with frequent"/>
   <result pre="is epidemiology in Sudan is remarkably limited. 2.1.5. Chikungunya Virus" exact="Chikungunya" post="virus (CHIKV; Togaviridae) is endemic with frequent upsurges in"/>
   <result pre="disease in Sudan in 1973 showed that the seroprevalence of" exact="CHIKV" post="infection in Central Sudan was 13% [28]. Similar seroprevalences"/>
   <result pre="in the western region of the country documented much higher" exact="CHIKV" post="seroprevalence, up to 44% [29,35]. An epidemiological survey in"/>
   <result pre="(qRT-PCR) showed that 24% of pregnant women were infected with" exact="CHIKV" post="and the infections were associated with preterm delivery [44]."/>
   <result pre="study across the country reported a relatively low seroprevalence of" exact="CHIKV" post="in East and Central Sudan (1.8%) with 100% dengue"/>
   <result pre="CrisisGlob. J. Epidemiol. Public Health20141576110.12974/2313-0946.2014.01.02.4 32.YuillT.M.WoodallJ.P.BaekelandS.Latest outbreak news from ProMED-mail." exact="Yellow fever" post="outbreakâ€&quot;Darfur Sudan and ChadInt. J. Infect. Dis.201317e476e47810.1016/j.ijid.2013.03.009 33.MarkoffL.Yellow Fever"/>
   <result pre="Systematic ReviewPLoS Negl. Trop. Dis.201610e000519410.1371/journal.pntd.000519427926925 41.SeidahmedO.M.E.HassanS.A.SoghaierM.A.SiamH.A.M.AhmedF.T.A.ElkarsanyM.M.SulaimanS.M.Spatial and Temporal Patterns of" exact="Dengue" post="Transmission along a Red Sea Coastline: A Longitudinal Entomological"/>
   <result pre="Port Sudan CityPLoS Negl. Trop. Dis.20126e182110.1371/journal.pntd.000182123029582 42.HamidZ.HamidT.AlsedigK.AbdallahT.ElaagipA.AhmedA.KhalidF.Abdel HamidM.Molecular Investigation of" exact="Dengue" post="virus serotype 2 Circulation in Kassala State, SudanJpn. J."/>
   <result pre="of El-Gadarif state, SudanBMC Public Health20181892110.1186/s12889-018-5853-330053811 54.AhmedA.EldumaA.MagboulB.HigaziT.AliY.The First Outbreak of" exact="Dengue" post="Fever in Greater Darfur, Western SudanTrop. Med. Infect. Dis.201944310.3390/tropicalmed401004330823624"/>
   <result pre="reemerging mosquito-borne viral disease in EuropeEmerg. Infect. Dis.1999564365010.3201/eid0505.99050510511520 59.DepoortereE.KavleJ.KeusK.ZellerH.MurriS.LegrosD.Outbreak of" exact="West Nile" post="virus causing severe neurological involvement in children, Nuba Mountains,"/>
   <result pre="Mountains, Sudan, 2002Trop. Med. Int. Health2004973073610.1111/j.1365-3156.2004.01253.x15189465 60.SoghaierM.A.AbdelgadirD.M.AbdelkhaligS.M.KafiH.ZarrougI.M.A.SallA.A.EldegaiM.H.ElagebR.M.OsmanM.M.KhogaliH.Evidence of pre-existing active" exact="Zika" post="virus circulation in Sudan prior to 2012BMC Res. Notes20181190610.1186/s13104-018-4027-930567583"/>
   <result pre="Indicates Vulnerability of Eastern and Central Sudan to Infection with" exact="Chikungunya" post="VirusVector Borne Zoonotic Dis.20161629029110.1089/vbz.2015.189726974266 62.collab: EMRO-WHO WHOWeekly Epidemiological Monitor:"/>
   <result pre="Chikungunya VirusVector Borne Zoonotic Dis.20161629029110.1089/vbz.2015.189726974266 62.collab: EMRO-WHO WHOWeekly Epidemiological Monitor:" exact="Chikungunya" post="in Sudan. Regional Office of the Eastern MediterraneanWeekly Epidemiol."/>
   <result pre="online: http://applications.emro.who.int/docs/epi/2018/Epi_Monitor_2018_11_39.pdf?ua=1(accessed on 12 October 2018) 63.collab: WHOEmergencies Preparedness, Response:" exact="Chikungunya" post="in SudanWHOGeneva, Switzerland2018Available online: http://www.who.int/csr/don/15-october-2018-chikungunya-sudan/en/(accessed on 23 November 2018)"/>
   <result pre="Organ.20179560760810.2471/BLT.16.18968828804174 Figure 1 Map of Sudan showing the prevalence of" exact="Yellow fever" post="virus infections (Yellow). Figure 2 Map of Sudan showing"/>
   <result pre="(Brown). Figure 3 Map of Sudan showing the prevalence of" exact="West Nile" post="virus infections (Green). Figure 4 Map of Sudan showing"/>
   <result pre="(Green). Figure 4 Map of Sudan showing the prevalence of" exact="Zika" post="virus infections (Grey). Figure 5 Map of Sudan showing"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7020001\results\search\tropicalVirus\results.xml">
   <result pre="other herpes viruses (HHV) [72,78,79,80,81], arthropod-borne flaviviruses such as the" exact="West Nile" post="virus (WNV), Japanese encephalitis virus (JEV), chikungunya virus (CHIKV),"/>
   <result pre="Nile virus (WNV), Japanese encephalitis virus (JEV), chikungunya virus (CHIKV)," exact="Zika" post="virus (ZIKV), alphaviruses such as the Venezuelan, Western and"/>
   <result pre="loss of synapses within the CA3 region after infection by" exact="WNV" post="[299,300]. The precise and complete etiology of several long-term"/>
   <result pre="Virol.201222698710.1002/rmv.71222086854 87.MackenzieJ.S.GublerD.J.PetersenL.R.Emerging flaviviruses: The spread and resurgence of Japanese encephalitis," exact="West Nile" post="and dengue virusesNat. Med.200410S98S10910.1038/nm114415577938 88.MuellerS.WimmerE.CelloJ.Poliovirus and poliomyelitis: A tale"/>
   <result pre="Hypotheses20107520421310.1016/j.mehy.2010.02.02320236772 105.LebovJ.F.BrownL.M.MacDonaldP.D.M.RobertsonK.BowmanN.M.HooperS.R.Becker-DrepsS.Review: Evidence of Neurological Sequelae in Children With Acquired" exact="Zika" post="Virus InfectionPediatr. Neurol.201885162010.1016/j.pediatrneurol.2018.03.00130343688 106.WeatherheadJ.E.MillerV.E.GarciaM.N.HasbunR.SalazarL.DimachkieM.M.MurrayK.O.Long-term neurological outcomes in West Nile"/>
   <result pre="With Acquired Zika Virus InfectionPediatr. Neurol.201885162010.1016/j.pediatrneurol.2018.03.00130343688 106.WeatherheadJ.E.MillerV.E.GarciaM.N.HasbunR.SalazarL.DimachkieM.M.MurrayK.O.Long-term neurological outcomes in" exact="West Nile" post="virus-infected patients: An observational studyAm. J. Trop. Med. Hyg2015921006101210.4269/ajtmh.14-061625802426"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7020694\results\search\tropicalVirus\results.xml">
   <result pre="several viral vectors including papaya mosaic virus (PapMV) carrying M2e," exact="HPV" post="VLPs conjugated to the M2 protein, or VLPs derived"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7031975\results\search\tropicalVirus\results.xml">
   <result pre="show that Venezuela has historically been an important source of" exact="DENV" post="dispersal in this region, even before the massive exodus"/>
   <result pre="population, suggesting already established paths of viral distribution. Like DENV," exact="CHIKV" post="was introduced into Ecuador at multiple time points in"/>
   <result pre="were associated with the Caribbean. Our findings indicated no direct" exact="CHIKV" post="connection between Ecuador, Colombia, and Venezuela as of 2015,"/>
   <result pre="between Ecuador, Colombia, and Venezuela as of 2015, suggesting that" exact="CHIKV" post="was, at this point, not following the paths of"/>
   <result pre="CHIKV was, at this point, not following the paths of" exact="DENV" post="spread. Conclusion Our results reveal that Ecuador is vulnerable"/>
   <result pre="healthcare for the vulnerable populations is of utmost importance. Keywords" exact="Dengue" post="Chikungunya Ecuador Venezuela Colombia Dissemination Funding http://dx.doi.org/10.13039/100014035Armed Forces Health"/>
   <result pre="for the vulnerable populations is of utmost importance. Keywords Dengue" exact="Chikungunya" post="Ecuador Venezuela Colombia Dissemination Funding http://dx.doi.org/10.13039/100014035Armed Forces Health Surveillance"/>
   <result pre="forms of dengue disease are on the rise [6, 7]." exact="Dengue" post="is not the only mosquito-borne disease to reemerge in"/>
   <result pre="not the only mosquito-borne disease to reemerge in the Americas." exact="Chikungunya" post="virus (CHIKV) has been suggested to have caused outbreaks"/>
   <result pre="long absence of the virus from this region [8, 9]." exact="CHIKV" post="reemerged in 2013 in the Caribbean and quickly spread"/>
   <result pre="and South America [10â€&quot;12]. In Ecuador, the first cases of" exact="CHIKV" post="were reported at the end of 2014, and in"/>
   <result pre="of suspected dengue cases were confirmed to actually be acute" exact="CHIKV" post="infections (only 28% were confirmed to be acute DENV)"/>
   <result pre="the invasion of CHIKV, an arbovirus novel to the region," exact="Zika" post="virus (ZIKV), was identified in the Americas [13]. It"/>
   <result pre="in the country. In recent years, all three arboviruses (DENV," exact="CHIKV" post="and ZIKV) have co-circulated in Ecuador and its neighboring"/>
   <result pre="in infectious diseases such as malaria, measles, diphtheria, dengue, chikungunya," exact="Zika" post="and others [25, 26]. The massive human movement from"/>
   <result pre="in the harbor city of Machala revealed the first characterized" exact="CHIKV" post="outbreak in the country, as well all four serotypes"/>
   <result pre="2014â€&quot;2015. In this study, we use the most prevalent Ecuadorian" exact="DENV" post="(DENV1 and DENV2) and CHIKV genomes from this time"/>
   <result pre="use the most prevalent Ecuadorian DENV (DENV1 and DENV2) and" exact="CHIKV" post="genomes from this time period to determine the origins"/>
   <result pre="area of Machala (Fig.Â 1). The sequenced genomes included two" exact="DENV" post="serotypes (1 and 2), that belonged to the genotype"/>
   <result pre="that belonged to the genotype V and Asian American, respectively." exact="CHIKV" post="genomes belonged to the Asian lineage, and are the"/>
   <result pre="to the Asian lineage, and are the first genomes of" exact="CHIKV" post="to be reported from the country of Ecuador (AdditionalÂ"/>
   <result pre="cases of DENV1 and DENV2, and the two introductions of" exact="Chikungunya" post="(CHIKV-i-I, CHIKV-i-II); clinics are shown by â€˜Hâ€™, with the"/>
   <result pre="consisting of ~â€‰300 genomes) and one E gene dataset per" exact="DENV" post="serotype were used in Bayesian analyses to investigate the"/>
   <result pre="between Brazil, Paraguay and also Bolivia. Several independent introductions of" exact="CHIKV" post="into Ecuador from the Caribbean/Central America CHIKV was circulating"/>
   <result pre="independent introductions of CHIKV into Ecuador from the Caribbean/Central America" exact="CHIKV" post="was circulating in Machala, Ecuador in 2015 (Additional file"/>
   <result pre="the Asian genotype MCC tree, indicating two independent introductions of" exact="CHIKV" post="into Ecuador (Fig.Â 3). Both introductions originated from the"/>
   <result pre="though the surveillance site was active in 2014, the first" exact="CHIKV" post="was sampled in March 2015, indicating a period of"/>
   <result pre="was sampled in March 2015, indicating a period of silent" exact="CHIKV" post="transmission in this region of 8â€‰months (second introduction) to"/>
   <result pre="dispersed across the city, indicating simultaneous circulation of the two" exact="CHIKV" post="strains across the same area (Fig. 1). Interestingly, CHIKV"/>
   <result pre="two CHIKV strains across the same area (Fig. 1). Interestingly," exact="CHIKV" post="in Colombia was not closely related to either of"/>
   <result pre="in mid-2014 (2014.4; HPD: 2014.2â€&quot;2014.6). Fig. 3 MCC tree of" exact="CHIKV" post="Asian lineage. Taxa from Ecuador are color coded in"/>
   <result pre="the text are noted next to the respective ancestor nodes" exact="CHIKV" post="genomes from Ecuador were screened for reported mutations that"/>
   <result pre="transmission and infection of the mosquito. As all Asian lineage" exact="CHIKV" post="strains, the viruses from Ecuador had the E1:A98T residue"/>
   <result pre="virus in Ae. aegypti, and has recently been observed in" exact="CHIKV" post="outbreaks in several regions of the world [30, 32]."/>
   <result pre="regions of the world [30, 32]. These results show that" exact="CHIKV" post="from Ecuador had not acquired all the mutations that"/>
   <result pre="to the main vector in Ecuador, Ae. aegypti. Table 1" exact="CHIKV" post="amino acid mutations associated with phenotype change in vector"/>
   <result pre="and DENV2 introductions into Ecuador, and the 2013/2014 DENV1 and" exact="CHIKV" post="introductions, both followed an increase of Colombian and Venezuelan"/>
   <result pre="of Venezuelan and Colombian citizens entering Ecuador. DENV1, DENV2 and" exact="CHIKV" post="introductions are noted as vertical lines. CHIKV lines are"/>
   <result pre="DENV1, DENV2 and CHIKV introductions are noted as vertical lines." exact="CHIKV" post="lines are black, and DENV lines are color coded"/>
   <result pre="are noted as vertical lines. CHIKV lines are black, and" exact="DENV" post="lines are color coded based on their country of"/>
   <result pre="color coded based on their country of origin association. b" exact="Dengue" post="incidence per 100,000 population in Colombia, Venezuela and Ecuador"/>
   <result pre="dengue infections to introductions of novel viruses - chikungunya and" exact="Zika" post="- and their sustained spread in the country. The"/>
   <result pre="Venezuela, with diseases such as malaria, measles, dengue, chikungunya and" exact="Zika" post="on the rise [35]. As the citizens are fleeing"/>
   <result pre="located along the Pan American Highway, near the Ecuador-Peru border." exact="DENV" post="is hyperendemic in Machala, and is transmitted by the"/>
   <result pre="Colombian and Venezuelan citizens in 2009 and 2012, respectively. Interestingly," exact="DENV" post="case count data indicate that both the 2011 and"/>
   <result pre="introductions into Ecuador were preceded by a sharp increase in" exact="DENV" post="cases in Colombia and Venezuela. This would indicate that"/>
   <result pre="Argentina, Nicaragua, Puerto Rico, Brazil and Ecuador, resulting in sustained" exact="DENV" post="spread in these countries [38â€&quot;40]. The potential of dengue"/>
   <result pre="America continues to affect arboviral dispersal. Our analyses of the" exact="CHIKV" post="outbreak in Machala reveled that this arbovirus, like dengue,"/>
   <result pre="in 2014 and later that same year. Unlike dengue, however," exact="CHIKV" post="had been introduced from the Caribbean. CHIKV genomes from"/>
   <result pre="Unlike dengue, however, CHIKV had been introduced from the Caribbean." exact="CHIKV" post="genomes from Colombia showed no correlation to the genomes"/>
   <result pre="and were estimated introduced into this country from Martinique. Although" exact="CHIKV" post="is spreading in Venezuela, no full genomes were available"/>
   <result pre="infer the contribution of this country to the spread of" exact="CHIKV" post="in the region [42]. Previous E gene analyses from"/>
   <result pre="viral relationships, but did indicate a close connection to the" exact="CHIKV" post="genomes from the Caribbean [43]. Thus, these and our"/>
   <result pre="at least until 2015, there was no direct connection of" exact="CHIKV" post="strains between these countries. However, more recent findings suggest"/>
   <result pre="strains between these countries. However, more recent findings suggest that" exact="CHIKV" post="infections are found close to the country borders, suggesting"/>
   <result pre="infections are found close to the country borders, suggesting that" exact="CHIKV" post="might have started following the patterns of dengue spread"/>
   <result pre="vector, Ae. aegypti in South America, the possibility of direct" exact="CHIKV" post="dissemination between these countries of South America is real."/>
   <result pre="qualitative real-time reverse transcriptase RT-PCR assays for DENV1â€&quot;4, CHIKV, and" exact="ZIKV" post="(diagnostic protocol described previously) [6]. RNA extracted from samples"/>
   <result pre="protocol described previously) [6]. RNA extracted from samples that were" exact="DENV" post="and CHIKV positive by RT-PCR were sent to WRAIR,"/>
   <result pre="previously) [6]. RNA extracted from samples that were DENV and" exact="CHIKV" post="positive by RT-PCR were sent to WRAIR, Viral Diseases"/>
   <result pre="produced using GADM shapefiles, in ArcGIS v 10.6.1 [47, 48]." exact="Dengue" post="case count data was retrieved from Pan American Health"/>
   <result pre="Here, extracted RNA was reverse transcribed and amplified utilizing serotype-specific" exact="DENV" post="(DENV1 or DENV2) primers (AdditionalÂ fileÂ 7-8) or CHIKV"/>
   <result pre="serotype-specific DENV (DENV1 or DENV2) primers (AdditionalÂ fileÂ 7-8) or" exact="CHIKV" post="specific primers (AdditionalÂ fileÂ 9). Two approaches of generating"/>
   <result pre="of DENV1 and 1113 E genes of DENV2. All available" exact="CHIKV" post="full genomes were downloaded from the ViPR curated database"/>
   <result pre="genome alignment of the Asian lineage was constructed using all" exact="CHIKV" post="sequences except genomes without collection location or date, or"/>
   <result pre="analyses The best-fit models of evolution for DENV1, DENV2 and" exact="CHIKV" post="datasets were determined using jModelTest v2.1.7 and chosen based"/>
   <result pre="(ML) phylogenetic trees for each of the DENV1, DENV2 and" exact="CHIKV" post="datasets were inferred using Phyml v 4.9.1 [55] using"/>
   <result pre="determined by aLRT (approximate Likelihood Ratio Test). DENV1, DENV2 and" exact="CHIKV" post="reference alignments were further down sampled for Bayesian tree"/>
   <result pre="genome sampling skew, references were also down sampled for each" exact="DENV" post="serotype, such that no country contributed with more than"/>
   <result pre="than 65 genes (Nâ€‰=â€‰515 for DENV1 and Nâ€‰=â€‰505 for DENV2)." exact="CHIKV" post="full genome alignment for BEAST analyses consisted of 103"/>
   <result pre="Circuits of the Access Array (Fluidigm). LINK Additional file 9." exact="CHIKV" post="Specific Primer Pairs Used on the Integrated Fluidic Circuits"/>
   <result pre="Bayesian Evolutionary Analysis by Sampling Trees BIC Bayesian Information Criterion" exact="CHIKV" post="Chikungunya virus DENV Dengue virus ESS Effective Sample Size"/>
   <result pre="Evolutionary Analysis by Sampling Trees BIC Bayesian Information Criterion CHIKV" exact="Chikungunya" post="virus DENV Dengue virus ESS Effective Sample Size GTRâ€‰+â€‰Iâ€‰+â€‰Î&quot;"/>
   <result pre="by Sampling Trees BIC Bayesian Information Criterion CHIKV Chikungunya virus" exact="DENV" post="Dengue virus ESS Effective Sample Size GTRâ€‰+â€‰Iâ€‰+â€‰Î&quot; General Time"/>
   <result pre="Sampling Trees BIC Bayesian Information Criterion CHIKV Chikungunya virus DENV" exact="Dengue" post="virus ESS Effective Sample Size GTRâ€‰+â€‰Iâ€‰+â€‰Î&quot; General Time Reversible"/>
   <result pre="of the most recent common ancestor ViPR Virus Pathogen Resource" exact="ZIKV" post="Zika virus Publisherâ€™s Note Springer Nature remains neutral with"/>
   <result pre="the most recent common ancestor ViPR Virus Pathogen Resource ZIKV" exact="Zika" post="virus Publisherâ€™s Note Springer Nature remains neutral with regard"/>
   <result pre="Mortal Wkly Rep198938244194212498633 6.Stewart-IbarraAMRyanSJKennesonAKingCAAbbottMBarbachano-GuerreroAet al.The burden of dengue fever and" exact="Chikungunya" post="in southern coastal Ecuador: epidemiology, clinical presentation, and Phylogenetics"/>
   <result pre="novel epistatic mutations (E1:K211E and E2:V264A) in structural proteins of" exact="Chikungunya" post="virus enhance fitness in Aedes aegyptiVirology2016497596810.1016/j.virol.2016.06.02527423270 31.TsetsarkinKAWeaverSCSequential adaptive mutations"/>
   <result pre="Aedes aegyptiVirology2016497596810.1016/j.virol.2016.06.02527423270 31.TsetsarkinKAWeaverSCSequential adaptive mutations enhance efficient vector switching by" exact="Chikungunya" post="virus and its epidemic emergencePLoS Pathog2011712e100241210.1371/journal.ppat.100241222174678 32.Maljkovic BerryIEyaseFPollettSKonongoiSLJoyceMGFigueroaKet al.Global"/>
   <result pre="in 2012â€&quot;2013Clin Microbiol Infect2015217713 e5713 e810.1016/j.cmi.2015.03.016 42.LizarazoEVincenti-GonzalezMGrilletMEBethencourtSDiazOOjedaNet al.Spatial dynamics of" exact="Chikungunya" post="virus, Venezuela, 2014Emerg Infect Dis201925467268010.3201/eid2504.17212130882314 43.CamachoDReyesJNegredoAHernandezLSanchez-SecoMComachGAsian genotype of Chikungunya"/>
   <result pre="of Chikungunya virus, Venezuela, 2014Emerg Infect Dis201925467268010.3201/eid2504.17212130882314 43.CamachoDReyesJNegredoAHernandezLSanchez-SecoMComachGAsian genotype of" exact="Chikungunya" post="virus circulating in Venezuela during 2014Acta Trop2017174889010.1016/j.actatropica.2017.06.02628690146 44.Carrillo-HernandezMYRuiz-SaenzJVillamizarLJGomez-RangelSYMartinez-GutierrezMCo-circulation and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7045448\results\search\tropicalVirus\results.xml">
   <result pre="mosquito-borne viral infections compared to south and eastern highland regions." exact="Yellow fever," post="chikungunya, dengue, Zika, Rift Valley fever, West Nile and"/>
   <result pre="highland regions. Yellow fever, chikungunya, dengue, Zika, Rift Valley fever," exact="West Nile" post="and Oâ€™nyongâ€™nyong have been reported in the country. These"/>
   <result pre="viruses were found circulating in human, wildlife and domestic animals." exact="Yellow fever" post="and chikungunya outbreaks have been frequently reported. Aedes aegypti"/>
   <result pre="belonging to the genus Aedes are the major vectors of" exact="Chikungunya" post="(CHIKV), Dengue (DENV), Rift Valley fever (RVFV), Yellow fever"/>
   <result pre="the genus Aedes are the major vectors of Chikungunya (CHIKV)," exact="Dengue" post="(DENV), Rift Valley fever (RVFV), Yellow fever (YFV) and"/>
   <result pre="vectors of Chikungunya (CHIKV), Dengue (DENV), Rift Valley fever (RVFV)," exact="Yellow fever" post="(YFV) and Zika (ZIKV) [4]. These mosquito-borne viral diseases"/>
   <result pre="Dengue (DENV), Rift Valley fever (RVFV), Yellow fever (YFV) and" exact="Zika" post="(ZIKV) [4]. These mosquito-borne viral diseases are often misdiagnosed"/>
   <result pre="Kongo-Central in 1912 [7]. Thereafter a number of studies on" exact="YFV" post="and other mosquito-borne viral infections were carried out and"/>
   <result pre="1960 [8]. During the past two decades, repeated outbreaks of" exact="Chikungunya" post="and Yellow fever have been reported in DRC. During"/>
   <result pre="During the past two decades, repeated outbreaks of Chikungunya and" exact="Yellow fever" post="have been reported in DRC. During the same time,"/>
   <result pre="of public health importance such as DENV, ZIKV, RVFV and" exact="West Nile" post="virus (WNV) have also been recorded [9â€&quot;11]. This review"/>
   <result pre="across the DRC. Among the Flaviviridae, four species, YFV, DENV," exact="ZIKV" post="and WNV, were recorded. Among the Alphaviridae, two species,"/>
   <result pre="ZIKV and WNV, were recorded. Among the Alphaviridae, two species," exact="CHIKV" post="and ONNV were reported. The recorded mosquito-borne viruses occurred"/>
   <result pre="during inter-epidemic periods. Most of the records were related to" exact="YFV" post="and CHIKV. A number of studies were carried during"/>
   <result pre="virus occurrence in between 1998 and 2018. Key: black rhombus," exact="West Nile" post="virus; purple triangle, chikungunya virus; red cross, dengue virus;"/>
   <result pre="purple triangle, chikungunya virus; red cross, dengue virus; black star," exact="Zika" post="virus; black line, borders of territories These viruses were"/>
   <result pre="studies reported co-occurrence or co-infections of mosquito-borne viruses. These included" exact="CHIKV" post="and YFV, CHIKV and DENV, YFV and DENV [9,"/>
   <result pre="or co-infections of mosquito-borne viruses. These included CHIKV and YFV," exact="CHIKV" post="and DENV, YFV and DENV [9, 10, 14â€&quot;16]. Yellow"/>
   <result pre="mosquito-borne viruses. These included CHIKV and YFV, CHIKV and DENV," exact="YFV" post="and DENV [9, 10, 14â€&quot;16]. Yellow fever virus The"/>
   <result pre="These included CHIKV and YFV, CHIKV and DENV, YFV and" exact="DENV" post="[9, 10, 14â€&quot;16]. Yellow fever virus The first yellow"/>
   <result pre="YFV, CHIKV and DENV, YFV and DENV [9, 10, 14â€&quot;16]." exact="Yellow fever" post="virus The first yellow fever outbreak in DRC was"/>
   <result pre="in 1912 at Matadi Beach [7]. Later in 1928, another" exact="YFV" post="outbreak occurred in the same area. This was the"/>
   <result pre="occurred in the same area. This was the first autochthonous" exact="YFV" post="outbreak in the DRC and it caused a mortality"/>
   <result pre="2004 [10]. In a demographic survey of 2013â€&quot;2014, an overall" exact="YFV" post="prevalence of 31.5% among children was reported in DRC"/>
   <result pre="a single Province of Kongo-Centrale [23]. The autochthonous cases of" exact="YFV" post="have also been documented in the provinces of Bas-Uele,"/>
   <result pre="belongs to an endemic geographical area at high risk for" exact="YFV" post="transmission [24]. YFV transmission in DRC varies from one"/>
   <result pre="endemic geographical area at high risk for YFV transmission [24]." exact="YFV" post="transmission in DRC varies from one region to another"/>
   <result pre="region to another and within the region. The absence of" exact="YFV" post="circulation or lowest seroprevalence (&amp;lt; 5%) has been observed"/>
   <result pre="into Tanganyika, Haut-Lomami, Haut-Katanga, Lualaba) [25]. The highest seroprevalence of" exact="YFV" post="(â‰¥ 30%) has been recorded from the savannah regions"/>
   <result pre="part of DRC [25, 26]. The identified territories with high" exact="YFV" post="transmission were Bosobolo and Mobayi-mbongo in the Province of"/>
   <result pre="provinces of the DRC, 1917â€&quot;2018. Key: light pink, provinces with" exact="YFV" post="seroprevalence &amp;lt; 10%; dark pink: provinces with YFV seroprevalence"/>
   <result pre="provinces with YFV seroprevalence &amp;lt; 10%; dark pink: provinces with" exact="YFV" post="seroprevalence ranging between 10â€&quot;20%; red, provinces with YFV seroprevalence"/>
   <result pre="provinces with YFV seroprevalence ranging between 10â€&quot;20%; red, provinces with" exact="YFV" post="seroprevalence &amp;gt; 20%; white line: borders of provinces Chikungunya"/>
   <result pre="with YFV seroprevalence &amp;gt; 20%; white line: borders of provinces" exact="Chikungunya" post="The two first reported chikungunya cases in the DRC"/>
   <result pre="Bas-UÃ©lÃ© in Bondo territory [15]. Since then, no circulation of" exact="CHIKV" post="was documented in DRC until 1998 [11]. In 1998,"/>
   <result pre="In 1998, of 45 patients sampled during an outbreak of" exact="WNV" post="in Kisangani City in Tshopo Province of the north-eastern"/>
   <result pre="of the north-eastern region, 28.8% patients were found positive for" exact="CHIKV" post="immunoglobulin M (IgM) antibodies [11]. Kinshasa, the capital of"/>
   <result pre="municipality. More than half (57.9%) the samples tested positive for" exact="CHIKV" post="IgM antibodies and nine strains were isolated in C6/36"/>
   <result pre="2011, of the 453 sera screened, two positive cases of" exact="CHIKV" post="were detected by RT-PCR. One case was from Gemena"/>
   <result pre="patients tested negative for malaria in Kinshasa, the seroprevalence of" exact="CHIKV" post="was 9.6% and 5 samples were found positive for"/>
   <result pre="CHIKV was 9.6% and 5 samples were found positive for" exact="CHIKV" post="by RT-PCR [30]. Based on a genetic study, the"/>
   <result pre="RT-PCR [30]. Based on a genetic study, the isolates of" exact="CHIKV" post="that were found to circulate in DRC belonged to"/>
   <result pre="Province have been identified as potential hosts or reservoirs of" exact="CHIKV" post="by detecting the presence of antibodies from these species"/>
   <result pre="circulating in diverse animals and mosquitoes in DRC, 1960â€&quot;2018 Animal/mosquito" exact="CHIKV" post="DENV YFV RVFV WNV ONNV Alphavirus Flavivirus Study location"/>
   <result pre="in diverse animals and mosquitoes in DRC, 1960â€&quot;2018 Animal/mosquito CHIKV" exact="DENV" post="YFV RVFV WNV ONNV Alphavirus Flavivirus Study location Chimpanzee"/>
   <result pre="diverse animals and mosquitoes in DRC, 1960â€&quot;2018 Animal/mosquito CHIKV DENV" exact="YFV" post="RVFV WNV ONNV Alphavirus Flavivirus Study location Chimpanzee +"/>
   <result pre="and mosquitoes in DRC, 1960â€&quot;2018 Animal/mosquito CHIKV DENV YFV RVFV" exact="WNV" post="ONNV Alphavirus Flavivirus Study location Chimpanzee + + +"/>
   <result pre="spp. + Kinshasa [13] Key: +, screened positive for virus" exact="Dengue" post="Three serotypes of dengue virus (DENV-1, DENV-2 and DENV-3)"/>
   <result pre="to 8.8% [9, 11, 30]. In Kisangani of Tshopo Province," exact="DENV" post="was reported to co-circulate with CHIKV during the West"/>
   <result pre="Kisangani of Tshopo Province, DENV was reported to co-circulate with" exact="CHIKV" post="during the West Nile outbreak of 1998 [11]. In"/>
   <result pre="Province, DENV was reported to co-circulate with CHIKV during the" exact="West Nile" post="outbreak of 1998 [11]. In Kinshasa, co-occurrence of dengue"/>
   <result pre="and chikungunya was reported during the outbreak of 2012 [16]." exact="Dengue" post="occurrence has been reported from western (Kinshasa, Kongo central),"/>
   <result pre="and north-eastern regions (Tshopo, Haut-uÃ©lÃ©, Bas-UÃ©lÃ©) (TableÂ 4). Antibodies against" exact="DENV" post="have also been reported from chimpanzee in 1960 and"/>
   <result pre="of Aedes mosquitoes collected around Ndjili River in Kinshasa [13]." exact="Zika" post="Two studies on Zika were identified during the review."/>
   <result pre="around Ndjili River in Kinshasa [13]. Zika Two studies on" exact="Zika" post="were identified during the review. In the first study,"/>
   <result pre="of 453 archived sera collected country-wide from 2003â€&quot;2011 that tested" exact="YFV" post="negative were also negative for ZIKV virus using RT-PCR"/>
   <result pre="from 2003â€&quot;2011 that tested YFV negative were also negative for" exact="ZIKV" post="virus using RT-PCR [10]. The second study analysed 978"/>
   <result pre="during 2013â€&quot;2014 showed that 34 samples (3.5%) were positive for" exact="Zika" post="antibodies using ELISA. However, of the 34 samples that"/>
   <result pre="that tested positive in ELISA, only one remained positive for" exact="ZIKV" post="by PRNT [9]. This positive case of Zika was"/>
   <result pre="positive for ZIKV by PRNT [9]. This positive case of" exact="Zika" post="was reported from the north-western part of DRC, from"/>
   <result pre="of DRC, from Sud-Ubangi Province bordering the Central African Republic." exact="West Nile" post="virus In the DRC, antibodies against WNV in humans"/>
   <result pre="African Republic. West Nile virus In the DRC, antibodies against" exact="WNV" post="in humans have been detected by virus neutralization tests,"/>
   <result pre="illness outbreak following heavy rainfall in Kisangani [11]. But no" exact="WNV" post="antibodies or RNA were detected in samples from Kinshasa"/>
   <result pre="detected in samples from Kinshasa collected during 1999â€&quot;2000 during a" exact="CHIKV" post="outbreak [28]. The specific neutralizing antibodies against WNV in"/>
   <result pre="during a CHIKV outbreak [28]. The specific neutralizing antibodies against" exact="WNV" post="in Haut-UelÃ© Province have been detected in chimpanzee in"/>
   <result pre="Kinshasa in 2004, nine (30%) out of 20 horses were" exact="WNV" post="seropositive using ELISA and western blot analysis [38]. Afterwards,"/>
   <result pre="and western blot analysis [38]. Afterwards, a 12.5% seroprevalence of" exact="WNV" post="was reported in Kinshasa [39]. These observations provide evidence"/>
   <result pre="evidence of an animal role in the enzootic circulation of" exact="WNV" post="in the DRC. Oâ€™nyongâ€™nyong virus Oâ€™nyongâ€™nyong virus (ONNV) is"/>
   <result pre="the DRC. Oâ€™nyongâ€™nyong virus Oâ€™nyongâ€™nyong virus (ONNV) is a closer" exact="CHIKV" post="related alphavirus vectored mainly by the Anopheles mosquito. Its"/>
   <result pre="have been amplified with specific primers for CHIKV, ONNV, YFV," exact="WNV" post="or DENV [13]. In the Ango and Bondo territories"/>
   <result pre="amplified with specific primers for CHIKV, ONNV, YFV, WNV or" exact="DENV" post="[13]. In the Ango and Bondo territories from Bas-UÃ©lÃ©,"/>
   <result pre="spread of mosquito-borne virus outbreaks [11, 41]. For instance, the" exact="WNV" post="outbreak in Kisangani started at army camps where immigrated"/>
   <result pre="fever outbreaks [18]. In addition, significant rates of antibodies against" exact="YFV" post="have been detected among chimpanzee from savannah areas compared"/>
   <result pre="outbreaks or positive cases occurred during the rainy seasons. The" exact="West Nile" post="outbreak was preceded by heavy rainfall in Kisangani in"/>
   <result pre="change this general trend. Although, there is evidence of ZIKV," exact="DENV" post="and RVFV circulation in DRC, no epidemic has been"/>
   <result pre="One Health approaches with emphasis on integrated vector control. Abbreviations" exact="CHIKV" post="chikungunya virus DENV dengue virus RVFV Rift Valley fever"/>
   <result pre="with emphasis on integrated vector control. Abbreviations CHIKV chikungunya virus" exact="DENV" post="dengue virus RVFV Rift Valley fever virus YFV yellow"/>
   <result pre="chikungunya virus DENV dengue virus RVFV Rift Valley fever virus" exact="YFV" post="yellow fever virus WNV West Nile virus ZIKV Zika"/>
   <result pre="virus RVFV Rift Valley fever virus YFV yellow fever virus" exact="WNV" post="West Nile virus ZIKV Zika virus DRC Democratic Republic"/>
   <result pre="RVFV Rift Valley fever virus YFV yellow fever virus WNV" exact="West Nile" post="virus ZIKV Zika virus DRC Democratic Republic of the"/>
   <result pre="fever virus YFV yellow fever virus WNV West Nile virus" exact="ZIKV" post="Zika virus DRC Democratic Republic of the Congo ELISA"/>
   <result pre="virus YFV yellow fever virus WNV West Nile virus ZIKV" exact="Zika" post="virus DRC Democratic Republic of the Congo ELISA enzymeâ€�linked"/>
   <result pre="Infect Dis.20161618310.1186/s12879-016-1511-527112553 6.Carrillo-HernÃ¡ndezMYRuiz-SaenzJVillamizarLJGÃ³mez-RangelSYMartÃ­nez-GutierrezMCo-circulation and simultaneous co-infection of dengue, chikungunya, and" exact="Zika" post="viruses in patients with febrile syndrome at the Colombian-Venezuelan"/>
   <result pre="Republic of the CongoVector Borne Zoonotic Dis.20181836437010.1089/vbz.2017.217629768102 11.NurYAGroenJHeuvelmansHTuynmanWCopraCOsterhausADAn outbreak of" exact="West Nile" post="fever among migrants in Kisangani, Democratic Republic of CongoAm"/>
   <result pre="la fiÃ¨vre jaune Ã GemenaAnn Soc Belge MÃ©d Trop.19626859864 19.WHO." exact="Yellow fever" post="in the Democratic Republic of the Congo. Geneva: World"/>
   <result pre="World Health Organisation; 2010. http://www.who.int/csr/don/2010_07_19a/. Accessed 13 Nov 2018. 20.WHO." exact="Yellow fever" post="in the Democratic Republic of Congo. Geneva: World Health"/>
   <result pre="World Health Organisation; 2013. http://www.who.int/csr/don/2013_06_14_yellowfever/en/. Accessed 13 Nov 2018. 21.WHO." exact="Yellow fever" post="Democratic Republic of the Congo. Geneva: World Health Organisation;"/>
   <result pre="the CongoMed Trop Rev Corps Sante Colon.200363637638 29.BosscheVDCnopsLMeersmanKDomingoCGompelVAEsbroeckVMChikungunya virus and" exact="West Nile" post="virus infections imported into Belgium, 2007â€&quot;2012Epidemiol Infect.20151432227223610.1017/S095026881400068524690286 30.Ido E,"/>
   <result pre="central AfricaTrans R Soc Trop Med Hyg.19423692010.1016/S0035-9203(42)90051-8 37.LucasseCFirst isolation of" exact="West Nile" post="virus in central AfricaBull Soc Path Ex196156156161 38.CabreOGrandadamMMariÃ©JLGravierPPrangÃ©ASantinelliYet al.West"/>
   <result pre="in horses, sub-Saharan AfricaEmerg Infect Dis.2006121958196010.3201/eid1212.06004217326952 39.DavoustBLeparc-GoffartIDemoncheauxJPTineRDiarraMTrombiniGet al.Serologic surveillance for" exact="West Nile" post="virus in dogsAfrica. Emerg Infect Dis.2014201415141710.3201/eid2008.13069125061842 40.RwagumaELutwamaJSempalaSKiwanukaNKamugishaJOkwareSet al.Emergence of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7052239\results\search\tropicalVirus\results.xml">
   <result pre="unfavorable conditions and may be implicated in dengue outbreaks. Since" exact="DENV" post="infection dynamics vary among wild-type viruses and vector populations,"/>
   <result pre="ecology Funding SÃ£o Paulo Research Foundation (FAPESP)- Grant #2016/12140â€&quot;0 Introduction" exact="Dengue" post="is considered the most serious re-emergent viral disease transmitted"/>
   <result pre="DENV5,10. The species has already been found naturally infected with" exact="DENV" post="in a pineapple plantation in Costa Rica11, but this"/>
   <result pre="as vertical transmission13,14. While in endemic areas the ability of" exact="DENV" post="to persist in the environment during periods that are"/>
   <result pre="indications that vertical transmission is an important maintenance mechanism for" exact="DENV" post="circulation during these periods15. Indeed, vertical transmission of this"/>
   <result pre="South America are the main continents where vertical transmission of" exact="DENV" post="in Ae. aegypti and Ae. albopictus under natural conditions"/>
   <result pre="locations. Investigation into the occurrence of natural vertical transmission of" exact="DENV" post="in Ae. aegypti and Ae. albopictus populations is therefore"/>
   <result pre="sought to investigate the occurrence of natural vertical transmission of" exact="DENV" post="in Ae. aegypti and Ae. albopictus mosquito populations in"/>
   <result pre="SÃ£o Paulo. Results Mosquitoes To detect natural vertical transmission of" exact="DENV" post="in Ae. aegypti and Ae. albopictus during two seasons"/>
   <result pre="much discussion27,28. The first report of natural vertical transmission of" exact="DENV" post="in the Americas was described in specimens from Trinidad"/>
   <result pre="serotypes were also reported in Brazil18,34â€&quot;36. Natural vertical transmission of" exact="DENV" post="in Ae. aegypti has been demonstrated in the states"/>
   <result pre="Janeiro43 and Amazonas44. Here, we report natural vertical transmission of" exact="DENV" post="in Ae. albopictus for the first time in the"/>
   <result pre="females of Ae. albopictus were able to transmit all four" exact="DENV" post="serotypes vertically to the offspring. The transmission rates varied"/>
   <result pre="to oral infection45. Similar results were found for a Brazilian" exact="DENV" post="strain and populations of Ae. aegypti and Ae. albopictus46,"/>
   <result pre="this species may be less relevant in the maintenance of" exact="DENV" post="during periods of low vector density45,47. Our results corroborate"/>
   <result pre="of Ae. albopictus when compared to Ae. aegypti24,25,48 which maintains" exact="DENV" post="circulation in areas with high concentrations of human beings"/>
   <result pre="and viruses make these parks high-risk areas for infection by" exact="DENV" post="and other arboviruses, raising the question of the relevance"/>
   <result pre="albopictus, such as its vector competence for dengue, yellow fever," exact="Zika" post="and chikungunya viruses in laboratory conditions46,62â€&quot;64, our findings reinforce"/>
   <result pre="Study area To investigate the occurrence of vertical transmission of" exact="DENV" post="in female and male Ae. aegypti and Ae. albopictus"/>
   <result pre="amplification (semi-nested PCR) that allows simultaneous detection of the four" exact="DENV" post="serotypes by generating DNA products of unique sizes, which"/>
   <result pre="2 Amplification of viral genetic material.Â Oligonucleotides used to amplify" exact="DENV" post="serotypes. Primer Sequence (5â€²-3â€²) Position in the genome Amplified"/>
   <result pre="(60â€‰Â°C, 30â€‰s) and extension (72â€‰Â°C, 1â€‰min). RNA from the four" exact="DENV" post="serotypes and ultrapure water were used as positive and"/>
   <result pre="method using the Big Dye Terminator Sequencing Kit (ABI) and" exact="DENV" post="serotype specific primers (TableÂ 2) in the ABI 3100"/>
   <result pre="3.Bennett, S. N. Taxonomy and evolutionary relationships of flaviviruses. in" exact="Dengue" post="and dengue hemorrhagic fever (eds. Gubler, D. J. &amp;amp;"/>
   <result pre="albopictus, and Culex quinquefasciatus (Diptera: Culicidae) as Potential Vectors of" exact="Zika" post="Virus in FloridaJ. Med. Entomol.201956101710.1093/jme/tjy14830165498 10.DegallierNet al.Aedes albopictus may"/>
   <result pre="in Southeastern Brazil and FloridaJ. Med. Entomol.20034078579410.1603/0022-2585-40.6.78514765654 27.KhinMMThanKATransovarial Transmission of" exact="Dengue" post="2 Virus by Aedes aegypti in NatureAm. J. Trop."/>
   <result pre="Trop. Med. Hyg.19833259059410.4269/ajtmh.1983.32.5906859404 28.WattsDMHarrisonBAPantuwatanaSKleinTABurkeDSFailure to Detect Natural Transovarial Transmission of" exact="Dengue" post="Viruses by Aedes aegypti and Aedes albopictus (Diptera: Culicidae)J."/>
   <result pre="albopictus (Diptera: Culicidae)J. Med. Entomol.19852226126510.1093/jmedent/22.3.2614009622 29.HullBTikasinghEde SouzaMMartinezRNatural Transovarial Transmission of" exact="Dengue" post="4 Virus in Aedes aegypti in TrinidadAm. J. Trop."/>
   <result pre="et al. Natural vertical infection by dengue virus serotype 4," exact="Zika" post="virus and Mayaro virus in Aedes (Stegomyia) aegypti and"/>
   <result pre="populations of Aedes aegyptiActa Trop.201717614014310.1016/j.actatropica.2017.07.01428743449 44.da CostaCFet al.Transovarial transmission of" exact="DENV" post="in Aedes aegypti in the Amazon basin: a local"/>
   <result pre="basin: a local model of xenomonitoringParasit. Vectors20171024910.1186/s13071-017-2194-528526066 45.RosenLShroyerDALienJCFreierJETeshRBTransovarial Transmission of" exact="Dengue" post="Viruses by Mosquitoes: Aedes albopictus and Aedes aegyptiAm. J."/>
   <result pre="no Estado de SÃ£o PauloBol. epidemiol. paul.201292240 53.FaresRCGSouzaKPRAÃ±ezGRiosMEpidemiological Scenario of" exact="Dengue" post="in BrazilBiomed Res. Int.2015201511310.1155/2015/321873 54.GuWNovakRJShort report: detection probability of"/>
   <result pre="genetic markersMed. Vet. Entomol.20031719520410.1046/j.1365-2915.2003.00424.x12823837 57.GrunnillMBootsMHow Important is Vertical Transmission of" exact="Dengue" post="Viruses by Mosquitoes (Diptera: Culicidae)?J. Med. Entomol.20165311910.1093/jme/tjv16826545718 58.ThongrungkiatSManeekanPWasinpiyamongkolLPrummongkolSProspective field"/>
   <result pre="American Countries as a Crucial Factor in the Spread of" exact="Chikungunya" post="VirusJ. Virol.2014886294630610.1128/JVI.00370-1424672026 62.Chouin-CarneiroTet al.Differential Susceptibilities of Aedes aegypti and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7053713\results\search\tropicalVirus\results.xml">
   <result pre="and Health Sciences : Tropical Diseases : Neglected Tropical Diseases:" exact="Dengue" post="Fever : Medicine and Health Sciences : Infectious Diseases"/>
   <result pre="Medicine and Health Sciences : Infectious Diseases : Viral Diseases:" exact="Dengue" post="Fever : Biology and Life Sciences : Evolutionary Biology"/>
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Genetics: Molecular"/>
   <result pre="medium, provided the original author and source are credited.pntd.0008049.pdf Abstract" exact="Dengue" post="fever, a mosquito-borne viral disease in humans, has been"/>
   <result pre="18 of 21 cities of Guangdong. Phylogenetic analyses revealed that" exact="DENV" post="sequences did not form a single cluster, indicating that"/>
   <result pre="genome sequences were inconclusive. In this study, we sequenced 114" exact="DENV" post="complete genomes of DENV1-4 obtained from 2013 to 2017"/>
   <result pre="preparation of the manuscript. fig-count: table-count: page-count: Data Availability The" exact="DENV" post="genome sequences generated in this study were deposited in"/>
   <result pre="the NCBI GenBank database under the accession no. MN018285-MN018398. Introduction" exact="Dengue" post="fever was listed as a major threat to global"/>
   <result pre="the deaths resulting from dengue infection by 2020 (WHO, https://www.who.int/emergencies/ten-threats-to-global-health-in-2019)." exact="Dengue" post="infection is a mosquito-borne disease widely distributed in tropical"/>
   <result pre="Southeast Asia, Africa, Eastern Mediterranean, Americas, and Western Pacific [2]." exact="Dengue" post="fever is caused by dengue virus (DENV), belonging to"/>
   <result pre="classified into four serotypes (DENV1-4) [4, 5]. The genome of" exact="DENV" post="is a single-strand positive-sense RNA of approximately 11 kb,"/>
   <result pre="whether dengue outbreaks have become endemic in Guangdong. 10.1371/journal.pntd.0008049.t001Table 1" exact="Dengue" post="cases from 2013 to 2017 in Guangdong Province. Year"/>
   <result pre="2017 in Guangdong Province. Year 2013 2014 2015 2016 2017" exact="Dengue" post="cases 2894 45189 1683 544 1662 In the current"/>
   <result pre="patient's history of travelling was obtained through inquiry. Patients with" exact="DENV" post="who did not leave Guangdong within two weeks prior"/>
   <result pre="bodies were used to identify the serotype by indirect immunofluorescence." exact="DENV" post="positive samples were further used for viral isolation by"/>
   <result pre="instructions. One-step RT-PCR kit (TaKaRa, Japan) was used to amplify" exact="DENV" post="sequences according to the manufacturerâ€™s protocols. PCR primer sequences"/>
   <result pre="sequences according to the manufacturerâ€™s protocols. PCR primer sequences of" exact="DENV" post="are provided in S1 Table. Sanger sequencing (ABI 3730)"/>
   <result pre="S1 Table. Sanger sequencing (ABI 3730) was performed to obtain" exact="DENV" post="sequences after PCR products purification (Qiagen, Germany). Sequences assemblies"/>
   <result pre="23, and DENV-4 = 9). Each analyses dataset of four" exact="DENV" post="serotypes was composed of complete genome sequences in this"/>
   <result pre="DENV-4 genome sequences) were collected for subsequent analyses. All published" exact="DENV" post="complete genome accessions involved in this study are supplied"/>
   <result pre="Results Sequence characteristics in this study One hundred and fourteen" exact="DENV" post="complete genomes were sequenced in this study (DENV-1 ="/>
   <result pre="23, DENV-4 = 9). In contrast, there were 79 published" exact="DENV" post="genome sequences (DENV-1 = 55, DENV-2 = 17, DENV-3"/>
   <result pre="temporal distribution, there were 4, 17, 43, 31, and 19" exact="DENV" post="genome sequences from 2013 to 2017, respectively (Fig 1B)."/>
   <result pre="2:7 in DENV-4 (Fig 1B). Fig 1 Statistical information of" exact="DENV" post="genome sequences. (A) No. of DENV sequences both in"/>
   <result pre="1 Statistical information of DENV genome sequences. (A) No. of" exact="DENV" post="sequences both in the present study and those isolated"/>
   <result pre="system in China, http://bzdt.ch.mnr.gov.cn/). In geographical distribution, 75 of 114" exact="DENV" post="genome sequences were derived from five cities, Guangzhou, Shenzhen,"/>
   <result pre="Shenzhen and Foshan simultaneously included DENV1-4, and there were three" exact="DENV" post="serotype sequences distributed in Guangzhou, Dongguan, Zhongshan, Shantou, Jiangmen,"/>
   <result pre="in Guangzhou, Dongguan, Zhongshan, Shantou, Jiangmen, and Yangjiang. Only one" exact="DENV" post="serotype was derived from Zhanjiang, Zhuhai, Zhaoqing, Shanwei, Huizhou,"/>
   <result pre="(Fig 1C). Phylogenetic relationship To illuminate the phylogenetic relationship among" exact="DENV" post="genome sequences in this study, we conducted maximum likelihood"/>
   <result pre="infection were from Southeast and South Asian countries and most" exact="DENV" post="isolates were closet to those from Southeast and South"/>
   <result pre="in their ML trees (S1 and S2 Figs) and most" exact="DENV" post="isolates were closely related to those from Southeast and"/>
   <result pre="S2 Fig), which demonstrated that recombinant events took place in" exact="DENV" post="genomes. Evidence of viral recombination Recombination analyses of DENV"/>
   <result pre="in DENV genomes. Evidence of viral recombination Recombination analyses of" exact="DENV" post="genome CDS regions was performed using Recombination Detection Program"/>
   <result pre="2013 or 2014 (Fig 4B). Fig 4 Recombinant information of" exact="DENV" post="genomic coding regions. UTR sequences were excluded for recombinant"/>
   <result pre="the CDS regions of DENV1-4, only one genomic organization of" exact="DENV" post="is represented in the upper panel. In the lower"/>
   <result pre="(primary axis) and frequency (secondary axis) of recombinant event per" exact="DENV" post="gene. Every involved gene will be counted once if"/>
   <result pre="events. The number and frequency of recombinant event in each" exact="DENV" post="gene were further examined and the results showed that"/>
   <result pre="results showed that recombinant event occurred in every gene of" exact="DENV" post="genome except 2K (Fig 4A and 4C). The recombinant"/>
   <result pre="recombination signal was detected simultaneously in DENV1-4. For the four" exact="DENV" post="serotypes in this study, recombination signal was detected in"/>
   <result pre="We further made a statistical analyses of SNP distribution along" exact="DENV" post="genome within each subtype. The results showed that NS5"/>
   <result pre="then normalized. The normalized SNP represented an even distribution along" exact="DENV" post="genome and it was further compared with that of"/>
   <result pre="results showed that no significant difference was found in intra-serotype" exact="DENV" post="genes (Fig 5A, p &amp;gt; 0.01), which indicated that"/>
   <result pre="a similar rate. Fig 5 The normalized SNP distributions along" exact="DENV" post="genome. (A) Intra-subtype comparison of normalized SNP distributions along"/>
   <result pre="DENV genome. (A) Intra-subtype comparison of normalized SNP distributions along" exact="DENV" post="genomic regions. The normalized SNP are obtained by total"/>
   <result pre="mutation rate (Fig 5C). Discussion In some Southeast Asia countries," exact="Dengue" post="fever outbreaks had been endemic [24, 25]. However, whether"/>
   <result pre="recent years [26â€&quot;28], while Wang and his colleagues believed that" exact="DENV" post="was an imported disease in Guangdong [29]. Compared to"/>
   <result pre="that is much more reliable about molecular epidemiological characteristics of" exact="DENV" post="in Guangdong in recent years. Genomic sequencing has played"/>
   <result pre="an important driver of viral evolution and adaption [34]. Numerous" exact="DENV" post="recombinant events have been identified in previous studies [26,"/>
   <result pre="that dengue disease is not endemic in Guangdong Province. Among" exact="DENV" post="genes, NS3 possessed the most recombinant events covering simultaneously"/>
   <result pre="in situ. Additionally, there were no obvious intra-serotype differences in" exact="DENV" post="genes, but more significant inter-subtype differences in non-structural genes"/>
   <result pre="in Guangdong is suitable for the multiplication of mosquitoes and" exact="DENV" post="transmission. Therefore, measures that are more effective for dengue"/>
   <result pre="Our investigation has provided further knowledge on the prevalence of" exact="DENV" post="in Guangdong and it is in favor with the"/>
   <result pre="for additional data file. S3 Fig The total SNPs among" exact="DENV" post="genome. (A) Total SNPs within UTR (green), non-synonymous (red)"/>
   <result pre="for additional data file. S2 Table GenBank accessions of published" exact="DENV" post="sequences in dataset. (PDF) LINK Click here for additional"/>
   <result pre="here for additional data file. S4 Table GenBank accessions of" exact="DENV" post="sequences in this study. (PDF) LINK Click here for"/>
   <result pre="diseases with significant public health impact caused by mosquito-borne flaviviruses:" exact="West Nile," post="Zika, dengue and yellow fever. Semin Diagn Pathol. 2019;"/>
   <result pre="10.1016/S1473-3099(16)00146-827091092 6KuhnRJ, ZhangW, MichaelGR, PletnevSV, CorverJ, LenchesE, et al.Structure of" exact="Dengue" post="Virus: Implications for Flavivirus Organization, Maturation, and Fusion. Cell."/>
   <result pre="Flavivirus Organization, Maturation, and Fusion. Cell. 2002;108(5):717â€&quot;725. 10.1016/s0092-8674(02)00660-811893341 7ChenB, LiuQY." exact="Dengue" post="fever in China. Lancet. 2015;385(9978):1621â€&quot;2. 10.1016/S0140-6736(15)60793-025943817 8GutiÃ©rrezG, LionelG, MarÃ­aP,"/>
   <result pre="of the Diagnostic Utility of the Traditional and Revised WHO" exact="Dengue" post="Case Definitions. PLoS Negl Trop Dis. 2013;7(8):e238510.1371/journal.pntd.000238523991237 9SunJ, LuL,"/>
   <result pre="Parasites &amp;amp; vectors. 2019;12(1):1710.1186/s13071-018-3281-y30621762 25MoorePR, van den HurkAF, MackenzieJS, PykeAT." exact="Dengue" post="viruses in Papua New Guinea: evidence of endemicity and"/>
   <result pre="JiangL, LuoL, FengH, LinP, et al.Evolutionary and phylodynamic analyses of" exact="Dengue" post="virus serotype I in Guangdong Province, China, between 1985"/>
   <result pre="2017;60(12):1â€&quot;4. 10.1007/s11427-017-9252-y28058635 32KittichaiV, SriprapunM, KonklongP, ThonsanginN, ChompoosriJ, TawatsinA, et al.Double" exact="Dengue" post="Serotypes in Asymptomatic Populations Living in An Area of"/>
   <result pre="Asymptomatic Populations Living in An Area of Thailand Endemic for" exact="Dengue" post="Hemorrhagic Fever. Thai J Vet Med. 2015;45(2):205â€&quot;12. 33LeeKS, LoS,"/>
   <result pre="of Ebola virus during 2014. Nat Microbiol. 2016;1(11):1615110.1038/nmicrobiol.2016.15127595345 41LazearHM, DiamondMS." exact="Zika" post="Virus: New Clinical Syndromes and Its Emergence in the"/>
   <result pre="the Western Hemisphere. J Virol. 2016;90(10):4864â€&quot;75. 10.1128/JVI.00252-1626962217 42SutharMS, DiamondMS, GaleM." exact="West Nile" post="virus infection and immunity. Nat Rev Microbiol. 2013;11(2):115â€&quot;128. 10.1038/nrmicro295023321534"/>
   <result pre="Nat Rev Microbiol. 2005;3(1):13â€&quot;22. 10.1038/nrmicro106715608696 44DiamondMS, PiersonTC. Molecular Insight into" exact="Dengue" post="Virus Pathogenesis and Its Implications for Disease Control. Cell."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7054940\results\search\tropicalVirus\results.xml">
   <result pre="virus after the past episodes and panics haunted by Ebola," exact="Zika" post="and Nipah viruses, as well as earlier emergencies posed"/>
   <result pre="IqbalH M N, et al.2017Advances in developing therapies to combat" exact="Zika" post="virus: current knowledge and future perspectives. Front Microbiol. 8:1469."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7057477\results\search\tropicalVirus\results.xml">
   <result pre="CentralLondon pmcid: 7057477115 doi: 10.1186/s40709-020-00115-4 : Review A review on" exact="Zika" post="virus outbreak, epidemiology, transmission and infection dynamics KazmiSyeda Sidra1AliWaqarwaqarali@bs.qau.edu.pk1BibiNousheen1NourozFaisal12[1],"/>
   <result pre="otherwise stated in a credit line to the data. Abstract" exact="Zika" post="virus (ZIKV) is a newly emergent relative of the"/>
   <result pre="of the Flaviviridae family and linked to dengue (DENV) and" exact="Chikungunya" post="(CHIVKV). ZIKV is one of the rising pathogens promptly"/>
   <result pre="Flaviviridae family and linked to dengue (DENV) and Chikungunya (CHIVKV)." exact="ZIKV" post="is one of the rising pathogens promptly surpassing geographical"/>
   <result pre="is one of the rising pathogens promptly surpassing geographical borders." exact="ZIKV" post="infection was characterized by mild disease with fever, headache,"/>
   <result pre="in fetus and new-borns inÂ BrazilÂ have been related to" exact="ZIKV" post="infection, raising serious worldwide public health concerns. ZIKV is"/>
   <result pre="related to ZIKV infection, raising serious worldwide public health concerns." exact="ZIKV" post="is transmitted by the bite of infected female mosquitoes"/>
   <result pre="we extensively described the current understanding of the effects of" exact="ZIKV" post="on heath, clinical manifestation, diagnosis and treatment options based"/>
   <result pre="on modern, alternative and complementary medicines regarding the disease. Keywords" exact="Zika" post="virus Aedes mosquito Epidemiology Guillainâ€&quot;BarrÃ© syndrome Microcephaly Treatment Introduction"/>
   <result pre="Guillainâ€&quot;BarrÃ© syndrome Microcephaly Treatment Introduction Among the family of viruses," exact="Zika" post="virus (ZIKV) is an emerging evolving virus on the"/>
   <result pre="initially reported from Uganda in 1940s [1, 2]. Transmission of" exact="ZIKV" post="is related to the two other imperative arbo-viruses including"/>
   <result pre="the blood of a sentinel rhesus macaque placed in the" exact="Zika" post="Forest of Uganda [4, 5]. ZIKV stayed relatively silent"/>
   <result pre="macaque placed in the Zika Forest of Uganda [4, 5]." exact="ZIKV" post="stayed relatively silent for almost 70Â years and all"/>
   <result pre="Islands to Brazil [6]. Recently it was identified that the" exact="ZIKV" post="strain found in the Americas had escalated to Angola"/>
   <result pre="above mentioned studies endorse overview of mosquito-borne transmission of the" exact="ZIKV" post="strain from the Americas into continental Africa. World Health"/>
   <result pre="international concern as a result of global alarm created by" exact="ZIKV" post="by becoming first foremost infectious disease coupled with defects"/>
   <result pre="than a half of century [10]. History and epidemiology of" exact="ZIKV" post="ZIKV is a member of family Flaviviridae and spread"/>
   <result pre="a half of century [10]. History and epidemiology of ZIKV" exact="ZIKV" post="is a member of family Flaviviridae and spread through"/>
   <result pre="family include arboviruses, dengue virus and Japanese encephalitis viruses [11]." exact="ZIKV" post="antibodies were also detected in animal species, especially non-human"/>
   <result pre="were also detected in animal species, especially non-human primates [12]." exact="ZIKV" post="was also isolated from several mosquito species in Africa"/>
   <result pre="aegypti [13] and Aedes albopictus, respectively [14]. Studies reported that" exact="ZIKV" post="has three main lineages, two from Africa and one"/>
   <result pre="strain as its own lineage. Epidemiology studies revealed distribution of" exact="ZIKV" post="in half of the north African continent, Vietnam, Malaysia,"/>
   <result pre="during a study indicating the presence of neutralizing antibodies to" exact="ZIKV" post="in sera [25]. Only few cases of infection in"/>
   <result pre="infection in human were reported before 2007 when outbreak of" exact="ZIKV" post="infection in humans occurred in Yap, Federated States of"/>
   <result pre="Pacific region [26]. In French Polynesia the largest epidemic of" exact="ZIKV" post="occurred during 2013 to 2014 and extended to New"/>
   <result pre="Vanuatu, Easter Island, Solomon Islands and other Pacific Islands [5]." exact="ZIKV" post="transmission is known in 55 countries and territories. However,"/>
   <result pre="affected with local infection [27]. Fig.Â 1 Chronological time-line of" exact="ZIKV" post="epidemic from 1947â€&quot;2016 Molecular biology and virology Flaviviridae family"/>
   <result pre="encephalitis, visceral involvement and hemorrhagic fever [29]. The length of" exact="ZIKV" post="genome is 10,794Â kb, comprising a positive sense single-stranded"/>
   <result pre="folding patterns are present in the 39 NCR of the" exact="ZIKV" post="genome [30]. These nucleotides and folding patterns may involve"/>
   <result pre="and genome stabilization [31]. Fig.Â 2 The genome organization of" exact="ZIKV" post="All identified structures of flaviviruses vary on the basis"/>
   <result pre="that is composed of two dissimilar proteins having 180 copies." exact="ZIKV" post="varies from other flaviviruses bulges by glycosylation spot on"/>
   <result pre="protein at this spot. Surrounding residues and glycosylation site on" exact="ZIKV" post="may be responsible for attachment of virus to human"/>
   <result pre="infect. If the function of glycosylation spot is analogous to" exact="DENV" post="(attachment to the cells receptor of human body) it"/>
   <result pre="be targeted by an antiviral compound [32]. Incubation period for" exact="ZIKV" post="disease is around 2â€&quot;7Â days [33], with symptoms like"/>
   <result pre="disturbances, photophobia, cough malaise, back pain, aphthous ulcers and sweating." exact="ZIKV" post="infection can be misdiagnosed with other arboviruses and bacterial"/>
   <result pre="with other arboviruses and bacterial infections as not explicit to" exact="ZIKV" post="infection, especially in prevalent areas. In French Polynesia serious"/>
   <result pre="was increased to 20-fold during the epidemic [35]. Transmission of" exact="ZIKV" post="ZIKV vector-borne transmission Aedes aegypti, Aedes polynesiensis and Aedes"/>
   <result pre="increased to 20-fold during the epidemic [35]. Transmission of ZIKV" exact="ZIKV" post="vector-borne transmission Aedes aegypti, Aedes polynesiensis and Aedes albopictus"/>
   <result pre="albopictus are the potential vectors responsible for the transmission of" exact="ZIKV" post="infection by biting. Aedes aegypti is the foremost vector"/>
   <result pre="infection by biting. Aedes aegypti is the foremost vector of" exact="DENV" post="and CHIKV. Aedes polynesiensis is the main vector responsible"/>
   <result pre="Polynesia these species of mosquitoes were collected and tested for" exact="ZIKV" post="infection by RT-PCR and only one Aedes aegypti mosquito"/>
   <result pre="RT-PCR and only one Aedes aegypti mosquito was confirmed having" exact="ZIKV" post="RNA; experimental investigations showed the French Polynesian strain of"/>
   <result pre="Polynesian strain of Aedes aegypti can replicate the French Polynesian" exact="ZIKV" post="strain (Additional file 1: Figure S1) [36]. Altogether, 61"/>
   <result pre="conventional competent Aedes aegypti vectors but have not yet documented" exact="ZIKV" post="transmission [37]. Thus, risk of ZIKV spread to other"/>
   <result pre="have not yet documented ZIKV transmission [37]. Thus, risk of" exact="ZIKV" post="spread to other countries is still likely. Might be"/>
   <result pre="was also reported in all areas with prior reports of" exact="ZIKV" post="transmission. Altogether in the African lineage eight mosquitoes were"/>
   <result pre="only mosquito isolated in the Asian lineage (Malaysia/1966). In 2007," exact="ZIKV" post="was identified in patients infected with Aedes aldopictusÂ mosquitoes"/>
   <result pre="that cause Micronesia outbreak [38]. Later on, in 2013, the" exact="ZIKV" post="spread out to French Polynesia, with consequent extent to"/>
   <result pre="Aedes aegyptiÂ is considered as the utmost common vector for" exact="DENV" post="[41]. Later on in 2006, Chouin-Carneiro reported that the"/>
   <result pre="and Aedes albopictus which found to be poor transmitters of" exact="ZIKV" post="results in continuous divergence of the Asian lineage [42]."/>
   <result pre="Indeed, whileÂ AedesÂ is widely accepted as the vector for" exact="ZIKV" post="[1, 43, 44], Guedes et al. has revealed that"/>
   <result pre="ZIKV [1, 43, 44], Guedes et al. has revealed that" exact="ZIKV" post="can infect and replicate in the salivary glands, midgut,"/>
   <result pre="Altogether this work suggests that the transmission vector range for" exact="ZIKV" post="may be larger than foreseen (although still a debatable"/>
   <result pre="debatable topic demanding more exploration). Non-vector-borne transmission Non-vector-borne transmission of" exact="ZIKV" post="infection can be caused during labor (mother to child),"/>
   <result pre="(Fig.Â 3). Fig.Â 3 Schematic diagram representing the transmission of" exact="ZIKV" post="Antibodies against ZIKV were detected by Serosurvey studies in"/>
   <result pre="3 Schematic diagram representing the transmission of ZIKV Antibodies against" exact="ZIKV" post="were detected by Serosurvey studies in goats, rodents (Meriones"/>
   <result pre="These studies suggest that there is no clear association between" exact="ZIKV" post="and a specific species of animal [36]. In humans,"/>
   <result pre="viral infection may also refer to sexual contact [5]. High" exact="ZIKV" post="RNA load has detected in breast milk, so transmission"/>
   <result pre="breast milk, so transmission is possible by breast feeding and" exact="ZIKV" post="can also be transmitted by blood transfusions [46] as"/>
   <result pre="reported on December 2015 in Brazil, the first case of" exact="ZIKV" post="blood transfusion transmission [47]. ZIKV is adopted to transmit"/>
   <result pre="Brazil, the first case of ZIKV blood transfusion transmission [47]." exact="ZIKV" post="is adopted to transmit by enzootic and sub Urban"/>
   <result pre="non-vector borne transmission of ZIKV. Fig.Â 4 Transmission cycle of" exact="ZIKV" post="Pathophysiology and diagnosis In the beginning, ZIKV infection was"/>
   <result pre="Transmission cycle of ZIKV Pathophysiology and diagnosis In the beginning," exact="ZIKV" post="infection was misdiagnosed with dengue infection. Virus isolation and"/>
   <result pre="serological methods are carried out for laboratory diagnosis examination for" exact="ZIKV" post="(TableÂ 1) [48]. Virus isolation needs several days (i.e."/>
   <result pre="serological methods [15]. Cell culture may be utilized to isolate" exact="ZIKV" post="[5] but specialized laboratories are required to practice it"/>
   <result pre="16]. Reverse transcription PCR (RT-PCR) is used for confirmation of" exact="ZIKV" post="infections whereas IgM against ZIKV can be detected by"/>
   <result pre="is used for confirmation of ZIKV infections whereas IgM against" exact="ZIKV" post="can be detected by ELISA [48]. RT-PCR is time"/>
   <result pre="is time saving, specific and sensitive in order to detect" exact="ZIKV" post="in serum or cell culture [15]. Molecular detection of"/>
   <result pre="ZIKV in serum or cell culture [15]. Molecular detection of" exact="ZIKV" post="was increased when saliva was used at the acute"/>
   <result pre="children and neonates as blood is difficult to collect [5]." exact="ZIKV" post="fever diagnosis from PAHO is shown in Fig.Â 5."/>
   <result pre="diagnosis from PAHO is shown in Fig.Â 5. RT-PCR for" exact="ZIKV" post="is done on blood or saliva sample. Sequencing is"/>
   <result pre="Sequencing is performed if the results of RT-PCR are positive." exact="ZIKV" post="IgM serology comprises detection by immunofluorescence or ELISA, with"/>
   <result pre="are equivocal or positive [36]. TableÂ 1 Differential diagnosis of" exact="ZIKV" post="infection includes various viral diseases with similar signs and"/>
   <result pre="includes various viral diseases with similar signs and symptoms as" exact="ZIKV" post="infection [49] No Viral diseases Similarities with Zika virus"/>
   <result pre="symptoms as ZIKV infection [49] No Viral diseases Similarities with" exact="Zika" post="virus Dissimilarities with Zika virus Diagnostic test 1 Dengue"/>
   <result pre="[49] No Viral diseases Similarities with Zika virus Dissimilarities with" exact="Zika" post="virus Diagnostic test 1 Dengue fever High fever, severe"/>
   <result pre="with Zika virus Dissimilarities with Zika virus Diagnostic test 1" exact="Dengue" post="fever High fever, severe muscle pain, and headache and"/>
   <result pre="be associated with hemorrhage Not associated with conjunctivitis Serology 2" exact="Chikungunya" post="High fever and intense joint pain affecting the hands,"/>
   <result pre="lymphadenopathy Not associated with conjunctivitis, coryza is not present in" exact="ZIKV" post="infection Serology 5 Measles Fever, cough, conjunctivitis, and lymphadenitis."/>
   <result pre="generalized rash Sore throat and coryza are not present in" exact="ZIKV" post="infection Serology 6 Leptospirosis Fever, rigors, myalgia, conjunctival suffusion,"/>
   <result pre="Leptospirosis Fever, rigors, myalgia, conjunctival suffusion, headache, arthralgiaÂ Distinguished from" exact="ZIKV" post="infection by the presence of jaundice Serology 7 Malaria"/>
   <result pre="smear and polymerase chain reaction Fig.Â 5 Flow scheme for" exact="ZIKV" post="fever diagnosis [73, 74] Neurological complications of ZIKV infection"/>
   <result pre="scheme for ZIKV fever diagnosis [73, 74] Neurological complications of" exact="ZIKV" post="infection Guillainâ€&quot;BarrÃ© syndrome and cases of other neurologic manifestations"/>
   <result pre="other neurologic manifestations appears in Brazil and French Polynesia throughout" exact="ZIKV" post="epidemics, even though it is self-limiting [50, 51]. A"/>
   <result pre="is a possible relation between fetal deformities and infection with" exact="ZIKV" post="in pregnancy, as the incidences of microcephaly cases among"/>
   <result pre="neonates have amplified by a factor of about 20 [51]." exact="ZIKV" post="infection in fetus can be identified by Ultrasound in"/>
   <result pre="after birth and 30 of these were associated to congenital" exact="ZIKV" post="infection [53]. It has been published from the ParaÃ­ba"/>
   <result pre="It has been published from the ParaÃ­ba State recently that" exact="ZIKV" post="infection was detected in newborns having severe congenital CNS"/>
   <result pre="with intertwined relation between congenital CNS malformations during pregnancy and" exact="ZIKV" post="infection [54]. Risk of Guillainâ€&quot;BarrÃ© syndrome Guillainâ€&quot;BarrÃ© syndrome (GBS)"/>
   <result pre="(GBS) is one of the new complications and manifestations of" exact="ZIKV" post="infection [34]. GBS is a serious and life threatening"/>
   <result pre="respiratory failure characterized by progressive muscular weakness [55]. Outbreak of" exact="ZIKV" post="in French Polynesia fourÂ years ago added it to"/>
   <result pre="GBS. Sufficient intravenous (IV) immunoglobulin (Ig) treatment for patients with" exact="ZIKV" post="related GBS should be applied [57]. Increased verification of"/>
   <result pre="related GBS should be applied [57]. Increased verification of a" exact="ZIKV" post="infection based on laboratory results and GBS prevalence have"/>
   <result pre="period from December 2015 to March 2016 [53]. Treatment of" exact="ZIKV" post="In ZIKV infection, individuals should have adequate water intake,"/>
   <result pre="December 2015 to March 2016 [53]. Treatment of ZIKV In" exact="ZIKV" post="infection, individuals should have adequate water intake, ample rest"/>
   <result pre="no specific medications or vaccine available to treat or prevent" exact="ZIKV" post="infections until now; only medications for symptomatic relief can"/>
   <result pre="medical condition [54]. Homeopathy is a worthy treatment option in" exact="ZIKV" post="infection as it proved to be effective in Japanese"/>
   <result pre="encephalitis virus which is included in the same genus like" exact="Zika" post="virus [33]. Treatment with belladonna efficaciously reduced the severity"/>
   <result pre="diseases and illnesses [62]. Fig.Â 6 Schematic representation of possible" exact="ZIKV" post="treatment Eupatorium is a naturally occurring pharmaceutical homeopathic compound"/>
   <result pre="naturally occurring pharmaceutical homeopathic compound effective against the symptoms of" exact="ZIKV" post="disease, so it can be utilized as prophylactic treatment"/>
   <result pre="disease, so it can be utilized as prophylactic treatment against" exact="ZIKV" post="infection [63]. Eupatorium perfoliatum, Rhustox and Atropa belladonna are"/>
   <result pre="belladonna are the homeopathic prescriptions that may be utilized for" exact="ZIKV" post="infection treatment. These medicinal agents are effective against the"/>
   <result pre="treatment. These medicinal agents are effective against the symptoms of" exact="ZIKV" post="infection [64]. During epidemics homeopathic pharmaceuticals are more effective"/>
   <result pre="these ayurvedic plants so they might also be effective for" exact="ZIKV" post="[33]. Beside homeopathic and ayurveda medicines, engineering approaches were"/>
   <result pre="directed towards resolving symptoms and not the actual infection; however," exact="ZIKV" post="treatments and vaccines are in development. In 2016, WHO"/>
   <result pre="all publicly affirmed commercial, government and academic-led projects focused at" exact="ZIKV" post="interventions, together with vaccines [69]. The list encompasses numerous"/>
   <result pre="71]. Suggested workflow for prompt discovery of drug counter to" exact="ZIKV" post="is presented in Fig.Â 7; whole process is proposed"/>
   <result pre="trial and if getting optimistic results, manufacturing the drug against" exact="ZIKV" post="by scale up process, advertising and dissemination of drug"/>
   <result pre="drug [72]. Fig.Â 7 Proposed workflow for drug development against" exact="ZIKV" post="Prevention and control of ZIKV Most precarious threats for"/>
   <result pre="workflow for drug development against ZIKV Prevention and control of" exact="ZIKV" post="Most precarious threats for ZIKV infection are mosquitoes including"/>
   <result pre="ZIKV Prevention and control of ZIKV Most precarious threats for" exact="ZIKV" post="infection are mosquitoes including their reproducing localities. Their encounter"/>
   <result pre="mosquitoes containing active ingredients Tetramethrin and Cypermethrin [75]. Tests against" exact="ZIKV" post="infection should be performed before blood transfusions to prevent"/>
   <result pre="related transmission. Pregnancy must be avoided in the high risk" exact="ZIKV" post="infection prone areas before complete eradication or extra care"/>
   <result pre="extra care must be exercised as microcephaly is associated with" exact="ZIKV" post="infection [76]. Besides, different vector control strategies for averting"/>
   <result pre="ZIKV infection [76]. Besides, different vector control strategies for averting" exact="Zika" post="virus spread can be employed. Subjugation of mosquito population"/>
   <result pre="on honeydew, fruit, and nectar [77]. Hence, the spread of" exact="ZIKV" post="can be encountered by utilizing these species. Aedes species"/>
   <result pre="it worldwide. At present there is no vaccine available for" exact="ZIKV" post="infection. Vaccines against flaviviral infections available for use of"/>
   <result pre="vector borne infections must be followed in order to prevent" exact="ZIKV" post="infection, as well as avoiding mosquito bite and control"/>
   <result pre="vector is the only available options. Animal models of the" exact="ZIKV" post="disease are immediately required not only for exhibiting the"/>
   <result pre="virus on hostâ€™s immunity and reproductive health throughout the life." exact="ZIKV" post="infection is increasing dramatically, so it is the need"/>
   <result pre="lethal infection and to constrain its future entrance as well." exact="ZIKV" post="specific rapid molecular diagnosis should be done urgently in"/>
   <result pre="of broad spectrum clinical consequences that are resulting from fetal" exact="ZIKV" post="infection and the environmental influences that effect their emergence."/>
   <result pre="effective medications and the vaccines to shield humans counter to" exact="ZIKV" post="disease. Supplementary information LINK Additional file 1: Figure S1:"/>
   <result pre="Hyg201610.4269/ajtmh.15-086626903610 4.PetersenLRJamiesonDJPowersAMHoneinMAZika virusN Eng J Med20163741552156310.1056/NEJMra1602113 5.MussoDRocheCRobinENhanTTeissierACao-LormeauV-MPotential sexual transmission of" exact="Zika" post="virusEmerg Infect Dis20152135936110.3201/eid2102.14136325625872 6.FauciASMorensDMZika virus in the Americasâ€&quot;yet another"/>
   <result pre="Med201637460160410.1056/NEJMp160029726761185 7.World Health Organization Regional Office for Africa. Microcephalyâ€&quot;suspected congenital" exact="Zika" post="syndrome, Angola. Weekly bulletin on outbreaks and other emergencies;"/>
   <result pre="Accessible at: https://apps.who.int/iris/bitstream/handle/10665/259557/OEW48- 2504122017.pdf?sequenceâ€‰=â€‰1. 8.SassettiMZÃ©-ZÃ©LFrancoJCunhaJDGomesATomÃ©Aet al.First case of confirmed congenital" exact="Zika" post="syndrome in continental AfricaTrans R Soc Trop Med Hyg201811245846210.1093/trstmh/try07430053235"/>
   <result pre="AfricaTrans R Soc Trop Med Hyg201811245846210.1093/trstmh/try07430053235 9.HillSCVasconcelosJNetoZJandondoDZÃ©-ZeLAguiarRSet al.Emergence of the" exact="Zika" post="virus Asian lineage in Angola: an outbreak investigationLancet Inf"/>
   <result pre="public health emergency of international concernJAMA Î�eurol.20167313951396 11.HamelRDejarnacOWichitSEkchariyawatPNeyretALuplertlopNet al.Biology of" exact="Zika" post="virus infection in human skin cellsJ Virol2015898880889610.1128/JVI.00354-1526085147 12.KiryaBGOkiaNOA yellow"/>
   <result pre="in human skin cellsJ Virol2015898880889610.1128/JVI.00354-1526085147 12.KiryaBGOkiaNOA yellow fever epizootic in" exact="Zika" post="Forest, Uganda, during 1972: part 2: Monkey serologyTrans R"/>
   <result pre="2: Monkey serologyTrans R Soc Trop Med Hyg19777130030310.1016/0035-9203(77)90104-3413216 13.MarchetteNJGarciaRRudnickAIsolation of" exact="Zika" post="virus from Aedes aegypti mosquitoes in MalaysiaAm J Trop"/>
   <result pre="Aedes albopictus?PLoS Negl Trop Dis.20148e268110.1371/journal.pntd.000268124516683 15.FayeOFayeODialloDDialloMWeidmannMSallAAQuantitative real-time PCR detection of" exact="Zika" post="virus and evaluation with field-caught mosquitoesVirol J.201320131031110.1186/1743-422X-10-311 16.LanciottiRSKosoyOLLavenJJVelezJOLambertAJJohnsonAJet al.Genetic"/>
   <result pre="with field-caught mosquitoesVirol J.201320131031110.1186/1743-422X-10-311 16.LanciottiRSKosoyOLLavenJJVelezJOLambertAJJohnsonAJet al.Genetic and serologic properties of" exact="Zika" post="virus associated with an epidemic, Yap State, Micronesia, 2007Emerg"/>
   <result pre="State, Micronesia, 2007Emerg Infect Dis2008141232123910.3201/eid1408.08028718680646 17.FayeOFreireCCMIamarinoAFayeOde OliveiraJVCDialloMet al.Molecular evolution of" exact="Zika" post="virus during its emergence in the 20th centuryPLoS Negl"/>
   <result pre="the 20th centuryPLoS Negl Trop Dis.20148e263610.1371/journal.pntd.000263624421913 18.HaddowADSchuhAJYasudaCYKasperMRHeangVHuyRet al.Genetic characterization of" exact="Zika" post="virus strains: geographic expansion of the Asian lineagePLoS Negl"/>
   <result pre="BahiaBrazil. Emerg Infect Dis.2015211885188610.3201/eid2110.15084726401719 21.ZanlucaCMeloVCMosimannALSantosGISantosCNLuzKFirst report of autochthonous transmission of" exact="Zika" post="virus in BrazilMem Inst Oswaldo Cruz201511056957210.1590/0074-0276015019226061233 22.WongsurawatTAthipanyasilpNJenjaroenpunPJunSRKaewnapanBWassenaarTMet al.Case of"/>
   <result pre="22.WongsurawatTAthipanyasilpNJenjaroenpunPJunSRKaewnapanBWassenaarTMet al.Case of microcephaly after congenital infection with Asian lineage" exact="Zika" post="virusThailand. Emerg Infect Dis.201810.3201/eid2409.18041629985788 23.LanPTQuangLCHuongVTQThuongNVHungPCHuongTTLNet al.Fetal Zika virus infection"/>
   <result pre="with Asian lineage Zika virusThailand. Emerg Infect Dis.201810.3201/eid2409.18041629985788 23.LanPTQuangLCHuongVTQThuongNVHungPCHuongTTLNet al.Fetal" exact="Zika" post="virus infection in VietnamPLOS Curr.201710.1371/currents.outbreaks.1c8f631e0ef8cd7777d639eba48647fa29188136 24.OlsonJGKsiazekTGSuhandimanTZika virus, a cause"/>
   <result pre="spread of a mosquito-borne virusBull World Health Organ20169467568610.2471/BLT.16.17108227708473 26.GourinatCAOâ€™ConnorOCalvezEGoarantCDupont-RouzeyrolMDetection of" exact="Zika" post="Virus in UrineEmerg Infect Dis201521848610.3201/eid2101.14089425530324 27.World Health Organization (2016)"/>
   <result pre="Zika Virus in UrineEmerg Infect Dis201521848610.3201/eid2101.14089425530324 27.World Health Organization (2016)" exact="Zika" post="virus: Fact sheet http://www.who.int/mediacentre/factsheets/zika/en/. Accessed 3 Feb 2016. 28.WongSSPoonRWWongSCZika"/>
   <result pre="flavivirusJ Virol199872738310.1128/JVI.72.1.73-83.19989420202 31.LindenbachBDRiceCMMolecular biology of flavivirusesAdv Virus Res200359236110.1016/S0065-3527(03)59002-914696326 32.Purdue University." exact="Zika" post="virus structure revealed a critical advance in the development"/>
   <result pre="and treatmentVirusDisease.20162711111510.1007/s13337-016-0307-y27366760 34.FontesMBZika virus-related hypertensive iridocyclitisArq Bras Oftalmol.2016796310.5935/0004-2749.2016002026840174 35.MussoDNhanTXEmergence of" exact="Zika" post="VirusClin Microbiol.201541000222 36.MussoDGublerDJZika VirusClin Microbiol Rev20162948752410.1128/CMR.00072-1527029595 37.World Health Organization."/>
   <result pre="37.World Health Organization. Countries and territories with current or previous" exact="Zika" post="virustransmission. Updated July 2019. https://www.who.int/emergencies/diseases/zika/countries-with-zika-and-vectors-table.pdf. 38.DuffyMRChenT-HHancockTWPowersAMKoolJLLanciottiRSet al.Zika virus outbreak"/>
   <result pre="in OceaniaWestern Pac Surveill Response J.2013481010.5365/wpsar.2013.4.2.00324015365 40.MussoDNillesEJCao-LormeauVMRapid spread of emerging" exact="Zika" post="virus in the Pacific areaClin Microbiol Infect201420O595O59610.1111/1469-0691.1270724909208 41.Lourenco-de-OliveiraRRuaAVVezzaniDWillatGVazeilleMMoussonLet al.Aedes"/>
   <result pre="of Aedes aegypti and Aedes albopictus from the Americas to" exact="Zika" post="VirusPLoS Negl Trop Dis.201610e000454310.1371/journal.pntd.000454326938868 43.HayesEBZika virus outside AfricaEmerg Infect"/>
   <result pre="virus outside AfricaEmerg Infect Dis2009151347135010.3201/eid1509.09044219788800 44.BerthetNNakounÃ©EKamgangBSelekonBDescorps-DeclÃ¨reSGessainAet al.Molecular characterization of three" exact="Zika" post="flaviviruses obtained from sylvatic mosquitoes in the Central African"/>
   <result pre="quinquefasciatus in BrazilEmerg Microbes Infect.20176e6910.1038/emi.2017.5928790458 46.BesnardMLastÃ¨reSTeissierACao-LormeauVMussoDEvidence of perinatal transmission of" exact="Zika" post="virus, French Polynesia, December 2013 and February 2014Euro Surveill2014192075110.2807/1560-7917.ES2014.19.13.2075124721538"/>
   <result pre="December 2013 and February 2014Euro Surveill2014192075110.2807/1560-7917.ES2014.19.13.2075124721538 47.ProMED-mail. 23 December 2015." exact="Zika" post="virusâ€&quot;Americas, Atlantic Ocean. ProMED-mail archive no. 20151223.3886435. http://www.promedmail.org. Accessed"/>
   <result pre="and seroepidemiological investigations in Oyo StateJ Hyg19798321321910.1017/S0022172400025997489960 49.LaBeaud AD. 2016." exact="ZIKV" post="infection: an overview. http://www.uptodate.com/contents/zika-virus-infection-an-overview. 50.IoosSMalletHPLeparc GoffartIGauthierVCardosoTHeridaMCurrent Zika virus epidemiology"/>
   <result pre="49.LaBeaud AD. 2016. ZIKV infection: an overview. http://www.uptodate.com/contents/zika-virus-infection-an-overview. 50.IoosSMalletHPLeparc GoffartIGauthierVCardosoTHeridaMCurrent" exact="Zika" post="virus epidemiology and recent epidemicsMed Mal Infect.20144430230710.1016/j.medmal.2014.04.00825001879 51.Rapid risk"/>
   <result pre="virus epidemiology and recent epidemicsMed Mal Infect.20144430230710.1016/j.medmal.2014.04.00825001879 51.Rapid risk assessment:" exact="Zika" post="virus epidemic in the Americas: potential association with microcephaly"/>
   <result pre="Organization (PAHO). 2016. Epidemiological Update Neurological syndrome, congenital anomalies, and" exact="Zika" post="virus infection. http://www.paho.org/hq/index.php?option=com_docman&amp;amp;task=doc_view&amp;amp;Itemid=270&amp;amp;gid=32879&amp;amp;lang=en. 54.European Centre for Disease Prevention and"/>
   <result pre="54.European Centre for Disease Prevention and Control. Rapid risk assessment:" exact="ZIKV" post="infection outbreak, Brazil and the Pacific region. 25 May"/>
   <result pre="55.PithadiaABKakadiaNGuillainâ€&quot;BarrÃ© syndrome (GBS)Pharmacol Rep.20106222023210.1016/S1734-1140(10)70261-920508277 56.Cao-LormeauVMBlakeAMonsSLastÃ¨reSRocheCVanhomwegenJet al.Guillainâ€&quot;BarrÃ© syndrome outbreak associated with" exact="Zika" post="virus infection in French Polynesia: a case-control studyLancet20163871531153910.1016/S0140-6736(16)00562-626948433 57.MalkkiHZika"/>
   <result pre="Research CollaborationJ Herb Pharmacother.20044619010.1080/J157v04n04_0615927926 63.CalvetGAguiarRSMeloASOSampaioSAde FilippisIFabriAet al.Detection and sequencing of" exact="Zika" post="virus from amniotic fluid of fetuses with microcephaly in"/>
   <result pre="medicinal plantâ€&quot;a reviewJ Med Plants Stud.201423247 68.JackmanJACostaVVParkSRealALCParkJHCardozoPLet al.Therapeutic treatment of" exact="Zika" post="virus infection using a brain-penetrating antiviral peptideNature Mater.20181797197710.1038/s41563-018-0194-230349030 69.QuanquinNWangLChengGPotential"/>
   <result pre="a brain-penetrating antiviral peptideNature Mater.20181797197710.1038/s41563-018-0194-230349030 69.QuanquinNWangLChengGPotential for treatment and a" exact="Zika" post="virus vaccineCurr Opin Pediatr20172911412110.1097/MOP.000000000000044127906864 70.FernandezEDiamondMSVaccination strategies against Zika virusCurr"/>
   <result pre="and a Zika virus vaccineCurr Opin Pediatr20172911412110.1097/MOP.000000000000044127906864 70.FernandezEDiamondMSVaccination strategies against" exact="Zika" post="virusCurr Opin Virol.201723596710.1016/j.coviro.2017.03.00628432975 71.AbbinkPStephensonKEBarouchDHZika virus vaccinesNat Rev Microbiol20181659460010.1038/s41579-018-0039-729921914 72.EkinsSMietchenDCoffeeMStrattonTPFreundlichJSFreitas-JuniorLet"/>
   <result pre="virus vaccinesNat Rev Microbiol20181659460010.1038/s41579-018-0039-729921914 72.EkinsSMietchenDCoffeeMStrattonTPFreundlichJSFreitas-JuniorLet al.Open drug discovery for the" exact="Zika" post="virusF1000Res2016515010.12688/f1000research.8013.127134728 73.Pan American Health Organization. 2015. Zika virus (ZIKV)"/>
   <result pre="discovery for the Zika virusF1000Res2016515010.12688/f1000research.8013.127134728 73.Pan American Health Organization. 2015." exact="Zika" post="virus (ZIKV) surveillance in the Americas: interim guidance for"/>
   <result pre="DC.http://www.paho.org/hq/index.php?option=com_docman&amp;amp;task=doc_view&amp;amp;gid=30176&amp;amp;Itemid=270. 74.OrganizationPan American HealthEpidemiological alert. Neurological syndrome, congenital malformations, and" exact="Zika" post="virus infections. Implications for public health in the Americas2015WashingtonPan"/>
   <result pre="public health and reproductive research: what history tells us about" exact="Zika" post="virusJ Assist Reprod Genet20163343944010.1007/s10815-016-0687-326943916 77.BenelliGJeffriesCLWalkerTBiological control of mosquito vectors:"/>
   <result pre="Q.20163615017510.1080/01652176.2016.118833327158761 79.RossiSLTeshRBAzarSRMuruatoAEHanleyKAAugusteAJet al.Characterization of a novel murine model to study" exact="Zika" post="virusAm J Trop Med Hyg2016941362136910.4269/ajtmh.16-011127022155 80.McGrathELRossiSLGaoJWidenSGGrantACDunnTJet al.Differential responses of"/>
   <result pre="al.Differential responses of human fetal brain neural stem cells to" exact="Zika" post="virus infectionStem Cell Reports.2017871572710.1016/j.stemcr.2017.01.00828216147"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7059383\results\search\tropicalVirus\results.xml">
   <result pre="equipment RVF Rift valley fever VHF Viral haemorrhagic fever YF" exact="Yellow fever" post="Publisherâ€™s Note Springer Nature remains neutral with regard to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7064018\results\search\tropicalVirus\results.xml">
   <result pre="due to the actual diseases. These were the cases of" exact="Zika" post="virus (a mild disease without any mortality excess whose"/>
   <result pre="Medicine (CARPEM). References REFERENCES 1MacciocchiDLaniniSVairoFZumlaAFigueiredoLTLauriaFNStradaGBrouquiPPuroVKrishnaSKremsnerPScognamiglioPKohlerCet alShort-term economic impact of the" exact="Zika" post="virus outbreakNew Microbiol201639428728928004846 2LiuzziGPuroVLaniniSVairoFNicastriECapobianchiMRDi CaroAPiacentiniMZumlaAIppolitoGZika virus and microcephaly: is"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7065369\results\search\tropicalVirus\results.xml">
   <result pre="health emergencies, such as dengue fever, Rift Valley fever and" exact="West Nile" post="fever [18]. The WHO is updating its COVID-19 dashboard"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7067471\results\search\tropicalVirus\results.xml">
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Medicine and Health Sciences : Infectious Diseases"/>
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Zika" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Zika" post="Virus : Medicine and Health Sciences: Epidemiology : Biology"/>
   <result pre="Areas: Rural Areas First report of Aedes albopictus infected by" exact="Dengue" post="and Zika virus in a rural outbreak in Brazil"/>
   <result pre="Areas First report of Aedes albopictus infected by Dengue and" exact="Zika" post="virus in a rural outbreak in Brazil Dengue and"/>
   <result pre="Dengue and Zika virus in a rural outbreak in Brazil" exact="Dengue" post="and Zika in Aedes albopictus in Brazil Ricas RezendeHelderConceptualizationInvestigationWriting"/>
   <result pre="Zika virus in a rural outbreak in Brazil Dengue and" exact="Zika" post="in Aedes albopictus in Brazil Ricas RezendeHelderConceptualizationInvestigationWriting â€&quot; review"/>
   <result pre="the original author and source are credited.pone.0229847.pdf Abstract In Brazil," exact="Dengue" post="(DENV) and Zika (ZIKV) viruses are reported as being"/>
   <result pre="and source are credited.pone.0229847.pdf Abstract In Brazil, Dengue (DENV) and" exact="Zika" post="(ZIKV) viruses are reported as being transmitted exclusively by"/>
   <result pre="This is the first report of A. albopictus infected by" exact="DENV" post="and ZIKV during an outbreak in a rural area"/>
   <result pre="the first report of A. albopictus infected by DENV and" exact="ZIKV" post="during an outbreak in a rural area in Brazil,"/>
   <result pre="manuscript and in GenBank under the accession number MN567709. Introduction" exact="Dengue" post="virus (DENV) and Zika virus (ZIKV) are etiological agents"/>
   <result pre="under the accession number MN567709. Introduction Dengue virus (DENV) and" exact="Zika" post="virus (ZIKV) are etiological agents of reemerging and emerging"/>
   <result pre="infected mosquitoes of the Aedes genus (Stegomya subgenus) [2]. Consequently," exact="DENV" post="and ZIKV present an epidemiological overlap, with occurrence influenced"/>
   <result pre="of the Aedes genus (Stegomya subgenus) [2]. Consequently, DENV and" exact="ZIKV" post="present an epidemiological overlap, with occurrence influenced by similar"/>
   <result pre="[3]. In 2019, more than 100 countries were endemic for" exact="DENV" post="and 87 had evidence of autochthonous transmission of ZIKV"/>
   <result pre="for DENV and 87 had evidence of autochthonous transmission of" exact="ZIKV" post="[4]. Brazil is currently the nation with the highest"/>
   <result pre="Brazil is currently the nation with the highest report of" exact="DENV" post="[5] and ZIKV infections in the world [4]. There,"/>
   <result pre="the nation with the highest report of DENV [5] and" exact="ZIKV" post="infections in the world [4]. There, Aedes aegypti is"/>
   <result pre="to this environment [7]. Aedes albopictus was never associated with" exact="DENV" post="and ZIKV transmission in Brazil, despite its recognition as"/>
   <result pre="environment [7]. Aedes albopictus was never associated with DENV and" exact="ZIKV" post="transmission in Brazil, despite its recognition as a competent"/>
   <result pre="Brazil [13, 27]. There, 73,998-suspected cases and 37 deaths by" exact="DENV" post="infection were reported in 2019 until the 39Â° epidemiological"/>
   <result pre="2019 until the 39Â° epidemiological week, and 1,055 registers of" exact="ZIKV" post="were made in the same period [28]. The introduction"/>
   <result pre="2019, an outbreak of dengue-like illness with 20-suspected cases of" exact="DENV" post="infection was reported in a rural area of Linhares"/>
   <result pre="reports of exanthematous febrile illness. Four cases were tested for" exact="DENV" post="infection by the public health authority: one was positive"/>
   <result pre="Molecular tests for arboviruses detection were made through Real-Time PCR." exact="Dengue" post="detection was made according to Huhtano et al. (2010)"/>
   <result pre="and probes serotype-specific described by Callahan et al. (2001) [32]." exact="Zika" post="RNA detection was done using the protocol developed by"/>
   <result pre="PCR The extracted RNAs that were positive for DENV-1 and" exact="ZIKV" post="were submitted to whole-genome amplification using a tiling, multiplex"/>
   <result pre="from Primal Scheme using as input the â€œZikaAsianâ€� scheme for" exact="ZIKV" post="(https://github.com/zibraproject) and the one described by Quick et al."/>
   <result pre="all identified as A. (Stegomyia) albopictus (Skuse, 1894) and females." exact="ZIKV" post="was amplified in the subsample 2f (subsample f of"/>
   <result pre="Virus Ct 2f 27 March 2019 8:30 amâ€&quot; 10:30 am" exact="ZIKV" post="35 3i 27 March 2019 2:30 pmâ€&quot; 4:00 pm"/>
   <result pre="ZIKV 35 3i 27 March 2019 2:30 pmâ€&quot; 4:00 pm" exact="DENV" post="23.7 Fourteen reads of the ZIKV gene were amplified"/>
   <result pre="2:30 pmâ€&quot; 4:00 pm DENV 23.7 Fourteen reads of the" exact="ZIKV" post="gene were amplified and sequenced, resulting in a consensus"/>
   <result pre="consensus sequence with 401 nucleotides, and 98.8% similarity with the" exact="ZIKV" post="genome. Due to the low sequence coverage, phylogenetic analysis"/>
   <result pre="study is the first to report A. albopictus infected by" exact="DENV" post="and ZIKV during an outbreak of a dengue-like illness"/>
   <result pre="the first to report A. albopictus infected by DENV and" exact="ZIKV" post="during an outbreak of a dengue-like illness in a"/>
   <result pre="typical of urban settings. Despite a tendency of expansion of" exact="DENV" post="to the countryside, all the explanations for this phenomenon"/>
   <result pre="of A. aegypti in smaller cities [39]. Differential diagnosis between" exact="DENV" post="and ZIKV infections is challenging due to their similar"/>
   <result pre="aegypti in smaller cities [39]. Differential diagnosis between DENV and" exact="ZIKV" post="infections is challenging due to their similar signs and"/>
   <result pre="an exanthematous febrile illness and four had laboratory confirmation for" exact="DENV" post="infection. One infection by DENV-1 was identified, and the"/>
   <result pre="in A. albopictus. Despite the absence of confirmed cases of" exact="ZIKV" post="infection in humans, six human cases of febrile illness"/>
   <result pre="of febrile illness were considered to be not caused by" exact="DENV" post="and could have plausibly been a result of ZIKV"/>
   <result pre="by DENV and could have plausibly been a result of" exact="ZIKV" post="infection or diseases with similar symptoms, such as those"/>
   <result pre="fever and yellow fever. A subsample of mosquitoes infected by" exact="ZIKV" post="was engorged, indicating the potential involvement of A. albopictus"/>
   <result pre="the sylvatic environment. Despite the lack of molecular detection of" exact="ZIKV" post="or other arboviruses in the studied human cases, the"/>
   <result pre="identified field-collected immature forms of A. albopictus infected by all" exact="DENV" post="serotypes [6, 17, 19, 45â€&quot;47], and by ZIKV [48]."/>
   <result pre="by all DENV serotypes [6, 17, 19, 45â€&quot;47], and by" exact="ZIKV" post="[48]. Despite the variation on the vector competence of"/>
   <result pre="in Brazil. A possible scenario of A. albopictus involvement in" exact="DENV" post="and ZIKV transmission in Brazil imposes a concern on"/>
   <result pre="A possible scenario of A. albopictus involvement in DENV and" exact="ZIKV" post="transmission in Brazil imposes a concern on the transmission"/>
   <result pre="the broad distribution with ecological plasticity, a possible â€œruralizationâ€� of" exact="DENV" post="and ZIKV may impose additional challenges for the control"/>
   <result pre="distribution with ecological plasticity, a possible â€œruralizationâ€� of DENV and" exact="ZIKV" post="may impose additional challenges for the control of these"/>
   <result pre="was not possible to identify if the mosquitoes positive for" exact="DENV" post="and ZIKV were collected in intradomicile, peridomicile, or in"/>
   <result pre="possible to identify if the mosquitoes positive for DENV and" exact="ZIKV" post="were collected in intradomicile, peridomicile, or in the cocoa"/>
   <result pre="Dzul-ManzanillaF, Gomez-DantÃ©sH, Pavia-RuzN, HladishTJ, LenhartA, et al.Spatio-temporal coherence of Dengue," exact="Chikungunya" post="and Zika outbreaks in Merida, Mexico.PLoS Negl Trop Dis."/>
   <result pre="Pavia-RuzN, HladishTJ, LenhartA, et al.Spatio-temporal coherence of Dengue, Chikungunya and" exact="Zika" post="outbreaks in Merida, Mexico.PLoS Negl Trop Dis. 2018;12: e000629810.1371/journal.pntd.000629829543910"/>
   <result pre="Mexico.PLoS Negl Trop Dis. 2018;12: e000629810.1371/journal.pntd.000629829543910 4collab: World Health Organization." exact="Zika" post="epidemiology update. Geneva: World Health Organization; 2019. 5BezerraJMT, AraÃºjoRGP,"/>
   <result pre="SouzaKPR, FigueiredoLB, ResendeMC. Natural vertical transmission by Stegomyia albopicta as" exact="Dengue" post="vector in Brazil.Braz J Biol. 2009;69: 123â€&quot;127. 10.1590/s1519-6984200900010001519347154 18Ceretti-JuniorW,"/>
   <result pre="Aedes aegypti and Aedes albopictus in an endemic area of" exact="Dengue" post="in Brazil.Rev Inst Med Trop Sao Paulo. 2019;61: e1810.1590/S1678-994620196101830970109"/>
   <result pre="31HuhtamoE, HasuE, UzcÃ¡teguiNY, ErraE, NikkariS, KanteleA, et al.Early diagnosis of" exact="Dengue" post="in travelers: Comparison of a novel Real-Time RT-PCR, NS1"/>
   <result pre="serotype- and group-specific fluorogenic reverse transcriptase PCR (TaqMan) assays for" exact="Dengue" post="virus.J Clin Virol. 2001;39: 4119â€&quot;4124. 33LanciottiRS, KosoyOL, LavenJJ, VelezJO,"/>
   <result pre="LavenJJ, VelezJO, LambertAJ, JohnsonAJ, et al.Genetic and serologic properties of" exact="Zika" post="virus associated with an epidemic, Yap State, Micronesia, 2007."/>
   <result pre="of a multiplex Real-Time RT-PCR assay for simultaneous detection of" exact="Dengue" post="and Chikungunya viruses. Arch Virol. 2015;160: 323â€&quot;327. 10.1007/s00705-014-2217-x25233940 35collab:"/>
   <result pre="multiplex Real-Time RT-PCR assay for simultaneous detection of Dengue and" exact="Chikungunya" post="viruses. Arch Virol. 2015;160: 323â€&quot;327. 10.1007/s00705-014-2217-x25233940 35collab: World Health"/>
   <result pre="et al.Multiplex PCR method for MinION and Illumina sequencing of" exact="Zika" post="and other virus genomes directly from clinical samples.Nat Protoc."/>
   <result pre="CalvezE, Chouin-CarneiroT, DialloD, FaillouxA-B. An overview of mosquito vectors of" exact="Zika" post="virus. Microbes Infect. 2018;20: 646e60.29481868 42CarneiroAR, CruzACR, VallinotoM, MeloDV,"/>
   <result pre="42CarneiroAR, CruzACR, VallinotoM, MeloDV, RamosRTJ, MedeirosDBA, et al.Molecular characterisation of" exact="Dengue" post="virus type 1 reveals lineage replacement during circulation in"/>
   <result pre="Cruz. 2012;107: 805â€&quot;812. 10.1590/s0074-0276201200060001622990972 43Ramos-CastaÃ±edaJ, SantosFB, MartÃ­nez-VegaR, AraujoJMG, JointG, SartiE." exact="Dengue" post="in Latin America: Systematic review of molecular epidemiological trends.PLoS"/>
   <result pre="1716010.1038/s41598-018-35622-x30464188 45SerufoJC, OcaHMd, TavaresVA, SouzaAM, RosaRV, JamalMC, et al.Isolation of" exact="Dengue" post="virus type 1 from larvae of Aedes albopictus in"/>
   <result pre="46FigueiredoMLG, GomesAC, AmarillaAA, LeandroAS, OrricoAS, AraujoRF, et al.Mosquitoes infected with" exact="Dengue" post="viruses in Brazil.Virol J. 2010;7: 15210.1186/1743-422X-7-15220624314 47PessanhaJEM, CaiaffaWT, CecilioAB,"/>
   <result pre="StennTMS, ChenT-Y, TeixeiraMG, QueirozEP, Souza Dos SantosL, et al.Evidence of" exact="Zika" post="virus RNA fragments in Aedes albopictus (Diptera: Culicidae) field-collected"/>
   <result pre="vector competency of Aedes albopictus populations from the Americas for" exact="Zika" post="virus. Am J Trop Med Hyg. 2017;97: 330â€&quot;339. 10.4269/ajtmh.16-096928829735"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7069648\results\search\tropicalVirus\results.xml">
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Research and Analysis Methods : Database and"/>
   <result pre="and Health Sciences : Tropical Diseases : Neglected Tropical Diseases:" exact="Dengue" post="Fever : Medicine and Health Sciences : Infectious Diseases"/>
   <result pre="Medicine and Health Sciences : Infectious Diseases : Viral Diseases:" exact="Dengue" post="Fever : Biology and Life Sciences : Molecular Biology"/>
   <result pre="of Indian origin in acute febrile patients in rural Kenya" exact="Dengue" post="virus type 2 of Indian origin in rural Kenya"/>
   <result pre="medium, provided the original author and source are credited.pntd.0008099.pdf Abstract" exact="Dengue" post="virus (DENV) has caused recent outbreaks in coastal cities"/>
   <result pre="of Kenya is largely unknown. We investigated the role of" exact="DENV" post="infection as a cause of acute febrile disease in"/>
   <result pre="Kibera, Nairobi (n = 233). The samples were studied for" exact="DENV" post="IgM, IgG, NS1 antigen and flaviviral RNA. IgG seroprevalence"/>
   <result pre="characteristics and future risks of dengue in Kenya. Author summary" exact="Dengue" post="virus (DENV) is an emerging mosquito-borne global health threat"/>
   <result pre="of symptoms from febrile illness to haemorrhagic fever. Information of" exact="DENV" post="in Africa is limited and fragmented. In Kenya, dengue"/>
   <result pre="that have experienced recent outbreaks. We investigated the role of" exact="DENV" post="infection as a cause of acute febrile disease in"/>
   <result pre="to better understanding of the epidemiological situation and origins of" exact="DENV" post="in Kenya. Funding Academy of FinlandVapalahtiOlli http://dx.doi.org/10.13039/100008376Helsingin ja Uudenmaan"/>
   <result pre="important mosquito-borne human pathogens such as the yellow fever, Zika," exact="West Nile" post="and dengue viruses, all found in Africa [1]. Dengue"/>
   <result pre="West Nile and dengue viruses, all found in Africa [1]." exact="Dengue" post="viruses (DENV-1 to 4) have a significant impact on"/>
   <result pre="demonstrating sustained DENV-2 circulation in Kenya. The other serotypes of" exact="DENV" post="have also been reported in Kenya, however the sequence"/>
   <result pre="and Kisumu, Western Kenya in 2014â€&quot;2015, with all the four" exact="DENV" post="serotypes detected by using DENV typing RT-PCR [14]. The"/>
   <result pre="2014â€&quot;2015, with all the four DENV serotypes detected by using" exact="DENV" post="typing RT-PCR [14]. The main vector of DENV Aedes"/>
   <result pre="by using DENV typing RT-PCR [14]. The main vector of" exact="DENV" post="Aedes (Stegomyia) aegypti is known to be present in"/>
   <result pre="and the coastal region of Kenya [15â€&quot;18]. Sylvatic cycles of" exact="DENV" post="are known to exist in Western Africa [19]. These"/>
   <result pre="and the environmental factors would likely allow sylvatic cycles of" exact="DENV" post="as well [20]. Detection of dengue or other flaviviral"/>
   <result pre="aim of this study was to determine the role of" exact="DENV" post="infection (and potentially other flaviviruses) in acute febrile patients"/>
   <result pre="and rural areas of Kenya. We investigated the role of" exact="DENV" post="infection as a cause of acute febrile disease in"/>
   <result pre="(Meridian Bioscience, Cincinnati, USA) prior to IgM IFA testing. Known" exact="DENV" post="IgG and IgM positive samples were used as positive"/>
   <result pre="Cypress, USA). Samples that were found to be positive in" exact="DENV" post="IgM EIA, IgG IFA or viral RNA screening were"/>
   <result pre="screening were additionally tested for dengue NS1 antigen using Platelia" exact="Dengue" post="NS1 Ag test (BIORAD). If there was enough sample"/>
   <result pre="Ag test (BIORAD). If there was enough sample volume left," exact="DENV" post="IgG IFA positive samples were further tested for anti-Zika"/>
   <result pre="commercial ELISA test (Euroimmun, Luebeck, Germany), and samples positive for" exact="DENV" post="IgM IFA were tested for anti-ZIKV IgM using an"/>
   <result pre="values of the model. Results Patient characteristics and associations with" exact="DENV" post="marker positivity A total of 560 samples (sera or"/>
   <result pre="patients (Table 1). According to Fisherâ€™s exact test (S1 Table)," exact="DENV" post="marker positivity was significantly more common in Taita-Taveta compared"/>
   <result pre="found (Table 2). 10.1371/journal.pntd.0008099.t002Table 2 Best logistic regression models for" exact="DENV" post="in the whole study group (Taita Taveta and Nairobi"/>
   <result pre="9.1% (51/560) of samples were found to be positive in" exact="DENV" post="IgG IFA and 3.9% (3/76) of IgM IFA positive"/>
   <result pre="screening dilution due to a lack of sample volume. In" exact="ZIKV" post="antibody tests, 1/51 and 1/57 were found to be"/>
   <result pre="tests, 1/51 and 1/57 were found to be positive for" exact="ZIKV" post="IgG and IgM, respectively. Acute DENV infection was documented"/>
   <result pre="to be positive for ZIKV IgG and IgM, respectively. Acute" exact="DENV" post="infection was documented by molecular methods in five patients"/>
   <result pre="collected in May 2016 and one in June 2016. The" exact="DENV" post="NS1 antigen assay was positive in three of the"/>
   <result pre="(IFA)titre IgM (IFA) IgM EIA dengue Pan- flavi virus RT-PCR" exact="DENV" post="NS1 Ag Virus isolation Sequence confirmation 76 Wundanyi16-May-2016 Nairobi"/>
   <result pre="fever *** available from the authors upon request; DENV-2 =" exact="Dengue" post="virus type 2 In addition to these five confirmed"/>
   <result pre="EIA (Capture DXSelect, Focus Diagnostics) result. The patients positive for" exact="DENV" post="IgG only (6.4%) were considered to have old flaviviral"/>
   <result pre="2014â€&quot;2015). Discussion Neither of our study areas had documented previous" exact="DENV" post="outbreaks. Dengue outbreaks have occurred previously mainly in the"/>
   <result pre="Neither of our study areas had documented previous DENV outbreaks." exact="Dengue" post="outbreaks have occurred previously mainly in the coastal area"/>
   <result pre="was available for rural Taitaâ€&quot;Taveta County regarding flavivirus seroprevalence or" exact="DENV" post="transmission. The flavivirus IgG seroprevalence in Taitaâ€&quot;Taveta was found"/>
   <result pre="in Taitaâ€&quot;Taveta were probably more likely to be exposed to" exact="DENV" post="or other flaviviruses during their life, than the younger"/>
   <result pre="is known to be endemic, in addition to DENV, to" exact="West Nile" post="virus, yellow fever virus (YFV) and Wesselsbron virus [5]."/>
   <result pre="Nile virus, yellow fever virus (YFV) and Wesselsbron virus [5]." exact="YFV" post="vaccination status of the patients was not known, but"/>
   <result pre="specificities via neutralization assays was not attempted. Notably, only two" exact="DENV" post="seropositive patients were found to be positive also for"/>
   <result pre="DENV seropositive patients were found to be positive also for" exact="ZIKV" post="NS1 specific antibodies: one for IgG and one for"/>
   <result pre="of these patients reported recent travel to western Kenya where" exact="ZIKV" post="neutralizing antibodies have been previously detected [7]. The reason"/>
   <result pre="The reason for the high number of patients positive for" exact="DENV" post="IgM IFA but negative in all other tests (n"/>
   <result pre="patients [45], the used diagnostic methods should have detected acute" exact="DENV" post="or other flaviviral infections. The statistical analyses of questionnaire"/>
   <result pre="further evidence of the occurrence of the local transmission of" exact="DENV" post="in Taitaâ€&quot;Taveta. The sequence analysis was restricted due to"/>
   <result pre="sequence analysis was restricted due to the limited amount of" exact="DENV" post="sequence data obtained in this study, and available in"/>
   <result pre="Kenya and the neighbouring countries. In this study, a single" exact="DENV" post="serotype (DENV-2) and genotype (Cosmopolitan) was detected. Our sequence"/>
   <result pre="once. Globalization has probably facilitated the introduction of the Indian" exact="DENV" post="to Kenya, as Kenya along with other African countries"/>
   <result pre="for trade and travel [47], and India is hyperendemic for" exact="DENV" post="[48]. To conclude, we detected unnoticed DENV-2 transmission outside"/>
   <result pre="outside epidemics and previously known endemic regions in rural Kenya." exact="Dengue" post="was not a common cause of acute febrile disease"/>
   <result pre="England). 2008;371(9611):500â€&quot;9. Epub 2008/02/12. 10.1016/s0140-6736(08)60238-x .18262042 2AmarasingheA, KuritskJN, LetsonGW, MargolisHS." exact="Dengue" post="virus infection in Africa. Emerging infectious diseases. 2011;17(8):1349â€&quot;54. Epub"/>
   <result pre="surveillance and seroprevalence studies: protocol of field studies of the" exact="Dengue" post="Vaccine Initiative. BMJ open. 2018;8(1):e017673 Epub 2018/01/24. 10.1136/bmjopen-2017-01767329358421 4MeaseLE,"/>
   <result pre="NgoiJM, de LaurentZR, GitongaJ, CottenM, et al.Complete Genome Sequences of" exact="Dengue" post="Virus Type 2 Strains from Kilifi, Kenya. Microbiology resource"/>
   <result pre="10.1128/mra.01566-1830701251 11GathiiK, NyatayaJN, MutaiBK, AwindaG, WaitumbiJN. Complete Coding Sequences of" exact="Dengue" post="Virus Type 2 Strains from Febrile Patients Seen in"/>
   <result pre="Patients Seen in Malindi District Hospital, Kenya, during the 2017" exact="Dengue" post="Fever Outbreak. Genome announcements. 2018;6(15). Epub 2018/04/14. 10.1128/genomeA.00076-1829650565 12ObonyoM,"/>
   <result pre="Epub 2018/04/14. 10.1128/genomeA.00076-1829650565 12ObonyoM, FidhowA, OfulaV. Investigation of laboratory confirmed" exact="Dengue" post="outbreak in North-eastern Kenya, 2011. PloS one. 2018;13(6):e0198556 Epub"/>
   <result pre="2016/11/07. 10.1186/s12985-016-0641-027814732 14VuDM, MutaiN, HeathCJ, VululeJM, MutukuFM, NdengaBA, et al.Unrecognized" exact="Dengue" post="Virus Infections in Children, Western Kenya, 2014â€&quot;2015. Emerging infectious"/>
   <result pre="tropical diseases. 2016;10(10):e0004981 Epub 2016/10/27. 10.1371/journal.pntd.000498127783626 16AghaSB, TchouassiDP, BastosADS, SangR." exact="Dengue" post="and yellow fever virus vectors: seasonal abundance, diversity and"/>
   <result pre="et al.Seroprevalence of Infections with Dengue, Rift Valley Fever and" exact="Chikungunya" post="Viruses in Kenya, 2007. PloS one. 2015;10(7):e0132645 Epub 2015/07/16."/>
   <result pre="Epub 2009/12/08. 10.1016/j.jcv.2009.11.001 .19963435 27ErraEO, KorhonenEM, VoutilainenL, HuhtamoE, VapalahtiO, KanteleA." exact="Dengue" post="in travelers: kinetics of viremia and NS1 antigenemia and"/>
   <result pre="2015/04/30. 10.1371/journal.pntd.000373325923210 45MullerDA, DepelsenaireAC, YoungPR. Clinical and Laboratory Diagnosis of" exact="Dengue" post="Virus Infection. The Journal of infectious diseases. 2017;215(suppl_2):S89â€&quot;s95. Epub"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7073332\results\search\tropicalVirus\results.xml">
   <result pre="treatments for viral infections1, including SARS-CoV17, MERS-CoV17, Ebola virus18, and" exact="Zika" post="virus14,19â€&quot;21. We recently presented an integrated antiviral drug discovery"/>
   <result pre="in the panomics eraBrief Bioinformatics20171868269727296652 11.ChengFMurrayJLRubinDHDrug repurposing: new treatments for" exact="Zika" post="virus infection?Trends Mol. Med.20162291992110.1016/j.molmed.2016.09.00627692879 12.SantosRet al.A comprehensive map of"/>
   <result pre="Med.20157282ra24910.1126/scitranslmed.3010286 20.BarrowsNJet al.A screen of FDA-approved drugs for inhibitors of" exact="Zika" post="virus infectionCell Host. Microbe20162025927010.1016/j.chom.2016.07.00427476412 21.XuMet al.Identification of small-molecule inhibitors"/>
   <result pre="virus infectionCell Host. Microbe20162025927010.1016/j.chom.2016.07.00427476412 21.XuMet al.Identification of small-molecule inhibitors of" exact="Zika" post="virus infection and induced neural cell death via a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7077324\results\search\tropicalVirus\results.xml">
   <result pre="Metabolic Activity in a Mouse Model of Infection with the" exact="Chikungunya" post="Virus East/Central/South African Genotype Ngwe TunMya Myat1MuthugalaRohitha1https://orcid.org/0000-0002-1384-8030Kyaw KyawAung12ShimadaSatoshi12MoritaKouichi12HayasakaDaisuke13*[1], myamyat@tm.nagasaki-u.ac.jprohithavm@yahoo.comkanomkrok77@gmail.commoritak@nagasaki-u.ac.jp[2],"/>
   <result pre="Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract Epidemics of the" exact="Chikungunya" post="virus (CHIKV) from 2004 onwards were caused by the"/>
   <result pre="explained. In this study, we examined the pathogenic potential of" exact="CHIKV" post="ECSA genotype M-30 (M-30) by comparing it with that"/>
   <result pre="virus proliferation, anti-type-II IFN response and metabolic activity in the" exact="CHIKV" post="ECSA virus in mice. CHIKV ECSA IFN-Î³ mouse model"/>
   <result pre="and metabolic activity in the CHIKV ECSA virus in mice." exact="CHIKV" post="ECSA IFN-Î³ mouse model viral pathogenesis 1. Introduction Chikungunya"/>
   <result pre="mice. CHIKV ECSA IFN-Î³ mouse model viral pathogenesis 1. Introduction" exact="Chikungunya" post="virus (CHIKV) belongs to the genus Alphavirus (family Togaviridae)"/>
   <result pre="mosquitoes such as Aedes aegypti and Aedes albopictus [1]. The" exact="CHIKV" post="genome is a single-stranded, positive-sense RNA virus with a"/>
   <result pre="composed of nonstructural proteins (5â€²-nsP1-nsP2-nsP3-nsP4) and structural proteins (C-E3-E2-6K-E1-3â€²) [3]." exact="CHIKV" post="strains are clustered into three distinct genotypes: West African,"/>
   <result pre="(ECSA) and Asian [4]. Historically, it has been recognized that" exact="CHIKV" post="infection causes similar clinical symptoms to dengue fever: fever,"/>
   <result pre="dengue fever: fever, rash and arthritis. During 2005 and 2006," exact="Chikungunya" post="fever emerged as a serious epidemic in India [5]."/>
   <result pre="been fully explained. Langsjoen et al., 2018 reported that Asian/American" exact="CHIKV" post="strains are less virulent than those in the Asian,"/>
   <result pre="study, we examined and compared the pathogenic potential of the" exact="CHIKV" post="ECSA genotype of the M-30 infection by comparing it"/>
   <result pre="mouse model. 2. Materials and Methods 2.1. Virus and Cells" exact="CHIKV" post="M-30 (KF 590566.1) was isolated from the acute serum"/>
   <result pre="cells were grown at 28 Â°C. Stock viruses of the" exact="CHIKV" post="M-30 and S-27 strains were prepared in C6/36 cells."/>
   <result pre="strains were prepared in C6/36 cells. All experiments using live" exact="CHIKV" post="were performed in a biosafety level 3 laboratory at"/>
   <result pre="Cytokines Using Real-Time Polymerase Chain Reaction As discussed above, following" exact="CHIKV" post="infection, the mice were sacrificed and their spleens and"/>
   <result pre="Map Kit Serum samples were collected from mice infected with" exact="CHIKV" post="(102 FFU) and from mock-infected mice at 5 days"/>
   <result pre="diseases. 4. Discussion In this study, we demonstrated that the" exact="CHIKV" post="ECSA genotype M-30 has a higher pathogenetic potential than"/>
   <result pre="induce atypical metabolic activity. Therefore, our established mouse model of" exact="CHIKV" post="infections may provide a novel concept of the pathogenic"/>
   <result pre="of viruses and their spread [26]. Similarly to other alphaviruses," exact="CHIKV" post="replication caused a dramatic shutoff of host gene expression,"/>
   <result pre="responses played a critical role in preventing lethal infections of" exact="CHIKV" post="because IFN responses of deficient A129 and AG129 mice"/>
   <result pre="in identifying the viral factors against type-II IFN responses in" exact="CHIKV" post="infections in vivo. Further studies, such as in vitro"/>
   <result pre="provide useful information to help elucidate the pathogenic mechanism of" exact="CHIKV" post="infections. In conclusion, our observations raise the concern that"/>
   <result pre="5.KaurP.PonniahM.MurhekarM.V.RamachandranV.RamachandranR.RajuH.K.PerumalV.MishraA.C.GupteM.D.Chikungunya outbreak, South India, 2006Emerg. Infect. Dis.2008141623162510.3201/eid1410.07056918826830 6.SergonK.NjugunaC.KalaniR.OfulaV.OnyangoC.KonongoiL.S.BednoS.BurkeH.DumillaA.M.KondeJ.et al.Seroprevalence of" exact="Chikungunya" post="virus (CHIKV) infection on Lamu Island, Kenya, October 2004Am."/>
   <result pre="study on La Reunion Island, 2005â€&quot;2009Neurology2016869410210.1212/WNL.000000000000223426609145 8.RamfulD.CarbonnierM.PasquetM.BouhmaniB.GhazouaniJ.NoormahomedT.BeullierG.AttaliT.SamperizS.FourmaintrauxA.et al.Mother-to-child transmission of" exact="Chikungunya" post="virus infectionPediatric Infect. Dis. J.20072681181510.1097/INF.0b013e3180616d4f 9.LangsjoenR.M.HallerS.L.RoyC.J.Vinet-OliphantH.BergrenN.A.ErasmusJ.H.LivengoodJ.A.PowellT.D.WeaverS.C.RossiS.L.Chikungunya Virus Strains Show"/>
   <result pre="mediated innate immune response in mice brain following infection with" exact="Chikungunya" post="virusVirus Res.201418919420510.1016/j.virusres.2014.05.01024905288 15.ChiamC.W.ChanY.F.OngK.C.WongK.T.SamI.C.Neurovirulence comparison of chikungunya virus isolates of"/>
   <result pre="mouse neuronal cells following infection with novel ECSA genotype of" exact="Chikungunya" post="virus with and without E1:A226V mutationInfect. Genet. Evol. J."/>
   <result pre="Evol. J. Mol. Epidemiol. Evol. Genet. Infect. Dis.20132039640610.1016/j.meegid.2013.09.030 25.VazeilleM.MoutaillerS.CoudrierD.RousseauxC.KhunH.HuerreM.ThiriaJ.DehecqJ.S.FontenilleD.SchuffeneckerI.et al.Two" exact="Chikungunya" post="isolates from the outbreak of La Reunion (Indian Ocean)"/>
   <result pre="and low titer 102 PFU (Dâ€&quot;F) of M-30 and S-27" exact="CHIKV" post="strains. The error bars represent the standard deviations. The"/>
   <result pre="and low titer 102 PFU (Dâ€&quot;F) of M-30 and S-27" exact="CHIKV" post="strains. The error bars represent the standard deviations. The"/>
   <result pre="subcutaneous infection with high titer 105 PFU M-30 and S-27" exact="CHIKV" post="strains. The asterisks show significant differences by one-way ANOVA"/>
   <result pre="subcutaneous infection with 102 PFU of the M-30 and S-27" exact="CHIKV" post="strains. The asterisks show significant differences by the Mannâ€&quot;Whitney"/>
   <result pre="subcutaneous infection with 102 PFU of the M-30 and S-27" exact="CHIKV" post="strains. Figure 6 mRNA levels of IFN-Î³, IL-6, IL-10,"/>
   <result pre="after subcutaneous infection with 102 PFU of M-30 and S-27" exact="CHIKV" post="strains. The asterisks show significant differences by the Kruskalâ€&quot;Wallis"/>
   <result pre="after subcutaneous infection with 102 PFU of M-30 and S-27" exact="CHIKV" post="strains. The asterisks show significant differences by the Kruskalâ€&quot;Wallis"/>
   <result pre="after subcutaneous infection with 102 PFU of M-30 and S-27" exact="CHIKV" post="strains. The asterisks show significant differences by the Kruskalâ€&quot;Wallis"/>
   <result pre="after subcutaneous infection with 102 PFU of M-30 and S-27" exact="CHIKV" post="strains. Asterisks show significant differences by Kruskal-Wallis test (*)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7077337\results\search\tropicalVirus\results.xml">
   <result pre="death. Unlike some viral infections, notably Ebola virus [70] and" exact="Zika" post="virus [80], the likelihood of intrauterine maternal-fetal transmission of"/>
   <result pre="with the SARS virusPLoS ONE2012711310.1371/annotation/2965cfae-b77d-4014-8b7b-236e01a35492 69.SchwartzD.A.Clinical trials and administration of" exact="Zika" post="virus vaccine in pregnant women: Lessons (that should have"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7077839\results\search\tropicalVirus\results.xml">
   <result pre="Jiangsu, China, 2010 [21] Serum collection non-HFMD inpatients non-HFMD inpatients" exact="Dengue" post="inpatients Healthy children in schools non-HFMD patients Healthy children"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7080275\results\search\tropicalVirus\results.xml">
   <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Medicine and Health Sciences : Pathology and"/>
   <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Organisms :"/>
   <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Microbiology :"/>
   <result pre="sub-clinical infections on the most populated island, Tahiti. Author summary" exact="Dengue" post="virus is the most significant arthropod-borne virus infecting man."/>
   <result pre="become a more general URL for full data availability. Introduction" exact="Dengue" post="is caused by any of four antigenically distinct dengue"/>
   <result pre="and DENV-4, which are transmitted by Aedes (Ae.) mosquito species." exact="Dengue" post="has become a major international public health concern and"/>
   <result pre="[1â€&quot;4]. More than 3.5 billion people are at risk of" exact="DENV" post="infection and it has been estimated that there are"/>
   <result pre="and it has been estimated that there are 390 million" exact="DENV" post="infections every year [5]. Understanding the spatio-temporal dynamics of"/>
   <result pre="infection, chains of transmission and quantifying the force of infection." exact="Dengue" post="epidemics occur intermittently, driven by climate suitability impacting mosquito"/>
   <result pre="a changing human background. Coupled with difficulties in differentiating among" exact="DENV" post="serotypes using serological methods and the high but variable"/>
   <result pre="as to whether French Polynesia is effectively a meta-population whereby" exact="DENV" post="is maintained by island-hopping or whether there is a"/>
   <result pre="infection on the main island of Tahiti that subsequently feeds" exact="DENV" post="into the smaller islands. We provide here the first"/>
   <result pre="Polynesia showing the five administrative subdivisions and associated islands. [12]." exact="Dengue" post="case data Institut Louis MalardÃ© (ILM) is a local"/>
   <result pre="mosquitoes with the serum from suspected cases (1979â€&quot;1980); isolation of" exact="DENV" post="on C6/36 mosquito cell culture (1984â€&quot;2005); IgM ELISA (from"/>
   <result pre="of a dengue-incident month across all islands and according to" exact="DENV" post="serotype is shown in Fig 3. Until 2013, DENV"/>
   <result pre="to DENV serotype is shown in Fig 3. Until 2013," exact="DENV" post="circulation was monotypic with very few occasions of co-circulation"/>
   <result pre="the zero month absence point on the Y-axis. However, because" exact="DENV" post="is mosquito-borne and can persist in the infected mosquito"/>
   <result pre="per island. Island size being clearly a limiting factor for" exact="DENV" post="persistence, we then addressed two population size dependent phenomena:"/>
   <result pre="duration of viral transmission within the island. The probability of" exact="DENV" post="establishing itself for at least two consecutive dengue incident"/>
   <result pre="size, the number of cases in the first month and" exact="DENV" post="serotype. We first assumed that at least two consecutive"/>
   <result pre="with population size, but to a lesser extent (lower OR)." exact="DENV" post="serotype (DENV-1, -2, -3, -4, or mixed -1 and"/>
   <result pre="was not found to be associated with the probability of" exact="DENV" post="transmission during two consecutive months (Wald Ï‡24 = 7.62,"/>
   <result pre="a function of population size, cumulative number of cases and" exact="DENV" post="serotype. Local transmission was presumed to have stopped when"/>
   <result pre="(RR = 2.49, 95%CI 2.13â€&quot;2.91, P&amp;lt;0.001) (S4 and S5 Figs)." exact="DENV" post="circulation was also longer for DENV-1 as compared to"/>
   <result pre="is useful, based on classical concepts of synchrony and persistence." exact="Dengue" post="incidence was largely asynchronous across subdivisions, but partially synchronous"/>
   <result pre="[23â€&quot;26], except for French Polynesia. Epidemic recrudescence of a persisting" exact="DENV" post="occurred in 2006, with the same viral strain as"/>
   <result pre="the 2001 epidemic. How in French Polynesia, whatever the serotype," exact="DENV" post="circulation can persist between epidemics for several months with"/>
   <result pre="epidemic occurring in the outlying islands. The long-term persistence of" exact="DENV" post="during inter-epidemic periods is remarkable and suggests that the"/>
   <result pre="(TIF) LINK Click here for additional data file. S1 Table" exact="Dengue" post="circulation within islands. Population size is the mid-term value"/>
   <result pre="to complete the dengue database. References References 1GublerD, KunoG, editors." exact="Dengue" post="and Dengue Hemorrhagic Fever. Wallingford: CAB International; 1997. 2LambrechtsL,"/>
   <result pre="the dengue database. References References 1GublerD, KunoG, editors. Dengue and" exact="Dengue" post="Hemorrhagic Fever. Wallingford: CAB International; 1997. 2LambrechtsL, ScottTW, GublerDJ."/>
   <result pre="Tropical Medicine and Hygiene2007; 77(5 suppl): 129. 24ChungueE, DeparisX, MurgueB." exact="Dengue" post="In French Polynesia: Major Features, Surveillance, Molecular Epidemiology And"/>
   <result pre="French Polynesia: Major Features, Surveillance, Molecular Epidemiology And Current Situation." exact="Dengue" post="Bulletin1998; 22: 74â€&quot;93. 25LiDS, LiuW, GuigonA, MostynC, GrantR, AaskovJ."/>
   <result pre="26Cao-LormeauV-M, RocheC, AubryM, TeissierA, LastereS, DaudensE, et al.Recent Emergence of" exact="Dengue" post="Virus Serotype 4 in French Polynesia Results from Multiple"/>
   <result pre="Islands. PLoS ONE2011; 6(12): e2955510.1371/journal.pone.002955522216313 27DesclouxE, Cao-LormeauVM, RocheC, De LamballerieX." exact="Dengue" post="1 diversity and microevolution, French Polynesia 2001â€&quot;2006: connection with"/>
   <result pre="e000592610.1371/journal.pntd.000592628953902 30AubryM, TeissierA, HuartM, VanhomwegenJ, MapotoekeM, Mariteragi-HelleT, et al.Seroprevalence of" exact="Dengue" post="and Chikungunya Virus Antibodies, French Polynesia, 2014â€&quot;2015. Emerg Infect"/>
   <result pre="TeissierA, HuartM, VanhomwegenJ, MapotoekeM, Mariteragi-HelleT, et al.Seroprevalence of Dengue and" exact="Chikungunya" post="Virus Antibodies, French Polynesia, 2014â€&quot;2015. Emerg Infect Dis2018; 24(3):"/>
   <result pre="CarvalhoMS, CruzOG, MagalhÃ£es MdeA, et al.Spatial Evaluation and Modeling of" exact="Dengue" post="Seroprevalence and Vector Density in Rio de Janeiro, Brazil."/>
   <result pre="MassadE, AlonsoWJ, et al.Spatio-Temporal Tracking and Phylodynamics of an Urban" exact="Dengue" post="3 Outbreak in SÃ£o Paulo, Brazil. PLoS Negl Trop"/>
   <result pre="36Vazquez-ProkopecGM, KitronU, MontgomeryB, HorneP, RitchieSA. Quantifying the Spatial Dimension of" exact="Dengue" post="Virus Epidemic Spread within a Tropical Urban Environment. PLoS"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7083784\results\search\tropicalVirus\results.xml">
   <result pre="diseases for instance Rift Valley fever, malaria, dengue fever, and" exact="West Nile" post="fever in endemic areas may occur (Okaka and Odhiambo,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7089181\results\search\tropicalVirus\results.xml">
   <result pre="central Africa in the 1970s [117], while outbreaks of mosquito-borne" exact="Chikungunya" post="virus [85] and Dengue virus infections in the Indian"/>
   <result pre="1970s [117], while outbreaks of mosquito-borne Chikungunya virus [85] and" exact="Dengue" post="virus infections in the Indian Ocean islands were seen"/>
   <result pre="(CNS) cells compared to sofosbuvir (Bugert-MBDC-2018-GO3), novel protease inhibitors for" exact="Zika" post="virus as surrogate virus for other flaviviruses using an"/>
   <result pre="an enzymatic assay for target validation as well as a" exact="Zika" post="mouse model (Silvestri-MBDC-2018-GO4), and BB4-D9, a dandelion natural extract"/>
   <result pre="model of the blood brain barrier (Hurler-MBDC-2018-GP2), a novel polymerase-inhibiting" exact="CHIKV" post="antiviral (MB-70, Hucke-MBDC-2018-GP4), a NS4a autophagy testing system for"/>
   <result pre="Alphaviruses can cause a number of diseases in humans, including" exact="Chikungunya" post="fever, Eastern, Western and Venezuelan equine encephalitis. The handling"/>
   <result pre="are rare, sporadic and unpredictable but explosive epidemics caused by" exact="Chikungunya" post="virus (CHIKV) have occurred in the last decade mainly"/>
   <result pre="Caribbean, globally amounting to millions of cases. Autochthonous cases of" exact="Chikungunya" post="fever have been reported in Italy [93]. Viremia with"/>
   <result pre="death of cells lining joints, causing arthritis and joint pain." exact="CHIKV" post="infections of neurons can result in potentially fatal encephalitis."/>
   <result pre="ribavirin may be more effective. Ribavirin resolves joint swelling in" exact="CHIKV" post="[121], but has no activity against VEEV in vitro"/>
   <result pre="various viruses, has been evaluated for in vitro activity against" exact="CHIKV" post="[40]. Among the most promising novel compounds is the"/>
   <result pre="are the old antiparasitic suramin, which shows ameliorating effects against" exact="CHIKV" post="infection in mice [82] and the anthelmintic ivermectin, which"/>
   <result pre="the cancer drugs mefenamic acid and sorafenib, inhibiting replication of" exact="CHIKV" post="and other alphaviruses via eIF4E dephosphorylation in vivo [90,"/>
   <result pre="25 that was identified in silico and optimized to inhibit" exact="CHIKV" post="replication in vitro [9], Prest-37 and -392, with in"/>
   <result pre="against VEEV nsP1 capping enzyme [41], and baicalin, which inhibits" exact="CHIKV" post="replication in vitro by interfering with a cellular target"/>
   <result pre="Flaviviruses causing hemorrhagic fever or severe encephalitis (Omsk hemorrhagic fever," exact="Dengue" post="and Yellow fever, Russian springâ€&quot;summer encephalitis/Tick Borne Encephalitis (TBEV))"/>
   <result pre="hemorrhagic fever or severe encephalitis (Omsk hemorrhagic fever, Dengue and" exact="Yellow fever," post="Russian springâ€&quot;summer encephalitis/Tick Borne Encephalitis (TBEV)) are listed as"/>
   <result pre="tick borne encephalitis with case fatality rates up to 20%," exact="Zika" post="and West Nile encephalitis). Human-to-human transmission is not effective."/>
   <result pre="encephalitis with case fatality rates up to 20%, Zika and" exact="West Nile" post="encephalitis). Human-to-human transmission is not effective. Live vaccines against"/>
   <result pre="number of inactivated TBEV vaccines, and most recently a live" exact="Dengue" post="virus vaccine are available. Flaviviruses are a large family"/>
   <result pre="animal models for the treatment of infections with Usutu (UsutuV)," exact="Dengue" post="(DENV) and Zika viruses (ZikaV) is their rather low"/>
   <result pre="the treatment of infections with Usutu (UsutuV), Dengue (DENV) and" exact="Zika" post="viruses (ZikaV) is their rather low efficacy [24, 101]."/>
   <result pre="vitamin A in measles infections [12], ribavirin with favipiravir in" exact="Zika" post="virus infections [75], and ribavirin with mefenamic acid in"/>
   <result pre="infections [75], and ribavirin with mefenamic acid in infections with" exact="Chikungunya" post="virus [126]. Antiviral drug combinations may also be a"/>
   <result pre="and has most recently been shown to be effective against" exact="Chikungunya" post="virus [40]. Natural product antivirals are single molecule natural"/>
   <result pre="the Kosovo warNephrol Dial Transpl1999141843184410.1093/ndt/14.8.1843 18.Bullard-FeibelmanKMGoveroJZhuZSalazarVVeselinovicMDiamondMSGeissBJThe FDA-approved drug sofosbuvir inhibits" exact="Zika" post="virus infectionAntivir Res201713713414010.1016/j.antiviral.2016.11.02327902933 19.CallawayEâ€˜Make Ebola a thing of the"/>
   <result pre="2000â€&quot;2008MMWR2009581321132619959985 23.ChanJF-WChikKK-HYuanSYipCC-YZhuZTeeK-MTsangJO-LChanCC-SPoonVK-MLuGZhangAJLaiK-KChanK-HKaoRY-TYuenK-YNovel antiviral activity and mechanism of bromocriptine as a" exact="Zika" post="virus NS2B-NS3 protease inhibitorAntivir Res.2017141293710.1016/j.antiviral.2017.02.00228185815 24.ChanJF-WZhuZChuHYuanSChikKK-HChanCC-SPoonVK-MYipCC-YZhangXTsangJO-LZouZTeeK-MShuaiHLuGYuenK-YThe celecoxib derivative kinase"/>
   <result pre="inhibitorAntivir Res.2017141293710.1016/j.antiviral.2017.02.00228185815 24.ChanJF-WZhuZChuHYuanSChikKK-HChanCC-SPoonVK-MYipCC-YZhangXTsangJO-LZouZTeeK-MShuaiHLuGYuenK-YThe celecoxib derivative kinase inhibitor AR-12 (OSU-03012) inhibits" exact="Zika" post="virus via down-regulation of the PI3K/Akt pathway and protects"/>
   <result pre="Zika virus via down-regulation of the PI3K/Akt pathway and protects" exact="Zika" post="virus-infected A129 mice: a host-targeting treatment strategyAntivir Res2018160384710.1016/j.antiviral.2018.10.00730326204 25.ChangJWarrenTKZhaoXGillTGuoFWangLComunaleMADuYAlonziDSYuWYeHLiuFGuoJ-TMehtaACuconatiAButtersTDBavariSXuXBlockTMSmall"/>
   <result pre="irmarovÃ¡JFojtÃ­kovÃ¡MÅ tefÃ¡nikMHaviernikJNenckaRde ClercqERÅ¯Å¾ekDAntiviral activity of the adenosine analogue BCX4430 against" exact="West Nile" post="virus and tick-borne flavivirusesAntivir Res2017142636710.1016/j.antiviral.2017.03.01228336346 40.FerreiraACReisPAde FreitasCSSacramentoCQVillas BÃ´as HoelzLBastosMMMattosMRochaNGomes"/>
   <result pre="Infect Dis198911Suppl 4S750S76110.1093/clinids/11.Supplement_4.S7502546248 66.HwangJJiangAFikrigEA potent prolyl tRNA synthetase inhibitor antagonizes" exact="Chikungunya" post="and Dengue virusesAntivir Res201916116316810.1016/j.antiviral.2018.11.01730521835 67.IppolitoGFeldmannHLaniniSVairoFDi CaroACapobianchiMRNicastriEViral hemorrhagic fevers: advancing"/>
   <result pre="4S750S76110.1093/clinids/11.Supplement_4.S7502546248 66.HwangJJiangAFikrigEA potent prolyl tRNA synthetase inhibitor antagonizes Chikungunya and" exact="Dengue" post="virusesAntivir Res201916116316810.1016/j.antiviral.2018.11.01730521835 67.IppolitoGFeldmannHLaniniSVairoFDi CaroACapobianchiMRNicastriEViral hemorrhagic fevers: advancing the level"/>
   <result pre="and ribavirin inhibit replication of Asian and African strains of" exact="Zika" post="virus in different cell modelsViruses201810.3390/v1002007230463206 76.KlempaBMeiselHRÃ¤thSBartelJUlrichRKrÃ¼gerDHOccurrence of renal and"/>
   <result pre="infection in rhesus monkeysAntivir Res19901313914910.1016/0166-3542(90)90029-72353804 93.MaranoGPupellaSPatiIMasielloFFranchiniMVaglioSVelatiCLiumbrunoGMTen years since the last" exact="Chikungunya" post="virus outbreak in Italy: history repeats itselfBlood Transfus20171548949010.2450/2017.0215-1729053100 94.MastrangeloEPezzulloMDe"/>
   <result pre="prospects for an old drugJ Antimicrob Chemother2012671884189410.1093/jac/dks14722535622 95.MatusaliGColavitaFBordiLLalleEIppolitoGCapobianchiMRCastillettiCTropism of the" exact="Chikungunya" post="virusViruses201910.3390/v1102017530791607 96.MazzonMOrtega-PrietoAMImrieDLuftCHessLCziesoSGroveJSkeltonJKFarleighLBugertJJWrightETempertonNAngellROxenfordSJacobsMKettelerRDornerMMarshMIdentification of broad-spectrum antiviral compounds by targeting viral"/>
   <result pre="Agents Chemother201357126246625310.1128/aac.00977-1324100494 105.MumtazNJimmersonLCBushmanLRKiserJJAronGReuskenCBEMKoopmansMPGvan KampenJJACell-line dependent antiviral activity of sofosbuvir against" exact="Zika" post="virusAntivir Res.201714616116310.1016/j.antiviral.2017.09.00428912011 106.NannettiGMassariSMercorelliBBertagninCDesantisJPalÃ¹GTabarriniOLoregianAPotent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target"/>
   <result pre="Synergistic effects of novel antivirals Cima 4 and cf2642 on" exact="Zika" post="virus. P114. DZIF Annual Meeting: 24â€&quot;26 Nov 2016, Cologne."/>
   <result pre="113.OoARausaluKMeritsAHiggsSVanlandinghamDBakarSAZandiKDeciphering the potential of baicalin as an antiviral agent for" exact="Chikungunya" post="virus infectionAntivir Res201815010111110.1016/j.antiviral.2017.12.01229269135 114.Osuna-RamosJFReyes-RuizJMBautista-CarbajalPCervantes-SalazarMFarfan-MoralesCNDe JesÃºs-GonzÃ¡lezLAHurtado-MonzÃ³nAMDel Ã�ngelRMEzetimibe inhibits dengue virus"/>
   <result pre="CaroAWoelfelRStoeckerKFleischmannEGabrielMWellerSAKoivoguiLDialloBKeitaSRambautAFormentyPGuntherSCarrollMWReal-time, portable genome sequencing for Ebola surveillanceNature201653022823210.1038/nature1699626840485 121.RavichandranRManianMRibavirin therapy for" exact="Chikungunya" post="arthritisJ Infect Dev Ctries2008214014210.3855/T2.2.14019738340 122.ReevesPBommariusBLebeisSMcNultySChristensenJSwimmAChahroudiAChavanRFeinbergMBVeachDBornmannWShermanMKalmanDDisabling poxvirus pathogenesis by inhibition"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7090748\results\search\tropicalVirus\results.xml">
   <result pre="were recorded in different regions, including Ebola in western Africa," exact="Zika" post="in South America, H7N9 in China and many Asian"/>
   <result pre="panel of viruses, including SARS-CoV, MERS-CoV, EBOV, influenza A virus," exact="Chikungunya" post="virus, human immunodeficiency virus, dengue virus, West Nile virus,"/>
   <result pre="influenza A virus, Chikungunya virus, human immunodeficiency virus, dengue virus," exact="West Nile" post="virus, Crimean Congo hemorrhagic fever virus, and hepatitis A"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7091072\results\search\tropicalVirus\results.xml">
   <result pre="(WHO) declaration of COVID-19 as a global pandemic. Abstract The" exact="Chikungunya" post="virus (CHIKV) belongs to the Alphavirus genus of Togaviridae"/>
   <result pre="due to a rapid increase in epidemics. Because handling of" exact="CHIKV" post="is restricted to Biosafety Level 3 (BSL-3) facilities, the"/>
   <result pre="we first iden-tified the whole structural polyprotein sequence of a" exact="CHIKV" post="strain isolated in South Korea (KNIH/2009/77). Phylogenetic analysis showed"/>
   <result pre="showed that this sequence clustered within the East/ Central/South African" exact="CHIKV" post="genotype. Using this sequence information, we constructed a CHIKV-pseudotyped"/>
   <result pre="a CHIKV-pseudotyped lenti-virus expressing the structural polyprotein of the Korean" exact="CHIKV" post="isolate (CHIKVpseudo) and dual reporter genes of green fluorescence"/>
   <result pre="CHIKVpseudo. Taken together, these results suggest that our PBNA for" exact="CHIKV" post="may serve as a useful and safe method for"/>
   <result pre="safe method for testing the neutralizing activity of antibodies against" exact="CHIKV" post="in BSL-2 facilities. Keywords Chikungunya virus Korean isolate Pseudovirus"/>
   <result pre="neutralizing activity of antibodies against CHIKV in BSL-2 facilities. Keywords" exact="Chikungunya" post="virus Korean isolate Pseudovirus Neutralization assay Human serum This"/>
   <result pre="grant from Korea Ministry of Health and Welfare (HI15C2971). The" exact="CHIKV" post="strain isolated in Korea (KNIH/2009/77) was obtained from the"/>
   <result pre="in this paper were originally collected as part of the" exact="Dengue" post="Vaccine Initiative (DVI) study conducted in Ouagadougou, Burkina Faso,"/>
   <result pre="AzamiNAMMoiMLTakasakiTNeutralization assay for chikungunya virus infection: plaque reduction neutralization testIn" exact="Chikungunya" post="Virus2016273282 BrehinACRubrechtLNavarro-SanchezMEMarechalVFrenkielMPLapaludPLauneDDespresPProduction and characterization of mouse monoclonal antibodies reactive"/>
   <result pre="Virus2016273282 BrehinACRubrechtLNavarro-SanchezMEMarechalVFrenkielMPLapaludPLauneDDespresPProduction and characterization of mouse monoclonal antibodies reactive to" exact="Chikungunya" post="envelope E2 glycoproteinVirology200837118519510.1016/j.virol.2007.09.02817949772 CarletonMLeeHMulveyMBrownDTRole of glycoprotein PE2 in formation"/>
   <result pre="formation and maturation of the Sindbis virus spikeJ. Virol199771155815668995682 ChaGWChoJELeeEJJuYRHanMGParkCJeongYETravel-associated" exact="Chikungunya" post="cases in South Korea during 2009-2010Osong Public Health Res."/>
   <result pre="ChangKSKimG-HHaYRJeongEJCKimHCKleinTAShinSHKimEJJegalSChungSJet al.Monitoring and Control of Aedes albopictus, a Vector of" exact="Zika" post="Virus, Near Residences of Imported Zika Virus Patients during"/>
   <result pre="albopictus, a Vector of Zika Virus, Near Residences of Imported" exact="Zika" post="Virus Patients during 2016 in South KoreaAm. J. Med."/>
   <result pre="4.0 using acidified, long shelf-life polyethylenimineCytotechnology201062738210.1007/s10616-010-9259-z20309632 GlaskerSLullaALullaVCoudercTDrexlerJFLiljestromPLecuitMDrostenCMeritsAKiimmererBMVirus replicon particle based" exact="Chikungunya" post="virus neutralization assay using Gaussia luciferase as readoutVirol. J.20131023510.1186/1743-422X-10-23523855906"/>
   <result pre="assay for chikungunya virus infectionJ. Clin. Microbiol2013511385139510.1128/JCM.03109-12 KuoSCChenYJWangYMTsuiPYKuoMDWuTYLoSJCell-based analysis of" exact="Chikungunya" post="virus El protein in membrane fusionJ. Biomed. Sci.2012194410.1186/1423-0127-19-4422520648 LeeHJMinKIParkKHChoiHJKimMKAhnCYHongYJKimYBComparison"/>
   <result pre="al.Development of a highly protective combination monoclonal antibody therapy against" exact="Chikungunya" post="virusPLoS Pathog.20139e100331210.1371/journal.ppat.100331223637602 PowersAMVaccine and therapeutic options to control chikungunya"/>
   <result pre="therapeutic options to control chikungunya virusClin. Microbiol. Rev.201831e001041629237708 PowersAMBraultACTeshRBWeaverSCRe-emergence of" exact="Chikungunya" post="and Oâ€™nyong-nyong viruses: evidence for distinct geographical lineages and"/>
   <result pre="in Italy: an outbreak in a temperate regionLancet20073701840184610.1016/S0140-6736(07)61779-618061059 SalvadorBZhouYMichaultAMuenchMOSimmonsGCharacterization of" exact="Chikungunya" post="pseudotyped viruses: Identification of refractory cell lines and demonstration"/>
   <result pre="by mutations in El glycoproteinVirology2009393334110.1016/j.virol.2009.07.01319692105 SamICLoongSKMichaelJCChuaCLSulaimanWYWVythilingamIChanSYChiamCWYeongYSAbu-BakarSGenotypic and phenotypic characterization of" exact="Chikungunya" post="virus of different genotypes from MalaysiaPLoS One20127e5047610.1371/journal.pone.005047623209750 SchwartzOAlbertMLBiology and"/>
   <result pre="recent epidemics and various evolutionary ratesJ. Virol2010846497650410.1128/JVI.01603-0920410280 VossJEVaneyMCDuquerroySVonrheinCGirard-BlancCCrubletEThompsonABricogneGReyFAGlycoprotein organization of" exact="Chikungunya" post="virus particles revealed by X-ray crystallographyNature201046870971210.1038/nature0955521124458 WeaverSCOsorioJELivengoodJAChenRStinchcombDTChikungunya virus and"/>
   <result pre="virus and prospects for a vaccineExpert. Rev. Vaccines2012111087110110.1586/erv.12.8423151166 WichitSHamelRBernardETalignaniLDiopFFerrarisPLiegeoisFEkchariyawatPLuplertlopNSurasombatpattanaPImipramine inhibits" exact="Chikungunya" post="virus replication in human skin fibroblasts through interference with"/>
   <result pre="WuJZhaoCLiuQHuangWWangYDevelopment and application of a bioluminescent imaging mouse model for" exact="Chikungunya" post="virus based on pseudovirus systemVaccine2017356387639410.1016/j.vaccine.2017.10.00729031692 YapMLKloseTUrakamiAHasanSSAkahataWRossmannMGStructural studies of Chikungunya"/>
   <result pre="for Chikungunya virus based on pseudovirus systemVaccine2017356387639410.1016/j.vaccine.2017.10.00729031692 YapMLKloseTUrakamiAHasanSSAkahataWRossmannMGStructural studies of" exact="Chikungunya" post="virus maturationProc. Natl. Acad. Sci. USA2017114137031370710.1073/pnas.171316611429203665 YeomJSCurrent status and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7095334\results\search\tropicalVirus\results.xml">
   <result pre="of SARS, MERS, Nipah, influenza A subtype H5N1, yellow fever," exact="Zika" post="and the continued spread of dengue. Epidemics overlap and"/>
   <result pre="trials underway in time to be useful63. In 2015, when" exact="Zika" post="was first internationally recognized as a pathogen that could"/>
   <result pre="the United States in 2016 that were at risk of" exact="Zika" post="transmission89. Rather than the whole country, or even only"/>
   <result pre="in response to the newly recognized association between infection with" exact="Zika" post="virus during pregnancy and microcephaly in the newborn. Developing"/>
   <result pre="developed guidance for including pregnant women and their babies in" exact="Zika" post="vaccine research95, and has since extended their scope to"/>
   <result pre="being born with microcephaly because their mothers were infected with" exact="Zika" post="during pregnancy. Tracking the development of these children increases"/>
   <result pre="development of these children increases understanding of the effects of" exact="Zika" post="infection and helps to define what medical and social"/>
   <result pre="Infect. Dis.201717e280e29228461209 64.SiednerMJRyanETBogochIIGone or forgotten? The rise and fall of" exact="Zika" post="virusLancet Public Health20183e109e11029519697 65.BarrettADTCurrent status of Zika vaccine development:"/>
   <result pre="and fall of Zika virusLancet Public Health20183e109e11029519697 65.BarrettADTCurrent status of" exact="Zika" post="vaccine development: Zika vaccines advance into clinical evaluationNPJ Vaccines201832429900012"/>
   <result pre="Zika virusLancet Public Health20183e109e11029519697 65.BarrettADTCurrent status of Zika vaccine development:" exact="Zika" post="vaccines advance into clinical evaluationNPJ Vaccines201832429900012 66.BurkiTCEPI: preparing for"/>
   <result pre="Monrovia, LiberiaBMJ Glob. Health20161e00000728588907 82.BrickleyEBRodriguesLCFurther pieces of evidence in the" exact="Zika" post="virus and microcephaly puzzleLancet Child Adolesc. Health2018216216430169250 83.collab: Ebola"/>
   <result pre="clinical trialsJ. Am. Med. Assoc.201832020772078 95.The Ethics Working Group on" exact="ZIKV" post="Research &amp;amp; Pregnancy. Pregnant Women &amp;amp; the Zika Virus"/>
   <result pre="Group on ZIKV Research &amp;amp; Pregnancy. Pregnant Women &amp;amp; the" exact="Zika" post="Virus Vaccine Research Agenda: Ethics Guidance on Priorities, Inclusion,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7095397\results\search\tropicalVirus\results.xml">
   <result pre="our health and safety. For example, a mutation in the" exact="Zika" post="virus membrane region (prM-S139N) emerged in a viral lineage"/>
   <result pre="to circulate that this mutation was the cause of congenital" exact="Zika" post="syndrome, specifically microcephaly. When Zika was detected in India"/>
   <result pre="was the cause of congenital Zika syndrome, specifically microcephaly. When" exact="Zika" post="was detected in India in 2018, these false claims"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7098069\results\search\tropicalVirus\results.xml">
   <result pre="niclosamide broad antiviral agents coronavirus SARS-CoV MERS-CoV SARS-CoV-2 (COVID-19) flavivirus" exact="Zika" post="virus Ebola virus human adenovirus This article is made"/>
   <result pre="respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV)," exact="Zika" post="virus (ZIKV), Japanese encephalitis virus (JEV), hepatitis C virus"/>
   <result pre="hepatitis C virus (HCV), Ebola virus (EBOV), human rhinoviruses (HRVs)," exact="Chikungunya" post="virus (CHIKV), human adenovirus (HAdV), and Epsteinâ€&quot;Barr virus (EBV)."/>
   <result pre="a genus of viruses in the family Flaviviridae, includes the" exact="Zika" post="virus (ZIKV), dengue virus four serotypes (DENV 1â€&quot;4), West"/>
   <result pre="the Zika virus (ZIKV), dengue virus four serotypes (DENV 1â€&quot;4)," exact="West Nile" post="virus (WNV), yellow fever virus (YFV), and Japanese encephalitis"/>
   <result pre="of these viruses are significant human pathogens. Among these viruses," exact="ZIKV" post="is a mosquito-borne flavivirus that is transmitted primarily by"/>
   <result pre="a mosquito-borne flavivirus that is transmitted primarily by Aedes mosquitoes." exact="ZIKV" post="infection can cause infants to be born with microcephaly"/>
   <result pre="adults such as Guillainâ€&quot;BarrÃ© syndrome, neuropathy, and myelitis.34âˆ’38 Outbreaks of" exact="ZIKV" post="infection have been recorded several times (2015 in Brazil,"/>
   <result pre="the latest one), and the World Health Organization (WHO) declared" exact="ZIKV" post="to be a global public health emergency. Xu et"/>
   <result pre="screening assay and discovered niclosamide as a potent inhibitor of" exact="ZIKV" post="infection, displaying an IC50 value of 0.37 Î¼M against"/>
   <result pre="displaying an IC50 value of 0.37 Î¼M against the intracellular" exact="ZIKV" post="RNA level.22 The time-of-addition studies indicated that niclosamide inhibits"/>
   <result pre="ZIKV RNA level.22 The time-of-addition studies indicated that niclosamide inhibits" exact="ZIKV" post="infection at a postentry stage, probably in a viral"/>
   <result pre="the endolysosomal compartments, acting as a proton carrier.50 Niclosamide and" exact="Chikungunya" post="Virus Chikungunya virus (CHIKV) is a positive-sense single-stranded RNA"/>
   <result pre="compartments, acting as a proton carrier.50 Niclosamide and Chikungunya Virus" exact="Chikungunya" post="virus (CHIKV) is a positive-sense single-stranded RNA virus belonging"/>
   <result pre="virus belonging to the genus Alphavirus of the family Togaviridae." exact="CHIKV" post="causes fever and joint pain, is transmitted by infected"/>
   <result pre="with a low micromolar EC50 value; it not only affects" exact="CHIKV" post="entry via blocking low-pH-dependent virus fusion but also inhibits"/>
   <result pre="low-pH-dependent virus fusion but also inhibits the cell-to-cell transmission of" exact="CHIKV" post="infection.51 Niclosamide and Human Adenovirus Human adenoviruses (HAdVs) are"/>
   <result pre="SARS-CoV severe acute respiratory syndrome coronavirus HCV hepatitis C virus" exact="DENV" post="dengue virus ZIKV Zika virus JEV Japanese encephalitis virus"/>
   <result pre="respiratory syndrome coronavirus HCV hepatitis C virus DENV dengue virus" exact="ZIKV" post="Zika virus JEV Japanese encephalitis virus WNV West Nile"/>
   <result pre="syndrome coronavirus HCV hepatitis C virus DENV dengue virus ZIKV" exact="Zika" post="virus JEV Japanese encephalitis virus WNV West Nile virus"/>
   <result pre="DENV dengue virus ZIKV Zika virus JEV Japanese encephalitis virus" exact="WNV" post="West Nile virus YFV yellow fever virus EBOV Ebola"/>
   <result pre="dengue virus ZIKV Zika virus JEV Japanese encephalitis virus WNV" exact="West Nile" post="virus YFV yellow fever virus EBOV Ebola virus HRV"/>
   <result pre="Zika virus JEV Japanese encephalitis virus WNV West Nile virus" exact="YFV" post="yellow fever virus EBOV Ebola virus HRV human rhinovirus"/>
   <result pre="YFV yellow fever virus EBOV Ebola virus HRV human rhinovirus" exact="CHIKV" post="Chikungunya virus HAdV human adenovirus EBV Epsteinâ€&quot;Barr virus (EBV)"/>
   <result pre="yellow fever virus EBOV Ebola virus HRV human rhinovirus CHIKV" exact="Chikungunya" post="virus HAdV human adenovirus EBV Epsteinâ€&quot;Barr virus (EBV) SKP2"/>
   <result pre="LiH. (2017) Existing drugs as broad-spectrum and potent inhibitors for" exact="Zika" post="virus by targeting NS2B-NS3 interaction. Cell Res.27, 1046â€&quot;1064. 10.1038/cr.2017.88.28685770"/>
   <result pre="MingG.-l.; ZhengW.; SongH.; TangH. (2016) Identification of small-molecule inhibitors of" exact="Zika" post="virus infection and induced neural cell death via a"/>
   <result pre="Vesnaver VipotnikT.; Fabjan VoduÅ¡ekV.; VizjakA.; PiÅ¾emJ.; PetrovecM.; AvÅ¡iÄ� Å½upancT. (2016)" exact="Zika" post="virus associated with microcephaly. N. Engl. J. Med.374, 951â€&quot;958."/>
   <result pre="10.1056/NEJMoa1600651.26862926 RasmussenS. A.; JamiesonD. J.; HoneinM. A.; PetersenL. R. (2016)" exact="Zika" post="virus and birth defects - reviewing the evidence for"/>
   <result pre="MattesF.; KiddM.; IppolitoG.; AzharE. I.; ZumlaA. (2016) Rapid spread of" exact="Zika" post="virus in the Americas - implications for public health"/>
   <result pre="MussoD.; FontanetA.; NeilJ.; GhawchÃ©F. (2016) Guillain-BarrÃ© Syndrome outbreak associated with" exact="Zika" post="virus infection in French Polynesia: a case-control study. Lancet387,"/>
   <result pre="(2016) Magnetic resonance imaging findings in Guillain-Barre syndrome caused by" exact="Zika" post="virus infection. Neuroradiology58, 837â€&quot;838. 10.1007/s00234-016-1687-9.27067205 ChambersT. J.; GrakouiA.; RiceC."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7100368\results\search\tropicalVirus\results.xml">
   <result pre="Media S.A. pmcid: 7100368 doi: 10.3389/fmicb.2020.00362 : Microbiology: Review Defeat" exact="Dengue" post="and Zika Viruses With a One-Two Punch of Vaccine"/>
   <result pre="pmcid: 7100368 doi: 10.3389/fmicb.2020.00362 : Microbiology: Review Defeat Dengue and" exact="Zika" post="Viruses With a One-Two Punch of Vaccine and Vector"/>
   <result pre="is permitted which does not comply with these terms. Abstract" exact="Dengue" post="virus (DENV) and Zika virus (ZIKV) are two mosquito-borne"/>
   <result pre="not comply with these terms. Abstract Dengue virus (DENV) and" exact="Zika" post="virus (ZIKV) are two mosquito-borne flaviviruses afflicting nearly half"/>
   <result pre="be manifested as hemorrhagic fever and hemorrhagic shock syndrome, and" exact="ZIKV" post="infection has been linked to increased incidence of peripheral"/>
   <result pre="these infectious diseases are either non-satisfactory or entirely lacking. Because" exact="DENV" post="and ZIKV have much similarities in genomic and structural"/>
   <result pre="diseases are either non-satisfactory or entirely lacking. Because DENV and" exact="ZIKV" post="have much similarities in genomic and structural features, almost"/>
   <result pre="countermeasures against both. Here, we review the existing knowledge on" exact="DENV" post="and ZIKV regarding epidemiology, molecular virology, protective immunity and"/>
   <result pre="both. Here, we review the existing knowledge on DENV and" exact="ZIKV" post="regarding epidemiology, molecular virology, protective immunity and vaccine development,"/>
   <result pre="vaccine and vector blockade to overcome antibody-dependent enhancement and defeat" exact="Dengue" post="and Zika viruses. dengue virus Zika virus epidemiology virology"/>
   <result pre="vector blockade to overcome antibody-dependent enhancement and defeat Dengue and" exact="Zika" post="viruses. dengue virus Zika virus epidemiology virology protective immunity"/>
   <result pre="antibody-dependent enhancement and defeat Dengue and Zika viruses. dengue virus" exact="Zika" post="virus epidemiology virology protective immunity vaccine mosquitoes Funding National"/>
   <result pre="Shanghai Municipality10.13039/501100003399 fig-count: table-count: equation-count: ref-count: page-count: word-count: Epidemiology of" exact="Dengue" post="Virus and Zika Virus Dengue virus (DENV) is the"/>
   <result pre="table-count: equation-count: ref-count: page-count: word-count: Epidemiology of Dengue Virus and" exact="Zika" post="Virus Dengue virus (DENV) is the most prevalent mosquito-borne"/>
   <result pre="ref-count: page-count: word-count: Epidemiology of Dengue Virus and Zika Virus" exact="Dengue" post="virus (DENV) is the most prevalent mosquito-borne flavivirus that"/>
   <result pre="population in 128 countries and regions (Brady et al., 2012)." exact="Zika" post="virus (ZIKV) is another virus that has caught public"/>
   <result pre="during 2014â€&quot;2016 (Baud et al., 2017). The transmitting vectors of" exact="DENV" post="and ZIKV are Aedes mosquitoes, mainly A. aegypti and"/>
   <result pre="(Baud et al., 2017). The transmitting vectors of DENV and" exact="ZIKV" post="are Aedes mosquitoes, mainly A. aegypti and A. albopictus"/>
   <result pre="but also have features that are distinct from each other." exact="Dengue" post="viruses are antigenically classified into four serotypes that originate"/>
   <result pre="(mostly children) progress to more severe forms of dengue disease," exact="Dengue" post="Hemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS), in"/>
   <result pre="severe forms of dengue disease, Dengue Hemorrhagic Fever (DHF) and" exact="Dengue" post="Shock Syndrome (DSS), in which plasma leakage and hemorrhagic"/>
   <result pre="al., 1984; Guzman et al., 2013; Katzelnick et al., 2017)." exact="Dengue" post="like disease has been a public health problem for"/>
   <result pre="the only licensed vaccine is far from satisfactory. In comparison," exact="Zika" post="virus emerged more recently as a public health concern."/>
   <result pre="recently as a public health concern. The historical documents of" exact="Zika" post="virus started as its first isolation from a monkey"/>
   <result pre="virus started as its first isolation from a monkey in" exact="Zika" post="forest of Uganda in 1947 (Dick et al., 1952)."/>
   <result pre="(Duffy et al., 2009; Grard et al., 2014). Symptoms of" exact="ZIKV" post="infection including fever, arthralgia, rash and conjunctivitis were presented"/>
   <result pre="was observed for the first time to be associated with" exact="Zika" post="virus infection, implicating the neurotropic feature of Zika virus"/>
   <result pre="associated with Zika virus infection, implicating the neurotropic feature of" exact="Zika" post="virus (Musso et al., 2018); additionally, detection of viral"/>
   <result pre="were also documented during this outbreak. Nevertheless, the threat of" exact="Zika" post="virus was not recognized until 2015â€&quot;2016 when it caused"/>
   <result pre="from northeast region of Brazil (Faria et al., 2017), where" exact="Zika" post="virus infected 63% peoples in Salvador. The virus spread"/>
   <result pre="and pacific islands (Baud et al., 2017). In Europe, travel-associated" exact="ZIKV" post="cases were reported in most EU (European Union) countries"/>
   <result pre="the Caribbean (Spiteri et al., 2017). During the Brazil outbreak," exact="ZIKV" post="has been suspected to persistently replicate in multiple organs"/>
   <result pre="babies (Weaver et al., 2016). Soon after, the association between" exact="Zika" post="virus infection and microcephaly was confirmed by extensive studies"/>
   <result pre="2017; Szaba et al., 2018). Furthermore, in vivo replication of" exact="ZIKV" post="in neuron, placenta and fetus was also verified by"/>
   <result pre="Mlakar et al., 2016). Since early 2016, WHO has declared" exact="Zika" post="virus disease as a public health emergency of global"/>
   <result pre="health emergency of global concern. It should be noted that" exact="ZIKV" post="and DENV spread through the same Aedes mosquito vectors"/>
   <result pre="of global concern. It should be noted that ZIKV and" exact="DENV" post="spread through the same Aedes mosquito vectors in overlapping"/>
   <result pre="and genomic structures should be of value. Virological Features of" exact="Dengue" post="Virus and Zika Virus Both Dengue virus and Zika"/>
   <result pre="should be of value. Virological Features of Dengue Virus and" exact="Zika" post="Virus Both Dengue virus and Zika virus belong to"/>
   <result pre="value. Virological Features of Dengue Virus and Zika Virus Both" exact="Dengue" post="virus and Zika virus belong to the genus of"/>
   <result pre="of Dengue Virus and Zika Virus Both Dengue virus and" exact="Zika" post="virus belong to the genus of flavivirus in the"/>
   <result pre="NS2A, NS2B, NS3, NS4A, NS5). Generally, the sequence homology between" exact="DENV" post="and ZIKV polyprotein is 55â€&quot;56%, whereas the homology among"/>
   <result pre="NS3, NS4A, NS5). Generally, the sequence homology between DENV and" exact="ZIKV" post="polyprotein is 55â€&quot;56%, whereas the homology among four serotype"/>
   <result pre="infected cells form the major architecture of viral particles of" exact="ZIKV" post="and DENV, whereas the non-structural proteins (except for NS1)"/>
   <result pre="recent study at 9 Ã… resolution showed structure of immature" exact="Zika" post="virus and demonstrated that there was a regular but"/>
   <result pre="capsid inside the membrane, implying a dynamical morphological alteration during" exact="Zika" post="virus maturation (Prasad et al., 2017). Despite minor differences,"/>
   <result pre="(Prasad et al., 2017). Despite minor differences, the structures of" exact="DENV" post="and ZIKV are generally similar. A noted difference exists"/>
   <result pre="al., 2017). Despite minor differences, the structures of DENV and" exact="ZIKV" post="are generally similar. A noted difference exists in a"/>
   <result pre="exists in a region surrounding glycosylation site at Asn154 of" exact="ZIKV" post="envelope protein and Asn153 of DENV envelope protein, these"/>
   <result pre="site at Asn154 of ZIKV envelope protein and Asn153 of" exact="DENV" post="envelope protein, these sites may influence virus transmission and"/>
   <result pre="surface. Functionally, in contrast to the mature virus, the immature" exact="DENV" post="and ZIKV are non-infectious, however, such immature virus particle"/>
   <result pre="in contrast to the mature virus, the immature DENV and" exact="ZIKV" post="are non-infectious, however, such immature virus particle can also"/>
   <result pre="et al., 2017; Bailey et al., 2018). Cell Tropism of" exact="Dengue" post="Virus and Zika Virus Transmission of DENV and ZIKV"/>
   <result pre="Bailey et al., 2018). Cell Tropism of Dengue Virus and" exact="Zika" post="Virus Transmission of DENV and ZIKV are mainly mediated"/>
   <result pre="Cell Tropism of Dengue Virus and Zika Virus Transmission of" exact="DENV" post="and ZIKV are mainly mediated by Aedes mosquitoes. When"/>
   <result pre="of Dengue Virus and Zika Virus Transmission of DENV and" exact="ZIKV" post="are mainly mediated by Aedes mosquitoes. When human is"/>
   <result pre="monocyte was the principle target cell among PBMCs for both" exact="DENV" post="and ZIKV infection, as well as the main mediators"/>
   <result pre="the principle target cell among PBMCs for both DENV and" exact="ZIKV" post="infection, as well as the main mediators for ADE"/>
   <result pre="circulating CD14 + monocytes were the primary cellular targets of" exact="ZIKV" post="infection in PBMCs (Foo et al., 2017; Michlmayr et"/>
   <result pre="disseminate through the circulatory and lymphatic system, dengue virus and" exact="Zika" post="virus spread to different tissues and organs. Dengue virus"/>
   <result pre="virus and Zika virus spread to different tissues and organs." exact="Dengue" post="virus infects primary vascular endothelial cells, splenic macrophage and"/>
   <result pre="2007; Dalrymple and Mackow, 2012). In contrast, besides these tissues," exact="Zika" post="virus also replicates in uterus and many immune privileged"/>
   <result pre="neuropathology, congenital disorders, and damages to reproductive organs. So far," exact="Zika" post="virus has been found to infect a wide range"/>
   <result pre="and Diamond, 2017; Qian et al., 2017). Several investigations indicated" exact="Zika" post="virus infects endothelial cells, the key component of blood"/>
   <result pre="tissue barriers, a fact that may help to explain how" exact="Zika" post="virus crosses blood brain barrier and placental barrier (Liu"/>
   <result pre="al., 2017). However, it is still controversial as to whether" exact="Zika" post="virus infection alters endothelial barrier integrity. A recent study"/>
   <result pre="infection alters endothelial barrier integrity. A recent study showed that" exact="ZIKV" post="infection of human umbilical vein endothelial cells (HUVECs) increased"/>
   <result pre="et al., 2019), whereas some other studies have demonstrated that" exact="Zika" post="virus directionally infected polarized epithelial cells from apical side"/>
   <result pre="of cell monolayer integrity (Tamhankar and Patterson, 2019). Understanding of" exact="ZIKV" post="cell tropism and dissemination across blood tissue barriers will"/>
   <result pre="dissemination across blood tissue barriers will help to better elucidate" exact="Zika" post="pathology, and provide opportunity for the development of efficient"/>
   <result pre="tissue tropism should also been considered during development of prophylactic" exact="ZIKV" post="vaccine. Its criteria for protective efficacies need to include"/>
   <result pre="Shan et al., 2017; Zou et al., 2018). Different from" exact="DENV" post="vaccine candidates, ZIKV vaccine might have to elicit higher"/>
   <result pre="2017; Zou et al., 2018). Different from DENV vaccine candidates," exact="ZIKV" post="vaccine might have to elicit higher level of immune"/>
   <result pre="studies of the incidence of fetal microcephaly in women received" exact="ZIKV" post="vaccine are also necessary in clinical trials. The Benefits"/>
   <result pre="clinical trials. The Benefits and Limitations of the Only Licensed" exact="Dengue" post="Vaccine With effort that lasted two decades, the first"/>
   <result pre="itself. Last but not the least, whether the emergence of" exact="Zika" post="virus in DENV endemic regions and prior ZIKV immunity"/>
   <result pre="not the least, whether the emergence of Zika virus in" exact="DENV" post="endemic regions and prior ZIKV immunity in vaccine recipients"/>
   <result pre="emergence of Zika virus in DENV endemic regions and prior" exact="ZIKV" post="immunity in vaccine recipients will affect the efficacy of"/>
   <result pre="unknown, and whether vaccination by Dengvaxia will enhance or prevent" exact="Zika" post="virus infection is also uncertain. As co-circulation of two"/>
   <result pre="uncertain. As co-circulation of two viruses and complicated interference between" exact="Dengue" post="and Zika virus-specific immunity have already been observed (Bardina"/>
   <result pre="co-circulation of two viruses and complicated interference between Dengue and" exact="Zika" post="virus-specific immunity have already been observed (Bardina et al.,"/>
   <result pre="al., 2019), it is worthwhile taking the probable influence of" exact="ZIKV" post="into consideration during dengue vaccine development. Therefore, either the"/>
   <result pre="new vaccines must be applied judiciously in epidemic regions. Other" exact="Dengue" post="and Zika Vaccines Currently in Clinical Trials Other Dengue"/>
   <result pre="must be applied judiciously in epidemic regions. Other Dengue and" exact="Zika" post="Vaccines Currently in Clinical Trials Other Dengue Vaccines in"/>
   <result pre="Other Dengue and Zika Vaccines Currently in Clinical Trials Other" exact="Dengue" post="Vaccines in Clinical Trials Besides the approved dengue vaccine"/>
   <result pre="protein vaccine, and one DNA vaccine (Table 1). TABLE 1" exact="Dengue" post="vaccines in clinical trials. Name Vaccine type Immunogen Developer"/>
   <result pre="on the backbone of attenuated DENV-4 NIAID/Butantan Institute Phase III" exact="DENV" post="subunit V180 Subunit protein Ectodomain (N-terminal 80%) of envelope"/>
   <result pre="antibody and provide protection against challenge with multiple serotypes of" exact="DENV" post="in murine and non-human primate models (Clements et al.,"/>
   <result pre="al., 2012), much of its results have not been published." exact="Zika" post="Vaccines in Clinical Trials In contrast to Dengue vaccines,"/>
   <result pre="been published. Zika Vaccines in Clinical Trials In contrast to" exact="Dengue" post="vaccines, Zika vaccines have only been developed recently since"/>
   <result pre="Zika Vaccines in Clinical Trials In contrast to Dengue vaccines," exact="Zika" post="vaccines have only been developed recently since the large"/>
   <result pre="Zika vaccines have only been developed recently since the large" exact="ZIKV" post="outbreaks in 2015â€&quot;2016. Multiple candidates are under development simultaneously,"/>
   <result pre="II clinical trials will be discussed (Table 2). TABLE 2" exact="Zika" post="vaccines in clinical trials. Name Vaccine type Immunogen Developers"/>
   <result pre="injection &amp;amp; electroporation GeneOne life science Inc./Inovio Pharmaceuticals Phase I" exact="ZIKV" post="purified inactivated vaccine (ZPIV) Inactivated vaccine Formalin-inactivated whole virus"/>
   <result pre="Valneva Australia GmbH Phase I rZIKV/D4delta30 Chimeric live attenuated vaccine" exact="ZIKV" post="prM and E genes inserted to DEN4delta30 NIAID Phase"/>
   <result pre="genes inserted to DEN4delta30 NIAID Phase I MV-ZIKA Viral vector" exact="ZIKV" post="prM and E genges inserted to measles virus vector"/>
   <result pre="prM and E ModernaTX, Inc. Phase I The most advanced" exact="Zika" post="vaccine candidates is a DNA vaccine containing Zika virus"/>
   <result pre="most advanced Zika vaccine candidates is a DNA vaccine containing" exact="Zika" post="virus prM and E genes (VRC5283) that is being"/>
   <result pre="DNA vaccine GLS-5700 (developed by GeneOne/Inovio) containing consensus sequences of" exact="ZIKV" post="prM and E genes, delivered via intradermal injection followed"/>
   <result pre="from vaccine recipients protected 92% immune deficient mice from lethal" exact="ZIKV" post="challenge (Tebas et al., 2017). The development of inactivated"/>
   <result pre="ZIKV challenge (Tebas et al., 2017). The development of inactivated" exact="Zika" post="vaccine was started soon after the ZIKV outbreaks. There"/>
   <result pre="development of inactivated Zika vaccine was started soon after the" exact="ZIKV" post="outbreaks. There are currently two purified inactivated Zika vaccine"/>
   <result pre="after the ZIKV outbreaks. There are currently two purified inactivated" exact="Zika" post="vaccine candidates in Phase I clinical trials, they were"/>
   <result pre="IgG from vaccine recipients to mice prior to challenge with" exact="ZIKV" post="led to reduced viremia in mice, indicating its potential"/>
   <result pre="a similar strategy for DENV-2 vaccine TV003/TV005, recombinant live attenuated" exact="Zika" post="vaccine has been constructed with the backbone of attenuated"/>
   <result pre="I clinical trial, and might be tested in combination with" exact="DENV" post="vaccine TV005 in the future (ID: NCT03611946) (Durbin and"/>
   <result pre="Measles vaccine virus has also been adapted to construct chimeric" exact="ZIKV" post="vaccine. One of such vaccine, MV-ZIKA, has been developed"/>
   <result pre="lipid nanoparticle-encapsulated modified mRNA has also been used to develop" exact="Zika" post="vaccine. An mRNA that contains prM-E genes of ZIKV"/>
   <result pre="develop Zika vaccine. An mRNA that contains prM-E genes of" exact="ZIKV" post="and optimized 5â€² and 3â€² untranslated sequences with type-1"/>
   <result pre="high titers (âˆ¼1/100,000) of neutralizing antibodies, and conferred protection against" exact="ZIKV" post="challenge in mice (Richner et al., 2017a). An mRNA-based"/>
   <result pre="Phase I clinical trial (ID: NCT03014089). Besides, other forms of" exact="ZIKV" post="vaccine, such as protein based subunit vaccine (Medina et"/>
   <result pre="et al., 2019; Slon-Campos et al., 2019) and live attenuated" exact="Zika" post="vaccines (Richner et al., 2017b; Xie et al., 2018;"/>
   <result pre="at the pre-clinical stage. Considering the cross-reactivity and ADE between" exact="ZIKV" post="and DENV, newly developed ZIKV vaccine should also be"/>
   <result pre="the cross-reactivity and ADE between ZIKV and DENV, newly developed" exact="ZIKV" post="vaccine should also be tested for DENV enhancement activity."/>
   <result pre="DENV, newly developed ZIKV vaccine should also be tested for" exact="DENV" post="enhancement activity. This additional requirement will likely to be"/>
   <result pre="requirement will likely to be a huge obstacle for both" exact="ZIKV" post="and DENV vaccines. Protective Immunity Against Dengue and Zika"/>
   <result pre="likely to be a huge obstacle for both ZIKV and" exact="DENV" post="vaccines. Protective Immunity Against Dengue and Zika Viruses Protective"/>
   <result pre="obstacle for both ZIKV and DENV vaccines. Protective Immunity Against" exact="Dengue" post="and Zika Viruses Protective Antibody Response Although various antibodies"/>
   <result pre="both ZIKV and DENV vaccines. Protective Immunity Against Dengue and" exact="Zika" post="Viruses Protective Antibody Response Although various antibodies targeting different"/>
   <result pre="indicated that E domain III was the predominant targets for" exact="DENV" post="neutralizing antibodies, and antibodies to this region are mainly"/>
   <result pre="III specific neutralizing antibodies only constitute a small proportion of" exact="DENV" post="antibody repertoire. Mapping antibody epitope using recombinant envelope proteins,"/>
   <result pre="Rouvinski et al., 2015). On the contrary, the importance of" exact="ZIKV" post="EDIII specific antibodies has been shown directly in some"/>
   <result pre="neutralization (Stettler et al., 2016). Additionally, using two cohorts of" exact="ZIKV" post="infected individuals from Mexico and Brazil, it was revealed"/>
   <result pre="the levels of antibodies specific for the lateral ridge of" exact="ZIKV" post="E domain III were positively correlated with sera neutralization"/>
   <result pre="quaternary epitopes formed between E domains II and III of" exact="Zika" post="virus were demonstrated to be both protective and therapeutic"/>
   <result pre="al., 2016; Hasan et al., 2017; Collins et al., 2019)." exact="DENV" post="and ZIKV show high level of structure homology between"/>
   <result pre="Hasan et al., 2017; Collins et al., 2019). DENV and" exact="ZIKV" post="show high level of structure homology between their envelope"/>
   <result pre="EDE1 antibodies, one subset of EDE antibodies originally isolated from" exact="DENV" post="patients, has been shown to potently neutralize Zika virus"/>
   <result pre="isolated from DENV patients, has been shown to potently neutralize" exact="Zika" post="virus in vitro and provides protection against lethal challenge"/>
   <result pre="virus in vitro and provides protection against lethal challenge of" exact="Zika" post="virus in mice. These antibodies recognize a conserved conformational"/>
   <result pre="antibodies that have broader footprints covering N153 glycosylation site of" exact="DENV" post="E proteins, these antibodies can also cross-neutralize ZIKV at"/>
   <result pre="site of DENV E proteins, these antibodies can also cross-neutralize" exact="ZIKV" post="at high concentrations (Fernandez et al., 2017; Abbink et"/>
   <result pre="al., 2017; Abbink et al., 2018; Figure 1A). In contrast," exact="ZIKV" post="neutralization antibodies targeting quaternary epitopes identified so far, such"/>
   <result pre="and EDE2 were isolated mainly from patients of acute secondary" exact="DENV" post="infection, whereas A9E and G9E were isolated from DENV"/>
   <result pre="secondary DENV infection, whereas A9E and G9E were isolated from" exact="DENV" post="naÃ¯ve ZIKV patients at 6 months after the onset"/>
   <result pre="infection, whereas A9E and G9E were isolated from DENV naÃ¯ve" exact="ZIKV" post="patients at 6 months after the onset of illness."/>
   <result pre="Rouvinski et al. (2017). Collectively, neutralization antibodies to dengue or" exact="Zika" post="viruses are mainly constituted of type specific EDIII antibodies,"/>
   <result pre="in vitro studies have already demonstrated that most antibodies to" exact="DENV" post="or ZIKV prM and E proteins have the potential"/>
   <result pre="studies have already demonstrated that most antibodies to DENV or" exact="ZIKV" post="prM and E proteins have the potential to enhance"/>
   <result pre="al., 2010; de Alwis et al., 2014). Further investigation on" exact="Zika" post="and dengue monoclonal antibodies indicates that antibody concentrations that"/>
   <result pre="to in vitro studies using human samples, ADE of heterotypic" exact="DENV" post="infection has been more stringently demonstrated in mouse models."/>
   <result pre="has been more stringently demonstrated in mouse models. Administering heterotypic" exact="DENV" post="immune sera or viral-specific monoclonal antibodies to AG129 immune"/>
   <result pre="(Zellweger et al., 2010). Consistently, clinical evidence of ADE in" exact="DENV" post="infection has been reported previously. Infants born to dengue"/>
   <result pre="6â€&quot;9 months of age, due to the decay of maternal-derived" exact="DENV" post="antibodies (Halstead, 2003). Further, the increased risk of hospitalization"/>
   <result pre="(Katzelnick et al., 2017). More significantly, a cross-serocomplex ADE between" exact="ZIKV" post="and DENV has also been reproduced in mouse model."/>
   <result pre="al., 2017). More significantly, a cross-serocomplex ADE between ZIKV and" exact="DENV" post="has also been reproduced in mouse model. DENV and"/>
   <result pre="ZIKV and DENV has also been reproduced in mouse model." exact="DENV" post="and WNV immune sera were both found to enhance"/>
   <result pre="DENV has also been reproduced in mouse model. DENV and" exact="WNV" post="immune sera were both found to enhance Zika virus"/>
   <result pre="DENV and WNV immune sera were both found to enhance" exact="Zika" post="virus infection in mice (Bardina et al., 2017). Also,"/>
   <result pre="accelerated fetal resorption (Leborgne et al., 2019). Reciprocally, maternally acquired" exact="Zika" post="virus antibodies also enhanced dengue disease severity in mice"/>
   <result pre="are not as clear. Two studies did not show enhanced" exact="Zika" post="virus infection in macaques that were infected by DENV"/>
   <result pre="enhanced Zika virus infection in macaques that were infected by" exact="DENV" post="either 420 days or 2.8 years before experiments (McCracken"/>
   <result pre="should be noted that the interval between primary and secondary" exact="DENV" post="infections is critical for disease severity, and DENV ADE"/>
   <result pre="and secondary DENV infections is critical for disease severity, and" exact="DENV" post="ADE in human has only occurred within a relatively"/>
   <result pre="has only occurred within a relatively narrow range of pre-existing" exact="DENV" post="antibody concentration (Katzelnick et al., 2017). In dengue infected"/>
   <result pre="usually 12 months or longer, but unknown for enhancement of" exact="Zika" post="virus infection. Limited data from a long-term cohort study"/>
   <result pre="long-term cohort study in Brazil before and after the 2015" exact="ZIKV" post="outbreak have found that the pre-existing DENV NS1 specific"/>
   <result pre="after the 2015 ZIKV outbreak have found that the pre-existing" exact="DENV" post="NS1 specific IgG3 antibody within 4â€&quot;6 months of infection"/>
   <result pre="of infection was positively associated with the risk of subsequent" exact="ZIKV" post="infection, but high titer of total IgG to DENV"/>
   <result pre="subsequent ZIKV infection, but high titer of total IgG to" exact="DENV" post="was associated with protection against the acquisition of ZIKV"/>
   <result pre="to DENV was associated with protection against the acquisition of" exact="ZIKV" post="infection (Rodriguez-Barraquer et al., 2019). Our previous study using"/>
   <result pre="convalescent dengue patients also revealed that stronger cross-serocomplex ADE of" exact="ZIKV" post="infection in PBMC appeared more often in sera obtained"/>
   <result pre="appeared more often in sera obtained within 3 months of" exact="DENV" post="infection (Li et al., 2018). These results are supportive"/>
   <result pre="two infections are important factors for determining cross-serocomplex enhancement between" exact="ZIKV" post="and DENV. Collectively, ADE is now considered to be"/>
   <result pre="development. Despite the impact of prior cross-serocomplex immunity for subsequent" exact="ZIKV" post="or DENV infections are clinically unknown, candidate vaccines that"/>
   <result pre="the impact of prior cross-serocomplex immunity for subsequent ZIKV or" exact="DENV" post="infections are clinically unknown, candidate vaccines that provide protection"/>
   <result pre="development. T Cell Responses Aside from the double-edged antibody responses," exact="DENV" post="and ZIKV infections also elicit strong T cell responses"/>
   <result pre="Cell Responses Aside from the double-edged antibody responses, DENV and" exact="ZIKV" post="infections also elicit strong T cell responses of dubious"/>
   <result pre="al., 2010). A subsequent human cohort study further illustrated that" exact="DENV" post="specific CD8 + T cell responses played protective roles"/>
   <result pre="specific CD8 + T cell responses played protective roles against" exact="DENV" post="infection in an HLA-linked manner (Weiskopf et al., 2013)."/>
   <result pre="full scope of T cell responses toward conserved epitopes. Similarly," exact="ZIKV" post="specific CD8 + T cells were also first showed"/>
   <result pre="Ngono et al., 2017; Huang et al., 2017), and human" exact="ZIKV" post="CD8 + T cells were revealed to have cytotoxic"/>
   <result pre="its antiviral cytotoxicity might be associated with neurological pathology in" exact="ZIKV" post="infection, the pre-existence of specific CD8 + T cells"/>
   <result pre="disease (Huang et al., 2017; Jurado et al., 2018). Whether" exact="ZIKV" post="CD4 + T cell responses are necessary for virus"/>
   <result pre="peptide immunization have been demonstrated to protect host from subsequent" exact="ZIKV" post="infection (Hassert et al., 2018; Elong Ngono et al.,"/>
   <result pre="2019). In one cohort study conducted in dengue endemic countries," exact="ZIKV" post="specific CD8 + T cell epitopes were found to"/>
   <result pre="al., 2017b). Cross-reactive T cell responses were often observed between" exact="DENV" post="and ZIKV, because of their homology at amino acid"/>
   <result pre="and ZIKV, because of their homology at amino acid level." exact="DENV" post="specific memory CD8 + T cells could cross-react with"/>
   <result pre="DENV specific memory CD8 + T cells could cross-react with" exact="Zika" post="virus and protected mice from subsequent lethal ZIKV challenge"/>
   <result pre="cross-react with Zika virus and protected mice from subsequent lethal" exact="ZIKV" post="challenge (Wen et al., 2017a). Adoptive transfer of DENV"/>
   <result pre="lethal ZIKV challenge (Wen et al., 2017a). Adoptive transfer of" exact="DENV" post="CD8 + T cells to pregnant mice inhibited Zika"/>
   <result pre="of DENV CD8 + T cells to pregnant mice inhibited" exact="Zika" post="virus replication in placenta and increased the survival of"/>
   <result pre="increased the survival of fetus (Regla-Nava et al., 2018). In" exact="DENV" post="convalescent patients, memory CD4 + and CD8 + T"/>
   <result pre="+ T cells could be activated by peptides derived from" exact="ZIKV" post="capsid and NS3 proteins, and the activated CD8 +"/>
   <result pre="proteins, and the activated CD8 + T cells could kill" exact="ZIKV" post="infected cells in vitro (Lim et al., 2018). Nevertheless,"/>
   <result pre="the cross-reactive CD4 + T cells are few, evidence for" exact="ZIKV" post="specific memory T cells cross-react with DENV antigens is"/>
   <result pre="few, evidence for ZIKV specific memory T cells cross-react with" exact="DENV" post="antigens is still lacking. All above demonstrate that T"/>
   <result pre="is an important element of adaptive immunity toward dengue and" exact="Zika" post="virus, and T cell component should be considered in"/>
   <result pre="the existing knowledge of vaccine immunology and protective immunity to" exact="DENV" post="and ZIKV, it is predicted that an ideal dengue"/>
   <result pre="and ZIKV, it is predicted that an ideal dengue or" exact="Zika" post="vaccine should induce both humoral and cellular immune response"/>
   <result pre="response to ensure full protection. Universal B Cell Vaccines for" exact="DENV" post="and ZIKV Previous investigation on dengue and Zika vaccine"/>
   <result pre="ensure full protection. Universal B Cell Vaccines for DENV and" exact="ZIKV" post="Previous investigation on dengue and Zika vaccine mainly focused"/>
   <result pre="Vaccines for DENV and ZIKV Previous investigation on dengue and" exact="Zika" post="vaccine mainly focused on the B cell immunity, aiming"/>
   <result pre="Because of the complex interaction among antibody responses to four" exact="DENV" post="serotypes and ZIKV, an ideal dengue vaccine should elicit"/>
   <result pre="broadly neutralizing antibodies that cross-react with all serotypes of viruses." exact="Zika" post="vaccines developed independently need to be able to trigger"/>
   <result pre="the antibody responses elicited by intact or recombinant dengue or" exact="Zika" post="viruses still maintain the dual functions of neutralization and"/>
   <result pre="strains. Epitopes on â€œprâ€� peptides are probably exposed on immature" exact="ZIKV" post="virus surface and elicit abundant ADE inducing antibodies, similar"/>
   <result pre="elicit abundant ADE inducing antibodies, similar to what happened in" exact="DENV" post="infected patients. The same issue must be dealt with"/>
   <result pre="selection and quality control. In most subunit candidate vaccines of" exact="DENV" post="and ZIKV, soluble EDIII or E80 as antigens were"/>
   <result pre="Figure 1B). Consistently, in a recent study, the covalently stabilized" exact="ZIKV" post="E dimer has successfully elicited protective antibody responses against"/>
   <result pre="ZIKV E dimer has successfully elicited protective antibody responses against" exact="ZIKV" post="infection in mice, without causing cross-reactivity to dengue viruses"/>
   <result pre="mice, without causing cross-reactivity to dengue viruses or ADE of" exact="DENV" post="(Slon-Campos et al., 2019). Currently, both Zika EDIII and"/>
   <result pre="or ADE of DENV (Slon-Campos et al., 2019). Currently, both" exact="Zika" post="EDIII and Dengue tetravalent EDIII vaccines are under development."/>
   <result pre="DENV (Slon-Campos et al., 2019). Currently, both Zika EDIII and" exact="Dengue" post="tetravalent EDIII vaccines are under development. The EDIII component"/>
   <result pre="vivo protection varies among four serotypes of dengue viruses or" exact="Zika" post="virus, to adjust the balance among immune responses in"/>
   <result pre="E80, further incorporation of consensus E80 monomers derived from both" exact="DENV" post="and ZIKV to a stabilized dimer might help to"/>
   <result pre="incorporation of consensus E80 monomers derived from both DENV and" exact="ZIKV" post="to a stabilized dimer might help to present most"/>
   <result pre="cell memory response is another essential aim for dengue or" exact="Zika" post="vaccine. In clinical trial of CYD-TDV, GMT of antibody"/>
   <result pre="we should be able to construct a universal dengue and" exact="Zika" post="B cell vaccine. Furthermore, with suitable heterologous vaccines in"/>
   <result pre="responses that have limited ADE effect. T Cell Vaccines for" exact="DENV" post="and ZIKV In contrast to the extensive attention on"/>
   <result pre="have limited ADE effect. T Cell Vaccines for DENV and" exact="ZIKV" post="In contrast to the extensive attention on B cell"/>
   <result pre="experienced than dengue naÃ¯ve vaccine recipients. As a chimera of" exact="Dengue" post="virus and YF-17D vaccine, CYD-TDV mainly elicited YFV specific"/>
   <result pre="chimera of Dengue virus and YF-17D vaccine, CYD-TDV mainly elicited" exact="YFV" post="specific T cell responses through YFV non-structural proteins, of"/>
   <result pre="vaccine, CYD-TDV mainly elicited YFV specific T cell responses through" exact="YFV" post="non-structural proteins, of which reactivity to dengue virus was"/>
   <result pre="infection, dengue specific memory T cell responses were boosted by" exact="YFV" post="cross-reactive epitopes in seropositive recipients and contributed to protection."/>
   <result pre="is complementary to traditional B cell vaccines for defense against" exact="DENV" post="and ZIKV. Distinct from B cell epitopes, T cell"/>
   <result pre="restricted. Some HLA-linked protective epitopes have already been identified for" exact="DENV" post="and ZIKV, it is worthwhile to study epitope distribution"/>
   <result pre="in a study of immunogenicity and protection efficacy of multiepitope" exact="DENV" post="NS3 DNA vaccine in Balb/c mice, and it demonstrated"/>
   <result pre="T cell responses. TAK-003 and TV003 containing non-structural proteins of" exact="DENV" post="have been shown to elicit both antibody responses and"/>
   <result pre="to induce protective T cell immunity toward four serotypes of" exact="DENV" post="and ZIKV simultaneously, and whether cross-reactive T cell responses"/>
   <result pre="protective T cell immunity toward four serotypes of DENV and" exact="ZIKV" post="simultaneously, and whether cross-reactive T cell responses could be"/>
   <result pre="we propose an improvement of the strategy for dengue and" exact="Zika" post="virus vaccine development by inclusion of T cell epitopes"/>
   <result pre="effect in vivo. Vector Blockade Through NS1 Antibodies As both" exact="DENV" post="and ZIKV are transmitted through Aedes mosquitoes, countermeasures that"/>
   <result pre="vivo. Vector Blockade Through NS1 Antibodies As both DENV and" exact="ZIKV" post="are transmitted through Aedes mosquitoes, countermeasures that block the"/>
   <result pre="blood meal. Furthermore, we demonstrated that NS1 antigenemia also determined" exact="ZIKV" post="infectivity in mosquitoes. Specifically, comparing with ZIKV Asian strains"/>
   <result pre="antigenemia also determined ZIKV infectivity in mosquitoes. Specifically, comparing with" exact="ZIKV" post="Asian strains that were isolated before recent outbreaks, contemporary"/>
   <result pre="enhanced infectivity in mosquitoes. This mechanism helps to explain how" exact="ZIKV" post="of Asian lineage acquired the ability to rapidly spread"/>
   <result pre="host pathology, some of which are completely opposite. Previously, soluble" exact="DENV" post="NS1 was found to contribute directly to vascular leakage"/>
   <result pre="al., 2017). Further study on DENV, WNV, YFV, JEV, and" exact="ZIKV" post="revealed that the effect of NS1 on cell permeability"/>
   <result pre="patterns for different viruses (Puerta-Guardo et al., 2019). In addition," exact="DENV" post="NS1 also facilitates viral immune evasion through inhibiting complement"/>
   <result pre="initiate complement dependent cytotoxicity (CDC). Recent investigations show that transferring" exact="ZIKV" post="NS1 antibodies from human or vaccinated mice to IFN"/>
   <result pre="apoptosis of endothelial cells, and thus leading to pathology in" exact="DENV" post="infections (Falconar, 1997; Lin et al., 2005; Cheng et"/>
   <result pre="in human vaccine might offer a better chance for defeating" exact="DENV" post="and ZIKV epidemics. Special Concerns in the Development of"/>
   <result pre="vaccine might offer a better chance for defeating DENV and" exact="ZIKV" post="epidemics. Special Concerns in the Development of ZIKV and"/>
   <result pre="DENV and ZIKV epidemics. Special Concerns in the Development of" exact="ZIKV" post="and DENV Vaccines Because ZIKV and DENV have different"/>
   <result pre="ZIKV epidemics. Special Concerns in the Development of ZIKV and" exact="DENV" post="Vaccines Because ZIKV and DENV have different pathogenic characteristics"/>
   <result pre="Concerns in the Development of ZIKV and DENV Vaccines Because" exact="ZIKV" post="and DENV have different pathogenic characteristics and tropism, special"/>
   <result pre="the Development of ZIKV and DENV Vaccines Because ZIKV and" exact="DENV" post="have different pathogenic characteristics and tropism, special issues should"/>
   <result pre="the development of vaccines to these viruses, especially for prophylactic" exact="ZIKV" post="vaccines which are currently under development by several research"/>
   <result pre="and to reduce mortality in lethal infection murine models. However," exact="ZIKV" post="has the ability to infect and replicate in reproductive"/>
   <result pre="Prisant et al., 2016; Miner and Diamond, 2017). Therefore, during" exact="ZIKV" post="vaccine development, specified criteria for protective efficacies should include"/>
   <result pre="and decreased damages to reproductive systems. In contrast, evaluation of" exact="DENV" post="vaccine in disease models mainly includes blockage of vascular"/>
   <result pre="dengue, and hospitalization were the three major parameters to evaluate" exact="DENV" post="vaccine candidates (Hadinegoro et al., 2015; Biswal et al.,"/>
   <result pre="In addition to these three parameters, for the evaluation of" exact="ZIKV" post="vaccine, other parameters might have to be included, such"/>
   <result pre="syndrome, fetal brain development abnormality). To fulfill the criteria above," exact="ZIKV" post="vaccine strategy should also be modified, since the characteristics"/>
   <result pre="weaker T cell responses were elicited by a live attenuated" exact="ZIKV" post="vaccine during pregnancy, comparing to that in non-pregnant mice."/>
   <result pre="required to protect pregnant mice and block vertical transmission of" exact="ZIKV" post="(Shan et al., 2019). Such evidence warrants a vaccine"/>
   <result pre="better approaches to defeat dengue viruses. The sudden outbreaks of" exact="Zika" post="virus has brought additional difficulties to solve the dengue"/>
   <result pre="additional difficulties to solve the dengue problem, because the pre-existing" exact="ZIKV" post="antibodies have the potential to enhance DENV infection, and"/>
   <result pre="because the pre-existing ZIKV antibodies have the potential to enhance" exact="DENV" post="infection, and antibodies elicited by dengue vaccines also have"/>
   <result pre="elicited by dengue vaccines also have the potential to augment" exact="ZIKV" post="infection. However, as for any other scientific challenges before,"/>
   <result pre="any other scientific challenges before, the large global outbreak of" exact="ZIKV" post="has brought in extensive investigations on flavivirus virology, immunology,"/>
   <result pre="approaches are necessary. FIGURE 3 Urban cycle of dengue and" exact="Zika" post="virus transmission can be blocked at multiple steps by"/>
   <result pre="multiple steps by vaccine elicited immune responses. Both dengue and" exact="Zika" post="viruses are transmitted between human through mosquitoes in urban"/>
   <result pre="T cells can be activated by infected cells that present" exact="DENV" post="or ZIKV peptides in the context of MHC-I molecules,"/>
   <result pre="can be activated by infected cells that present DENV or" exact="ZIKV" post="peptides in the context of MHC-I molecules, and activated"/>
   <result pre="existing knowledge on epidemiology, molecular virology, and vaccine development of" exact="DENV" post="and ZIKV; and updated our understanding on protective immunity"/>
   <result pre="and ZIKV; and updated our understanding on protective immunity against" exact="DENV" post="and ZIKV. We have also discussed recent discoveries on"/>
   <result pre="a potential one-two punch strategy that overcomes ADE and defeats" exact="Dengue" post="and Zika viruses through a combination of vaccines and"/>
   <result pre="one-two punch strategy that overcomes ADE and defeats Dengue and" exact="Zika" post="viruses through a combination of vaccines and vector blockade."/>
   <result pre="(2018). Therapeutic and protective efficacy of a dengue antibody against" exact="Zika" post="infection in rhesus monkeys.Nat. Med.24721â€&quot;723. 10.1038/s41591-018-0056-029867228 AvirutnanP.FuchsA.HauhartR. E.SomnukeP.YounS.DiamondM. S.et"/>
   <result pre="(2019). Antibodies elicited by an ns1-based vaccine protect mice against" exact="Zika" post="Virus.MBio10e2861â€&quot;e2818. 10.1128/mBio.02861-1830940710 BaileyM. J.DuehrJ.DulinH.BroeckerF.BrownJ. A.ArumemiF. O.et al. (2018). Human"/>
   <result pre="10.1128/mBio.02861-1830940710 BaileyM. J.DuehrJ.DulinH.BroeckerF.BrownJ. A.ArumemiF. O.et al. (2018). Human antibodies targeting" exact="Zika" post="virus NS1 provide protection against disease in a mouse"/>
   <result pre="Commun.9:4560. 10.1038/s41467-018-07008-030385750 BardinaS. V.BunducP.TripathiS.DuehrJ.FrereJ. J.BrownJ. A.et al. (2017). Enhancement of" exact="Zika" post="virus pathogenesis by preexisting antiflavivirus immunity.Science356175â€&quot;180. 10.1126/science.aal436528360135 BarnettR. (2017)."/>
   <result pre="(2016). Infection dynamics in a traveller with persistent shedding of" exact="Zika" post="virus RNA in semen for six months after returning"/>
   <result pre="2016.Euro Surveill21:30316. 10.2807/1560-7917.ES.2016.21.32.3031627542178 BaudD.GublerD. J.SchaubB.LanteriM. C.MussoD. (2017). An update on" exact="Zika" post="virus infection.Lancet3902099â€&quot;2109. 10.1016/S0140-6736(17)31450-228647173 BeattyP. R.Puerta-GuardoH.KillingbeckS. S.GlasnerD. R.HopkinsK.HarrisE. (2015). Dengue"/>
   <result pre="on Zika virus infection.Lancet3902099â€&quot;2109. 10.1016/S0140-6736(17)31450-228647173 BeattyP. R.Puerta-GuardoH.KillingbeckS. S.GlasnerD. R.HopkinsK.HarrisE. (2015)." exact="Dengue" post="virus NS1 triggers endothelial permeability and vascular leak that"/>
   <result pre="L.SimmonsC. P.MacagnoA.SimonelliL.QuyenN. T.et al. (2010). The human immune response to" exact="Dengue" post="virus is dominated by highly cross-reactive antibodies endowed with"/>
   <result pre="mice.J. Virol.759731â€&quot;9740. 10.1128/JVI.75.20.9731-9740.200111559806 BlaneyJEJr.SatheN. S.GoddardL.HansonC. T.RomeroT. A.HanleyK. A.et al. (2008)." exact="Dengue" post="virus type 3 vaccine candidates generated by introduction of"/>
   <result pre="J. Trop. Med. Hyg.7274â€&quot;81. 10.4269/ajtmh.2005.72.7415728870 CamposG. S.BandeiraA. C.SardiS. I. (2015)." exact="Zika" post="virus outbreak. Bahia, Brazil.Emerg. Infect. Dis.211885â€&quot;1886. 10.3201/eid2110.15084726401719 CapedingM. R.TranN."/>
   <result pre="phase 3, randomised, observer-masked, placebo-controlled trial.Lancet3841358â€&quot;1365. 10.1016/S0140-6736(14)61060-625018116 CareyD. E. (1971)." exact="Chikungunya" post="and dengue: a case of mistaken identity?J. Hist. Med."/>
   <result pre="on platelets and inhibit platelet aggregation.Mol. Immunol.47398â€&quot;406. 10.1016/j.molimm.2009.08.03319822367 ClarkeT. (2002)." exact="Dengue" post="virus: break-bone fever.Nature416672â€&quot;674. 10.1038/416672a11961522 ClementsD. E.CollerB. A.LiebermanM. M.OgataS.WangG.HaradaK. E.et"/>
   <result pre="A.Gimblet-OchiengC.LiouG. A.JadiR. S.MetzS. W.et al. (2019). Human antibody response to" exact="Zika" post="targets type-specific quaternary structure epitopes.JCI Insight4:e123588. 10.1172/jci.insight.12458830996133 CostaS. M.YorioA."/>
   <result pre="USA.Vaccine315047â€&quot;5054. 10.1016/j.vaccine.2013.08.08824021313 de AlwisR.WilliamsK. L.SchmidM. A.LaiC. Y.PatelB.SmithS. A.et al. (2014)." exact="Dengue" post="viruses are enhanced by distinct populations of serotype cross-reactive"/>
   <result pre="enhance dengue virus infection in humans.Science328745â€&quot;748. 10.1126/science.118518120448183 DejnirattisaiW.SupasaP.WongwiwatW.RouvinskiA.Barba-SpaethG.DuangchindaT.et al. (2016)." exact="Dengue" post="virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika"/>
   <result pre="with dengue virus.Nat. Immunol.16170â€&quot;177. 10.1038/ni.305825501631 DickG. W.KitchenS. F.HaddowA. J. (1952)." exact="Zika" post="virus. I. Isolations and serological specificity.Trans. R Soc. Trop."/>
   <result pre="10.1073/pnas.101086710720837518 DuffyM. R.ChenT. H.HancockW. T.PowersA. M.KoolJ. L.LanciottiR. S.et al. (2009)." exact="Zika" post="virus outbreak on Yap Island. Federated States of Micronesia.N."/>
   <result pre="children with dengue.J. Immunol.1847281â€&quot;7287. 10.4049/jimmunol.090326220483770 DurbinA.Wilder-SmithA. (2017). An update on" exact="Zika" post="vaccine developments.Expert Rev. Vaccines16781â€&quot;787. 10.1080/14760584.2017.134530928633549 DurbinA. P.KirkpatrickB. D.PierceK. K.ElwoodD.LarssonC."/>
   <result pre="and role of the CD8(+) T cell response during primary" exact="Zika" post="Virus Infection in Mice.Cell Host Microbe2135â€&quot;46. 10.1016/j.chom.2016.12.01028081442 Elong NgonoA.YoungM."/>
   <result pre="CD4+ T cells promote humoral immunity and viral control during" exact="Zika" post="virus infection.PLoS Pathog.15:e1007474. 10.1371/journal.ppat.100747430677097 FalconarA. K. (1997). The dengue"/>
   <result pre="M.ThezeJ.de JesusJ. G.GiovanettiM.et al. (2017). Establishment and cryptic transmission of" exact="Zika" post="virus in Brazil and the Americas.Nature546406â€&quot;410. 10.1038/nature2240128538727 FatimaK.SyedN. I."/>
   <result pre="to the dengue virus E-dimer epitope have therapeutic activity against" exact="Zika" post="virus infection.Nat. Immunol.181261â€&quot;1269. 10.1038/ni.384928945244 FooS. S.ChenW.ChanY.BowmanJ. W.ChangL. C.ChoiY.et al."/>
   <result pre="infection.Nat. Immunol.181261â€&quot;1269. 10.1038/ni.384928945244 FooS. S.ChenW.ChanY.BowmanJ. W.ChangL. C.ChoiY.et al. (2017). Asian" exact="Zika" post="virus strains target CD14(+) blood monocytes and induce M2-skewed"/>
   <result pre="in mice.Cell Host Microbe24, 743.E5â€&quot;750.e5. 10.1016/j.chom.2018.09.01530439343 GaucherD.TherrienR.KettafN.AngermannB. R.BoucherG.Filali-MouhimA.et al. (2008)." exact="Yellow fever" post="vaccine induces integrated multilineage and polyfunctional immune responses.J. Exp."/>
   <result pre="M.HuZ.YamshchikovG.RothwellR. S.et al. (2018). Safety, tolerability, and immunogenicity of two" exact="Zika" post="virus DNA vaccine candidates in healthy adults: randomised, open-label,"/>
   <result pre="Clinical Trial.J. Infect. Dis.2121032â€&quot;1041. 10.1093/infdis/jiv17925791116 GlasnerD. R.RatnasiriK.Puerta-GuardoH.EspinosaD. A.BeattyP. R.HarrisE. (2017)." exact="Dengue" post="virus NS1 cytokine-independent vascular leak is dependent on endothelial"/>
   <result pre="endothelial glycocalyx components.PLoS Pathog.13:e1006673. 10.1371/journal.ppat.100667329121099 GoveroJ.EsakkyP.ScheafferS. M.FernandezE.DruryA.PlattD. J.et al. (2016)." exact="Zika" post="virus infection damages the testes in mice.Nature540438â€&quot;442. 10.1038/nature2055627798603 GovindarajanD.MeschinoS.GuanL.ClementsD."/>
   <result pre="efficacy in nonhuman primates.Vaccine334105â€&quot;4116. 10.1016/j.vaccine.2015.06.06726144900 GrardG.CaronM.MomboI. M.NkogheD.Mboui OndoS.JiolleD.et al. (2014)." exact="Zika" post="virus in Gabon (Central Africa)â€&quot;2007: a new threat from"/>
   <result pre="GriffinB. D.MuthumaniK.WarnerB. M.MajerA.HaganM.AudetJ.et al. (2017). DNA vaccination protects mice against" exact="Zika" post="virus-induced damage to the testes.Nat. Commun.8:15743. 10.1038/ncomms1574328589934 GrifoniA.AngeloM. A.LopezB.Oâ€™RourkeP."/>
   <result pre="(2017b). Prior dengue virus exposure shapes T Cell Immunity to" exact="Zika" post="Virus in Humans.J. Virol.91:e01469-17. 10.1128/JVI.01469-1728978707 GrifoniA.Costa-RamosP.PhamJ.TianY.RosalesS. L.SeumoisG.et al. (2018)."/>
   <result pre="edge: transcriptional profiling reveals multifunctional and cytotoxic antiviral responses of" exact="Zika" post="Virus-Specific CD8(+) T Cells.J. Immunol.2013487â€&quot;3491. 10.4049/jimmunol.180109030413672 GublerD. J. (1987)."/>
   <result pre="Zika Virus-Specific CD8(+) T Cells.J. Immunol.2013487â€&quot;3491. 10.4049/jimmunol.180109030413672 GublerD. J. (1987)." exact="Dengue" post="and dengue hemorrhagic fever in the Americas.P R Health"/>
   <result pre="of dengue viruses.Adv. Virus Res.60421â€&quot;467. 10.1016/s0065-3527(03)60011-414689700 HalsteadS. B.DansL. F. (2019)." exact="Dengue" post="infection and advances in dengue vaccines for children.Lancet Child"/>
   <result pre="Hyg.32154â€&quot;156. 10.4269/ajtmh.1983.32.1546824120 HasanS. S.MillerA.SapparapuG.FernandezE.KloseT.LongF.et al. (2017). A human antibody against" exact="Zika" post="virus crosslinks the E protein to prevent infection.Nat. Commun.8:14722."/>
   <result pre="E.DiPaoloR. J.BrienJ. D.PintoA. K. (2018). CD4+T cells mediate protection against" exact="Zika" post="associated severe disease in a mouse model of infection.PLoS"/>
   <result pre="(2017). CD8(+) T Cell Immune Response in Immunocompetent Mice during" exact="Zika" post="Virus Infection.J. Virol.91e900â€&quot;e917. 10.1128/JVI.00900-1728835502 JessieK.FongM. Y.DeviS.LamS. K.WongK. T. (2004)."/>
   <result pre="Transcriptome profiling reveals Pro-Inflammatory cytokines and matrix metalloproteinase activation in" exact="Zika" post="Virus infected human umbilical vein endothelial cells.Front. Pharmacol.10:642. 10.3389/fphar.2019.0064231249527"/>
   <result pre="cells.Front. Pharmacol.10:642. 10.3389/fphar.2019.0064231249527 KhaiboullinaS. F.RibeiroF. M.UppalT.MartynovaE. V.RizvanovA. A.VermaS. C. (2019)." exact="Zika" post="virus transmission through blood tissue barriers.Front. Microbiol.10:1465. 10.3389/fmicb.2019.0146531333605 KirkpatrickB."/>
   <result pre="in duchenne muscular dystrophy patients.Cell Immunol.342:103780. 10.1016/j.cellimm.2018.03.00429571923 LiC.XuD.YeQ.HongS.JiangY.LiuX.et al. (2016)." exact="Zika" post="virus disrupts neural progenitor development and leads to microcephaly"/>
   <result pre="and function of human monoclonal antibodies contribute to enhancement of" exact="Zika" post="virus infectivity in vitro.Sci. China Life Sci.601396â€&quot;1398. 10.1007/s11427-017-9192-029134418 LiM.ZhaoL.ZhangC.WangX.HongW.SunJ.et"/>
   <result pre="infectivity in vitro.Sci. China Life Sci.601396â€&quot;1398. 10.1007/s11427-017-9192-029134418 LiM.ZhaoL.ZhangC.WangX.HongW.SunJ.et al. (2018)." exact="Dengue" post="immune sera enhance Zika virus infection in human peripheral"/>
   <result pre="Life Sci.601396â€&quot;1398. 10.1007/s11427-017-9192-029134418 LiM.ZhaoL.ZhangC.WangX.HongW.SunJ.et al. (2018). Dengue immune sera enhance" exact="Zika" post="virus infection in human peripheral blood monocytes through Fc"/>
   <result pre="monocytes through Fc gamma receptors.PLoS One13:e0200478. 10.1371/journal.pone.020047830044839 LiangH.YangR.LiuZ.LiM.LiuH.JinX. (2018). Recombinant" exact="Zika" post="virus envelope protein elicited protective immunity against Zika virus"/>
   <result pre="(2018). Recombinant Zika virus envelope protein elicited protective immunity against" exact="Zika" post="virus in immunocompetent mice.PLoS One13:e0194860. 10.1371/journal.pone.019486029590178 LimM. Q.KumaranE. A."/>
   <result pre="function of dengue capsid and NS3-specific memory T Cells Toward" exact="Zika" post="Virus.Front. Immunol.9:2225. 10.3389/fimmu.2018.0222530327651 Limon-FloresA. Y.Perez-TapiaM.Estrada-GarciaI.VaughanG.Escobar-GutierrezA.Calderon-AmadorJ.et al. (2005). Dengue virus"/>
   <result pre="Cells Toward Zika Virus.Front. Immunol.9:2225. 10.3389/fimmu.2018.0222530327651 Limon-FloresA. Y.Perez-TapiaM.Estrada-GarciaI.VaughanG.Escobar-GutierrezA.Calderon-AmadorJ.et al. (2005)." exact="Dengue" post="virus inoculation to human skin explants: an effective approach"/>
   <result pre="transgenic mice.PLoS One12:e0184207. 10.1371/journal.pone.018420728863168 LiuY.LiuJ.DuS.ShanC.NieK.ZhangR.et al. (2017). Evolutionary enhancement of" exact="Zika" post="virus infectivity in Aedes aegypti mosquitoes.Nature545482â€&quot;486. 10.1038/nature2236528514450 LiuI. J.ChiuC."/>
   <result pre="T. (2016). AXL-Mediated Productive Infection of Human Endothelial Cells by" exact="Zika" post="Virus.Circ. Res.1191183â€&quot;1189. 10.1161/CIRCRESAHA.116.30986627650556 LokS. M.KostyuchenkoV.NybakkenG. E.HoldawayH. A.BattistiA. J.Sukupolvi-PettyS.et al."/>
   <result pre="of surface glycoproteins.Nat. Struct. Mol. Biol.15312â€&quot;317. 10.1038/nsmb.138218264114 MaW.LiS.MaS.JiaL.ZhangF.ZhangY.et al. (2016)." exact="Zika" post="virus causes testis damage and leads to male infertility"/>
   <result pre="(2004). Emerging flaviviruses: the spread and resurgence of Japanese encephalitis," exact="West Nile" post="and dengue viruses.Nat. Med.10(Suppl.), S98â€&quot;S109. 10.1038/nm114415577938 ManoffS. B.SausserM.Falk RussellA.MartinJ.RadleyD.HyattD.et"/>
   <result pre="in flavivirus-naive adults.Hum. Vaccin Immunother.152195â€&quot;2204. 10.1080/21645515.2018.154652330427741 MansuyJ. M.DutertreM.MengelleC.FourcadeC.MarchouB.DelobelP.et al. (2016)." exact="Zika" post="virus: high infectious viral load in semen, a new"/>
   <result pre="(1999). Infection of primary cultures of human Kupffer cells by" exact="Dengue" post="virus: no viral progeny synthesis, but cytokine production is"/>
   <result pre="RamosA. M.DaviH. P.IgleziasS. D.KanamuraC. T.et al. (2016). Pathology of congenital" exact="Zika" post="syndrome in Brazil: a case series.Lancet388898â€&quot;904. 10.1016/S0140-6736(16)30883-227372395 McCrackenM. K.GromowskiG."/>
   <result pre="La BarreraR.et al. (2017). Impact of prior flavivirus immunity on" exact="Zika" post="virus infection in rhesus macaques.PLoS Pathog.13:e1006487. 10.1371/journal.ppat.100648728771605 McGeeC. E.TsetsarkinK.VanlandinghamD."/>
   <result pre="MetzS. W.ThomasA.BrackbillA.ForsbergJ.MileyM. J.LopezC. A.et al. (2019). Oligomeric state of the" exact="ZIKV" post="E protein defines protective immune responses.Nat. Commun.10:4606. 10.1038/s41467-019-12677-631601808 MichlmayrD.AndradeP.GonzalezK.BalmasedaA.HarrisE."/>
   <result pre="10.1038/s41467-019-12677-631601808 MichlmayrD.AndradeP.GonzalezK.BalmasedaA.HarrisE. (2017). CD14(+)CD16(+) monocytes are the main target of" exact="Zika" post="virus infection in peripheral blood mononuclear cells in a"/>
   <result pre="paediatric study in Nicaragua.Nat. Microbiol.21462â€&quot;1470. 10.1038/s41564-017-0035-028970482 MinerJ. J.DiamondM. S. (2017)." exact="Zika" post="virus pathogenesis and tissue tropism.Cell Host Microbe21134â€&quot;142. 10.1016/j.chom.2017.01.00428182948 MitragotriS."/>
   <result pre="liquid jet injectors.Nat. Rev. Drug Discov.5543â€&quot;548. 10.1038/nrd207616816837 MlakarJ.KorvaM.TulN.PopovicM.Poljsak-PrijateljM.MrazJ.et al. (2016)." exact="Zika" post="virus associated with microcephaly.N. Engl. J. Med374951â€&quot;958. 10.1056/NEJMoa160065126862926 ModhiranN.WattersonD.MullerD."/>
   <result pre="Engl. J. Med374951â€&quot;958. 10.1056/NEJMoa160065126862926 ModhiranN.WattersonD.MullerD. A.PanettaA. K.SesterD. P.LiuL.et al. (2015)." exact="Dengue" post="virus NS1 protein activates cells via Toll-like receptor 4"/>
   <result pre="and immunogenicity results from three trials of a purified inactivated" exact="Zika" post="virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical"/>
   <result pre="randomised, double-blind, placebo-controlled clinical trials.Lancet391563â€&quot;571. 10.1016/S0140-6736(17)33106-929217375 MussoD.BossinH.MalletH. P.BesnardM.BroultJ.BaudouinL.et al. (2018)." exact="Zika" post="virus in French Polynesia 2013-14: anatomy of a completed"/>
   <result pre="the maternal-fetal interface.Science3361317â€&quot;1321. 10.1126/science.122003022679098 NettoE. M.Moreira-SotoA.PedrosoC.HoserC.FunkS.KucharskiA. J.et al. (2017). High" exact="Zika" post="virus seroprevalence in salvador, northeastern brazil limits the potential"/>
   <result pre="Disease.Bull. Hist Med.90193â€&quot;221. 10.1353/bhm.2016.004127374846 PantojaP.Perez-GuzmanE. X.RodriguezI. V.WhiteL. J.GonzalezO.SerranoC.et al. (2017)." exact="Zika" post="virus pathogenesis in rhesus macaques is unaffected by pre-existing"/>
   <result pre="P.MeurenL. M.CoelhoS. V. A.LucasC. G. O.MustafaY. M.Lemos MatassoliF.et al. (2017)." exact="Zika" post="Virus infects, activates, and crosses brain microvascular endothelial cells,"/>
   <result pre="al. (2007). The stoichiometry of antibody-mediated neutralization and enhancement of" exact="West Nile" post="virus infection.Cell Host Microbe1135â€&quot;145. 10.1016/j.chom.2007.03.00218005691 PorterK. R.EwingD.ChenL.WuS. J.HayesC. G.FerrariM.et"/>
   <result pre="10.1016/j.vaccine.2011.10.08522085548 PrasadV. M.MillerA. S.KloseT.SirohiD.BudaG.JiangW.et al. (2017). Structure of the immature" exact="Zika" post="virus at 9 A resolution.Nat. Struct. Mol. Biol.24184â€&quot;186. 10.1038/nsmb.335228067914"/>
   <result pre="A resolution.Nat. Struct. Mol. Biol.24184â€&quot;186. 10.1038/nsmb.335228067914 PrisantN.BujanL.BenichouH.HayotP. H.PaviliL.LurelS.et al. (2016)." exact="Zika" post="virus in the female genital tract.Lancet Infect Dis.161000â€&quot;1001. 10.1016/S1473-3099(16)30193-1"/>
   <result pre="10.1016/j.celrep.2019.01.03630726741 QianX.NguyenH. N.JacobF.SongH.MingG. L. (2017). Using brain organoids to understand" exact="Zika" post="virus-induced microcephaly.Development144952â€&quot;957. 10.1242/dev.14070728292840 QuickeK. M.BowenJ. R.JohnsonE. L.McDonaldC. E.MaH.Oâ€™NealJ. T.et"/>
   <result pre="microcephaly.Development144952â€&quot;957. 10.1242/dev.14070728292840 QuickeK. M.BowenJ. R.JohnsonE. L.McDonaldC. E.MaH.Oâ€™NealJ. T.et al. (2016)." exact="Zika" post="Virus Infects Human Placental Macrophages.Cell Host Microbe2083â€&quot;90. 10.1016/j.chom.2016.05.01527247001 Regla-NavaJ."/>
   <result pre="Regla-NavaJ. A.Elong NgonoA.ViramontesK. M.HuynhA. T.WangY. T.NguyenA. T.et al. (2018). Cross-reactive" exact="Dengue" post="virus-specific CD8(+) T cells protect against Zika virus during"/>
   <result pre="al. (2018). Cross-reactive Dengue virus-specific CD8(+) T cells protect against" exact="Zika" post="virus during pregnancy.Nat. Commun.9:3042. 10.1038/s41467-018-05458-030072692 RichnerJ. M.HimansuS.DowdK. A.ButlerS. L.SalazarV.FoxJ."/>
   <result pre="A.ButlerS. L.SalazarV.FoxJ. M.et al. (2017a). Modified mRNA vaccines protect against" exact="Zika" post="Virus Infection.Cell169:176. 10.1016/j.cell.2017.03.01628340344 RichnerJ. M.JaggerB. W.ShanC.FontesC. R.DowdK. A.CaoB.et al."/>
   <result pre="M.JaggerB. W.ShanC.FontesC. R.DowdK. A.CaoB.et al. (2017b). Vaccine mediated protection against" exact="Zika" post="virus-induced congenital disease.Cell170273.e12â€&quot;283.e12. 10.1016/j.cell.2017.06.04028708997 RivinoL.TanA. T.ChiaA.KumaranE. A.GrotenbregG. M.MacAryP. A.et"/>
   <result pre="S.SacramentoG. A.et al. (2019). Impact of preexisting dengue immunity on" exact="Zika" post="virus emergence in a dengue endemic region.Science363607â€&quot;610. 10.1126/science.aav661830733412 RothmanA."/>
   <result pre="is hierarchical.Mol. Immunol.113115â€&quot;119. 10.1016/j.molimm.2018.08.01130146122 Sanchez-San MartinC.LiT.BouquetJ.StreithorstJ.YuG.ParanjpeA.et al. (2018). Differentiation enhances" exact="Zika" post="virus infection of neuronal brain cells.Sci. Rep.8:14543. 10.1038/s41598-018-32400-730266962 SangkawibhaN.RojanasuphotS.AhandrikS.ViriyapongseS.JatanasenS.SalitulV.et"/>
   <result pre="10.1093/oxfordjournals.aje.a1139326496446 SapparapuG.FernandezE.KoseN.BinC.FoxJ. M.BombardiR. G.et al. (2016). Neutralizing human antibodies prevent" exact="Zika" post="virus replication and fetal disease in mice.Nature540443â€&quot;447. 10.1038/nature2056427819683 ShanC.MuruatoA."/>
   <result pre="D.MedeirosD. B. A.et al. (2017). A single-dose live-attenuated vaccine prevents" exact="Zika" post="virus pregnancy transmission and testis damage.Nat. Commun.8:676. 10.1038/s41467-017-00737-828939807 ShanC.XieX.LuoH.MuruatoA."/>
   <result pre="ShanC.XieX.LuoH.MuruatoA. E.LiuY.WakamiyaM.et al. (2019). Maternal vaccination and protective immunity against" exact="Zika" post="virus vertical transmission.Nat. Commun.10:5677. 10.1038/s41467-019-13589-131831806 SharmaM.GlasnerD. R.WatkinsH.Puerta-GuardoH.KassaY.EganM. A.et al."/>
   <result pre="G.et al. (2016). The 3.8 A resolution cryo-EM structure of" exact="Zika" post="virus.Science352467â€&quot;470. 10.1126/science.aaf531627033547 Slon-CamposJ. L.DejnirattisaiW.JaggerB. W.Lopez-CamachoC.WongwiwatW.DurnellL. A.et al. (2019). A"/>
   <result pre="virus.Science352467â€&quot;470. 10.1126/science.aaf531627033547 Slon-CamposJ. L.DejnirattisaiW.JaggerB. W.Lopez-CamachoC.WongwiwatW.DurnellL. A.et al. (2019). A protective" exact="Zika" post="virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement"/>
   <result pre="antibody-dependent enhancement of dengue infection.Nat. Immunol.201291â€&quot;1298. 10.1038/s41590-019-0477-z31477918 SpiteriG.SudreB.SeptfonsA.BeauteJ.collab: The European," exact="Zika" post="Surveillanceet al. (2017). Surveillance of Zika virus infection in"/>
   <result pre="10.1038/s41590-019-0477-z31477918 SpiteriG.SudreB.SeptfonsA.BeauteJ.collab: The European, Zika Surveillanceet al. (2017). Surveillance of" exact="Zika" post="virus infection in the EU/EEA, June 2015 to January"/>
   <result pre="al. (2016). Specificity, cross-reactivity, and function of antibodies elicited by" exact="Zika" post="virus infection.Science353823â€&quot;826. 10.1126/science.aaf850527417494 SunJ.LiM.WangY.HaoP.JinX. (2017). Elaboration of tetravalent antibody"/>
   <result pre="envelope sequence.Vaccine356308â€&quot;6320. 10.1016/j.vaccine.2017.09.06328987441 SzabaF. M.TigheM.KummerL. W.LanzerK. G.WardJ. M.LanthierP.et al. (2018)." exact="Zika" post="virus infection in immunocompetent pregnant mice causes fetal damage"/>
   <result pre="Pathog.14:e1006994. 10.1371/journal.ppat.100699429634758 TamhankarM.PattersonJ. L. (2019). Directional entry and release of" exact="Zika" post="virus from polarized epithelial cells.Virol. J.16:99. 10.1186/s12985-019-1200-231395061 TebasP.RobertsC. C.MuthumaniK.ReuschelE."/>
   <result pre="dengue vaccines.Vaccine363411â€&quot;3417. 10.1016/j.vaccine.2018.02.06229525283 VermillionM. S.LeiJ.ShabiY.BaxterV. K.CrillyN. P.McLaneM.et al. (2017). Intrauterine" exact="Zika" post="virus infection of pregnant immunocompetent mice models transplacental transmission"/>
   <result pre="mice.Front. Microbiol.10:1113. 10.3389/fmicb.2019.0111331134046 WeaverS. C.CostaF.Garcia-BlancoM. A.KoA. I.RibeiroG. S.SaadeG.et al. (2016)." exact="Zika" post="virus: History, emergence, biology, and prospects for control.Antiviral. Res.13069â€&quot;80."/>
   <result pre="infection.J. Virol.8811383â€&quot;11394. 10.1128/JVI.01108-1425056881 WenJ.Elong NgonoA.Regla-NavaJ. A.KimK.GormanM. J.DiamondM. S.et al. (2017a)." exact="Dengue" post="virus-reactive CD8(+) T cells mediate cross-protection against subsequent Zika"/>
   <result pre="(2017a). Dengue virus-reactive CD8(+) T cells mediate cross-protection against subsequent" exact="Zika" post="virus challenge.Nat. Commun.8:1459. 10.1038/s41467-017-01669-z29129917 WenJ.TangW. W.SheetsN.EllisonJ.SetteA.KimK.et al. (2017b). Identification"/>
   <result pre="virus challenge.Nat. Commun.8:1459. 10.1038/s41467-017-01669-z29129917 WenJ.TangW. W.SheetsN.EllisonJ.SetteA.KimK.et al. (2017b). Identification of" exact="Zika" post="virus epitopes reveals immunodominant and protective roles for dengue"/>
   <result pre="mosquitoes, mice, and rhesus monkeys.Vaccine214307â€&quot;4316. 10.1016/s0264-410x(03)00488-214505913 Wilder-SmithA.VanniceK.DurbinA.HombachJ.ThomasS. J.ThevarjanI.et al. (2018)." exact="Zika" post="vaccines and therapeutics: landscape analysis and challenges ahead.BMC Med.16:84."/>
   <result pre="Control: New Edition.Geneva: WHO. collab: World Health Organization [WHO] (2017)." exact="Dengue" post="vaccine: WHO position paper, July 2016 - recommendations.Vaccine351200â€&quot;1201. 10.1016/j.vaccine.2016.10.07028185744"/>
   <result pre="10.1073/pnas.130633311023686453 ZouJ.XieX.LuoH.ShanC.MuruatoA. E.WeaverS. C.et al. (2018). A single-dose plasmid-launched live-attenuated" exact="Zika" post="vaccine induces protective immunity.EBioMedicine3692â€&quot;102. 10.1016/j.ebiom.2018.08.05630201444"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7101119\results\search\tropicalVirus\results.xml">
   <result pre="pmid: 3204395918-1739 doi: 10.3201/eid2604.181739 : Research: Research: Comprehensive Profiling of" exact="Zika" post="Virus Risk with Natural and Artificial Mitigating Strategies, United"/>
   <result pre="Natural and Artificial Mitigating Strategies, United States Comprehensive Profiling of" exact="Zika" post="Virus Risk with Natural and Artificial Mitigating Strategies, United"/>
   <result pre="Risk with Natural and Artificial Mitigating Strategies, United States Profiling" exact="Zika" post="Virus Risk, United States MinaMichael J.1GutermanL. Beryl1AllenKristen E.OmerSaad B.[],"/>
   <result pre="St, Buffalo, NY 14203, USA; email: lberylguterman@gmail.com ppub: 2020-4264700710 Abstract" exact="Zika" post="virus is transitioning to become a long-term public health"/>
   <result pre="We developed a stochastic epidemiologic model to profile risk for" exact="Zika" post="virus emergence, including trimester-specific fetal risk across time, in"/>
   <result pre="should serve as a critical resource for resource allocation. Keywords:" exact="Zika" post="transmission control viruses United States mosquitoborne diseases vector-borne infections"/>
   <result pre="viruses United States mosquitoborne diseases vector-borne infections viruses risk profiling" exact="Zika" post="virus is a flavivirus spread by Aedes mosquitoes that"/>
   <result pre="an esoteric threat to human health (1). However, the recent" exact="Zika" post="epidemic, which erupted in South America in 2015 and"/>
   <result pre="classified a global emergency by the World Health Organization (WHO)," exact="Zika" post="virus emergence and transmission continues globally, and WHO warns"/>
   <result pre="virus emergence and transmission continues globally, and WHO warns that" exact="Zika" post="virus is set to remain as a long-term public"/>
   <result pre="public health challenge (3). Given the critical importance of preventing" exact="Zika" post="virus infections, especially during pregnancy, transmission anywhere requires that"/>
   <result pre="entirely susceptible populations. Numerous models for the potential emergence of" exact="Zika" post="virus in the United States focus largely on the"/>
   <result pre="the year are more limited. Here we present a stochastic" exact="Zika" post="virus compartment model that considers the overlap of vector"/>
   <result pre="Rico. The model was used to profile the risk for" exact="Zika" post="virus transmission, assuming an initial introduction into each county,"/>
   <result pre="under varying control measures. We tested 3 approaches to controlling" exact="Zika" post="virus transmission and assessed their utility in preventing or"/>
   <result pre="virus transmission and assessed their utility in preventing or abrogating" exact="Zika" post="virus transmission. These approaches include reducing humanâ€&quot;vector contact (i.e.,"/>
   <result pre="once herd-immunity thresholds are achieved (11). Methods We modeled county-level" exact="Zika" post="virus transmission using a coupled 2-system stochastic humanâ€&quot;mosquito differential"/>
   <result pre="(12) describing the ecologic extent of the major vectors of" exact="Zika" post="virus, Ae. aegypti and Ae. albopictus mosquitoes, with dynamic"/>
   <result pre="virus, Ae. aegypti and Ae. albopictus mosquitoes, with dynamic temperature-dependent" exact="Zika" post="virus and Aedes life-stage models, local climate data, and"/>
   <result pre="information, including population and monthly birth cohort data. We simulated" exact="Zika" post="virus transmission given a single importation (index case) into"/>
   <result pre="fitting nonlinear models to county-level monthly birth data, trimester-specific fetal" exact="Zika" post="virus exposures. To remain relevant to local, state, and"/>
   <result pre="Table 1; Appendix Figure 1). Given the novelty of the" exact="Zika" post="virus as a major human pathogen, relatively limited information"/>
   <result pre="flavivirus that shares the same mosquito vector host system as" exact="Zika" post="virus. Such a strategy is commonly used in modeling"/>
   <result pre="is commonly used in modeling for emerging pathogens, including other" exact="Zika" post="virus transmission models (7,14). Trimester-Specific Pregnancies and Exposure Calculations"/>
   <result pre="transmission models (7,14). Trimester-Specific Pregnancies and Exposure Calculations Infection with" exact="Zika" post="virus is most concerning during pregnancy, where maternal infection"/>
   <result pre="(15). These defects appear to be most strongly associated with" exact="Zika" post="virus infection during the first and second trimesters (16,17)."/>
   <result pre="reported or published estimated incidence and case counts for known" exact="Zika" post="that have arisen from local transmission in the United"/>
   <result pre="against the respective simulated data. In addition, given similarities between" exact="Zika" post="virus and dengue virus, such as common transmission vectors"/>
   <result pre="used 2 resources to derive estimates of monthly and cumulative" exact="Zika" post="virus incidence across Puerto Ricoâ€™s 8 health regions. Official"/>
   <result pre="validation (Appendix). Results Across the United States, when an infectious" exact="Zika" post="virusâ€&quot;infected person was introduced during peak Aedes abundance for"/>
   <result pre="(Figure 1, panel A; Appendix Figures 4â€&quot;6). Figure 1 County-level" exact="Zika" post="virus risk profiling, United States including Puerto Rico. A)"/>
   <result pre="duration of outbreaks. Shown is the median monthly incidence of" exact="Zika" post="virus infections from August index cases. E) Total number"/>
   <result pre="F; Appendix Figure 13). These findings are consistent with previous" exact="Zika" post="epidemics among island populations, where seropositivity reached 50%â€&quot;70% (24,25)."/>
   <result pre="and 3% sustained through the second and third winters, respectively." exact="Zika" post="Virus Infections during Pregnancy We found that natural seasonality"/>
   <result pre="of first- and second-trimester pregnancies that are out-of-phase with peak" exact="Zika" post="virus infections in the model (Figure 2, panel A)"/>
   <result pre="Our model indicates that birth seasonality alone reduced risk for" exact="Zika" post="virus exposure during first- (versus second- and third-) trimester"/>
   <result pre="risk 0.89 [95% CI 0.80â€&quot;0.99]; p = 0.012). Figure 2" exact="Zika" post="virus infections during pregnancy and effects of natural birth"/>
   <result pre="States and Texas are plotted against the simulated and standardized" exact="Zika" post="epidemic curves for each county and for every month"/>
   <result pre="generalized additive model fit to the county-level data. B, C)" exact="Zika" post="virus exposure risk ratio and 95% CI during (B)"/>
   <result pre="to the baseline incidence (Figure 3, panel C). Figure 3" exact="Zika" post="prevention and control strategies, United States. For each county"/>
   <result pre="panels Gâ€&quot;I). This finding is consistent with an R0 for" exact="Zika" post="virus of 3â€&quot;4, based on the simple but robust"/>
   <result pre="estimates (26,27). Model Validation We validated the model against known" exact="Zika" post="outbreaks in the United States including Puerto Rico since"/>
   <result pre="0.980; p&amp;lt;0.001; Figure 4, panel A). In Miami-Dade County, where" exact="Zika" post="virus transmitted locally in 2016, the model estimated a"/>
   <result pre="reported by CDC (20,28,29). In Brownsville County, Texas, where local" exact="Zika" post="virus transmission was detected during Octoberâ€&quot;December 2016 and infected"/>
   <result pre="of 4 cases (IQR 1â€&quot;8). Figure 4 Model validation for" exact="Zika" post="virus infection cases reported or estimated and simulated for"/>
   <result pre="addition, these counties might serve as optimal US settings for" exact="Zika" post="vaccine efficacy trials. Zika outbreaks are likely to be"/>
   <result pre="serve as optimal US settings for Zika vaccine efficacy trials." exact="Zika" post="outbreaks are likely to be highly restricted by both"/>
   <result pre="uninterrupted transmission. These findings are also consistent with CDCâ€™s reported" exact="Zika" post="virus disease trends among travelers for 2016 and 2017,"/>
   <result pre="addition, planned seasonal conception (based on birth seasonality and local" exact="Zika" post="virus transmission data) is a viable intervention to pursue"/>
   <result pre="transmission data) is a viable intervention to pursue while maternal" exact="Zika" post="virus vaccine and risk profiles, as they relate to"/>
   <result pre="in 2016. Previous estimates by Ellington et al. (29) using" exact="Zika" post="case data projected that â‰ˆ7,800 exposures in pregnancy would"/>
   <result pre="the proposed model might influence county level risk profiles for" exact="Zika" post="virus transmission. For areas with a high level of"/>
   <result pre="For areas with a high level of travel-associated imports of" exact="Zika" post="virus cases, such as cities with cruise ship ports"/>
   <result pre="certain parameters (e.g., incubation period and period of infectiousness of" exact="Zika" post="virus infection) and transmission pathways (e.g., sexual transmission of"/>
   <result pre="Zika virus infection) and transmission pathways (e.g., sexual transmission of" exact="Zika" post="virus) are not fully understood and might contribute to"/>
   <result pre="not fully understood and might contribute to elevated risk for" exact="Zika" post="epidemics (36,37). Zika virus transmission is expected to persist"/>
   <result pre="and might contribute to elevated risk for Zika epidemics (36,37)." exact="Zika" post="virus transmission is expected to persist as a long-term"/>
   <result pre="entirely susceptible population, with risk for transmission. As long as" exact="Zika" post="virus circulates anywhere, the continued importation into the United"/>
   <result pre="local, state, and national resources aimed at preventing and controlling" exact="Zika" post="virus transmission and should provide critical information to inform"/>
   <result pre="future vaccination efforts. Appendix Additional information about comprehensive profiling of" exact="Zika" post="virus risk with natural and artificial mitigating strategies, United"/>
   <result pre="MJ, Guterman LB, Allen KE, Omer SB. Comprehensive profiling of" exact="Zika" post="virus risk with natural and artificial mitigating strategies, United"/>
   <result pre="develop and implement vaccine programs. References References 1. FauciAS, MorensDM." exact="Zika" post="virus in the Americasâ€&quot;yet another arbovirus threat.N Engl J"/>
   <result pre="J Med. 2016;374:601â€&quot;4. 10.1056/NEJMp160029726761185 2. JohanssonMA, Mier-y-Teran-RomeroL, ReefhuisJ, GilboaSM, HillsSL." exact="Zika" post="and the risk of microcephaly.N Engl J Med. 2016;375:1â€&quot;4."/>
   <result pre="2016;375:1â€&quot;4. 10.1056/NEJMp160536727222919 3. collab: World Health Organization. WHO response to" exact="Zika" post="virus [cited 2017 Feb 7]. http://www.who.int/emergencies/zika-virus 4. RasmussenSA, JamiesonDJ,"/>
   <result pre="[cited 2017 Feb 7]. http://www.who.int/emergencies/zika-virus 4. RasmussenSA, JamiesonDJ, HoneinMA, PetersenLR." exact="Zika" post="virus and birth defectsâ€&quot;reviewing the evidence for causality.N Engl"/>
   <result pre="MajorCG, MayshackM, MedinaN, MatosD, RyffKR, et al.Guillain-BarrÃ© syndrome during ongoing" exact="Zika" post="virus transmissionâ€&quot;Puerto Rico, January 1â€&quot;July 31, 2016.MMWR Morb Mortal"/>
   <result pre="BradyOJ, PigottDM, ShearerFM, WeissDJ, et al.Mapping global environmental suitability for" exact="Zika" post="virus.eLife. 2016;5:e15272. 10.7554/eLife.1527227090089 7. BogochII, BradyOJ, KraemerMUG, GermanM, CreatoreMI,"/>
   <result pre="KraemerMUG, GermanM, CreatoreMI, KulkarniMA, et al.Anticipating the international spread of" exact="Zika" post="virus from Brazil.Lancet. 2016;387:335â€&quot;6. 10.1016/S0140-6736(16)00080-526777915 8. collab: Centers for"/>
   <result pre="Pastore-PionttiA, ChinazziM, MistryD, DeanNE, et al.Quantifying the risk of local" exact="Zika" post="virus transmission in the contiguous US during the 2015-2016"/>
   <result pre="Zika virus transmission in the contiguous US during the 2015-2016" exact="ZIKV" post="epidemic.BMC Med. 2018;16:195. 10.1186/s12916-018-1185-530336778 10. CastroLA, FoxSJ, ChenX, LiuK,"/>
   <result pre="10. CastroLA, FoxSJ, ChenX, LiuK, BellanSE, DimitrovNB, et al.Assessing real-time" exact="Zika" post="risk in the United States.BMC Infect Dis. 2017;17:284. 10.1186/s12879-017-2394-928468671"/>
   <result pre="10.1063/1.274529917581038 14. PerkinsTA, SirajAS, RuktanonchaiCW, KraemerMUG, TatemAJ. Model-based projections of" exact="Zika" post="virus infections in childbearing women in the Americas.Nat Microbiol."/>
   <result pre="10.1038/nmicrobiol.2016.12627562260 15. PachecoO, BeltrÃ¡nM, NelsonCA, ValenciaD, TolosaN, FarrSL, et al." exact="Zika" post="virus disease in Colombiaâ€&quot;preliminary report. N Engl J Med."/>
   <result pre="JaenischT, RosenbergerKD, BritoC, BradyO, BrasilP, MarquesET. Risk of microcephaly after" exact="Zika" post="virus infection in Brazil, 2015 to 2016.Bull World Health"/>
   <result pre="Health Organ. 2017;95:191â€&quot;8. 10.2471/BLT.16.17860828250532 17. GÃ©rardinP, Cao-LormeauV-M, MussoD, DesprÃ¨sP, BesnardM." exact="Zika" post="rash and increased risk of congenital brain abnormalities.Lancet. 2017;389:151â€&quot;2."/>
   <result pre="AlamriYS, RabhanFS, AlabdullahAA, AlsanieNA, AlmarshadFA, et al.Overview of dengue and" exact="Zika" post="virus similarity, what can we learn from the Saudi"/>
   <result pre="Health Sci (Qassim). 2018;12:77â€&quot;82.29623022 19. McNeilDG, FernandezM. Local transmission of" exact="Zika" post="virus is reported in Texas. The New York Times."/>
   <result pre="2017 Apr 28]. https://www.nytimes.com/2016/11/28/health/zika-case-texas.html 20. collab: Florida Department of Health." exact="Zika" post="virus [cited2017 Apr 28]. http://www.floridahealth.gov/diseases-and-conditions/zika-virus 21. RadkeEG, GregoryCJ, KintzigerKW,"/>
   <result pre="West, Florida, USA, 2009.Emerg Infect Dis. 2012;18:135â€&quot;7. 10.3201/eid1801.11013022257471 22. ReyJR." exact="Dengue" post="in Florida (USA).Insects. 2014;5:991â€&quot;1000. 10.3390/insects504099126462955 23. ChevalierMS, BiggerstaffBJ, BasavarajuSV,"/>
   <result pre="Climent-PerisC, et al.Use of blood donor screening data to estimate" exact="Zika" post="virus incidence, Puerto Rico, Aprilâ€&quot;August 2016.Emerg Infect Dis. 2017;23:790â€&quot;5."/>
   <result pre="24. CauchemezS, BesnardM, BompardP, DubT, Guillemette-ArturP, Eyrolle-GuignotD, et al.Association between" exact="Zika" post="virus and microcephaly in French Polynesia, 2013-15: a retrospective"/>
   <result pre="MubayiA, Romero-VivasCME. Estimate of the reproduction number of the 2015" exact="Zika" post="virus outbreak in Barranquilla, Colombia, and estimation of the"/>
   <result pre="FergusonNM, CucunubÃ¡ZM, DorigattiI, Nedjati-GilaniGL, DonnellyCA, BasÃ¡Ã±ezM-G, et al.EPIDEMIOLOGY. Countering the" exact="Zika" post="epidemic in Latin America.Science. 2016;353:353â€&quot;4. 10.1126/science.aag021927417493 28. collab: Puerto"/>
   <result pre="Puerto Rico Department of Health. Weekly report on arboviral diseases," exact="Zika" post="report by municipalities [in Spanish] [cited 2016 Dec 19]."/>
   <result pre="Perez-PadillaJ, et al.Estimating the number of pregnant women infected with" exact="Zika" post="virus and expected infants with microcephaly following the Zika"/>
   <result pre="with Zika virus and expected infants with microcephaly following the" exact="Zika" post="virus outbreak in Puerto Rico, 2016.JAMA Pediatr. 2016;170:940â€&quot;5. 10.1001/jamapediatrics.2016.297427544075"/>
   <result pre="32. HallV, WalkerWL, LindseyNP, LehmanJA, KolsinJ, LandryK, et al.Update: noncongenital" exact="Zika" post="virus disease casesâ€&quot;50 U.S. States and the District of"/>
   <result pre="2018;67:265â€&quot;9. 10.15585/mmwr.mm6709a129518067 33. HayJA, NouvelletP, DonnellyCA, RileyS. Potential inconsistencies in" exact="Zika" post="surveillance data and our understanding of risk during pregnancy.PLoS"/>
   <result pre="during pregnancy.PLoS Negl Trop Dis. 2018;12:e0006991. 10.1371/journal.pntd.000699130532143 34. MartinezME. Preventing" exact="Zika" post="virus infection during pregnancy using a seasonal window of"/>
   <result pre="DudasG, TanAL, GangavarapuK, et al.Genomic epidemiology reveals multiple introductions of" exact="Zika" post="virus into the United States.Nature. 2017;546:401â€&quot;5. 10.1038/nature2240028538723 36. LesslerJ,"/>
   <result pre="CarcelenAC, KonikoffJM, WilliamsonJ, BiQ, et al.Times to key events in" exact="Zika" post="virus infection and implications for blood donation: a systematic"/>
   <result pre="CounotteMJ, KimCR, WangJ, BernsteinK, DealCD, BroutetNJN, et al.Sexual transmission of" exact="Zika" post="virus and other flaviviruses: A living systematic review.PLoS Med."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7101124\results\search\tropicalVirus\results.xml">
   <result pre="Letter: Research Letter: Detection of Rocio Virus SPH 34675 during" exact="Dengue" post="Epidemics, Brazil, 2011â€&quot;2013 Detection of Rocio Virus SPH 34675"/>
   <result pre="Epidemics, Brazil, 2011â€&quot;2013 Detection of Rocio Virus SPH 34675 during" exact="Dengue" post="Epidemics, Brazil, 2011â€&quot;2013 Detection of Rocio Virus SPH 34675"/>
   <result pre="Epidemics, Brazil, 2011â€&quot;2013 Detection of Rocio Virus SPH 34675 during" exact="Dengue" post="Epidemics, Brazil, 2011â€&quot;2013 SaivishMarielena V.da CostaVivaldo G.RodriguesRoger L.FÃ©resValÃ©ria C.R.Montoya-DiazEduardoMoreliMarcos"/>
   <result pre="infection. During the outbreak, the city reported â‰ˆ88,000 cases of" exact="DENV" post="infection (6). Of the 647 samples screened for DENV"/>
   <result pre="of DENV infection (6). Of the 647 samples screened for" exact="DENV" post="by use of serologic and molecular methods, 121 were"/>
   <result pre="encephalitis virus; TBEV, tick-borne encephalitis virus; USUV, Usutu virus; WNV," exact="West Nile" post="virus; YFV, yellow fever virus; ZIKV, Zika virus. The"/>
   <result pre="virus; WNV, West Nile virus; YFV, yellow fever virus; ZIKV," exact="Zika" post="virus. The 2 ROCV-positive samples were from a 33-year-old"/>
   <result pre="KeaseySL, PughCL, JensenSMR, SmithJL, HontzRD, DurbinAP, et al.Antibody responses to" exact="Zika" post="virus infections in environments of flavivirus endemicity.Clin Vaccine Immunol."/>
   <result pre="JulianoR, VelezJ, NogueiraRMR, KomarN. Serological evidence of widespread circulation of" exact="West Nile" post="virus and other flaviviruses in equines of the Pantanal,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7102540\results\search\tropicalVirus\results.xml">
   <result pre="single molecules of RNA or DNA [46]. It can detect" exact="Dengue" post="or Zika virus single-stranded RNA as well as mutations"/>
   <result pre="of RNA or DNA [46]. It can detect Dengue or" exact="Zika" post="virus single-stranded RNA as well as mutations in patient"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7102556\results\search\tropicalVirus\results.xml">
   <result pre="in clinical samples [23]. The method can detect hCoVs, and" exact="Zika" post="and Ebola viruses. The last one, the paper-based colorimetric"/>
   <result pre="peptide nucleic acid-induced AgNPs aggregation for detecting MERS-CoV, MTB, and" exact="HPV" post="OligonucleotidesAnal Chem891020175428543528394582 25RajV.S.MouH.SmitsS.L.DekkersD.H.MullerM.A.DijkmanR.Dipeptidyl peptidase 4 is a functional receptor"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7102570\results\search\tropicalVirus\results.xml">
   <result pre="in Patients With Severe InfluenzaNCT03394209https://clinicaltrials.gov/ct2/show/NCT033942092018 Cardona-OspinaJ.A.Henao-SanMartinV.Paniz-MondolfiA.E.Rodriguez-MoralesA.J.Mortality and fatality due to" exact="Chikungunya" post="virus infection in ColombiaJournal of Clinical Virology702015141526305812 CarolineA.L.PowellD.S.BethelL.M.OuryT.D.ReedD.S.HartmanA.L.Broad spectrum"/>
   <result pre="treatment of argentine hemorrhagic feverAntiviral Research23199423318141590 Escribano-RomeroE.JimÃ©nez de OyaN.DomingoE.SaizJ.C.Extinction of" exact="West Nile" post="virus by favipiravir through lethal mutagenesisAntimicrobial Agents and Chemotherapy61112017"/>
   <result pre="virusIntervirology2919883013102852653 MorreyJ.D.TaroB.S.SiddharthanV.WangH.SmeeD.F.ChristensenA.J.FurutaY.Efficacy of orally administered T-705 pyrazine analog on lethal" exact="West Nile" post="virus infection in rodentsAntiviral Research80200837737918762216 NaesensL.GuddatL.W.KeoughD.T.van KuilenburgA.B.MeijerJ.Vande VoordeJ.BalzariniJ.Role of"/>
   <result pre="endonuclease inhibitor baloxavir marboxilScientific Reports82018963329941893 PhilpottD.C.E.NolanM.S.EvertN.MayesB.HesalroadD.FonkenE.MurrayK.O.Acute and delayed deaths after" exact="West Nile" post="virus infection, Texas, USA, 2002-2012Emerging Infectious Diseases252019256264 PomfretE.A.PomposelliJ.J.JenkinsR.L.Live donor"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7106000\results\search\tropicalVirus\results.xml">
   <result pre="by S. calcitrans may include equine infectious anaemia virus (EIAV)," exact="West Nile" post="fever virus (WNFV), Rift Valley fever virus (RVFV), lumpy"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7110270\results\search\tropicalVirus\results.xml">
   <result pre="ZhaoSMusaSSFuHHeDQinJSimple framework for real-time forecast in a data-limited situation: the" exact="Zika" post="virus (ZIKV) outbreaks in Brazil from 2015 to 2016"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7112750\results\search\tropicalVirus\results.xml">
   <result pre="countries (LMICs) Sustainable developmental goals (SDGs) Gender Women Covid-19 Ebola" exact="Zika" post="SARS Background On March 11, 2020, the World Health"/>
   <result pre="staff, issues of food security, decrease in cross-border trade. 2015," exact="Zika" post="[21] 86 countries have reported evidence of Zika Declared"/>
   <result pre="trade. 2015, Zika [21] 86 countries have reported evidence of" exact="Zika" post="Declared PHEIC on February 8, 2016 African Region, Region"/>
   <result pre="Disruption of Womenâ€™s SRHRs in LMICs and experiences from Ebola," exact="Zika" post="and Covid-19 The findings of the Guttmacherâ€&quot;Lancet Commission on"/>
   <result pre="for the CARICOMJ Family Med Prim Care20176346346710.4103/jfmpc.jfmpc_75_1729416990 21.SikkaVChattuVKPopliRKGalwankarSCKelkarDSawickiSGStawickiSPPapadimosTJThe emergence of" exact="Zika" post="virus as a global health security threat: a review"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7113926\results\search\tropicalVirus\results.xml">
   <result pre="new creations are licensed under the identical terms. Abstract Introduction:" exact="Dengue" post="fever is a common mosquito-borne viral disease which has"/>
   <result pre="Asia countries, the Caribbean, Central, and South America, and Africa." exact="Dengue" post="virus (DENV) infection is the most rapidly spreading disease"/>
   <result pre="the first dengue hemorrhagic fever occurred in Calcutta in 1963.[2]" exact="Dengue" post="is caused by one of the four serotypes of"/>
   <result pre="virus have been in circulation and documented in Tamil Nadu.[4]" exact="Dengue" post="fever is an acute febrile illness with frontal headache,"/>
   <result pre="(38.5%) Leucopenia (&amp;lt;4000/mm3) 77 (16.5%) Raised hematocrit 29 (6.2%) Discussion" exact="Dengue" post="is emerging as a major health problem and regular"/>
   <result pre="and their transfusion profileRev Bras Hematol Hemoter2014361152024790536 19ThomasEAJohnMKanishBMucocutaneous manifestations of" exact="Dengue" post="feverIndian J Dermatol201055798520418984 20RoweEKLeoYSWongJGTheinTLGanVCLeeLKChallenges in dengue fever in the"/>
   <result pre="Health2012325922668442 29AgrawalVKPrustyBSKReddyCSMohan ReddyGKAgrawalRKSekher Srinivasarao BandaruVCClinical profile and predictors of Severe" exact="Dengue" post="disease: A study from South IndiaCaspian J Intern Med2018933434030510647"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7114986\results\search\tropicalVirus\results.xml">
   <result pre="Syndrome (or MERS), Nipah and Hendra, Ebola virus disease and" exact="Zika" post="fever and others have been reported. In this chapter"/>
   <result pre="victims in Africa being children, will also be addressed. Keywords" exact="West Nile" post="Virus Yellow Fever Human Rabies ZIKV Infection Lassa Fever"/>
   <result pre="be addressed. Keywords West Nile Virus Yellow Fever Human Rabies" exact="ZIKV" post="Infection Lassa Fever Hemorrhagic Fevers The viral hemorrhagic fevers"/>
   <result pre="hemorrhagic fever Crimean-Congo hemorrhagic fever Marburg virus disease Lassa fever" exact="Yellow fever" post="Reported geographic distribution Most wide spread tick-borne viral infection"/>
   <result pre="are however, not limited to causing only one clinical syndrome." exact="West Nile" post="virus may for example cause unapparent infection in up"/>
   <result pre="of arboviruses worldwide [83, 84]. Examples include the introduction of" exact="West Nile" post="virus to North America in 1999 [85, 86], the"/>
   <result pre="Ocean Islands and the Caribbean [88], and the emergence of" exact="Zika" post="virus (ZIKV) in Latin America in 2014 [89]. Clinical"/>
   <result pre="will focus on the newly emerging ZIKV. Epidemiological Aspects of" exact="ZIKV" post="The WHO declared the ZIKV outbreak in the Americas"/>
   <result pre="emerging ZIKV. Epidemiological Aspects of ZIKV The WHO declared the" exact="ZIKV" post="outbreak in the Americas a Public Health Emergency of"/>
   <result pre="born with microcephaly and other neurological abnormalities observed [92]. The" exact="ZIKV" post="was reported for the first time following yellow fever"/>
   <result pre="the first time following yellow fever research conducted in the" exact="Zika" post="Forest of Uganda in 1947 when it was isolated"/>
   <result pre="febrile patients in Nigeria [94]. In the years to follow," exact="ZIKV" post="remained mostly a research curiosity with a handful of"/>
   <result pre="and Southeast Asia. In 2007, the first major outbreak of" exact="ZIKV" post="was reported from the Yap Islands of Micronesia where"/>
   <result pre="introduced as early as late 2014 [108â€&quot;110]. By September 2016," exact="ZIKV" post="was reported from more than 47 countries in Latin"/>
   <result pre="direct mosquito transmission is mostly implicated in transmission of the" exact="ZIKV" post="to humans, transmission in-utero, intrapartum and through sexual transmission"/>
   <result pre="exposures have also been reported [105, 134]. Clinical Aspects of" exact="ZIKV" post="Following the bite of an infected mosquito, an incubation"/>
   <result pre="some infected individuals will develop the signs and symptoms of" exact="ZIKV" post="infection [100]. An estimated 80% of humans becoming infected"/>
   <result pre="asthenia, much like dengue fever [100, 135]. Clinical diagnosis of" exact="ZIKV" post="infection is complicated due to its non-specific presentation, but"/>
   <result pre="which cause clinically indistinguishable disease in most cases. Co-infection of" exact="ZIKV" post="and dengue or chikungunya virus has also been reported"/>
   <result pre="leptospirosis, malaria and rickettsiosis [139]. Hospitalization is rarely required for" exact="ZIKV" post="infection [103, 140, 141]. The case fatality rate of"/>
   <result pre="ZIKV infection [103, 140, 141]. The case fatality rate of" exact="ZIKV" post="is considered low and probably associated with comorbidities in"/>
   <result pre="noted in such cases [100, 140, 143, 144]. Complications of" exact="ZIKV" post="Infection Neurological complications have been implicated as untoward effects"/>
   <result pre="Infection Neurological complications have been implicated as untoward effects of" exact="ZIKV" post="infection. Such neurological deficits have also been reported with"/>
   <result pre="Guillian-BarrÃ© syndrome has been reported as a rare complication of" exact="ZIKV" post="infection, although the true extent of the association and"/>
   <result pre="of brain ischemia, encephalitis and myelitis have been reported following" exact="ZIKV" post="infection [149â€&quot;152]. A place and time association was noted"/>
   <result pre="place and time association was noted with the outbreak of" exact="ZIKV" post="in Brazil and concomitant rise in number of babies"/>
   <result pre="support this hypothesis [154]. As such, current opinion is that" exact="ZIKV" post="infection during pregnancy can be linked to microcephaly and"/>
   <result pre="of the development of the birth cohort affected by the" exact="ZIKV" post="outbreak will reveal the breadth of neurological damage possibly"/>
   <result pre="of microcephaly and other abnormalities in babies born during the" exact="ZIKV" post="outbreak in French Polynesia [161]. The possible link between"/>
   <result pre="French Polynesia [161]. The possible link between these cases and" exact="ZIKV" post="infection was not made at the time, most likely"/>
   <result pre="resulted in malformations and neurodevopmental problems [162]. Laboratory Diagnosis of" exact="ZIKV" post="Specialized laboratory testing is required for confirmation of a"/>
   <result pre="ZIKV Specialized laboratory testing is required for confirmation of a" exact="ZIKV" post="diagnosis. In some settings this service is provided by"/>
   <result pre="possible infection [163]. It is recommended that laboratory tests for" exact="ZIKV" post="infection include RT-PCR detection of the viral RNA in"/>
   <result pre="brain tissue has also been reported. Treatment and Prevention of" exact="ZIKV" post="No specific treatment is yet available for ZIKV infection."/>
   <result pre="Prevention of ZIKV No specific treatment is yet available for" exact="ZIKV" post="infection. Treatment is supportive and constitutes bed rest, oral"/>
   <result pre="recommended [149, 164, 172]. No vaccines are currently available for" exact="ZIKV" post="infection but current progress is encouraging [173]. Various approaches"/>
   <result pre="to become pregnant and their partners not to travel to" exact="ZIKV" post="affected areas. Affected countries have advised woman to delay"/>
   <result pre="advised woman to delay pregnancy at the time of the" exact="ZIKV" post="outbreak, which is a difficult approach in countries where"/>
   <result pre="a result of occupational exposure, the burden of rabies and" exact="Zika" post="infections is borne by children and the fetus respectively."/>
   <result pre="2016 31.Centers for Disease Control and Prevention. Question and answers:" exact="Zika" post="virus infection (Zika) and pregnancy. http://www.cdc.gov/zika/pregnancy/questionÂ¬answers.html. Accessed 5 Feb"/>
   <result pre="and bunyavirusesLab Med200940423724010.1309/LMPX9OEOAOPPBCJH 82.HayesEBSejvarJJZakiSRet al.Virology, pathology, and clinical manifestations of" exact="West Nile" post="virus diseaseEmerg Infect Dis20051181174117910.3201/eid1108.050289b16102303 83.GublerDJThe global emergence/resurgence of arboviral"/>
   <result pre="evolution and emergence of arboviral diseaseNat Rev Microbiol200421078980110.1038/nrmicro100615378043 85.GarmendiaAEVan KruiningenHJFrenchRAThe" exact="West Nile" post="virus: its recent emergence in North AmericaMicrobes Infect20013322322910.1016/S1286-4579(01)01374-011358716 86.NashDMostashariFFineAet"/>
   <result pre="recent emergence in North AmericaMicrobes Infect20013322322910.1016/S1286-4579(01)01374-011358716 86.NashDMostashariFFineAet al.The outbreak of" exact="West Nile" post="virus infection in the New York City area in"/>
   <result pre="threatN Engl J Med2016374760160410.1056/NEJMp160029726761185 90.MoulinESelbyKCherpillodPKaiserLBoillat-BiancoNSimultaneous outbreaks of dengue, chikungunya and" exact="Zika" post="virus infections: diagnosis challenge in a returning traveller with"/>
   <result pre="traveller with nonspecific febrile illnessNew Microbes New Infect2016116710.1016/j.nmni.2016.02.00327006779 91.Gulland A." exact="Zika" post="virus is a global public health emergency, declares WHO."/>
   <result pre="PakistanTrans R Soc Trop Med Hyg198377444244510.1016/0035-9203(83)90106-26314612 96.HaddowAJWilliamsMCWoodallJPet al.Twelve isolations of" exact="Zika" post="virus from Aedes (Stegomyia) africanus (Theobald) taken in and"/>
   <result pre="outside AfricaEmerg Infect Dis200915134710.3201/eid1509.09044219788800 102.LanciottiRSKosoyOLLavenJJet al.Genetic and serologic properties of" exact="Zika" post="virus associated with an epidemic, Yap State, Micronesia, 2007Emerg"/>
   <result pre="Micronesia, 2007Emerg Infect Dis200814123210.3201/eid1408.08028718680646 103.Cao-LormeauV-MBlakeAMonsSet al.Guillain-BarrÃ© Syndrome outbreak associated with" exact="Zika" post="virus infection in French Polynesia: a case-control studyLancet2016387100271531153910.1016/S0140-6736(16)00562-626948433 104.MussoDNillesEJCao-LormeauV-MRapid"/>
   <result pre="in French Polynesia: a case-control studyLancet2016387100271531153910.1016/S0140-6736(16)00562-626948433 104.MussoDNillesEJCao-LormeauV-MRapid spread of emerging" exact="Zika" post="virus in the Pacific areaClin Microbiol Infect20142010O595O59610.1111/1469-0691.1270724909208 105.MussoDNhanTRobinEet al.Potential"/>
   <result pre="virus in the Pacific areaClin Microbiol Infect20142010O595O59610.1111/1469-0691.1270724909208 105.MussoDNhanTRobinEet al.Potential for" exact="Zika" post="virus transmission through blood transfusion demonstrated during an outbreak"/>
   <result pre="Polynesia, South Pacific, 2013EID201420610851086 107.TognarelliJUlloaSVillagraELagosJAguayoCFasceRParraBMoraJBecerraNLagosNVeraLA report on the outbreak of" exact="Zika" post="virus on Easter Island, South Pacific, 2014Arch Virol2016161366566810.1007/s00705-015-2695-526611910 108.CamposGSBandeiraACSardiSIZika"/>
   <result pre="epidemiological and genetic findingsScience201635234510.1126/science.aaf503627013429 110.ZanlucaCMeloVCADMosimannALPSantosGIVDSantosCNDDLuzKFirst report of autochthonous transmission of" exact="Zika" post="virus in BrazilMem Inst Oswaldo Cruz2015110456957210.1590/0074-0276015019226061233 111.World Health Organization"/>
   <result pre="virus in BrazilMem Inst Oswaldo Cruz2015110456957210.1590/0074-0276015019226061233 111.World Health Organization (2016)." exact="Zika" post="virus. Microcephaly Guillian-BarrÃ© syndrome situation report 29 September 2016."/>
   <result pre="of Aedes aegypti and Aedes albopictus from the Americas to" exact="Zika" post="VirusPLoS Negl Trop Dis2016103e000454310.1371/journal.pntd.000454326938868 114.DiagneCTDialloDFayeOet al.Potential of selected Senegalese"/>
   <result pre="of selected Senegalese Aedes spp. mosquitoes (Diptera: Culicidae) to transmit" exact="Zika" post="virusBMC Infect Dis2015151110.1186/s12879-015-1231-225567701 115.DialloDSallAADiagneCTet al.Zika virus emergence in mosquitoes"/>
   <result pre="southeastern Senegal, 2011PLoS One2014910e10944210.1371/journal.pone.010944225310102 116.FayeOFayeODialloDet al.Quantitative real-time PCR detection of" exact="Zika" post="virus and evaluation with field-caught mosquitoesVirol J2013101110.1186/1743-422X-10-31123279912 117.GrardGCaronMMomboIMet al.Zika"/>
   <result pre="Trop Dis201482e268110.1371/journal.pntd.000268124516683 118.LedermannJPGuillaumotLYugLet al.Aedes hensilli as a potential vector of" exact="Chikungunya" post="and Zika virusesPLoS Negl Trop Dis2014810e318810.1371/journal.pntd.000318825299181 119.LiMIWongPSJNgLCTanCHOral susceptibility of"/>
   <result pre="118.LedermannJPGuillaumotLYugLet al.Aedes hensilli as a potential vector of Chikungunya and" exact="Zika" post="virusesPLoS Negl Trop Dis2014810e318810.1371/journal.pntd.000318825299181 119.LiMIWongPSJNgLCTanCHOral susceptibility of Singapore Aedes"/>
   <result pre="Dis2014810e318810.1371/journal.pntd.000318825299181 119.LiMIWongPSJNgLCTanCHOral susceptibility of Singapore Aedes (Stegomyia) aegypti (Linnaeus) to" exact="Zika" post="virusPLoS Negl Trop Dis201268e179210.1371/journal.pntd.000179222953014 120.MarcondesCBXimenesMDFFDZika virus in Brazil and"/>
   <result pre="Trop201649141010.1590/0037-8682-0220-201526689277 121.WongPSJLiMZIChongCSet al.Aedes (Stegomyia) albopictus (Skuse): a potential vector of" exact="Zika" post="virus in SingaporePLoS Negl Trop Dis201378e234810.1371/journal.pntd.000234823936579 122.AtkinsonBHearnPAfroughBet al.Detection of"/>
   <result pre="Zika virus in SingaporePLoS Negl Trop Dis201378e234810.1371/journal.pntd.000234823936579 122.AtkinsonBHearnPAfroughBet al.Detection of" exact="Zika" post="virus in semenEmerg Infect Dis201622594010.3201/eid2205.16010727088817 123.BesnardMLastereSTeissierACao-LormeauVMMussoDEvidence of perinatal transmission"/>
   <result pre="virus in semenEmerg Infect Dis201622594010.3201/eid2205.16010727088817 123.BesnardMLastereSTeissierACao-LormeauVMMussoDEvidence of perinatal transmission of" exact="Zika" post="virus, French Polynesia, December 2013 and February 2014Euro Surveill201419132075110.2807/1560-7917.ES2014.19.13.2075124721538"/>
   <result pre="Surveill201419132075110.2807/1560-7917.ES2014.19.13.2075124721538 124.BrooksJTUpdate: interim guidance for prevention of sexual transmission of" exact="Zika" post="virus - United States, July 2016MMWR Morb Mortal Wkly"/>
   <result pre="Wkly Rep20166512012110.15585/mmwr.mm6505e126866485 125.CalvetGAguiarRSMeloASSampaioSAde FilippisIFabriAAraujoESde SequeiraPCde MendonÃ§aMCde OliveiraLTschoekeDADetection and sequencing of" exact="Zika" post="virus from amniotic fluid of fetuses with microcephaly in"/>
   <result pre="Engl J Med2016374222142215110.1056/NEJMoa160182427028667 127.FoyBDKobylinskiKCChilson FoyJLBlitvichBJTravassos da RosaAHaddowADLanciottiRSTeshRBProbable non-vector-borne transmission of" exact="Zika" post="virus, Colorado, USAEmerg Infect Dis201117588088210.3201/eid1705.10193921529401 128.MussoDRocheCNhanTXet al.Detection of Zika"/>
   <result pre="of Zika virus, Colorado, USAEmerg Infect Dis201117588088210.3201/eid1705.10193921529401 128.MussoDRocheCNhanTXet al.Detection of" exact="Zika" post="virus in salivaJ Clin Virol201568535510.1016/j.jcv.2015.04.02126071336 129.MussoDRocheCRobinEet al.Potential sexual transmission"/>
   <result pre="virus in salivaJ Clin Virol201568535510.1016/j.jcv.2015.04.02126071336 129.MussoDRocheCRobinEet al.Potential sexual transmission of" exact="Zika" post="virusEmerg Infect Dis201521235936110.3201/eid2102.14136325625872 130.Oliveira MAS, Aguiar RS, Ramos Amorim"/>
   <result pre="and fetal demisePLoS Negl Trop Dis2016102e000451710.1371/journal.pntd.000451726914330 133.VenturiGZammarchiLFortunaCRemoliMEBenedettiEFiorentiniCTrottaMRizzoCMantellaARezzaGBartoloniAAn autochthonous case of" exact="Zika" post="due to possible sexual transmission, Florence, Italy, 2014Euro Surveill20162183014810.2807/1560-7917.ES.2016.21.8.3014826939607"/>
   <result pre="possible sexual transmission, Florence, Italy, 2014Euro Surveill20162183014810.2807/1560-7917.ES.2016.21.8.3014826939607 134.FilipeARMartinsCMVRochaHLaboratory infection with" exact="Zika" post="virus after vaccination against yellow feverArch Gesamte Virusforsch197343431531910.1007/BF015561474799154 135.BrasilPCalvetGASiqueiraAMWakimotoMde"/>
   <result pre="epidemiological and virological aspectsPLoS Negl Trop Dis2016104e000463610.1371/journal.pntd.000463627070912 136.Dupont-RouzeyrolMOâ€™ConnorOCalvezEet al.Co-infection with" exact="Zika" post="and dengue viruses in 2 patients, New Caledonia, 2014Emerg"/>
   <result pre="2014Emerg Infect Dis201521238138210.3201/eid2102.14155325625687 137.RothAMercierALepersCet al.Concurrent outbreaks of dengue, chikungunya and" exact="Zika" post="virus infections-an unprecedented epidemic wave of mosquito-borne viruses in"/>
   <result pre="viruses in the Pacific 2012-2014Euro Surveill201419412092910.2807/1560-7917.ES2014.19.41.2092925345518 138.Villamil-GÃ³mezWEGonzÃ¡lez-CamargoORodriguez-AyubiJet al.Dengue, chikungunya and" exact="Zika" post="co-infection in a patient from ColombiaJ Infect Public Health20169568468610.1016/j.jiph.2015.12.00226754201"/>
   <result pre="a patient from ColombiaJ Infect Public Health20169568468610.1016/j.jiph.2015.12.00226754201 139.LaBeaud AD (2016)" exact="Zika" post="virus infection: an overview. In: Hirsch MS, Baron EL,"/>
   <result pre="Health Care Providers caring for infants and children with possible" exact="Zika" post="Virus infection United StatesMMWR Morb Mortal Wkly Rep201665718218710.15585/mmwr.mm6507e126914500 144.KarwowskiMPNelsonJMStaplesJEet"/>
   <result pre="on Reunion IslandPLoS Negl Trop Dis20148e299610.1371/journal.pntd.000299625033077 146.Oâ€™LearyDRKuhnSKnissKLet al.Birth outcomes following" exact="West Nile" post="virus infection of pregnant women in the United States:"/>
   <result pre="listLancet20163871486148810.1016/S0140-6736(16)00564-X26948432 149.BaudDVan MieghemTMussoDet al.Clinical management of pregnant women exposed to" exact="Zika" post="virusLancet Infect Dis201616552310.1016/S1473-3099(16)30008-127056096 150.CarteauxGMaquartMBedetAet al.Zika virus associated with meningoencephalitisN"/>
   <result pre="with meningoencephalitisN Engl J Med20163741595159610.1056/NEJMc160296426958738 151.MÃ©charlesSHerrmannCPoullianPet al.Acute myelitis due to" exact="Zika" post="virus infectionLancet2016387148110.1016/S0140-6736(16)00644-926946926 152.RozÃ© B, Najioullah F, Signate A et"/>
   <result pre="infectionLancet2016387148110.1016/S0140-6736(16)00644-926946926 152.RozÃ© B, Najioullah F, Signate A et al (2016)" exact="Zika" post="virus detection in cerebrospinal fluid from two patients with"/>
   <result pre="2016. Euro Surveill 21(16), pii: 30205. 153.Schuler-FacciniLRibeiroEMIMLFet al.Possible association between" exact="Zika" post="virus infection and microcephalyâ€&quot;Brazil, 2015MMWR Morb Mortal Wkly Rep2016653596210.15585/mmwr.mm6503e226820244"/>
   <result pre="infection and microcephalyâ€&quot;Brazil, 2015MMWR Morb Mortal Wkly Rep2016653596210.15585/mmwr.mm6503e226820244 154.RodriguesLCMicrocephaly and" exact="Zika" post="virus infectionLancet2016387100332070207210.1016/S0140-6736(16)00742-X26993880 155.TetroJAZika and microcephaly: causation, correlation, or coincidenceMicrobes"/>
   <result pre="LC, de Alencar Ximenes RA et al (2016). Association between" exact="Zika" post="virus infection and microcephaly in Brazil, January to May,"/>
   <result pre="dysfunction in fetuses and newborns following the 2013 to 2014" exact="Zika" post="virus epidemic in French PolynesiaEuro Surveill201621133018110.2807/1560-7917.ES.2016.21.13.30181 162.Ticconi C, Pietropolli"/>
   <result pre="in French PolynesiaEuro Surveill201621133018110.2807/1560-7917.ES.2016.21.13.30181 162.Ticconi C, Pietropolli A, Rezza G." exact="Zika" post="virus infection and pregnancy: what we do and do"/>
   <result pre="Glob Health. 2016. 163.World Health Organization (2016) Laboratory testing for" exact="Zika" post="virus infection. Interim guidance. WHO/ZIKV/LAB/16.1. Available from: http://apps.who.int/iris/bitstream/10665/204671/1/WHO_ZIKV_LAB_16.1_eng.pdf. Accessed"/>
   <result pre="on 20 Oct 2016. 164.FalcaoMBCimermanSLuzKGet al.Management of infection by the" exact="Zika" post="virusAnn Clin Microbiol Antimicrob2016155710.1186/s12941-016-0172-y27686610 165.BarzonLPacentiMBertoAet al.Isolation of infectious Zika"/>
   <result pre="the Zika virusAnn Clin Microbiol Antimicrob2016155710.1186/s12941-016-0172-y27686610 165.BarzonLPacentiMBertoAet al.Isolation of infectious" exact="Zika" post="virus from saliva and prolonged viral RNA shedding in"/>
   <result pre="Dominican Republic to Italy, January 2016Euro Surveill20162110Article 110.2807/1560-7917.ES.2016.21.10.30159 166.Dupont-RouzeyrolMBironAOâ€™ConnorOet al.Infectious" exact="Zika" post="viral particles in breastmilkLancet201638710023105110.1016/S0140-6736(16)00624-326944028 167.FrÃ©ourTMiralliÃ©SHubertBet al.Sexual transmission of Zika"/>
   <result pre="al.Infectious Zika viral particles in breastmilkLancet201638710023105110.1016/S0140-6736(16)00624-326944028 167.FrÃ©ourTMiralliÃ©SHubertBet al.Sexual transmission of" exact="Zika" post="virus in an entirely asymptomatic couple returning from a"/>
   <result pre="Zika virus in an entirely asymptomatic couple returning from a" exact="Zika" post="epidemic area, France, April 2016Euro Surveill201621233025410.2807/1560-7917.ES.2016.21.23.30254 168.MansuyJMDutertreMMengelleCet al.Zika virus:"/>
   <result pre="the female genital tractLancet Infect Dis20161691000100110.1016/S1473-3099(16)30193-127427201 170.HarrowerJKiedrzynskiTBakerSet al.Sexual transmission of" exact="Zika" post="virus and persistence in semen, New Zealand, 2016Emerg Infect"/>
   <result pre="in semen, New Zealand, 2016Emerg Infect Dis201622101855185710.3201/eid2210.16095127454745 171.LustigYMendelsonEParanNet al.Detecton of" exact="Zika" post="virus RNA in whole blood in imported Zika virus"/>
   <result pre="al.Detecton of Zika virus RNA in whole blood in imported" exact="Zika" post="virus disease cases up to 2 months after symptom"/>
   <result pre="2016Euro Surveill201621263026910.2807/1560-7917.ES.2016.21.26.30269 172.VougaMMussoDVan MieghemTBaudDCDC guidelines for pregnant woman during the" exact="Zika" post="virus outbreakLancet201638784384410.1016/S0140-6736(16)00383-426898855 173.Kennedy RB. Pushing forward with Zika vaccines."/>
   <result pre="during the Zika virus outbreakLancet201638784384410.1016/S0140-6736(16)00383-426898855 173.Kennedy RB. Pushing forward with" exact="Zika" post="vaccines. EBioMedicine. 2016. 174.TrippRARossTMDevelopment of a Zika vaccineExpert Rev"/>
   <result pre="Pushing forward with Zika vaccines. EBioMedicine. 2016. 174.TrippRARossTMDevelopment of a" exact="Zika" post="vaccineExpert Rev Vaccines20161591083108510.1080/14760584.2016.119247427212079 175.Ndeffo-MbahMLParpiaASGalvaniAPMitigating prenatal zika virus infection in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7118414\results\search\tropicalVirus\results.xml">
   <result pre=": Original Paper Global transmission and evolutionary dynamics of the" exact="Chikungunya" post="virus DeebaF.1HaiderM. S. H.1AhmedA.23https://orcid.org/0000-0001-8944-318XTazeenA.1FaizanM. I.1SalamN.4HussainT.2AlameryS. F.2https://orcid.org/0000-0002-6359-0760ParveenS.1[1], Centre for Interdisciplinary"/>
   <result pre="in any medium, provided the original work is properly cited.S0950268820000497a.pdf" exact="Chikungunya" post="virus (CHIKV) is a re-emerging pathogen of global importance."/>
   <result pre="the world. We describe transmission dynamics and genetic characterisation of" exact="CHIKV" post="across the globe during the last 65 years from"/>
   <result pre="65 years from 1952 to 2017. The evolutionary pattern of" exact="CHIKV" post="was analysed using the E1 protein gene through phylogenetic,"/>
   <result pre="evolutionary rate of 2.78 Ã— 10âˆ’4 substitutions/site/year. Genetic characterisation of" exact="CHIKV" post="strains was carried out in terms of variable sites,"/>
   <result pre="The present study augments global epidemiological and population dynamics of" exact="CHIKV" post="warranting undertaking of appropriate control measures. The identification of"/>
   <result pre="strategies against this re-emerging viral pathogen. Key words Bayesian analysis" exact="Chikungunya" post="virus docking entropy networking phylogenetics selection pressure fig-count: table-count:"/>
   <result pre="entropy networking phylogenetics selection pressure fig-count: table-count: ref-count: page-count: Introduction" exact="Chikungunya" post="fever is caused by Chikungunya virus (CHIKV), an arboviral"/>
   <result pre="fig-count: table-count: ref-count: page-count: Introduction Chikungunya fever is caused by" exact="Chikungunya" post="virus (CHIKV), an arboviral pathogen that has caused numerous"/>
   <result pre="numerous outbreaks across the globe. It has been suggested that" exact="CHIKV" post="probably originated in the Central/East Africa probably around 300â€&quot;500"/>
   <result pre="Central/East Africa probably around 300â€&quot;500 years ago [1, 2]. Phylogenetically," exact="CHIKV" post="consists of three separate clades namely (i) The â€˜West"/>
   <result pre="(ii) â€˜Asianâ€™ and (iii) â€˜East Central South Africanâ€™ (ECSA) [3]." exact="CHIKV" post="has now been recognised as a global pathogen due"/>
   <result pre="in a wide geographical range [3]. Increased global travel from" exact="CHIKV" post="endemic regions has been the major cause of dispersal"/>
   <result pre="the virus to non-endemic regions of the Americas and Europe." exact="CHIKV" post="has succeeded to maintain its mosquitoâ€&quot;human life cycle causing"/>
   <result pre="the situation stands today, there is no local transmission of" exact="CHIKV" post="in the USA currently. The virus has adapted itself"/>
   <result pre="to previously unexposed populations [5, 6]. The genomic analyses of" exact="CHIKV" post="sequences reported from India during the 2009â€&quot;2010 outbreak revealed"/>
   <result pre="of the virus to locally available vector populations [7, 8]." exact="CHIKV" post="is currently circulating in around 100 countries worldwide as"/>
   <result pre="world map showing the distribution of different lineages of the" exact="Chikungunya" post="virus. Regions with the evidence of well-established CHIKV circulation"/>
   <result pre="of the Chikungunya virus. Regions with the evidence of well-established" exact="CHIKV" post="circulation are circled whereas imported cases of CHIKV are"/>
   <result pre="of well-established CHIKV circulation are circled whereas imported cases of" exact="CHIKV" post="are denoted by stars in the map. (The map"/>
   <result pre="the infection. We undertook global distribution and evolutionary analysis of" exact="CHIKV" post="using phylogenetic, networking and Bayesian methods. This also included"/>
   <result pre="if there is a set pattern of the emergence of" exact="Chikungunya" post="fever in different geographical regions. This information can be"/>
   <result pre="information can be useful for the prevention and control of" exact="CHIKV" post="outbreaks globally. Transmission and evolutionary analysis of the virus"/>
   <result pre="virus will help elucidate hostâ€&quot;pathogen dynamics during the course of" exact="CHIKV" post="infections in humans. Materials and methods DNA sequences The"/>
   <result pre="till March 2019) of the partial E1 protein gene of" exact="CHIKV" post="were downloaded after an extensive search in GenBank. The"/>
   <result pre="The complete E1 sequence of the S27 prototype strain of" exact="CHIKV" post="(AF369024) was used for the analysis. The IEDB (Immune"/>
   <result pre="recent past. Fig. 2. The ML phylogenetic tree of the" exact="Chikungunya" post="virus. The tree was generated by 1000 bootstrap values"/>
   <result pre="are shown at nodes. Further, the analysis of the global" exact="CHIKV" post="sequences suggested interesting clustering pattern of the sequences, i.e."/>
   <result pre="(Fig. 3, Supplementary Fig. S2 and Table S1). All the" exact="CHIKV" post="strains formed a network that is illustrated in panels"/>
   <result pre="illustrated in panels a, b and c. Panel â€˜aâ€™ contains" exact="CHIKV" post="strains reported from Tanzania in 1952 (first reported strain)"/>
   <result pre="strains. Fig. 3. The phylogenetic Network showing clusters of the" exact="Chikungunya" post="virus sequences from different geographical regions. The network shows"/>
   <result pre="geographical regions. The network shows the pattern of emergence of" exact="CHIKV" post="related to the first isolated strains. The size of"/>
   <result pre="African Republic reported during 1952â€&quot;56 (ECSA genotype). The recently circulating" exact="CHIKV" post="in countries like India, Bhutan, Vietnam, Cambodia, Myanmar, Thailand,"/>
   <result pre="such as Indonesia, Malaysia, Philippines and Thailand. Several recently reported" exact="CHIKV" post="strains (2012â€&quot;17) from Brazil, Mexico, Puerto Rico, Columbia, Guatemala,"/>
   <result pre="of the sequences as described earlier by phylogenetic analysis. The" exact="CHIKV" post="was calculated to be originated around 491 years ago"/>
   <result pre="respectively. Fig. 4. The MCMC Bayesian tree generated using different" exact="Chikungunya" post="virus strains from various parts of the world. The"/>
   <result pre="5) [30]. The plot showed almost a constant phase of" exact="CHIKV" post="infection till 2000 and then a slight decrease. Following"/>
   <result pre="plot shows viral population vs. time of circulation of the" exact="Chikungunya" post="virus strains from India. Shannon entropy analysis The Shannon"/>
   <result pre="1. Selection pressure analysis of the E1 gene of the" exact="Chikungunya" post="virus. The details of positively selected sites under different"/>
   <result pre="31 potential epitopes were shortlisted in the E1 protein of" exact="CHIKV" post="and were analysed in subsequent steps. Three peptides (YPFMWGGAY,"/>
   <result pre="The potential epitopes for MHC-II in the E1 protein of" exact="CHIKV" post="were initially predicted in IEDB peptide binding to MHC-II"/>
   <result pre="of the potential epitopes of the E1 protein of the" exact="Chikungunya" post="virus with MHCI/II alleles. The images a, b and"/>
   <result pre="83, LYS 111, GLN 34, GLU 36, ARG 39 Discussion" exact="CHIKV" post="has been described from different geographical regions including autochthonous"/>
   <result pre="A few reports also relate to the evolutionary divergence of" exact="CHIKV" post="in different parts of the world [1, 2, 31]."/>
   <result pre="different parts of the world [1, 2, 31]. Outbreaks of" exact="Chikungunya" post="fever across the globe, spread of infection across a"/>
   <result pre="of the world. We evaluated the transmission dynamics of the" exact="CHIKV" post="across the globe using phylogenetic, Network and Bayesian analysis"/>
   <result pre="sites, entropy, selection pressure and epitope mapping. The evidence of" exact="CHIKV" post="occurrence in different geographical regions was reported as early"/>
   <result pre="Gujarat in 1824â€&quot;25 [32]. Our data also supported that the" exact="CHIKV" post="infection in humans originated around 491 years ago (1526)."/>
   <result pre="is similar to the reports that described the origin of" exact="CHIKV" post="to be of 300â€&quot;500 years age [1, 2]. The"/>
   <result pre="the central, East and South African regions. Later on, the" exact="CHIKV" post="diverged from these initial strains and were transmitted to"/>
   <result pre="gene [2]. The phylogenetic and Bayesian analyses of the global" exact="CHIKV" post="sequences revealed interesting clustering of the sequences. Both the"/>
   <result pre="suggested a similar branching pattern thereby delineating the spread of" exact="CHIKV" post="in different geographic regions. The ECSA strains formed three"/>
   <result pre="Network analysis revealed that in the West African region, Nigerian" exact="CHIKV" post="strain further diverged to Senegal and Cote D'ivoire [2,"/>
   <result pre="Mexico and French Polynesia [9, 38â€&quot;40]. The Asian genotype of" exact="CHIKV" post="was reported to have caused epidemics in many Asian"/>
   <result pre="strains in the Asian countries were initiated during 2004 [41]." exact="CHIKV" post="initially circulated in major parts of Africa till 2004."/>
   <result pre="subsequently to other Asian countries [42]. This progressive spread of" exact="CHIKV" post="initiated an explosive epidemic that affected millions of inhabitants"/>
   <result pre="from Angola to the USA [9]. These branching patterns of" exact="CHIKV" post="strains across the globe based on the E1 gene"/>
   <result pre="and consistent evolution. A detailed genetic characterisation of the global" exact="CHIKV" post="strains was done using the variable sites, selection pressure"/>
   <result pre="described in the crystal structure of the structural polyproteins of" exact="CHIKV" post="[50]. The T-cell epitopes induce long-lasting cell-mediated innate immune"/>
   <result pre="viral pathogen. Conclusions The reconstruction of the geographic distribution of" exact="CHIKV" post="suggested a distinctive branching pattern owing to gradual alterations"/>
   <result pre="associated with travel cases and its autochthonous transmission. Co-circulation of" exact="CHIKV" post="with other arthropod-borne viruses like Dengue and Zika in"/>
   <result pre="autochthonous transmission. Co-circulation of CHIKV with other arthropod-borne viruses like" exact="Dengue" post="and Zika in many regions has been reported from"/>
   <result pre="Co-circulation of CHIKV with other arthropod-borne viruses like Dengue and" exact="Zika" post="in many regions has been reported from different geographical"/>
   <result pre="particularly in underdeveloped countries, can complicate the accurate reporting of" exact="CHIKV" post="infections. Therefore, a comprehensive surveillance of all the arthropod-borne"/>
   <result pre="References 1.CherianSSet al. (2009) Evolutionary rates and timescale comparison of" exact="Chikungunya" post="viruses inferred from the whole genome/E1 gene with special"/>
   <result pre="various evolutionary rates. Journal of Virology84, 6497â€&quot;6504.20410280 3.DeebaFet al. (2016)" exact="Chikungunya" post="virus: recent advances in epidemiology, host pathogen interaction and"/>
   <result pre="vaccine strategies. Pathogens and Disease74, ftv119.26657109 4.EvansD and MeiresJL (2016)" exact="Chikungunya" post="virus: a rising health risk in the United States"/>
   <result pre="Practitioners12, 289â€&quot;298. 5.NgLC and HapuarachchiHC (2010) Tracing the path of" exact="Chikungunya" post="virus â€&quot; evolution and adaptation. Infection, Genetics and Evolution10,"/>
   <result pre="Euro Surveillance21, 30234. 7.SumathyK and EllaKM (2012) Genetic diversity of" exact="Chikungunya" post="virus, India 2006â€&quot;2010: evolutionary dynamics and serotype analyses. Journal"/>
   <result pre="vex010.28480053 9.NunesMRTet al. (2015) Emergence and potential for spread of" exact="Chikungunya" post="virus in Brazil. BMC Medicine13, 102.25976325 10.MachadoLCet al. (2019)"/>
   <result pre="vaccine: in silico approach for the epitope-based peptide vaccine against" exact="Zika" post="virus envelope glycoprotein. Immunology149, 386â€&quot;399.27485738 27.HoofIet al. (2009) NetMHCpan,"/>
   <result pre="al.(2017) Potential entry inhibitors of the envelope protein (E2) of" exact="Chikungunya" post="virus: in silico structural modeling, docking and molecular dynamic"/>
   <result pre="genome tracking of East, Central and South African genotype of" exact="Chikungunya" post="virus in South-east Asia between 2006 and 2009. Asian"/>
   <result pre="2009. Asian Pacific Journal of Tropical Medicine4, 535â€&quot;540.21803304 32.CareyDE (1971)" exact="Chikungunya" post="and dengue: a case of mistaken identity?Journal of the"/>
   <result pre="Journal of Tropical Medicine and Hygiene72, 616â€&quot;621.15891138 34.NimmannityaSet al. (1969)" exact="Dengue" post="and chikungunya virus infection in man in Thailand, 1962â€&quot;64."/>
   <result pre="Journal of Tropical Medicine and Hygiene18, 954â€&quot;971.5355242 35.LamSet al. (2001)" exact="Chikungunya" post="infection â€&quot; an emerging disease in Malaysia. Southeast Asian"/>
   <result pre="Southeast Asian J Trop Medical Health32, 447â€&quot;451. 36.Dupont-RouzeyrolMet al. (2012)" exact="Chikungunya" post="virus and the mosquito vector Aedes aegypti in New"/>
   <result pre="1036â€&quot;1041.23167500 37.LanciottiRS and ValadereAM (2014) Transcontinental movement of Asian genotype" exact="Chikungunya" post="virus. Emerging Infectious Diseases20, 1400â€&quot;1402.25076384 38.AubryMet al. (2015) Chikungunya"/>
   <result pre="genotype Chikungunya virus. Emerging Infectious Diseases20, 1400â€&quot;1402.25076384 38.AubryMet al. (2015)" exact="Chikungunya" post="outbreak, French Polynesia, 2014. Emerging Infectious Diseases21, 724.25811534 39.ChiuCYet"/>
   <result pre="cases. Genome Announcements3, e00300â€&quot;15.25953170 41.ArankalleVAet al. (2007) Genetic divergence of" exact="Chikungunya" post="viruses in India (1963â€&quot;2006) with special reference to the"/>
   <result pre="epidemic potential. PLoS Pathogens3, e201.18069894 44.StaplesJE, BreimanRF and PowersAM (2009)" exact="Chikungunya" post="fever: an epidemiological review of a re-emerging infectious disease."/>
   <result pre="Number 8â€&quot;August 2009-Emerging Infectious Disease journal-CDC. 46.DuongV (2012) Reemergence of" exact="Chikungunya" post="Virus in Cambodia-Volume 18, Number 12â€&quot;December 2012-Emerging Infectious Disease"/>
   <result pre="Cambodia-Volume 18, Number 12â€&quot;December 2012-Emerging Infectious Disease journal-CDC. 47.WangchukS (2013)" exact="Chikungunya" post="Fever Outbreak, Bhutan, 2012-Volume 19, Number 10â€&quot;October 2013-Emerging Infectious"/>
   <result pre="19, Number 10â€&quot;October 2013-Emerging Infectious Disease journal-CDC. 48.LuXet al. (2014)" exact="Chikungunya" post="emergency in China: microevolution and genetic analysis for a"/>
   <result pre="ECSA genotype with replacement of K211E in E1 gene of" exact="Chikungunya" post="virus in Delhi from 2010 to 2014. Asian Pacific"/>
   <result pre="of Tropical Disease6, 564â€&quot;566. 50.VossJEet al. (2010) Glycoprotein organization of" exact="Chikungunya" post="virus particles revealed by X-ray crystallography. Nature468, 709â€&quot;712.21124458 51.ChiouS-Set"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7119994\results\search\tropicalVirus\results.xml">
   <result pre="shown a significant emergence worldwide in the last 50 years." exact="Dengue" post="dynamics are notable for the global circulation of four"/>
   <result pre="implications of interactions between ADE and such immunity [69, 70]." exact="Dengue" post="dynamics are therefore complex and multifactorial: an understanding of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7120481\results\search\tropicalVirus\results.xml">
   <result pre="and emerging disease epidemics such as SARS, avian influenza, and" exact="West Nile" post="virus [90]. Having a national system with medical and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7120597\results\search\tropicalVirus\results.xml">
   <result pre="of survivors have persistent neurologic disability. â€¢â€ƒSoutheast Asia â€¢â€ƒBangladesh â€¢â€ƒPakistan" exact="West Nile" post="virus â€¢â€ƒThalamus â€¢â€ƒCerebellum â€¢â€ƒSubstantia nigra â€¢â€ƒPons â€¢â€ƒMedulla oblongata â€¢â€ƒSpinal"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7120709\results\search\tropicalVirus\results.xml">
   <result pre="isolated WN virus from the blood of a patient in" exact="West Nile" post="district, Uganda. 1940, FLOREY, CHAIN and HEATLEY prepared purified"/>
   <result pre="Sindbis virus from the mosquito Culex univittatus in Egypt. 1952â€&quot;1953," exact="Chikungunya" post="virus was isolated during epidemics in Tanzania and Uganda."/>
   <result pre="appeared in Great Britain in 1986. 1996, an outbreak of" exact="West Nile" post="encephalitis in Romania (&amp;gt;500 patients). 1998, PHILBEY, KIRKLAND, ROSS"/>
   <result pre="humans) in Malaysia. 1999 â€&quot;2006, a very surprising epidemic of" exact="West Nile" post="encephalitis in New York after an importation of WNV"/>
   <result pre="West Nile encephalitis in New York after an importation of" exact="WNV" post="(probably from Israel), with a following spread over whole"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7120784\results\search\tropicalVirus\results.xml">
   <result pre="diseases including Rift Valley fever, yellow fever, dengue, chikungunya and" exact="West Nile," post="transmitted by arthropods from animal reservoirs, occur frequently in"/>
   <result pre="in the affected countries (Linthicum et al. 2016). Yellow Fever" exact="Yellow fever," post="caused by the yellow fever virus (YFV), is another"/>
   <result pre="veterinary pathogens in the genus include dengue, Japanese encephalitis and" exact="West Nile" post="viruses (McLinden et al. 2017). Yellow fever is a"/>
   <result pre="Japanese encephalitis and West Nile viruses (McLinden et al. 2017)." exact="Yellow fever" post="is a zoonotic disease, maintained in nature by non-human"/>
   <result pre="of other arboviruses has been demonstrated in the case of" exact="West Nile" post="and Chikungunya viruses over the past 15Â years (Nash"/>
   <result pre="has been demonstrated in the case of West Nile and" exact="Chikungunya" post="viruses over the past 15Â years (Nash et al."/>
   <result pre="FeverJournal of Infectious Diseases1987155344545510.1093/infdis/155.3.4453805772 McLindenJHBhattaraiNStapletonJTet al.Yellow fever virus, but not" exact="Zika" post="virus or dengue virus, inhibits T-cell receptor-mediated T-cell function"/>
   <result pre="sectional qualitative studyBMC Health Serv Res201919111710.1186/s12913-019-3923-630760259 NashDMostashariFFineAet al.The outbreak of" exact="West Nile" post="virus infection in the new York City area in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7120977\results\search\tropicalVirus\results.xml">
   <result pre="must be infectious by the intravenous route. The advent of" exact="West Nile" post="fever in the United Sates was yet another unexpected"/>
   <result pre="involved in the spread of BSE and vCJD. In 1999," exact="West Nile" post="virus (WNV) was identified for the first time in"/>
   <result pre="naturally infected by mosquitoes [3]. Universal blood donor testing for" exact="WNV" post="RNA was in place by mid-2003. WNV is an"/>
   <result pre="donor testing for WNV RNA was in place by mid-2003." exact="WNV" post="is an arbovirus, transmitted by culicine mosquitoes, and the"/>
   <result pre="or potentially transmissible by transfusion. They include dengue, chikungunya, and" exact="Zika" post="viruses. Most recently, Zika virus has received particular attention,"/>
   <result pre="transfusion. They include dengue, chikungunya, and Zika viruses. Most recently," exact="Zika" post="virus has received particular attention, largely because it is"/>
   <result pre="earliest (unexpected) evidence of transfusion transmission of some known agents." exact="West Nile" post="virus is good example of this situation. Prediction Given"/>
   <result pre="the Americas, and they illustrate different circumstances. The appearance of" exact="West Nile" post="virus in the United States in 1999 could not"/>
   <result pre="could not have been predicted. In contrast, the appearance of" exact="Zika" post="virus in the United States led to rapid and"/>
   <result pre="the association of the virus with the severe impact of" exact="Zika" post="virus on the fetus, encouraged manufacturers to research the"/>
   <result pre="United States for travel to areas affected by outbreaks of" exact="Zika" post="virus, although the questioning stopped once universal donor testing"/>
   <result pre="the United States, as a measure to reduce risk of" exact="West Nile" post="virus infection. This approach is potentially sensitive but has"/>
   <result pre="This approach has proved effective for acute infections such as" exact="West Nile" post="fever and Zika. Direct Tests The most obvious direct"/>
   <result pre="NAT is used as the sole approach to detection of" exact="WNV" post="and Zika virus, both of which are arboviruses causing"/>
   <result pre="used as the sole approach to detection of WNV and" exact="Zika" post="virus, both of which are arboviruses causing acute infection."/>
   <result pre="These factors contributed to the rapid adoption of tests for" exact="WNV" post="and Zika virus in the United States. However, they"/>
   <result pre="contributed to the rapid adoption of tests for WNV and" exact="Zika" post="virus in the United States. However, they are not"/>
   <result pre="in the United States as an alternative to NAT for" exact="Zika" post="virus. This system has also been approved in place"/>
   <result pre="safetyVox Sanguinis, Published early on-line 22nd January201811322010.1111/vox.12631 3.PealerLNMarfinAAPetersenLRLanciottiRSPagePLStramerSLet al.Transmission of" exact="West Nile" post="virus through blood transfusion in the United States in"/>
   <result pre="and Drug Administration. Revised recommendations for reducing the risk of" exact="Zika" post="virus transmission by blood and blood products. Guidance for"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7121185\results\search\tropicalVirus\results.xml">
   <result pre="infections and antimicrobial resistance. Viral infections (SARS, MERS-CoV, Zika, Chikungunya," exact="West Nile," post="Ebola virus infection, etc.) emerged or re-emerged with threatening"/>
   <result pre="recent emergence of Zika, the spread of Dengue, Chikungunya, and" exact="West Nile" post="fever in countries that was not present in the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7121192\results\search\tropicalVirus\results.xml">
   <result pre="severe acute respiratory syndrome (SARS), Ebola (Singh et al. 2017a)," exact="Zika" post="(Singh et al. 2017b), etc. Despite the vaccines and"/>
   <result pre="group of viruses 6. NCBI-VVR Influenza virus, dengue virus, rotavirus," exact="West Nile" post="virus, Ebola virus, Zika virus and Corona virus Virus"/>
   <result pre="Influenza virus, dengue virus, rotavirus, West Nile virus, Ebola virus," exact="Zika" post="virus and Corona virus Virus Variation Resource (NCBI-VVR) The"/>
   <result pre="a set of viruses, viz. influenza virus, dengue virus, rotavirus," exact="West Nile" post="virus, Ebola virus, Zika virus and MERS coronavirus (Resch"/>
   <result pre="influenza virus, dengue virus, rotavirus, West Nile virus, Ebola virus," exact="Zika" post="virus and MERS coronavirus (Resch et al. 2009). It"/>
   <result pre="HCV database HCV http://hcv.lanl.gov 3 PaVE Papillomavirus http://pave.niaid.nih.gov 4 REGA" exact="HPV" post="subtyping tool Human papillomavirus (HPV) Alcantara et al. (2009)"/>
   <result pre="Hepatitis C virus Alcantara et al. (2009) http://bioafrica.mrc.ac.za/rega-genotype/html 10 Dengue," exact="Zika" post="and chikungunya viruses typing tool Dengue, Zika &amp;amp; Chikungunya"/>
   <result pre="http://bioafrica.mrc.ac.za/rega-genotype/html 10 Dengue, Zika and chikungunya viruses typing tool Dengue," exact="Zika" post="&amp;amp; Chikungunya Viruses http://bioafrica.mrc.ac.za/rega-genotype/html 11 CoVDB Coronavirus genes/genomes http://covdb.microbiology.hku.hk"/>
   <result pre="Dengue, Zika and chikungunya viruses typing tool Dengue, Zika &amp;amp;" exact="Chikungunya" post="Viruses http://bioafrica.mrc.ac.za/rega-genotype/html 11 CoVDB Coronavirus genes/genomes http://covdb.microbiology.hku.hk 12 FLAVIdB"/>
   <result pre="virus genotyping toolÂ â€&quot; RIVM Hepatitis E virus https://www.rivm.nl/mpf/typingtool/hev/ 23" exact="Yellow fever" post="virus phylogenetic typing tool Yellow fever virus http://bioafrica2.mrc.ac.za/rega-genotype/typingtool/yellowfevervirus/ 24"/>
   <result pre="E virus https://www.rivm.nl/mpf/typingtool/hev/ 23 Yellow fever virus phylogenetic typing tool" exact="Yellow fever" post="virus http://bioafrica2.mrc.ac.za/rega-genotype/typingtool/yellowfevervirus/ 24 FluTE Influenza A virus Chao et"/>
   <result pre="proteinsJ Mol Biol199929051031104110.1006/jmbi.1999.279610438601 SinghRKDhamaKKarthikKTiwariRKhandiaRMunjalAIqbalHMMalikYSBueno-MarÃ­RAdvances in diagnosis, surveillance, and monitoring of" exact="Zika" post="virus: an updateFront Microbiol20178267710.3389/fmicb.2017.0267729403448 SinghRKDhamaKMalikYSRamakrishnanMAKarthikKTiwariRKhandiaRMunjalASaminathanMSachanSDesinguPAKattoorJJIqbalHMNJoshiSKEbola virusÂ â€&quot; epidemiology, diagnosis"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7121210\results\search\tropicalVirus\results.xml">
   <result pre="viruses. Keywords Human Immunodeficiency Virus Bovine Spongiform Encephalopathy Viral Quasispecies" exact="West Nile" post="Fever H1N1 Pandemic Virus Introduction RNA viruses are important"/>
   <result pre="from animal reservoirs, including human immunodeficiency virus (HIV), SARS, influenza," exact="West Nile" post="fever, Ebola, and dengue fever, among others. RNA viruses"/>
   <result pre="Italy, and France (Powers and Logue 2007). Serial passage of" exact="CHIKV" post="in ribavirin or fluorouracil resulted in the selection of"/>
   <result pre="and generates populations with reduced genetic diversity. In mosquitoes, high-fidelity" exact="CHIKV" post="produces lower infection and dissemination titers than wild-type. In"/>
   <result pre="infection and dissemination titers than wild-type. In newborn mice, high-fidelity" exact="CHIKV" post="produces truncated viremias and lower organ titers. These results"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7121243\results\search\tropicalVirus\results.xml">
   <result pre="(Ghosh et al. 2010), rotavirus VP7 (Ghosh et al. 2012)," exact="Zika" post="virus (Dey et al. 2017a) and others (Dey et"/>
   <result pre="of 2014â€&quot;2016 in West Africa (over 15,000 deaths) and the" exact="Zika" post="virus pandemic that struck the Americas in 2015â€&quot;2017 (&amp;gt;200,000"/>
   <result pre="in form of gR values. In their study of the" exact="Zika" post="envelope gene, Dey et al. (2017a) evaluated partial CDS"/>
   <result pre="virus (DENV2) which belongs to the flavivirus family along with" exact="Zika" post="virus, yellow fever virus, West Nile virus and Japanese"/>
   <result pre="the flavivirus family along with Zika virus, yellow fever virus," exact="West Nile" post="virus and Japanese encephalitis virus, among others. The envelope"/>
   <result pre="of human papillomavirusCancer Informat201615S111610.4137/CIN.S39071 DeySNandyABasakSCNandyPDasSA bioinformatics approach to designing a" exact="Zika" post="virus vaccineComput Biol Chem20176814315210.1016/j.compbiolchem.2017.03.00228342423 Dey S, Roy P, Nandy"/>
   <result pre="S, Das S (2017b) Comparison of base distributions in Dengue," exact="Zika" post="and Other Flavivirus envelope and NS5 genes. Paper presented"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7121290\results\search\tropicalVirus\results.xml">
   <result pre="families are summarized. Keywords Human Immunodeficiency Virus Herpes Simplex Virus" exact="West Nile" post="Virus Lumbar Puncture Central Nervous System Infection Introduction Children"/>
   <result pre="+ + Cerebellitis, granulomatous, arteritis. Shingles, postherpetic neuralgia, vasculopathy Africa" exact="Chikungunya" post="virus ++ Epidemics Arthritis associated with febrile illness Poliovirus"/>
   <result pre="Travel in Eastern Europe, tick bites, upper limb flaccid paralysis" exact="West Nile" post="virus +++ + + Flaccid paralysis, parkinsonian movement disorder"/>
   <result pre="Machupo, Guanarito, Sabia viruses) ++ Hemorrhagic fever Asia and Pacific" exact="Chikungunya" post="virus ++ Epidemics Arthritis associated with febrile illness Japanese"/>
   <result pre="Travel in Eastern Europe Tick bites, Upper limb flaccid paralysis" exact="West Nile" post="virus (excluding Asia) + + + Australia Hendra virus"/>
   <result pre="encephalitis virus + (+) Single-stranded RNA Tick-borne encephalitis virus +" exact="West Nile" post="virus + Paramyxoviridae Measles virus + (âˆ’) Single-stranded RNA"/>
   <result pre="T-lymphotropic virus-1 Rhabdoviridae Rabies virus + (âˆ’) Single-stranded RNA Togaviridae" exact="Chikungunya" post="virus + + (+) Single-stranded RNA Eastern equine encephalitis"/>
   <result pre="virus Measles virus St. Louis encephalitis virus Tick-borne encephalitis virus" exact="West Nile" post="virus Cerebellum Epstein-Barr virus Human enteroviruses West Nile virus"/>
   <result pre="encephalitis virus West Nile virus Cerebellum Epstein-Barr virus Human enteroviruses" exact="West Nile" post="virus Varicella-zoster virus Brain stem Human enteroviruses Poliovirus Rabies"/>
   <result pre="virus Varicella-zoster virus Brain stem Human enteroviruses Poliovirus Rabies virus" exact="West Nile" post="virus Thalamus Human enteroviruses Rabies virus West Nile virus"/>
   <result pre="Rabies virus West Nile virus Thalamus Human enteroviruses Rabies virus" exact="West Nile" post="virus Hippocampus Human enteroviruses Rabies virus West Nile virus"/>
   <result pre="Rabies virus West Nile virus Hippocampus Human enteroviruses Rabies virus" exact="West Nile" post="virus Choroid plexus/Ependyma Cytomegalovirus Human enteroviruses Lymphocytic choriomeningitis virus"/>
   <result pre="enteroviruses Japanese encephalitis virus Poliovirus Rabies virus Tick-borne encephalitis virus" exact="West Nile" post="virus Adapted from Swanson and McGavern [2] and Glaser"/>
   <result pre="RNA viruses of which tick-borne encephalitis virus, Japanese encephalitis virus," exact="Zika" post="virus and West Nile virus (WNV) are responsible for"/>
   <result pre="which tick-borne encephalitis virus, Japanese encephalitis virus, Zika virus and" exact="West Nile" post="virus (WNV) are responsible for severe CNS infections [3]."/>
   <result pre="like chikungunya virus, from the family Togaviridae [58]. Outbreaks of" exact="WNV" post="are increasing in Europe and North America, and a"/>
   <result pre="mention [3]. Only a small portion of patients infected with" exact="WNV" post="are symptomatic; 20% develop a self-limiting flu-like disease and"/>
   <result pre="they are worse in immunocompromised patients [80]. The use of" exact="WNV" post="PCR for diagnostic purposes is limited, because the viremia"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7121352\results\search\tropicalVirus\results.xml">
   <result pre="infections with pathogens such as Cryptococcus neoformans, Legionella, and also" exact="West Nile" post="virus. Respiratory infections due to pathogens such as Streptococcus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7121578\results\search\tropicalVirus\results.xml">
   <result pre="World Trade Center, epidemics of such emerging viral infections as" exact="West Nile" post="virus, avian influenza, and SARS became a major issue"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7121609\results\search\tropicalVirus\results.xml">
   <result pre="Bats SA/P4/ H/HF 25Â +Â % mortality Yun (2012) Flavivirus" exact="Dengue" post="fever Asia, Africa, Americas Monkey? Aedes aeypti, A. albopictus"/>
   <result pre="Ticks HT + tick bite SA/P4/ H/ENC, mortality 1â€&quot;2Â %" exact="West Nile" post="virus WW Horse/bird Mosquito HT: Mosquito bite Z H/ENC"/>
   <result pre="bite Z H/ENC mortality 35Â % Zacks and Paessler (2010)" exact="Yellow fever" post="Africa, South America Monkeys Mosquito HT: Mosquito bite Z/P3"/>
   <result pre="Encephalitis Virus), and it confers no cross-immunity against flaviviruses (e.g.," exact="West Nile" post="Virus) or bunyaviruses (e.g., La Crosse Virus) In the"/>
   <result pre="analysesJ Clin Microbiol19842034864896490832 Monath T, Cetron MS, Teuwen DE. (2008)" exact="Yellow fever" post="vaccine. In: Plotkin SA, Orenstein WA, Offit PA, eds."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7121691\results\search\tropicalVirus\results.xml">
   <result pre="precancerous lesions with human papillomavirus (HPV) genotypes detected with the" exact="HPV" post="DNA chip microarray methodCancer2003971672168010.1002/cncr.1123512655524 AndersonBTRuaneACRoadsJOKanamitsuMSalvucciGA new metric for estimating"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7121724\results\search\tropicalVirus\results.xml">
   <result pre="headlines appeared alongside those pertaining to Ebola virus disease (EVD)," exact="West Nile" post="virus, and the recently infamous â€œGiant Frozen Virus Still"/>
   <result pre="infamous â€œGiant Frozen Virus Still Infectious After 3000 Years.â€� Keywords" exact="West Nile" post="Virus Severe Acute Respiratory Syndrome Emotional Contagion Suicide Prevention"/>
   <result pre="headlines appeared alongside those pertaining to Ebola virus disease (EVD)," exact="West Nile" post="virus, and the recently infamous â€œGiant Frozen Virus Still"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7121847\results\search\tropicalVirus\results.xml">
   <result pre="virus, infectious bursal disease (IBD) and zoonotic diseases such as" exact="West Nile" post="fever, Rift Valley fever, SARS-coronavirus, Nipah virus infection, Hendra"/>
   <result pre="pathogens of zoonotic significance including rabies virus, Rift Valley fever," exact="West Nile" post="virus, avian influenza A (bird flu), swine influenza A"/>
   <result pre="Crimeanâ€&quot;Congo haemorrhagic fever (CCHF), Hendra virus, Nipah virus, Ebola and" exact="Zika" post="viruses. There is also a need to monitor wildlife,"/>
   <result pre="gastroenteritis (TGE) in pigs; swine vesicular disease; Rift Valley fever;" exact="West Nile" post="fever; Eastern equine encephalomyelitis (EEE); Western equine encephalomyelitis (WEE);"/>
   <result pre="emergence of new viral diseases/infections, such as Rift Valley fever," exact="West Nile" post="fever, SARS-coronavirus, Hendra virus, avian influenza A H5N1, Nipah"/>
   <result pre="fever, SARS-coronavirus, Hendra virus, avian influenza A H5N1, Nipah virus," exact="Zika" post="virus and swine influenza A (H1N1) virus, from time"/>
   <result pre="negative by PCR test for freedom from virus. Information that" exact="Zika" post="and Ebola viruses may be excreted in the semen"/>
   <result pre="Bueno-MarÃ­ R (2017) Advances in diagnosis, surveillance, and monitoring of" exact="Zika" post="virus: an update. Front Microbiol. 10.3389/fmicb.2017.02677 Singh RK, Dhama"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7122085\results\search\tropicalVirus\results.xml">
   <result pre="- HIV and NeuroAIDS978-1-4939-7288-3978-1-4939-7290-6 pmcid: 712208530 doi: 10.1007/978-1-4939-7290-6_30 : Article" exact="Zika" post="Virus and HIV/AIDS ShapshakPaulpshapshak@gmail.com1LevineAndrew J.+11562-477-5963ajlevine@mednet.ucla.edu2FoleyBrian T.btf@lanl.gov3SomboonwitCharurutcharurut@gmail.com4SingerElyse+11310-869-0544esinger@ucla.edu5ChiappelliFrancescofchiappelli@dentistry.ucla.edu6SinnottJohn T.johntsinnott@gmail.com7[1], 0000 0001"/>
   <result pre="of the HIV pandemic is mirrored by the spread of" exact="Zika" post="virus (ZikaV). Humans were probably first infected with HIV"/>
   <result pre="1940s and ZikaV was first detected in humans in the" exact="Zika" post="forest in the 1950s. Aedes aegypti and Aedes albopictus"/>
   <result pre="and Walter Reed ZikaV vaccines are on the way. Keywords" exact="Zika" post="virus HIV AIDS Retrovirus Flavivirus Arbovirus Mosquito Fear Education"/>
   <result pre="Public health Global warming NIH CDC Core Message The new" exact="Zika" post="epidemic has many similarities and parallels with the HIV/AIDS"/>
   <result pre="response has been evident in the publicâ€™s reaction to the" exact="Zika" post="pandemic. This and many other factors closely mirror the"/>
   <result pre="falls even further due to opportunistic infection, without treatment [7]." exact="Zika" post="Virus Zikavirus (ZikaV) is a flavivirus , which is"/>
   <result pre="to ZikaV, these viruses include dengue (DEN), Japanese encephalitis (JE)," exact="West Nile" post="virus (WNV), chikungunya fever (CHIK), hemorrhagic fevers such as"/>
   <result pre="Occupational exposure [24] Needle/syringe stab Miscellaneous [24] Bites Wound contact" exact="Zika" post="Virus Vectors Recent reviews summarized the status of clinical"/>
   <result pre="ZikaV. Issues discussed include ZikaV associated microcephaly, Guillainâ€&quot;BarrÃ© syndrome, potential" exact="Dengue" post="virusâ€&quot;ZikaV interactions, and the prospects of a future medical"/>
   <result pre="way from NIH and Walter Reed [30]. A Comparison of" exact="Zika" post="Virus and HIV/AIDS Modes of Transmission Although many modes"/>
   <result pre="the HIV/AIDS and ZikaV. Figure 30.3: Modes of transmission for" exact="Zika" post="and HIV Fig. 30.3 A comparison of the modes"/>
   <result pre="A comparison of the modes of transmission between HIV and" exact="Zika" post="Pathways HIV Pathway Figure 30.4: HIV pathway [32, 33]"/>
   <result pre="[34, 35] Fig. 30.5 HIV -&amp;gt; AIDS pathway [34, 35]" exact="Zika" post="Virus Pathway Figure 30.6: Zika virus pathway [36] Fig."/>
   <result pre="-&amp;gt; AIDS pathway [34, 35] Zika Virus Pathway Figure 30.6:" exact="Zika" post="virus pathway [36] Fig. 30.6 Zika pathway [36] HIV/AIDS"/>
   <result pre="Virus Pathway Figure 30.6: Zika virus pathway [36] Fig. 30.6" exact="Zika" post="pathway [36] HIV/AIDS Epidemic The HIV/AIDS epidemic forever changed"/>
   <result pre="most rapid and preventable approaches against acquiring and transmitting HIV." exact="Zika" post="Virus Epidemic On April 18, 1947, the first documented"/>
   <result pre="the first documented case of the ZikaV emerged in the" exact="Zika" post="forest of Uganda [31]. This information only surfaced as"/>
   <result pre="ZikaV global spread was methodically tracked as follows: 1947Â â€&quot;" exact="Zika" post="forest, Uganda, Nigeria, east Africa; 1954Â â€&quot; India; 1978Â"/>
   <result pre="territory (other than Guam and Alaska) had reported cases of" exact="Zika" post="totaling 36,323. Locally acquired cases were restricted to South"/>
   <result pre="for funding of such efforts are underway [19, 20, 49]." exact="Zika" post="Virus and HIV/AIDS The expansion of the ZikaV pandemic"/>
   <result pre="HIV ZikaV Retrovirus Arbovirus closely related to dengue, chikungunya, and" exact="West Nile" post="viruses Effects children and adults alike, yet with treatment"/>
   <result pre="before adverse health seen because of infection Originated in Africa," exact="Zika" post="Forest in 1950s, years before adverse health seen because"/>
   <result pre="R Soc Lond Ser B Biol Sci201436916452013042610.1098/rstb.2013.042624821913 2.World Health Organization" exact="Zika" post="virus [Internet] World Health Organization [Cited 2016 Nov 22]."/>
   <result pre="diseases2015New YorkSpringer Publications425455 19.Shapshak P, Somboonwit C, Foley BT (2015)" exact="Zika" post="virus In: Chapter 18 in Global virology I â€&quot;"/>
   <result pre="Culicidae), in BrazilAnn Entomol Soc Am200497113013910.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2 21.WHO Situation Report (2017)" exact="Zika" post="virus, microcephaly, Guillain-Barre Syndrome (GBS). http://www.who.int/emergencies/zika-virus/situation-report/en/ 22.KrauerFRiesenMReveizLOladapoOTMartÄ±nez-VegaRPorgoTVZika virus infection"/>
   <result pre="and Guillainâ€&quot;Barre syndrome: systematic reviewPLoS Med2017141e100220310.1371/journal.pmed.100220328045901 23.WHO Situation Report (2016)" exact="Zika" post="virus, microcephaly, Guillain-Barre Syndrome (GBS). http://www.who.int/emergencies/zika-virus/situation-report/en/http://apps.who.int/iris/bitstream/10665/254714/1/zikasitrep10Mar17-eng.pdf?ua=1 24.Centers for Disease"/>
   <result pre="Human Retrovirol 18:S25â€&quot;S29 30.Centers for Disease Control and Prevention (2016)" exact="Zika" post="virusÂ â€&quot; transmissions and risk. https://www.niaid.nih.gov/diseases-conditions/zika-vaccines 31.Powell J (2016)"/>
   <result pre="C, Foley BT, Alrabaa SF, Wills T, Sinnott JT (2015)" exact="Zika" post="virus In: Global virology I Springer Publications, pp 477â€&quot;500"/>
   <result pre="42.HayesEBZika virus outside AfricaEmerg Infect Dis20091591347135010.3201/eid1509.09044219788800 43.FoyBDKobylinskiKCFoyJLBlitvichBJTravassosAHaddowADLanciottiRSTeshRBProbable non-vector-borne transmission of" exact="Zika" post="virus, Colorado, USAEmerg Infect Dis201117588088210.3201/eid1705.10193921529401 44.Centers for Disease Control"/>
   <result pre="USAEmerg Infect Dis201117588088210.3201/eid1705.10193921529401 44.Centers for Disease Control and Prevention (2016)" exact="Zika" post="virus in the United States, 2015-2016 45.AnthonySMorensDMZika virus in"/>
   <result pre="species and on human healthEcol Lett20058555857410.1111/j.1461-0248.2005.00755.x17637849 50.HeymannDLLiuJLillywhiteLPartnerships, not parachutists, for" exact="Zika" post="researchN Engl J Med2016374161504150510.1056/NEJMp160227826958936 51.Brasil P, Pereira JP Jr,"/>
   <result pre="P, Pereira JP Jr, Raja Gabaglia C et al (2016)" exact="Zika" post="virus infection in pregnant women in Rio de Janeiroâ€&quot;preliminary"/>
   <result pre="10.1056/NEJMoa1602412 52.Meaney-Delman D, Rasmussen SA, Staples JE et al (2016)" exact="Zika" post="virus and pregnancy: what obstetric health care providers need"/>
   <result pre="Keshavarz E, Poretti A, Hazin AN (2016) Neuroimaging findings of" exact="Zika" post="virus infection: a review article. Jpn J Radiol. doi:10.1007/s11604-016-0588-5"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7122139\results\search\tropicalVirus\results.xml">
   <result pre="Pertussis Arboviral neuroinvasive and nonneuroinvasive diseases (e.g., St. Louis encephalitis," exact="West Nile" post="virus disease) Plague Botulism Poliomyelitis, paralytic and nonparalytic Brucellosis"/>
   <result pre="Syphilis Malaria Varicella (morbidity or mortality) Measles Vibriosis Meningococcal disease" exact="Yellow fever" post="Mumps Surveillance Surveillance is the systematic collection of data"/>
   <result pre="or environmental factors (surveillance of dead birds in association with" exact="West Nile" post="disease) (Patnaik et al., 2007). A more detailed discussion"/>
   <result pre="syndrome on aircraftN. Engl. J. Med.20033492416242210.1056/NEJMoa03134914681507 PatnaikJ.LJuliussonLVogtR.LEnvironmental predictors of human" exact="West Nile" post="virus infections, ColoradoEmerg. Infect Dis2007131788179018217573 PronovostP.NeedhamD.BerenholtzS.SinopoliD.ChuH.CosgroveS.SextonB.HyzyR.WelshR.RothG.BanderJ.KeprosJ.GoeschelC.An intervention to decrease"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7122166\results\search\tropicalVirus\results.xml">
   <result pre="therapy is lacking in most cases. Other New Virulent Viruses" exact="Zika" post="virusâ€&quot;newly discovered flavivirus in South America, with mild to"/>
   <result pre="European encephalitis viruses Venezuelan equine encephalitis virus Moderate to severe" exact="Yellow fever" post="virus Africa, America Moderate to severe Semliki Forest virus"/>
   <result pre="to severe Semliki Forest virus Africa, epidemic Mild to fatal" exact="Dengue" post="virus All tropical-subtropical areas Mild to fatal Japanese B"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7122297\results\search\tropicalVirus\results.xml">
   <result pre="popularity of LAMP starts only after 2003 following emergence of" exact="West Nile" post="and SARS viruses. This technique was first described and"/>
   <result pre="Coltivirus; respiratory syncytial virus (Ushio et al. 2005); flavivirus causing" exact="West Nile" post="fever (Parida et al. 2004); enterovirus 71 (Shi et"/>
   <result pre="that of RT-PCR, with a detection limit of 0.1 PFU." exact="Dengue" post="virus is a mosquito-borne flavivirus and the most widely"/>
   <result pre="developed real-time reverse transcription LAMP method for rapid detection of" exact="West Nile" post="virus by using envelope gene of West Nile (WN)"/>
   <result pre="detection of West Nile virus by using envelope gene of" exact="West Nile" post="(WN) virus. Suebsing et al. (2011) developed reverse transcription"/>
   <result pre="ParidaMPosadasGInoueSHasebeFMoritaKReal-time reverse transcription loop-mediated isothermal amplification for rapid detection of" exact="West Nile" post="virusJ Clin Microbiol200442125714715762 ParidaMMHoriokeKIshidaHDashPKSaxenaPJanaAMIslamMAInoueSHosakaNMoritaKRapid detection and differentiation of dengue"/>
   <result pre="virusJ Clin Microbiol2006444172417817005741 ParidaMMSanthoshSRDashPKTripathiNKLakshmiVMamidiNShrivastvaAGuptsNSaxenaPPardeep BabuJLakshmana RaoPVMoritaKRapid and real-time detection of" exact="Chikungunya" post="virus by reverse transcription loop-mediated isothermal amplification assayJ Clin"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7122369\results\search\tropicalVirus\results.xml">
   <result pre="on NVCP, HBV core antigen (HBcAg), and enveloped protein of" exact="West Nile" post="virus [31]. VLP based on NVCP is one of"/>
   <result pre="Biotechnol. J.2010852552820500680 128.LaiHet al.Monoclonal antibody produced in plants efficiently treats" exact="West Nile" post="virus infection in miceProc. Natl. Acad. Sci. U.S.A.20101072419242420133644 129.LaiHHeJEngleMDiamondMSChenQRobust"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7122539\results\search\tropicalVirus\results.xml">
   <result pre="in serum and whole bloodClin Vaccine Immunol2008151596310.1128/CVI.00218-0718003814 75.YapGPokKYLaiYLet al.Evaluation of" exact="Chikungunya" post="diagnostic assays: differences in sensitivity of serology assays in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7122560\results\search\tropicalVirus\results.xml">
   <result pre="socioeconomic, political and behavioral barriers remains to be overcome. Keywords" exact="West Nile" post="Virus Rabies Virus Hepatitis Delta Virus Lassa Fever Central"/>
   <result pre="hundred cases), St. Louis encephalitis virus infection (1975, 3,000 cases)," exact="West Nile" post="virus (encephalitis or meningitis, 2,800 cases in 2003 and"/>
   <result pre="families of viruses, HSV-1 and HSV-2, and several subtypes of" exact="HPV" post="are common causes of conditions of the genital tract."/>
   <result pre="25 years of age [83]. The two major manifestations of" exact="HPV" post="infection are genital warts and squamous cell neoplasia. HPV"/>
   <result pre="of HPV infection are genital warts and squamous cell neoplasia." exact="HPV" post="types 6 and 11 and less frequently other types"/>
   <result pre="1 % of the women developed warts each year [86]." exact="HPV" post="types 16 and 18 and less frequently other types"/>
   <result pre="a minority of women carrying those specific types. Annually worldwide," exact="HPV" post="causes about 500,000 cases of cervical cancer and ten"/>
   <result pre="delta virus, HEV hepatitis E virus, HIV human immunodeficiency virus," exact="HPV" post="human papilloma virus, HTLV-I/HTLV-II human T-lymphotropic virus type I/human"/>
   <result pre="to be transmissible by transfusion (HBV, HIV-1/HIV-2, HCV, HTLV-I/HTLV-II, and" exact="West Nile" post="virus), the US Food and Drug Administration has orchestrated"/>
   <result pre="that appear to provide unexpectedly high protection (e.g., HBV and" exact="HPV" post="vaccines). In the case of hepatitis A, both inactivated"/>
   <result pre="against measles and rubella by 2020 and plans for administering" exact="HPV" post="vaccine to 180,000 preadolescent girls in the first phase"/>
   <result pre="data synthesis and meta-analysisInt J infect Dis201317e2723059625 22.JohanssonMAArana-VizcarrondoNBiggerstaffBJStaplesJEIncubation periods of" exact="Yellow fever" post="virusAm J Trop Med Hyg201083183820595499 23.Center for Food Security"/>
   <result pre="http://www.cdc.gov/std/stats/STI-Estimates-Fact-Sheet-Feb-2013.pdf. Accessed 13 Apr 2013. 84.Sexually Transmitted Diseases (STDs): genital" exact="HPV" post="infection. 2013. At: http://www.cdc.gov/std/HPV/STDFact-HPV.htm#a5. Accessed 14 Apr 2013, 85.KjaerSKTranTNSparenPet"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7122844\results\search\tropicalVirus\results.xml">
   <result pre="was the first evidence of an animal pathogenic virus. Keywords" exact="West Nile" post="Virus Tobacco Mosaic Virus Rabies Virus Classical Swine Fever"/>
   <result pre="pigs and, via these intermediate hosts, also humans. Birds carried" exact="West Nile" post="virus from Africa to North America, and avian flu"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7122895\results\search\tropicalVirus\results.xml">
   <result pre="in Table 17.1. It includes mosquito-borne infections (malaria, dengue fever," exact="Zika" post="virus, chikungunya virus, and Japanese encephalitis), mite-borne scrub typhus"/>
   <result pre="and rash with a relatively short incubation period (&amp;lt;21 days)" exact="Dengue" post="fever (flavivirus) Zika virus (flavivirus) Chikungunya virus and other"/>
   <result pre="a relatively short incubation period (&amp;lt;21 days) Dengue fever (flavivirus)" exact="Zika" post="virus (flavivirus) Chikungunya virus and other uncommon alphaviruses Scrub"/>
   <result pre="incubation period (&amp;lt;21 days) Dengue fever (flavivirus) Zika virus (flavivirus)" exact="Chikungunya" post="virus and other uncommon alphaviruses Scrub typhus (Orientia tsutsugamushi)"/>
   <result pre="U/L (8â€&quot;37 U/L). Antibody tests for dengue virus, chikungunya virus," exact="Zika" post="virus, and leptospirosis were sent to the US Centers"/>
   <result pre="test came back positive. Antibody tests for dengue, chikungunya, and" exact="Zika" post="viruses were negative. Table 17.2 Laboratory values Test name"/>
   <result pre="Negative Malaria smear (Giemsa), thick and thin smears Negative Negative" exact="Dengue" post="fever Ab, IgG Negative Negative Dengue fever Ab, IgM"/>
   <result pre="thin smears Negative Negative Dengue fever Ab, IgG Negative Negative" exact="Dengue" post="fever Ab, IgM Negative Negative Chikungunya Ab, IgG Negative"/>
   <result pre="Ab, IgG Negative Negative Dengue fever Ab, IgM Negative Negative" exact="Chikungunya" post="Ab, IgG Negative Negative Chikungunya Ab, IgM Negative Negative"/>
   <result pre="fever Ab, IgM Negative Negative Chikungunya Ab, IgG Negative Negative" exact="Chikungunya" post="Ab, IgM Negative Negative Leptospira Ab, IgM Positive Negative"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7122901\results\search\tropicalVirus\results.xml">
   <result pre="date, there are no data on antiviral efficacy against bocavirus." exact="Chikungunya" post="Virus Chikungunya virus, a mosquito-borne alphavirus transmitted by Aedes"/>
   <result pre="are no data on antiviral efficacy against bocavirus. Chikungunya Virus" exact="Chikungunya" post="virus, a mosquito-borne alphavirus transmitted by Aedes aegypti and"/>
   <result pre="vaccination, the usual duration of viral shedding in stool [182]." exact="West Nile" post="Virus West Nile virus (WNV) was initially isolated from"/>
   <result pre="duration of viral shedding in stool [182]. West Nile Virus" exact="West Nile" post="virus (WNV) was initially isolated from a febrile patient"/>
   <result pre="(WNV) was initially isolated from a febrile patient in the" exact="West Nile" post="Province in Uganda in the 1930s and has been"/>
   <result pre="approximately 80% of infections are asymptomatic, 20% of patients develop" exact="West Nile" post="fever, characterized by fever, malaise, anorexia, nausea, myalgias, headache,"/>
   <result pre="in a patient with meningoencephalitis should raise the suspicion of" exact="WNV" post="infection. MRI may demonstrate meningeal or periventricular enhancement, sometimes"/>
   <result pre="months to 10 years posttransplant [185, 199â€&quot;202]. A study of" exact="WNV" post="infection during an outbreak in Toronto noted that liver,"/>
   <result pre="more likely to develop meningoencephalitis in the setting of acute" exact="West Nile" post="virus infection than immunocompetent hosts, perhaps with a higher"/>
   <result pre="negative in CSF and blood in most cases. Diagnosis of" exact="WNV" post="infection was made by PCR performed on serum and"/>
   <result pre="serum and CSF. All of the described patients died. Diagnosisof" exact="WNV" post="infection in immunocompetent hosts may be made serologically or"/>
   <result pre="no antiviral agents that have proven efficacy in thetreatment of" exact="WNV" post="infection. Ribavirin possesses in vitro activity but demonstrates poor"/>
   <result pre="[184, 210, 211]. A report of successful treatment of donor-transmitted" exact="WNV" post="infection in a liver transplant recipient by reducing immunosuppression"/>
   <result pre="been published [212]. Overall case fatality rates of infection with" exact="WNV" post="are 4â€&quot;20% [189, 192], with significantly higher rates in"/>
   <result pre="severity of initial clinical presentation does not predict theprognosis of" exact="WNV" post="infection [187, 190, 213]. Survivors frequently suffer from prolonged"/>
   <result pre="[214]. Transplant recipients should be educated about the transmission of" exact="West Nile" post="virus and urged to remove any stagnant water collections"/>
   <result pre="of the immunocompromised hostClin Infect Dis2014583091810.1093/cid/cit81624421306 183.GublerDJThe continuing spread of" exact="West Nile" post="virus in the western hemisphereClin Infect Dis20074510394610.1086/52191117879923 184.PlanitzerCBModrofJKreilTRWest Nile"/>
   <result pre="US plasma-derived immunoglobulin productsJ Infect Dis20071964354010.1086/51939217597458 185.NashDMostashariFFineAet al.The outbreak of" exact="West Nile" post="virus infection in the New York City area in"/>
   <result pre="optionsAnn Intern Med20041405455310.7326/0003-4819-140-7-200404060-0001515068983 187.FergusonDDGershmanKLeBaillyAet al.Characteristics of the rash associated with" exact="West Nile" post="virus feverClin Infect Dis2005411204710.1086/44450616163642 188.SejvarJJThe long-tern outcomes of human"/>
   <result pre="Nile virus feverClin Infect Dis2005411204710.1086/44450616163642 188.SejvarJJThe long-tern outcomes of human" exact="West Nile" post="virus infectionClin Infect Dis20074416172410.1086/51828117516407 189.BodeAVSejvarJJPapeJet al.West Nile virus disease:"/>
   <result pre="in 2003Clin Infect Dis20064212344010.1086/50303816586381 190.SejvarJJHaddadMBTierneyBCet al.Neurologic manifestations and outcome of" exact="West Nile" post="virus infectionJAMA2003290511510.1001/jama.290.4.51112876094 191.PaddockCDNicholsonWLBhatnagerJet al.Fatal hemorrhagic fever caused by West"/>
   <result pre="West Nile virus infectionJAMA2003290511510.1001/jama.290.4.51112876094 191.PaddockCDNicholsonWLBhatnagerJet al.Fatal hemorrhagic fever caused by" exact="West Nile" post="virus in the United StatesClin Infect Dis20064215273510.1086/50384116652309 192.Centers for"/>
   <result pre="Dis20064215273510.1086/50384116652309 192.Centers for Disease Control and Prevention (CDC). Possible dialysis-related" exact="West Nile" post="virus transmission-Georgia, 2003. MMWR Morb Mortal Wkly Rep. 2004;53:738â€&quot;9."/>
   <result pre="2003. MMWR Morb Mortal Wkly Rep. 2004;53:738â€&quot;9. 193.IwamotoMJerniganDBGuaschAet al.Transmission of" exact="West Nile" post="virus from an organ donor to four transplant recipientsN"/>
   <result pre="194.Centers for Disease Control and Prevention (CDC). Public health dispatch:" exact="West Nile" post="virus infection in organ donor and transplant recipients-Georgia and"/>
   <result pre="195.Centers for Disease Control and Prevention (CDC). Update: investigations of" exact="West Nile" post="virus infections in recipients of organ transplantation and blood"/>
   <result pre="Disease Control and Prevention (CDC). Public health dispatch: investigations of" exact="West Nile" post="virus infections in recipients of blood transfusions. MMWR Morb"/>
   <result pre="recipients: another high-risk group for meningoencephalitis and deathTransplantation200477466910.1097/01.TP.0000101434.98873.CB14966429 201.KumarDPrasadGVZaltzmanJet al.Community-acquired" exact="West Nile" post="virus infection in solid-organ transplant recipientsTransplantation20047739940210.1097/01.TP.0000101435.91619.3114966414 202.Kleinschmidt-DeMastersBKMarderBALeviMEet al.Naturally acquired"/>
   <result pre="Nile virus infection in solid-organ transplant recipientsTransplantation20047739940210.1097/01.TP.0000101435.91619.3114966414 202.Kleinschmidt-DeMastersBKMarderBALeviMEet al.Naturally acquired" exact="West Nile" post="virus encephalitis in transplant recipients: clinical, laboratory, diagnostic, and"/>
   <result pre="clinical, laboratory, diagnostic, and neuropathological featuresArch Neurol20046112102010.1001/archneur.61.8.121015313837 203.PennRGGuarnerJSejvarJJet al.Persistent neuroinvasive" exact="West Nile" post="virus infection in an immunocompromised patientClin Infect Dis200642680310.1086/50021616447115 204.HongDSJacobsonKLRaadIIet"/>
   <result pre="and literature reviewClin Infect Dis2003371044910.1086/37827814523768 205.HiattBDesjardinLCarterTet al.A fatal case of" exact="West Nile" post="virus infection in a bone marrow transplant recipientClin Infect"/>
   <result pre="marrow transplant recipientClin Infect Dis200337e1293110.1086/37889114557983 206.TilleyPAFoxJDJayaramanGCet al.Nucleic acid testing for" exact="West Nile" post="virus RNA in plasma enhances rapid diagnosis of acute"/>
   <result pre="acute infection in symptomatic patientsJ Infect Dis20061931361410.1086/50357716619182 207.JordanIBrieseTFischerNet al.Ribavirin inhibits" exact="West Nile" post="virus replication and cytopathic effect in neural cellsJ Infect"/>
   <result pre="of intravenous immunoglobulin therapy in a lung transplant recipient with" exact="West Nile" post="virus encephalitisTranspl Infect Dis20024160210.1034/j.1399-3062.2002.01014.x12421462 209.Ben-NathanDLustigSTamGet al.Prophylactic and therapeutic efficacy"/>
   <result pre="al.Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating" exact="West Nile" post="virus infection in miceJ Infect Dis200318851210.1086/37687012825165 210.MakhoulBBraunEHerskovitzMet al.Hyperimmune gammaglobulin"/>
   <result pre="miceJ Infect Dis200318851210.1086/37687012825165 210.MakhoulBBraunEHerskovitzMet al.Hyperimmune gammaglobulin for the treatment of" exact="West Nile" post="Virus encephalitisIsr Med Assoc J200911151319544704 211.CarsonPJKonewkoPWoldKSet al.Long-term clinical and"/>
   <result pre="Med Assoc J200911151319544704 211.CarsonPJKonewkoPWoldKSet al.Long-term clinical and neuropsychological outcomes of" exact="West Nile" post="virus infectionClin Infect Dis2006437233010.1086/50693916912946 212.MorelliMCSambriVGraziGLet al.Absence of neuroinvasive disease"/>
   <result pre="of neuroinvasive disease in a liver transplant recipient who acquired" exact="West Nile" post="Virus (WNV) infection from the organ donor and who"/>
   <result pre="Virus (WNV) infection from the organ donor and who received" exact="WNV" post="antibodies prophylacticallyClin Infect Dis201051e34710.1086/65514620597692 213.MartinJEPiersonTCHubkaSet al.A West Nile virus"/>
   <result pre="and who received WNV antibodies prophylacticallyClin Infect Dis201051e34710.1086/65514620597692 213.MartinJEPiersonTCHubkaSet al.A" exact="West Nile" post="virus DNA vaccine induces neutralizing antibody in healthy adults"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7122971\results\search\tropicalVirus\results.xml">
   <result pre="and contact with other animals (zoonosis). Keywords Respiratory Syncytial Virus" exact="West Nile" post="Virus Tobacco Mosaic Virus Dengue Virus Yellow Fever Definition"/>
   <result pre="Keywords Respiratory Syncytial Virus West Nile Virus Tobacco Mosaic Virus" exact="Dengue" post="Virus Yellow Fever Definition of a Virus Although viruses"/>
   <result pre="Papilloma virus-16 and dengue virus (ICTVdB picture gallery with permission)." exact="Dengue" post="virus is an enveloped virus AndrÃ© Lwoff, a French"/>
   <result pre="the best studied cases include yellow fever, dengue virus, and" exact="West Nile" post="feverâ€&quot;viruses all transmitted by mosquitoes. The many modes by"/>
   <result pre="vomiting, gastric pain Insect transmission by mosquitoes Dengue, yellow fever," exact="West Nile" post="fever High fever, hemorrhagic fever, internal bleeding Sexual transmission"/>
   <result pre="through the fecal-oral route and are discussed separately. Insect Route" exact="Dengue" post="virus is a leading cause of illness and death"/>
   <result pre="slow pace of transport and limited travel at that time." exact="Dengue" post="has emerged as a worldwide problem since the 1950s,"/>
   <result pre="a similar pattern of infection for the yellow fever virus." exact="West Nile" post="Virus is among the most common mosquito-borne viruses in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7123112\results\search\tropicalVirus\results.xml">
   <result pre="between 1980 and 2017 Newly emerging Re-emerging Deliberately emerging HIV" exact="West Nile" post="virus Anthrax (bioterrorism) Cryptosporidiosis Methicillin-resistant Staph aureus Hepatitis C"/>
   <result pre="coli O157:H7 Human monkeypox E coli O104:H4 Plague H1N1 influenza" exact="Chikungunya" post="fever H5N1 influenza Cholera H7N9 influenza Human African trypanosomiasis"/>
   <result pre="H5N1 influenza Cholera H7N9 influenza Human African trypanosomiasis H3N2v influenza" exact="Yellow fever" post="SARS Dengue MERS-CoV Adenovirus SFTSV bunyavirus Listeriosis Hantavirus pulmonary"/>
   <result pre="H7N9 influenza Human African trypanosomiasis H3N2v influenza Yellow fever SARS" exact="Dengue" post="MERS-CoV Adenovirus SFTSV bunyavirus Listeriosis Hantavirus pulmonary syndrome Ebola"/>
   <result pre="Adenovirus SFTSV bunyavirus Listeriosis Hantavirus pulmonary syndrome Ebola hemorrhagic fever" exact="Zika" post="virus Drug resistant malaria Nipah virus Diphtheria Hendra virus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="ami_virus_1\PMC7123295\results\search\tropicalVirus\results.xml">
   <result pre="also be quick to control. The emergence of the 2015" exact="Zika" post="virus epidemic in Brazil took the global community by"/>
   <result pre="is another example of the risks of a zoonotic disease." exact="Zika" post="was first identified in Uganda in 1947 in rhesus"/>
   <result pre="have been infected with the virus. Despite the fact that" exact="Zika" post="itself is very rarely fatal, there has been growing"/>
   <result pre="observed an increase in Guillain-BarrÃ© syndrome , which coincided with" exact="Zika" post="virus infections in the general public. These concerns culminated"/>
   <result pre="These concerns culminated in the WHO declaring, in February 2016," exact="Zika" post="â€œa Public Health Emergency of International Concernâ€� (WHO 2016)."/>
   <result pre="Resources slated for Ebola is being reallocated to fight the" exact="Zika" post="virus. Money was raised rapidly from the international communi"/>
  </snippets>
 </snippetsTree>
</projectSnippetsTree>
